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Abstract 
Studies of respiratory disease in different populations of horses were undertaken, 
including a case control study, using clinically apparent respiratory disease in 
Thoroughbred racehorses as the case definition. Controls were matched on date and 
training yard and data were analysed using conditional logistic regression. Disease was 
statistically associated with several infectious and non-infectious risk factors. Younger 
horses, those entering training within the last 3 months and those with 
ActinobacilluslPasteurella spp. or Mycoplasma felis isolated from the trachea were at 
increased risk of clinical disease. When all controls with sub-clinical disease were 
excluded, tracheal Streptococcus zooepidemicus infection was significantly associated 
with disease. 
An experimental bacterial vaccine against S. zooepidemicus and Actinobacillus 
spp. was evaluated for its effect on natural respiratory disease in Welsh Mountain pony 
foals using a blinded, randomised, controlled trial. Weekly examinations were conducted 
in 29 ponies, of which 12 received vaccine, 12 received placebo and 5 were untreated. 
Data were analysed using a multilevel modeling approach, with autoregressive variables to 
adjust for significant effects of disease in previous time periods. Tracheal infection with S. 
zooepidemicus was a significant risk factor for aggregated clinical scores and clinical signs 
of nasal discharge, cough and dyspnoea. There was evidence for a significant dose 
response between S. zooepidemicus infection and dyspnoea and inflammatory airway 
disease. Both pony-level and observation-level analyses demonstrated significant variation 
in clinical scores between ponies with transferrin haplotypes D or F2. 
Tracheal and nasopharyngeal isolates of S. zooepidemicus from the ponies in the 
vaccination study were typed by polymerase chain reaction of the hypervariable region of 
the M-protein (5 possible types) and the 16S-23S RNA gene intergenic spacer (8 possible 
types). More S. zooepidemicus types were isolated from the trachea than the 
nasopharynx. There was evidence for clonal succession of types over time and novel S. 
zooepidemicus types were identified. There were apparent differences in the strength of 
association of different S. zooepidemicus types with respiratory disease in these ponies 
during the study period. 
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Preface 
This thesis comprises 6 sections with chapters within each section. Sections 
include the introduction, descriptions of a case control study of clinical respiratory disease 
in racehorses, a study of natural respiratory disease in Welsh Mountaion pony foals, a 
study of the molecular epidemiology of Streptococcus zooepidemicus infection in the 
ponies, conclusions and future work and references and appendices. 
The first introduction section is a single chapter which provides an overview of 
equine respiratory disease and its research at the AHT and selective reviews of clinical 
signs of respiratory disease in the horse, the iron-binding protein transferrin and typing of 
the bacterium S. zooepidemicus. 
The subsequent 3 sections describe the different studies and comprise 4 chapters 
each of introduction, materials and methods, results and discussion. The introduction 
chapters provide a brief background and aims for each study. The materials and methods 
chapters describe the equine populations, sampling strategies, laboratory methods and 
statistical approaches adopted. The results chapters summarise results of statistical 
analyses but with the quantity of presented data limited wherever possible and the 
discussion chapters discuss the relevance of these results to current knowledge of equine 
respiratory disease. 
The penultimate section surnmarises conclusions for each study and discusses what 
I future work is required from them. The final section of references and appendices includes 
the results of the majority of statistical analyses, which are not presented in the results 
chapters. 
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CHAPTERI 
INTRODUCTION 
1.1 Overview 
1.1.1 Significance of respiratory disease to equine morbidity 
It has been increasingly recognised across the world that respiratory disease is an 
important cause of morbidity in horses and ponies. A study of the demography and 
diseases of the equine population of Scotland and the 5 northernmost English counties 
identified that respiratory disease was the second most common health problem after 
lameness (Mellor, 1997). The findings of the importance and impact of respiratory disease 
in that study was in broad agreement with those of other recent demographic studies of 
different types of horses in North America (Kaneene et aL, 1997; Gross el aL, 2000). In 
addition, studies on the causes of racehorses failing to achieve optimal training and racing 
performance (so-called racehorse 'wastage') conducted in the UK, Australia, New 
Zealand, South Mrica and Germany have consistently reported respiratory disease as the 
second most common cause of wastage after lameness (Jeffcott el aL, 1982; Rossdale el 
aL, 1985; Bailey et aL, 1999). 
Although case-specific mortality rates for most respiratory diseases are much less 
than for other conditions such as colic or catastrophic orthopaedic injury (Kaneene el aL, 
1997), respiratory illness frequently clusters in both time and space, often resulting in 
many horses being affected simultaneously. Respiratory disease of different types occurs 
in horses of different ages and in individual horses is frequently chronic and recurrent in 
nature. Respiratory infections are more common in younger animals and can recur over 
many months. Chronic allergic respiratory disease is more common in older horses and 
frequently recurs following repeated exposure to environmental factors. 
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Respiratory disease, therefore, contributes to a considerable proportion of equine 
morbidity and in some cases, mortality. Consequently, research that contributes to a better 
understanding of the reasons for and ultimately ways of reducing such morbidity and 
mortality is ethically justified. It is with this common and fundamental aim of improving 
equine welfare that studies of respiratory disease in horses, over many years and in many 
forms, have been conducted at the Animal Health Trust (AHT) in Newmarket. 
1.1.2 Previous equine respiratory disease research at the AHT 
The AHT, as a dedicated equine research organisation, has long recognised the 
importance of respiratory disease in horses and the extensive and varied work conducted 
by its clinicians and researchers over several decades is testament to this. 
Bob Cook was one of the first clinicians to report on using flexible endoscopes for 
the examination of the equine upper respiratory tract (Cook, 1974c). His work using 
endoscopy included characterising many different conditions of the upper respiratory tract 
(Cook, 1974c; Cook & Littlewort, 1974) including laryngeal herniplegia, for which he was 
awarded a PhD in 1974 (Cook, 1974b). In addition, he identified that blood observed at 
the nostrils (epistaxis) in racehorses actually originated from the lungs in these animals and 
he postulated that this condition may have been causally associated with chronic allergic 
lung disease (Cook, 1974a). He also contributed to descriptions (Cook, 1976) and 
aetiological hypotheses (Cook & Rossdale, 1963) of this chronic allergic disease, which 
was subsequently termed 'chronic obstructive pulmonary disease' or COPD (Muylle & 
Oyaert, 1973) and has since been re-termed 'recurrent airway obstruction' or RAO 
(Robinson, 2001). 
David Powell, an equine epidemiologist, based at the AHT and supported by 
laboratory services provided by the Animal Virus Research Institute and the Royal 
Veterinary College, conducted investigations of outbreaks of suspected infectious 
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respiratory disease in racehorses between 1971 and 1976 (Powell, 1976; Powell et aL, 
1978; Wood, 1999). These investigations confirmed equine influenza as an important 
cause of respiratory disease (Powell el aL, 1974b; Powell, 1975) and suggested that 
equine herpes virus (EHV) was associated with around half of respiratory disease 
outbreaks in racehorses (Powell el aL, 1974a; Powell, 1975; Powell et aL, 1978). There 
were also attempts made at this time to demonstrate the role of bacteria and mycoplasma 
in outbreaks of respiratory disease (Allam et aL, 1973; Allarn & Lemcke, 1975) but no 
significant association was detected, possibly due to the inappropriate site of sampling in 
the upper rather than lower respiratory tract (Windsor, 1973). 
Dr Jenny Mumford has been head of the equine virology unit (EVU) at the AHT 
since it was established in 1981 following an outbreak of paralytic EHV-1 infection on a 
Newmarket stud and an equine influenza epidemic that disrupted racing, both in 1979. 
The unit was set up to provide dedicated diagnostic services to the United Kingdom's 
equine industry, a role it continues to play to this day. Research in the EVU at the AHT 
has since contributed hugely to many aspects of equine respiratory virology, including 
improved knowledge of the epidemiology, immunology and pathogenesis of influenza, 
EHV and equine viral arteritis (EVA). This has led to improvements in management of 
outbreaks of viral-associated diseases and most importantly in preventive strategies, 
particularly through vaccination. 
In addition to research on equine respiratory viruses, work at the AHT under 
I Jenny Mumford has also re-examined the role of other organisms in different forms of 
respiratory disease in horses. Mike Burrell initiated this in the 1980s with the first use of 
flexible endoscopes to examine and sample horses' distal. tracheas (Burrell, 1995; Burrell 
et aL, 1986b). Through Burrell's observations, in conjunction with detailed cytological 
(Whitwell & Greet, 1984) and bacteriological (Burrell et aL, 1986a; 1986b; Wood et aL, 
1993a) examinations of tracheal lavages and subsequent analyses using appropriate 
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statistical methods (Wood et aL, 1993b), the distal airways have become recognised as the 
site of inflammatory airway disease (IAD) in young racehorses (Wood el aL, 1993a; 
Burrell et aL, 1994; 1996). IAD is characterised by endoscopically visible mucus and a 
cytologically evident neutrophilic inflammatory response (Whitwell & Greet, 1984; 
Burrell, 1985). A pilot longitudinal study in a Newmarket training yard suggested'that 
IAD was not necessarily associated with viral infections but may be associated with 
infection with several different species of bacteria and occurred in the absence of clinical 
signs such as coughing and nasal discharge (Burrell et aL, 1994; Burrell et aL, 1996). 
Results of these studies suggested the likely pathogenic potential of Streplococcus 
pneumoniae capsule type 3 (Burrell el aL, 1986b), which was confirmed in subsequent 
experimental challenge infection in ponies (Blunden et aL, 1991; 1994). Analyses 
demonstrated a significant association between IAD and infection with Streplococcus 
zooepidemicits and/or A clinobacilluslPasteurella spp. (Wood et aL, 1993 a). 
In late 1993, an outbreak of respiratory disease in a Newmarket training yard that 
was not attributable to recognised bacterial or viral infections, was associated with 
respiratory infection vvith Mycoplasma felis (Wood el aL, 1997a). Subsequently, a 
longitudinal study was conducted to specifically examine the role of bacteria, 
mycoplasmas and viruses in various forms of respiratory disease (nasal discharge and 
IAD) in racehorses (Wood, 1999). The results of the longitudinal study confirmed many 
of Burrell el al's findings; IAD was much more prevalent than upper respiratory tract 
disease as defined by nasal discharge and varied significantly with age, trainer and season 
of the year. Analyses suggested that the odds of IAD were approximately double in horses 
that were affected the previous month, consistent with horses, once they became affected, 
having IAD for an average of around 2 months. Results confirmed the association of IAD 
with various infections including S. zooepidemicus, ActinobacilluslPasteurella spp., S. 
pneumoniae, M equirhinis and EHV. Also, bacteria were much more important than 
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previously thought and their association with 1AD was not dependent on prior viral 
infection. 
During most of the period so far described there was very little work conducted to 
examine the epidemiology and aetiology of clinical presentations of respiratory disease in 
racehorses. There were limited reports of outbreaks of clinical upper respiratory tract 
(URT) disease associated with viral infections among Standardbred racehorses in Ontario, 
Canada (Sherman et aL, 1977; 1979). These studies identified that clinical disease was 
associated with infection with EHV-1 and equine influenza virus, particularly H7N7 
subtype but not with any bacterial species isolated from the URT (Sherman ef aL, 1977). 
Investigations also showed that URT disease decreased with age and outbreaks tended to 
recur when the proportion of the population of horses that had not previously been 
affected increased to 30%-40% (Sherman el al., 1979). 
During his time at the AHT Dr Neil Chanter contributed considerably to advances 
in understanding of the role of bacteria in equine respiratory disease. Much of this work 
was involved with infection by Streptococcus equi in equine 'strangles'. This work 
included recognition of the importance of asymptornatic carriers in strangles epidemiology 
(Wood el aL, 1993c; Newton el al., 1997a; 1997b; Newton el aL, 1999c; Chanter el aL, 
2000), the development of more sensitive methods of S. equi detection through 
discriminatory polymerase chain reaction (PCR) assays (Chanter el aL, 1997; 2000; 
Newton el aL, 2000b), development of carrier treatment regimens (Newton el al., 1999c; 
Verheyen el al., 2000) and use of modem molecular techniques in the identification and 
examination of specific virulence determinants (Chanter et aL, 1994; Chanter, 1998; 
Chanter et aL, 1999; 2000). The identification of S. equi virulence determinants has 
recently been considerably enhanced by the near completion of the sequencing of the 
entire genome of the strangles organism. This milestone in strangles research was made 
possible through a grant awarded by the Home of Rest for Horses to a collaborative 
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group that included Neil Chanter and should form the basis for development of the first 
truly efficacious strangles vaccines. In addition, Neil Chanter developed and described 
methods for the molecular subtyping of S. zooepidemicus (Chanter, 1997), techniques that 
have been subsequently applied to generate data that are analysed and presented in this 
thesis. Detailed typing of a subset of Actinobacillus and Pasteurella spp. isolated from 
tracheal washes demonstrated that presumptive typing tests were not sufficiently accurate 
in differentiating specific species of these organisms (Ward et aL, 1998; Wood, 1999). 
This finding has meant that Actinobacillus and Pasteurella spp. have been pooled for 
statistical purposes in the studies. 
Due to the more clinical emphasis of the studies in this thesis, the remainder of this 
section initially reviews clinical signs of respiratory disease in horses and considers the use 
of 'clinical scoring' to define disease outcome. Definitions and scoring of subclinical 
respiratory disease are then considered briefly. There were 2 particular areas of interest in 
the pony study. Aspects relevant to i) equine transferrin, an iron binding protein that may 
act as a source of iron for respiratory bacteria and ii) subtypes of the S. zooepidemicus 
bacterium, are both considered. Finally, the design & analysis of studies of respiratory 
disease in horses are briefly examined. 
1.2 Clinical signs of respiratory disease in horses 
Clinical signs that are most frequently and specifically associated with equine 
respiratory disease are reviewed here. Association of other signs, including reduced 
athletic performance, swelling of the distal limbs or abnormal haerhatological parameters 
with outbreaks of respiratory disease in racehorses has been largely anecdotal (Mumford 
& Rossdale, 1980). However, because of their lack of specificity to disease of the 
respiratory tract these signs will not be considered further here. 
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1.2.1 Pyrexia 
Although pyrexia (or fever) is not a sign that is specific to respiratory disease, it is 
frequently identified among a range of clinical signs demonstrated by horses with 
respiratory pathology and, therefore, warrants specific discussion. 
1.2.1.1 Physiology ofpyrexia 
Pyrexia describes the physiological rise in body temperature above the normal 
range, which for non-newbom horses is between 36.5 and 38.50C (Rose & Hodgson, 
1993). This occurs because of an increase in the hypothalan-ft thermoregulatory set point, 
most commonly in response to fever-producing substances known as pyrogens, which can 
be either endogenous or exogenous in origin (Guyton & Hall, 1996; Eckert el aL, 1988; 
Cunningham, 2002). Pyrexia is believed to be an evolutionary physiological adaptation to 
reduce morbidity and mortality from infections manifested through increasing leucocyte 
activity (Eckert et al., 1988; Cunningham, 2002). 
Exogenous pyrogens, which include bacterial endotoxins such as 
lipopolysaccharide complexes, frequently lead to the release of endogenous pyrogenic 
substances from leucocytes, which act directly on the hypothalamic temperature 
regulatory centre (Eckert et al., 1988). Endogenous pyrogens include interleukin-I (IL-1), 
turnour necrosis factor (TNF), interleukin-6 (IL-6), interferon QFN) and platelet 
activating factor and are involved in the acute stages of viral and bacterial diseases 
(Cunningham, 2002). In this mechanism of pyrexia, exogenous pyrogens appear to act 
indirectly by stimulation of the release of endogenous pyrogens and there is evidence in 
horses that successive administration of E. coli lipopolysaccharide endotoxin initiates 
tolerance (Allen el aL, 1996; Krurnrych et aL, 1998). 
Prostaglandins are also important components of the pathogenesis of fever and are 
produced by endothelial cells via the arachidonic acid cascade in response to exogenous 
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pyrogens and pathogenic challenge of the host. Endogenous pyrogens and prostaglandins 
act on a highly vacularised area of the hypothalamus known as the organa vasculosurn of 
the lamina terminalis which is in close proximity to large numbers of thermosensitive 
neurons. This results in inhibition of these thermosensitive neurons by reducing their firing 
rate and, therefore, causes the set point of the thermoregulatory centre to rise (Guyton & 
Hall, 1996; Cunningham, 2002). Elevation of this set point causes the animal to conserve 
and produce heat by mechanisms such as shivering, peripheral vasoconstriction and 
piloerection until the body temperature reaches the new higher set point. This is 
maintained until pyrogens and prostagandins are metabolised and their production ceases, 
at which stage the set point decreases to normal and the animal initiates mechanisms to 
lose heat such as peripheral vasodilation and sweating (Guyton & Hall, 1996; 
Cunningham, 2002). 
1.2.1.2 Riskfactorsfor pyrexia in respiratory disease of horses 
As already described, pyrexia is a cardinal feature of infectious processes in many 
mammalian species and this is especially true in the horse for diseases of the respiratory 
tract. There are many respiratory diseases of the horse for which pyrexia is a clinical 
feature and these include infections with different types of organisms such as bacteria, 
viruses, mycoplasma and fungi. There may also be related predisposing factors such as 
transportation, vaccination and other underlying pathological conditions. 
Bactefial infections 
Of the bacterial respiratory infections, Streplococcus equi, the cause of 'strangles', 
has been accepted as one of very few primary pathogens of the horse. Pyrexia has been 
reported as a clinical sign in most published outbreaks (Ebert, 1969; Piche, 1984; 
Timoney & Powell, 1988; Dalgleish et aL, 1993; Hamlen et aL, 1994; Fintl et aL, 2000; 
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Newton ef aL, 2000b). In addition, previously unpublished daily clinical data from an 
experimental S. equi challenge at the AHT, following intranasal inoculation of 10"' colony 
forming units (cfu) of 4-hour-old S. equi cultures in 7 susceptible Welsh Mountain ponies, 
confirmed marked and prolonged pyrexia, which was initiated within a short period of 
challenge (Figure 1.1). These data are consistent with continued exposure of ponies to 
pyrogens of bacterial origin over a number of weeks following infection. The pattern of 
prolonged pyrexia corresponded with the persistence ofS. equi infection identified in most 
of the group during the latter part of the period. 
Figure I. I: Mean daily rectal temperatures (± 95% confidence intervals) during an 
experimental S. equi infection in 7 susceptible Welsh Mountain ponies 
(controls) conducted at the AHT (pyrexia II defined as >38.5'C) 
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discharge or coughing (Burrell ef al., 1994,1996). In a study of pyrexia associated with 
respiratory signs in young Thoroughbreds, Burrell el al. (1994) found that the 
predominant organisms isolated from tracheal lavage samples were S. zooepidemicus, S. 
pieumonitte and Ptisleurellci spp., with most horses having bacterial counts ýý, 104 CfU/Ml Of 
tracheal wash. These observations corroborated results of experimental infections in 
horses with intravenously administered S. zooepidemicus (Varma el al., 1984) and 
endoscopically intratracheal administered S. pneumoniae (Blunden ef al., 1991; 1994). 
Figure 1.2 summarises mean daily rectal temperature data for 7 ponies experimentally 
challenged with 10ml of 10' cfu/ml of S. piieumotfiae (data courtesy of A. Blunden). 
These data show a much reduced duration of pyrexia compared to the S. equi challenge 
infection, with a mean rectal temperature >3 8.5'C on only 3 of 10 days after inoculation. 
Figure 1.2: Mean daily rectal temperatures (± 95% confidence intervals) during 
experimentalS. pneumoniae infections in 7 Welsh Mountain ponies 
conducted at the AHT (pyrexia II defined as >38.5'C) 
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In other animals, particularly foals or those being transported long distances, 
pyrexia may be associated with severe bacterial broncho- or pleuropneumonia, respiratory 
compromise and even death (Sweeney et aL, 1984; Bernard Strother & Mansmann, 1985; 
Sweeney et aL, 1985b; Mair & Yeo, 1987; Sweeney et aL, 1987a; Mair, 1989; Mair & 
Lane, 1989; Mair, 1991; Sweeney et aL, 1991; Hayakawa et aL, 1993; Oikawa el aL, 
1994; Mair, 1996a; Wiegand & Schusser, 1997). Rhodococcus equi, although not 
prevalent in the LTK, is recognised in foals in warm, dry climates as the cause of marked 
pyrexia associated with suppurative bronchopneurnonia (Smith & Robinson, 1981; Zinck 
et aL, 1986; Prescott et aL, 199 1; Hoffman et aL, 1993 c; Knottenbelt, 1993; Burks, 1996; 
Kolk et aL, 1999). In older animals pneumonia is usually associated with mixed infections 
involving both aerobic and facultatively anaerobic bacterial species (Mair & Yeo, 1987; 
Mair & Lane, 1989; Mair, 1991; Raidal, 1995; Mair, 1996a). Bacterial species associated 
with equine pneumonia include S. zooepidemicus, PasteurellaActinobaciffits spp., 
Enterobacteria spp., Pseudomonas spp., Bacteriodes spp., Slaphylococcus spp. and 
Bordefella bronchiseptica (Naglic el aL, 1982; Raphel & Beech, 1982; Sweeney el aL, 
1984; 1985b; Mair & Yeo, 1987; Mair & Lane, 1989; Racklyeft & Love, 1990; Bailey & 
Love, 1991; Mair, 1991; Sweeney et aL, 1991; Collins et aL, 1994; Mair, 1996a; 
Racklyeft & Love, 2000). Pyrexia associated with bronchopneumonia and, respiratory 
infection with Bordefella bronchiseplica has been described in horses (Koehne el aL, 
198 1; Bayly et aL, 1982). 
1 
Viral infection 
There are several important respiratory viral infections of horses that result in 
pyrexia among clinical signs. However, where infection occurs in partially immune horses, 
I most clinical signs including fever may be significantly attenuated, although these animals 
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may still be infected and hence potentially infectious to other individuals (Mumford, 
1998). 
Pyrexia with other clinical signs including harsh, dry cough, nasal discharge and 
occasional secondary bacterial pneumonia is a feature of natural outbreaks of equine 
influenza virus infection in naive horses (Gerber, 1970, Powell el cil., 1974b; Wood, 19911 
Powell el at, 1994, Newton & Mumford, 1995-, Powell el al., 1995, Newton ef al., 
1999a, 2000a). Experimental infections with equine influenza viruses have allowed 
specific clinical signs including pyrexia to be more precisely characterised with respect to 
time since infection (Hannant el aL, 1988; Mumford el al., 1990; 1994c, 1994d, Gross el 
ti[, 1998, Kastner el cil., 1999). Figure 1.3 summarises daily rectal temperature data for 
susceptible control ponies experimentally challenged with various influenza viruses at the 
AHT (data courtesy of J. Daly and L. Spencer). 
Figure 1.3: Mean daily rectal temperatures (± 95% confidence intervals) during 
experimental influenza virus infections in susceptible Welsh Mountain 
ponies (controls) conducted at the AHT (pyrexia defined as 
>38.50C) 
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Other significant respiratory viral pathogens of horses are equine herpes viruses- I and 
-4 (EHV-1 and EHV-4), both of which may have pyrexia as a charactenstic clinical sqpi in 
both natural (Doll & Bryans, 1963; Allen & Bryans, 1986, Fu el al., 1986, Ostlund, 19933, 
McCartan el aL, 1995, Murray el aL, 1998b) and experimental infections (Seahorn el ed., 
1990, Mumford et aL, 1994a; Sutton ef aL, 1998, Heldens el ciL, 200 1 ). Mean daily rectal 
temperature data from experimental infections (Figure 1-4) among susceptible Welsh 
Mountain ponies (controls) at the AHT have corroborated suggestions that EHV-1 
infection elicits more marked clinical signs than EHV-4 (Heldens el al., 2001) (data 
courtesy of J. Mumford). 
Figure 1.4: Mean daily rectal temperatures (± 95% confidence intervals) during 
experimental EHV-1 and EHV-4 infections in susceptible Welsh 
Mountain ponies (controls) conducted at the AHT (pyrexia 
defined as >38.5'C) 
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Pyrexia has also been observed in conjunction with respiratory signs during 
infections with equine arteritis virus in both natural (McCollum & Swerczek, 1978, 
Timoney & McCollum, 1990, Camm & Thursby Pelham, 1993, Monreal el aL, 1995, 
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Wood el al., 1995, Del Piero ef aL, 1997) and experimental infections (McCollum el al., 
1988,1995, Paweska el aL, 1996, Fukunaga ef aL, 1997, Castillo Olivares el aL, 2001). 
Figure 1.5 summarises mean daily rectal temperature data for 19 susceptible Welsh 
Mountain ponies (controls) experimentally challenged with equine arteritis virus at the 
AHT (data courtesy of J. Castillo-Olivares). These data show mean rectal temperatures 
>38.5'C between days 2 and 8 after infection, with mean temperatures returning to 
normal levels shortly before increases in virus neutralising antibody titres would usually 
occur, suggesting attenuation of pyrexia coinciding with immunity developing. 
Figure 1.5: Mean daily rectal temperatures (± 95% confidence intervals) during 
experimental EAV infections (day 0) in 19 susceptible Welsh Mountain 
ponies (controls) conducted at the AHT (pyrexia defined as 
>38.50C) 
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Pyrexia associated with respiratory infection by equine herpes virus-2 (EHV-2) 
has only been reported by one group (Palfi el al., 19781 1979) and the role of this gamma 
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herpesvirus in equine respiratory disease remains controversial and poorly understood 
(Studdert, 1996; Wood, 1999). 
Although both experimental and natural infection with equine rhinovirus-I (ERV- 
1) has been associated with pyrexia and other clinical respiratory signs (Plummer, 1962; 
Plummer & Kerry, 1962; Hofer el aL, 1973; Moraillon et aL, 1973; Powell, 1975; 
Studdert & Gleeson, 1978), infections with this virus are frequently subdinical (Hofer el 
aL, 1973; Studdert & Gleeson, 1978) as are infections with ERV-2 (Mumford & 
Thomson, 1978) 
Despite an outbreak of severe upper respiratory tract disease including pyrexia 
occurring in a group of horses in Canada in 1961 being attributed to infection with 
parainfluenza-3 (PI-3) virus and from which virus was isolated (Ditchfield el aL, 1963), 
there have been few subsequent reports of equine respiratory disease associated with PI-3 
infection. 
Infections with 'exotic' viruses may cause pyrexia and respiratory signs. Two of 
the most important of these are African horse sickness virus (Best el aL, 1975; Mellor et 
aL, 1990; Laegreid et al., 1992; 1993; Mellor, 1994; Skowronek et al., 1995; Sailleau et 
aL, 1997; Wohlsein et al., 1998) and Hendra virus, previously referred to as equine 
morbillivirus (Murray et aL, 1995; Hooper et aL, 1997; Murray el al., 1998a; Williamson 
el aL, 1998; Westbury, 2000). Neither of these infections has been identified in the UK 
and will not be considered further here. 
Mycoplasma infections 
Observations of acute respiratory disease in horses including pyrexia have 
suggested a possible aetiological role for mycoplasma species, particularly M equirhinis 
and M felis, although concurrent infection with other organisms could not be ruled out in 
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these studies (Antal el aL, 1988; 1989; Stipkovits et aL, 1990; Wood & Chanter, 1996; 
Carman et al., 1997; Wood el aL, 1997a). 
Mycoplasma felis has been specifically implicated in pyrexia associated with 
respiratory signs in horses subsequently diagnosed vAth pleuritis (Ogilvie et aL, 1983; 
Rosendal et aL, 1986; Hoffman et al., 1992a) and in one horse with pericarditis and 
pleuritis (Morley el aL, 1996). Experimental thoracic inoculation with M felis in a 
yearling pony produced fever and respiratory signs and the organism was recovered in 
large numbers from pleural exudate collected 4 days after inoculation (Ogilvie el aL, 
1983). Pyrexia was also observed in an outbreak of acute lower airway disease associated 
with M felis infection that occurred in young racehorses in training in Newmarket in 1993 
(Wood & Chanter, 1996; Wood et al., 1997a). 
Fungal and pneumocystis infections 
Respiratory disease in response to allergic reaction to fungal and mould antigens, 
now referred to as recurrent airway obstruction (RAO) and previously as chronic 
obstructive pulmonary disease (COPD), is prevalent among older horses and is not 
generally characterised by pyrexia (Robinson et aL, 1996; Robinson, 2001). In contrast, 
reports of fungal infections of the airways resulting in pyrexia and respiratory signs are 
rare, although there may be an underestimation of its occurrence as fungal pneumonia may 
be frequently misdiagnosed due to its clinical similarity to bacterial pneumonia (Nappert et 
aL, 1996; Carrasco et aL, 1997; Sweeney & Habecker, 1999). 
Although some horses with mycotic pneumonia may have had an overwhelming 
challenge (Ruoff, 1989; Carrasco el aL, 1997), others are as a result of prolonged courses 
of antibacterial treatment (Long & Mitchell, 1971; Pearson et al., 1983; Cornick, 1990; 
Pace el aL, 1994; Nappert et aL, 1996). Cases may be associated with various causes of 
immunocompromise including use of glucocorticoids (Green et aL, 1987; Nappert et al., 
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1996) pituitary adenoma (King, 1993) and myeloproliferative neoplasia (Blue el aL, 1987; 
Buechner-Maxwell el aL, 1994) or with presumptive dissemination from pre-existing 
intestinal pathology (Riley et aL, 1992; Johnson el aL, 1999). 
Specific reports of airway fungal infections associated with clinical presentation of 
pyrexia and other respiratory signs include a case of pulmonary histoplasmosis diagnosed 
by radiography and cytology of transtracheal. and lung aspirates (Cornick, 1990). A mare, 
previously treated for bacterial pneumonia, with prolonged pyrexia (up to 42"C) and 
ultrasonographically and radiographically apparent pneumonia also had large numbers of 
fungal hyphae on cytology of a transtracheal wash sample from which abundant colonies 
of Scopulariopsis spp. were also isolated (Nappert et al., 1996). Fatal invasive pulmonary 
mycosis by mixed infection with Aspergillus niger and Rhizopus stolonifer was reported 
in 3 Thoroughbreds with severe signs of pneumonia and pyrexia following housing in a 
disused, uncleaned stable (Carrasco et aL, 1997). Pyrexia and tachypnoea were also 
observed shortly prior to death in a horse with acute pulmonary Aspergillosis following 
abdominal surgery (Johnson et al., 1999). 
Pneumonia with infection with Pneumocystis carinii, as with humans, occurs most 
commonly in animals with acquired, inherited or drug-induced immunodeficiencies 
(Perryman et aL, 1978; Ewing et aL, 1994). Pyrexia with respiratory signs has been 
reported for equine Pneumocystis carinii pneumonia among Arabian foals with inherited 
combined immunodeficiency (Shively et aL, 1973; Perryman el aL, 1978), in a Quarter 
horse foal (Ewing et al., 1994) and Throughbred foals without evidence of 
immunosuppression (Whitwell, 1992; Peters el aL, 1994; Tanaka et aL, 1994). 
Other factors 
Various factors associated with transportation may be important in predisposing to 
respiratory disease with pyrexia in horses, a phenomenon commonly referred to as 
18 
Equme Influmatory Auway Diseme Epidmology 
'shipping fever' (Mair & Lane, 1989; Leadon el aL, 199 1; Hayakawa et aL, 1993; Oikawa 
et aL, 1994; Leadon, 1995; Oikawa et al., 1995). In addition to factors such as increased 
stress and associated immunosuppression and increased exposure to envirorunental 
irritants, an important factor is confinement of horses with their heads in an upright 
position. Maintaining horses with their heads in an upright position results in accumulation 
of airway secretions in the lower respiratory tract and consequently increases bacterial 
numbers by interfering with tracheal mucociliary transportation (Racklyeft et aL, 1991; 
Raidal el aL, 1995; 1996; 1997a; 1997c). 
There have been occasional reports of pyrexia and respiratory signs in horses 
shortly following vaccination, including with vaccines against equine influenza (Dixon el 
aL, 1996) and S. equi (Smith, 1994). However, such adverse reactions are less commonly 
reported with modern vaccines and when they occur they are frequently attributable to 
concurrent infection with another organism, such as EHV (Dixon et al., 1996) (AHT 
unpublished observations). 
There are a number of reports of pyrexia associated with respiratory signs in 
horses which are attributed to very unusual conditions and these include pleuropulmonary 
abscessation secondary to a gastric foreign body (Tremaine el aL, 1995), 
pleuropneumonia associated with pulmonary hydatidosis (McGorurn et aL, 1994), mitral 
regurgitation and congestive heart failure (Reef et aL, 1998) and iatragenic lipoid 
pneumonia secondary to inappropriate nasogastric deposition of mineral oil (Scarratt et 
aL, 1998). 
1.2.2 Nasal discharge 
The nares (or nostrils) are the most rostral anatomical site of the respiratory tract 
and so, by definition, signs of abnormal discharges that are observed at this location are 
usually indicative of some form of respiratory pathology. As the nares are anatomically 
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linked via the nasal passages and pharynx to the oesophagus and gastrointestinal tract, it is 
possible that abnormal nasal discharge may arise from a dysfunction of swallovving 
(dysphagia), oesophageal obstruction ('choke') or gastric reflux (Rose & Hodgson, 
1993). As these conditions are usually easily distinguished from disease of the respiratory 
tract by the presence of food material in the discharge and other non-respiratory clinical 
signs, they will not be considered further here. 
It is important that the anatomy of the entire respiratory tract is considered when 
reviewing possible causes of nasal discharge as a clinical sign of respiratory disease in 
horses. Causes of nasal discharge relating to specific anatomical sites (i. e. the nares and 
nasal passages, paranasal sinuses, pharynx and guttural pouches and larynx) in the upper 
respiratory tract (URT) are discussed, but were not the specific focus of study for this 
thesis. Diseases producing nasal discharges originating from the trachea and distal airways 
include EIPH and excessive airway mucus. 
1.2.2.1 Nasal discharges originatingfrom diseases of the upper respiratory tract 
Nares and nasal passages 
The equine nasal passages are linked to the exterior by the nares, which are 
capable of expansion during exercise to maxirnise air intake and are where nasal 
discharges are observed (Lakritz et al., 1997). 
The bilateral nasal passages are divided medially by the median septum vAth the 
space divided into 3 nasal meati (spaces) by the ventral and nasal conchae, which are 
highly vascularised, scrolled turbinate bones that contribute to regulating airflow and air 
temperature and removal of large-sized particles by generating turbulence over their large 
surface area. The ventral meatus is larger than either the middle or dorsal meati and is 
usually the only route by which endoscopes, nasopharyngeal. swabs and nasogastric tubes 
are able to pass during veterinary investigation or treatment. 
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Nasal discharges may occasionally be associated with pathology and infection of 
the nasal passages, usually presenting as abnormal respiratory noise or dyspnoea due to 
impaired airflow from space occupying lesions within the nose (Leyland & Baker, 1975; 
Reed et aL, 1979; Roberts et aL, 198 1; Hodgin et aL, 1984; Shaw et aL, 1987; Nappert et 
aL, 1988; Casper el aL, 1994; Richardson et aL, 1994b). Lesions identified in such cases 
have included nasal amyloidosis (Shaw et al., 1987; Nappert et aL, 1988; Casper et aL, 
1994), coccidiomycosis and cryptococcal granuloma (Reed et aL, 1979; Roberts et aL, 
1981; Hodgin et aL, 1984) and various other neoplastic and granulomatous lesions 
(Leyland & Baker, 1975; Richardson et aL, 1994b). Unilateral congenital choanal atresia, 
characterised by obstructing tissue between a nasal passage and the nasopharynx, has been 
a rare cause of unilateral mucopurulent nasal discharge in young foals, with the discharge 
appearing contralateral to the atresia (Hogan el aL, 1995). 
In addition to the dorsal and ventral conchae, the ethmoturbinate bones also 
occupy space in the dorsocaudal region of the nasal passages and are the location for 
formation of progressive ethmoid haernatomas, which are frequently implicated in 
serosanguinous nasal discharges or epistaxis (Cook & Littlewort, 1974; Leyland & Baker, 
1975; Specht ef at, 1990; Laing & Hutchins, 1992; Nickels, 1993; Behring, 1999; 
Tremaine & Dixon, 2001). Foreign bodies located in various different sites in the 
respiratory tract and associated trauma and infection may be the source of purulent nasal 
discharges in horses (Arvidsson, 1981; Urquhart el al., 1981; Brown & Collier, 1983; 
Duckett et aL, 1983; Mair, 1987; Scheidemann et aL, 1993). 
Paranasal sinuses 
In the horse there are 6 paired paranasal sinuses (dorsal conchal, middle conchal, 
ventral conchal, maxillary, frontal and sphenopalatine), which as diverticula of the nasal 
cavity each connect directly or indirectly to it. The maxillary sinus is the largest paranasal 
21 
Eqme IrWarnmatmy Airway Disease Epi&rrtiology 
sinus and contains the roots of the upper 3 rd 4 th ,5 
th and Oh cheek teeth. Consequently, the 
volume of the maxillary sinus effectively increases with age as the cheek teeth grow out to 
compensate as they are worn down. 
Discharges draining from the paranasal sinuses into the nasal passages may be 
swallowed or appear at the nostrils as nasal discharges. Conditions causing this include 
sinus cysts, primary bacterial and mycotic sinusitis, neoplasia, and secondary sinusitis, 
most commonly due to tooth root abnormalities in the maxillary sinus (Leyland & Baker, 
1975; Cannon et al., 1976; Moor et aL, 1982; Boulton, 1985; Chan & Collins, 1985; 
Coumbe et aL, 1987; Lane, 1987; Lane et al., 1987a; 1987b; Schumacher et al., 1987; 
Hilbert et aL, 1988; Beard et aL, 1990; Sundararaj & Viswanathan, 1992; Latimer & 
Thrall, 1994; Henninger & Reifinger, 1998; Dixon & Head, 1999; Head & Dixon, 1999; 
Dixon et aL, 2000; Feige et aL, 2000; Tremaine & Dixon, 200 1). 
Phajynx and gultural pouches 
The pharynx anatomically constitutes the junction between the respiratory and 
gastrointestinal tracts, with the soft palate within the pharynx comprising both the ventral 
border of the respiratory tract (nasopharynx) and the dorsal border of the gastrointestinal 
tract (oropharynx). The pharyngeal openings of the guttural pouches, large air-filled 
diverticula of the equine Eustachian (auditory) tubes, are situated in the lateral walls of the 
nasopharynx. 
The exact role of the guttural pouches is not clear, although recent studies have 
provided evidence that they are part of an important mechanism for the cooling of blood 
entering the brain during strenuous exercise (Baptiste, 1998). 
When the horse lowers its head to the ground the pharyngeal openings are the 
most dependent (ventral) part of the guttural pouches and this facilitates natural drainage 
of any accumulated fluid from the pouches into the pharynx, where they are either 
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swallowed or appear as a nasal discharge. The dorsal nasopharynx comprises the ventral 
floor of the guttural pouches vvith associated lymphoid tissue and a caudal dilation of the 
pharynx known as the pharyngeal recess. The retropharyngeal lymph nodes (RPLN) are 
situated bilaterally and slightly more caudally than the pharynx and are also in close 
apposition with the ventral aspect of the guttural pouches. The RPLNs receive lymphatic 
drainage from a large part of the caudal head including the tongue, palate, tonsils, caudal 
nasal cavity and sinuses, guttural pouches, larynx, pharynx and the more rostral parotid 
and submandibular lymph nodes. 
The respiratory tract continues beyond the pharynx through the ostium of the 
larynx. Various cartilages of the larynx protrude into the caudal pharynx, supported by the 
hyoid apparatus, of which the stylohyoid bone transects each guttural pouch. The junction 
between the larynx and pharynx is bounded by bilateral continuations of the soft palate 
known as the palatopharyngeal arches and the reflection of the mucosae onto the laryngeal 
cartilages as they protrude is the pyriform recess. 
Strangles, caused by infection with S. equi, is the most common cause of nasal 
discharge with its origin in the pharynx and guttural pouches (Breuer et aL, 1975; Knight 
et aL, 1975; Rooney, 1979; Nyack et aL, 1981; 1983; Noren, 1985; Sweeney et aL, 
1987b; Wood et aL, 1993c; Bentz et aL, 1996; Adkins et aL, 1997; Newton et aL, 1997b; 
Fintl el aL, 2000; Verheyen et aL, 2000). Strangles in horses frequently results in both 
pharyngitis and migration of S. equi to the RPLNs vvith subsequent abscessation (Knight 
el aL, 1975; Rooney, 1979; Nyack el al., 1983; Wood et al., 1993c; Newton et al, 
1997b; Judy et aL, 1999; Fintl et aL, 2000). The close apposition of the medial RPLNs to 
the guttural pouches means that rupture of these lymph nodes results in guttural pouch 
empyerna that is frequently shortly followed by the appearance of a profuse mucopurulent 
nasal discharge, particularly when the horse lowers its head to the ground. 
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In a series of 46 cases of RPLN infections reported in Australia, there was a 
history of contact with S. equi infection in the preceeding 8 weeks in 39% of cases and 
20% of all cases presented with a purulent nasal discharge (Golland el aL, 1995). 
Other infections of the guttural pouches that have resulted in nasal discharges are 
less common but include Pseudomonas aeruginosa (Govan et aL, 1992) and Pasteurella 
multocida (Jaeschke & Weiler, 1998). The majority of descriptions of guttural pouch 
mycosis report that cases present with blood appearing at the nostrils (epistaxis) rather 
than purulent discharges and/or dysphagia (Breuer et aL, 1975; Mongeon, 1977; Nation, 
1978; Owen & McKelvey, 1979; Grabner, 1984; Church el al., 1986; Ryan el aL, 1992; 
Junot et aL, 1999). This is presumably because the mycosis remains clinically inapparent 
prior to either the rupture of large blood vessels, which results in acute haemorrhage or 
dysphagia due to disruption of cranial nerves VII, IX, X and XI which traverse the dorsal 
aspect of the guttural pouches. However, one study from Japan described 3 cases of 
mycosis in which respiratory signs including purulent nasal discharges had been observed 
for about one month before haemoffhage occurred (Takatori el al, 1984). The specific 
aetiology of the mucopurulent nasal discharges was not determined in these cases. 
Another report from the UK described a horse with bilateral nasal discharge of 2 month's 
duration prior to epistaxis and isolation of Aspergillusfumigatils from a necrotic guttural 
pouch lesion at post mortem examination (Dixon & Rowlands, 198 1). 
Both congenital and acquired defects of the pharyngeal region in horses may result 
in nasal discharge in conjunction with other respiratory signs including inhalation 
pneumonia. The most commonly reported congenital defect in this region is cleft palate, 
which usually results in the discharge of food or milk from the nostrils (Haynes & Qualls, 
198 1; Shappell et aL, 1989; Dixon et aL, 1993 a; Giles et al., 1993; Puyalto Moussu et aL, 
1998). Hypoplasia of the soft palate has been reported in a foal with bilateral nasal 
discharge, dyspnoea and aspiration pneumonia (Riley et al., 1991) and a 4-year-old mare 
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with a chronic bilateral nasal discharge (Proudman et aL, 1991). Cases of rostral 
displacement of the palatopharyngeal arch may present with nasal discharges containing 
food material (Deegen & Klein, 1987; Dixon et al., 1993a)., Subepiglottic cysts have been 
found in foals with bilateral nasal discharges, coughing and aspiration pneumonia (Stick & 
Boles, 1980; Sheridan, 1990). 
Larynx 
The larynx forms the junction of the respiratory tract between the pharynx and the 
trachea and comprises a series of conjoined cartilages, which include single cricoid, 
thyroid and epiglottic cartilages and paired arytenoid, corniculate and cuneiform 
cartilages. The larynx is supported from the base of the skull by the hyoid apparatus. 
Through its range of normal movement, facilitated by the hyoid apparatus and 
attachments to the base of the tongue and soft palate, the larynx functions to prevent air 
from entering the oesophagus and digestive system as well as stopping food and saliva 
from entering the trachea and respiratory tract. Normal laryngeal and pharyngeal function 
is a complex process that is controlled by synchronisation of multiple muscles innervated 
by branches of the IXth, Xth and XIth cranial nerves. 
Laryngeal malfunction most commonly occurs in larger horses from idiopathic, 
ipsilateral. dysfunction of the recurrent laryngeal nerve branch of the Xth cranial (vagus) 
nerve, resulting in left-sided laryngeal hemiplegia. This condition leads to obstruction of 
the laryngeal opening (rima glottis) during maximal exertion due to inspiratory dynamic 
collapse of the left arytenoid cartilage across the rima glottis. Restricted abduction of the 
left arytenoid cartilage is usually confirmed either endoscopically or by laryngeal palpation 
in athletic horses that have been presented for characteristic respiratory noise and 
associated poor performance. The condition may be corrected surgically by a range of 
different procedures, including partial arytenoidectomy (Speirs, 1986; Hay et aL, 1993), 
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ventriculectomy or 'Hobday' and prosthetic laryngoplasty or 'tieback' (Rose & Hodgson, 
1993). 
It is unusual for the primary condition of laryngeal herniplegia to present with a 
nasal discharge where as it is not uncommon that horses develop discharges either as a 
temporary sign shortly after surgery or more rarely as a long-term complication of surgical 
correction of the condition (Hawkins el aL, 1997; Speirs, 1986). 
1.2.2.2 Nasal discharges originatingftom diseases of the trachea and distal ahways 
The trachea, due to the series of incomplete concentric cartilage rings running 
along its length, is effectively a serni-rigid tube that extends from the larynx to its 
bifurcation into the primary cartilaginous bronchi at the carina (Lakritz el al, 1997). 
Thereafter, there is further multiple branching of the conducting airways through several 
generations of bronchi to non-cartilagenous, smooth muscle-walled bronchioles and then 
tertninating in the alveolar ducts and acini, where gas exchange occurs with the pulmonary 
capillary blood supply (Lakritz et al., 1997; Pirie et al., 1990). 
The airways are lined by fluid which between the trachea and bronchioles is a 
bilayer comprising a low-viscosity, periciliary basal layer and an overlying mucus layer 
(Dixon, 1992; Robinson, 1997c). This bilayer protects the airways in a number of different 
ways including trapping of inhaled material, absorption of inhaled chemicals and gases, 
humidifying inspired air, maintaining hydration of the mucous membrane and contributing 
to immunological defence of the airway by providing a medium for inflammatory cells, 
immunoglobulins, lactoferrin and lysozyme (Dixon, 1992). Material trapped in the fluid 
lining the airways is removed proximally through movement of the mucus by the co- 
ordinated beating motion of the cilia on the epithelial surface, the so-called 'mucociliary 
escalator' (Dixon, 1992; Robinson, 1997c). The term 'mucopus' is often used 
interchangeably with mucus and describes respiratory secretions that have a purulent 
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appearance characterised by a yellow or green discolouration (Dixon, 1992; Robinson, 
1997c). The discolouration of mucopus may arise vvith increased amounts of neutrophilic 
or bacterial DNA (Robinson, 1997c), vvith myeloperoxidase, released from leucocytes in 
static secretions (Dixon, 1992), or more rarely with high eosinophil levels (Dixon, 1992). 
The gross visible differentiation of mucus and mucopus is subjective and for the purposes 
of this thesis no distinction will be made between the 2 terms. 
Conditions that result in excessive material being cleared from the distal airways to 
the pharynx may result in the appearance of abnormal nasal discharges. As well as the 
effects of the underlying pathological conditions, additional factors that may be important 
in contributing to the appearance of nasal discharge include i) the position of the horse's 
head and neck (i. e. lowered versus raised) ii) the action of mucokinetic drugs (i. e. those 
effecting mucociliary clearance) such as mucolytics, bronchodilators and 
bronchomucotropic agents (Dixon, 1992; Robinson, 1997b), iii) exercise and iv) 
coughing. Exercise has been found to enhance the clearance of material from the lower 
airways into the trachea (Burrell, 1985; Lumsden el aL, 1995) and in recent studies of 
IAD in racehorses endoscopy has usually been conducted following exercise (Wood, 
1999; Chapman et aL, 2000). 
Exercise induced pulmonary haemorrhage (EWH) 
Blood appearing at the nostrils or epistaxis, as already discussed, may originate 
from URT pathology such as ethmoid haematomas (Cook & Littlewort, 1974; Leyland & 
Baker, 1975; Specht el al., 1990; Laing & Hutchins, 1992; Nickels, 1993; Behring, 1999; 
Tremaine & Dixon, 2001) or guttural pouch mycoses (Breuer ef aL, 1975; Mongeon, 
1977; Nation, 1978; Owen & McKelvey, 1979; Dixon & Rowlands, 1981; Grabner, 1984; 
Church el aL, 1986; Ryan et aL, 1992; Junot et aL, 1999). 
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Epistaxis occurring during or soon after exercise has been recognised in horses for 
centuries (Pascoe & Wheat, 1980; Pascoe & Raphel, 1982) but it was only with 
endoscopic examination of the equine trachea and lower respiratory tract that this 
haemorrhage was confirmed to originate from the lungs (Cook, 1974). Lower airway 
endoscopy also demonstrated that lung bleeds in exercised horses were actually far more 
prevalent than epistaxis (Pascoe & Wheat, 1980, Pascoe & Raphel, 1982) and the term 
'exercise induced pulmonary haemorrhage' or EIPIL was adopted for this condition 
(Pascoe et al., 1981). Since then there has been much research and scientific debate 
directed towards determining the definitive cause and pathogenesis of EIPH (and hence 
epistaxis) in horses. 
Cook (1974a), in his review of epistaxis in the racehorse, attributed the condition 
to underlying respiratory disease, particularly recurrent airway obstruction (RAO), but no 
data from non-affected control horses were presented to strengthen his argument. Small 
airway obstruction as a cause of EIPH was proposed and justified in detailed physiological 
terms (Robinson & Derksen, 1980) and EIPH was later reproduced in horses with 
experimentally induced allergic lung disease (Derksen et al., 1992). Clarke (1985) 
reviewed existing knowledge of EIPH and proposed that the primary mechanism was 
mechanical stress in the dorsocaudal region of the lung, the predominant site of pulmonary 
pathology (O'Callaghan et aL, 1987). It has been hypothesised that upper airway 
obstruction was the cause of EIPH (Cook el aL, 1988) and that stress failure of 
pulmonary capillaries was the specific mechanism for the condition (West el aL, 1993). 
More recently possible roles of oxidant injury in the pathogenesis through nitrous oxide 
production (Mills & Higgins, 1997) and locomotory impact induced trauma as the 
underlying cause of EIPH have been proposed (Schroter et al., 1998). 
However, failure to completely reconcile EIPH to any one of these many and 
diverse theories suggests that the aetiology and pathogenesis of EIPH is actually a 
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complex interplay of many factors relating to both the physiology and pathology of 
pulmonary function and exercise. Although the association of EIPH with exercise intensity 
has been well documented (Raphel & Soma, 1982; Sweeney & Soma, 1983; Burrell, 
1985) and most (but not all) observational studies have shown an increased prevalence 
with increasing age (Cook, 1974; Raphel & Soma, 1982; Clarke, 1985; Chapman et al, 
2000), the epidemiology of EIPH and epistaxis has been poorly described. 
A recent study of risk factors associated with EIPH-related epistaxis in racing 
horses in Japan showed that blood at the nostrils was more prevalent in older horses, in 
those racing distances :! ý1600 metres, in females and in steeplechasers compared to flat 
horses (Takahashi et aL, 200 1). Recent analyses of data from a longitudinal study of 
respiratory disease (Wood, 1999) have provided evidence that EIPH in young 
Thoroughbreds during training was associated with increasing age, different seasons of 
the year, airway inflammation (and mucus) and evidence of fungal material in the airways 
(Newton & Wood, 2002). 
Excessive airway mucus 
As with EIPH and epistaxis, excessive mucus being cleared from the lungs by 
mucociliary clearance may result in the appearance of material as a mucoid (or 
mucopurulent) nasal discharge. In common with the relationship between blood in the 
airways and epistaxis, excessive mucus in the respiratory tract is much more prevalent 
than abnormal, mucoid or mucopurulent nasal discharge (Wood et aL, 1998; Wood, 
1999). 
There has been considerable confusion, probably due to unquestionable clinical 
and cytological similarities, in the classification of the condition of excessive mucus in the 
airways of horses of different ages. However, it now appears generally accepted that there 
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are 2 epidemiologically distinct equine respiratory disease syndromes that manifest as an 
airway neutrophilic inflammatory response characterised by excessive airway mucus. 
Inflammatory airway disease (IAD), which has been most intensively studied in 
racehorses (Sweeney el aL, 1992; Burrell et aL, 1996; Moore, 1996; Wood el aL, 1998; 
Wood, 1999), occurs in young horses and decreases in prevalence with increasing age 
(Burrell et aL, 1996; Wood et al., 1998; Wood, 1999). In contrast, recurrent airway 
obstruction (RAO), previously called chronic obstructive pulmonary disease (COPD) or 
'heaves', occurs in older animals (usually at least 7-years-old), is thought to be allergic in 
origin and increases in prevalence with increasing age (Cook, 1976; McPherson el aL, 
1979a; Derksen, 1993; Dixon el aL, 1995b; Robinson, 2001). The syndrome 'summer- 
pasture associated obstructive pulmonary disease' (SPAOPD), which is clinically and 
pathologically identical to RAO and as the name suggests occurs in older horses at 
pasture, may also be associated with nasal discharge (Seahorn & Beadle, 1993; Seahorn & 
Beadle, 1994; Mair, 1996b; Seahom et al, 1996; Hudson, 1999; McGorum & Dixon, 
1999; Costa et aL, 2000). 
These disease syndromes may or may not include nasal discharge among their 
signs and may or may not occur in the same horses at different times during their lives 
(Wood, 1999; Robinson, 2001). Nasal discharge was reported as a presenting clinical sign 
in only 50% of 50 horses with RAO referred to Edinburgh University in 1990 and 6% had 
discharge that was unilateral (McGorum, 1994). 
In addition to EIPH, IAD, RAO and SPAOPD affecting the distal airways, various 
types of infectious pneumonia have nasal discharges among their presenting clinical signs 
(Hilbert ef al., 1980; Smith & Robinson, 198 1; Pearson et aL, 1983; Falcon et aL, 1985; 
Knottenbelt, 1993; Raidal, 1995; Carr el aL, 1997; Wiegand & Schusser, 1997). 
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1.2.2.3 Riskfactorsfor nasal discharge in respiratory disease of horses 
A Ze 
Age as a risk factor for the specific clinical sign of nasal discharge has not been 
widely examined with the exceptions of several longitudinal studies of respiratory disease 
in young Thoroughbred racehorses (Morley, 1995; Burrell ef aL, 1996; Wood et al., 
1998; Wood, 1999). 
Analyses by Burrell el aL (1996) of risk factors for nasal discharge during the 
month preceeding examination in horses in one training yard, after controlling for 
significant infectious variables, demonstrated no significant difference in risk between 2- 
and 3-year-old horses. This non-significant finding was apparently later qualified by Wood 
and co-workers (Wood el aL, 1998; Wood, 1999) who found that there was a 
significantly increased risk of nasal discharge in yearlings compared to older horses. The 
prevalence of nasal discharge in yearlings (32%) was far greater than in any other age 
group (<6%) and suggested that nasal discharges occurred most commonly soon after 
horses first entered training (Wood, 1999) (Figure 1.6, with permission from Wood et aL 
[1998]). 
In studies of infectious upper respiratory tract disease, defined by mucopurulent 
nasal discharge and/or acute persistent coughing (these signs were not differentiated for 
separate analyses) in Thoroughbred racehorses in Saskatchewan, Canada, Morley (1995) 
found that horses younger than 4-years-old were at significantly increased risk than older 
animals of disease caused by influenza virus, EHV-4 and S. equi. 
Although RAO is recognised to increase in prevalence with increasing age (Cook, 
1976; McPherson el aL, 1979a) and the risk of nasal discharge associated with it may also 
be expected to increase with increasing age, the author is not aware of any data that 
specifically confirms this. 
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Figure 1.6: Age-specific prevalence of nasal discharge during a longitudinal study of 
respiratory disease in Thoroughbred racehorses (from Wood et at 
119981) 
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Infections 
Among bacterial Infections, marked bilateral, mucopurulent nasal discharges are 
frequently observed with S. equi (Ebert, 1969, Piche, 1984, Timoney & Powell, 1988, 
Dalgleish el cit, 1993, Hamlen el cil., 1994; Fintl el cil., 2000, Newton el tiL, 2000b). 
Other bacterial species that have been associated with nasal discharges, particularly in 
young horses, include S. zooepidemicus (Mair & Lane, 1989; Hoffman el 41t, 1993a, 
1993b; Burrell el cil., 1994, Wood, 1999), S. pneumonitte (Huber el al., 1988, - Blunden el 
aL, 1991-, 1994-, Burrell el aL, 1994,1996), Pasieurella Actinobacillus spp (Burrell ef 
al., 1994-, Carr el al., 1997), Rhodococcus equi (Smith & Robinson, 198 11 Zinck el a/., 
1986, Prescott el ciL, 1991; Hoffman el aL, 1993cl Knottenbelt, 1993, Burks, 1996, Kolk 
ei al., 1999), Bordelella bi-otichisepticci (Cockram ei at, 198 1, Bayly ei al., 1982, 
Vandevenne el al., 1995) and anaerobic species (Sweeney el al., 1984-, 1985b, Mair & 
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Yeo, 1987; Sweeney ef aL, 1991; Raidal, 1995; Burrell et aL, 1996; Racklyeft & Love, 
2000). 
Among viral infections, equine herpes viruses, including EHV-2, have been 
frequently associated with nasal discharge (Powell, 1975; Palfi. et al., 1978; Riveros el al., 
1978; Palfi et al., 1979; Belak el aL, 1980; Fu et aL, 1986; Seahom et aL, 1990; Adeyefa, 
1992; Gilkerson et aL, 1994; McCartan et aL, 1995; Burrell el al., 1996). Infection with 
influenza virus in neve horses is frequently accompanied by profuse, 'mucopurulent nasal 
discharge (Gerber, 1970; Lucam et aL, 1974; Powell et aL, 1974b; Hannant et aL, 1988; 
Mumford et aL, 1990; Wood, 1991; Mumford et aL, 1994c; 1994d; Powell et aL, 1994; 
Morley, 1995; Newton & Mumford, 1995; Powell el aL, 1995; Gross el aL, 1998; 
Kastner et aL, 1999; Newton et aL, 1999a; Morley ef aL, 2000; Newton et al., 2000a). In 
populations of partially immune vaccinated horses where clinical signs are not necessarily 
typical of influenza, one of the most common signs is a rapidly spreading nasal discharge 
(Newton et aL, 1999a; Wood, 1999; Newton et aL, 2000a). In 2 longitudinal studies of 
respiratory disease in racehorses, infection with influenza virus has been strongly 
associated with nasal discharge (and other signs of upper respiratory tract disease) 
(Morley, 1995; Wood, 1999). Among other viral infections, nasal discharges have been 
observed with equine arteritis virus (Cole et aL, 1986; Timoney & McCollum, 1990; 
Johnson et al, 1991; Holyoak et al., 1993; McCollum et aL, 1995; Wood et aL, 1995; 
Paweska et aL, 1996; Paweska, 1997; Castillo Olivares et aL, 2001), equine rhinovirus 
(Plummer, 1962; Plummer & Kerry, 1962; Hofer et aL, 1973; Moraillon et aL, 1973; 
Powell, 1975; Studdert & Gleeson, 1978), equine adenovirus (Pascoe et aL, 1974; 
Kamada et aL, 1977) and parainfluenza-3 virus (Ditchfield et aL, 1963). 
Organisms less frequently isolated from horses with signs of nasal discharge 
include Pseudomonas spp. (Govan et aL, 1992; Lal ef al., 1992), Chlamydia psitacci 
(Moorthy & Spradbrow, 1978; Burrell et aL, 1986a; Wills et al., 1990) and Cryptococcus 
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neoformans (fElbert et al, 1980; Pearson et al., 1983). Logistic regression modelling of 
nasal discharge in racehorses identified a significant association with non-felis glucose 
fermenting mycoplasmas in tracheal washes and a marginally significant association with 
ERV-1 infection (Wood, 1999). 
Although respiratory infection of horses by the lungworm Diqyocauhis arnfieldi 
is rare and usually characterised by chronic coughing (Clayton & Murphy, 1980; Clayton 
& Duncan, 1981; Nielsen & Andersen, 1981; Fischer el al., 1982; Lyons ef aL, 1982; 
Goetz, 1984; Lester, 1993), nasal discharge may be observed in some cases (Round 1972; 
1976; Lester, 1993). 
Other factors 
As discussed for pyrexia, transport of horses is frequently associated with signs of 
respiratory disease or so called 'shipping fever'. Maintaining horses with their heads and 
necks elevated for prolonged periods, such as when being transported, predisposes to 
accumulation of mucus and associated bacterial infection in the trachea, which may appear 
as a nasal discharge when horses subsequently lower their heads. It has been shown that 
experimental exposure of horses to levels of, atmospheric ammonia equivalent to those 
found during transport caused marked, nasal discharge and coughing (Katayama et aL, 
1995). 
Nasal discharge has been occasionally reported as an adverse reaction in several 
different veterinary interventions. Nasal discharge was reported shortly after vaccination 
in a small proportion of horses receiving influenza and/or tetanus vaccinations (Mair, 
1988), although no definitive causal link between immunisation and development of 
clinical signs has yet been established (Dixon el aL, 1996). The potential of mucokinetic 
drugs in predisposing to nasal discharge. was, demonstrated in a report of an adverse 
reaction to clenbuterol in a 22-year-old horse receiving treatment for signs of RAO 
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(Gustin ef aL, 1987). The horse developed nasal discharge, among other signs, shortly 
after administration of the 02-adrenergic agonist. This may be explained because as well as 
causing bronchodilation through relaxation of smooth muscle, clenbuterol also increases 
mucociliary clearance by effectively thinning the mucus layer, improving the effectiveness 
of coughing and promoting secretion of water into the periciliary layer of the epithelial 
lining fluid (Dixon, 1992). Nasal discharge was observed with coughing in a report of 
pulmonary complications associated with maintaining horses for variable periods in 
flotation tanks (hydrotherapy) for treatment of skeletal injuries (McClintock el aL, 1986). 
1.2.3 Coughing 
Coughing is an inherent protective, reflex mechanism of the respiratory tract, 
which by its very occurrence may be taken to indicate some form of insult or abnormality. 
This section initially describes the cough reflex and then goes on to consider factors that 
are important in the occurrence of coughing in respiratory disease in horses. 
1.2.3.1 The cough reflex 
Coughing is a protective physiological mechanism for clearing foreign material 
from the larger conducting airways distal to the pharynx, particularly the larynx, trachea 
and bronchi (Dixon, 1992; Robinson, 1987; 1997c). 
The cough reflex is initiated when irritant receptors in the airway epithelium of the 
larynx, trachea or bronchi are stimulated. These irritant receptors are most common in the 
airways just proximal and distal to the tracheal bifurcation at the carina. (Robinson, 1987; 
1997c) hence the need for administration of local anaesthetic during routine 
bronchoalveolar lavage (BAL) of the distal airways to reduce coughing prior to the 
passage of BAL tubing beyond the carina (Wehrli et aL, 2000). However, in a horse with 
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a sensitised larynx and/or trachea, for instance due to inflammation and/or infection, a 
cough reflex may be initiated by palpation of these structures externally (Mair, 1994). 
Following stimulation of the irritant receptors, the neural signal passes along 
myelinated afferent fibres in the vagus nerve to the 'cough centre' in the medulla 
oblongata of the central nervous system (Karlsson el aL, 1988; Kenney & Divers, 1993). 
The efferent limb of the cough reflex passes along various different spinal nerves to 
complete inhalation and close the glottis, effectively sealing off the lower respiratory tract 
from the exterior. At the same time, pressure within the thorax is markedly increased by 
contraction of the expiratory muscles, particularly the abdominal muscles, resulting in 
compression of the air in the lungs and reduction in the cross-sectional area of the trachea 
and bronchi due to dynamic intrathoracic airway collapse. Coughing occurs when the 
glottis is opened and the compressed air in the lungs is expelled at high velocity through 
the constricted airways, blasting out foreign material to the pharynx and beyond 
(Robinson, 1987; 1997c). It is noteworthy that dynamic collapse of the airways, which 
only occurs within the thorax due to increased intrathoracic pressure from contraction of 
the expiratory muscles, means that coughing is less effective for clearing material from the 
extra-thoracic trachea which is not subject to dynamic collapse (Robinson, 1987). 
Therefore, the majority of routine lower airway endoscopy performed in studies of IAD in 
young horses (Burrell el aL, 1996; Christley et aL, 1999b; Wood, 1999; Chapman el aL, 
2000) and in equine practice is generally restricted to the part of the airway that is least 
well cleared by coughing. This is probably fortunate in maximising the association of 
coughing and visible IAD. 
Irritant receptors are stimulated when they are deformed by the presence of 
material on the epithelial surface, such as with accumulated secretions or foreign bodies, 
or by contraction of smooth muscle within the -walls of the airways (i. e. with 
bronchoconstriction) (Robinson, 1987; 1997c). Therefore, cough is a clinical sign that is 
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associated with respiratory diseases producing impaired. mucociliary clearance and 
consequent mucus accumulation, such as with IAD and RAO and/or with conditions 
resulting in bronchospasm, as with RAO. In these cases, coughing can be relieved by use 
of bronchodilator drugs. The sensitivity of the irritant receptors is increased by airway 
inflammation and pathological exposure of the epithelial. surface, which is most commonly 
seen with viral infections such as equine influenza and herpes viruses (ONiell et al., 1984; 
Willoughby el aL, 1992; Sutton et al., 1997). In conditions where mucociliary clearance is 
compromised, coughing becomes the most important mechanism for clearance of material 
from the airways and for this reason antitussive drugs that suppress coughing are not 
recommended for use in equine respiratory disease (Dixon, 1992). The consequences of 
losing the cough reflex were demonstrated in a 10-year-old mare with severe necrotising 
bronchopneumonia secondary to a melanoma in the caudal brainstern (Kenney & Divers, 
1993). Loss of the cough reflex had been noted during endoscopy of the airways distal to 
the carina. Temporary loss of the cough and swallow reflexes was also noted as a post 
operative complication of left-sided prosthetic laryngoplasty in a Throughbred gelding due 
to probable surgical trauma to the cranial laryngeal nerve, which serves afferent sensory 
fibres in the larynx (Ahem, 1996). 
1.2.3.2 Viral infections 
Equine influenza viru 
The disease now known to be caused by equine influenza virus has long been 
recognised in completely nalve horses by characteristic coughing that is harsh and dry in 
nature, acute in onset and transmitted rapidly both within and between groups of 
susceptible animals (Gerber, 1970; Mumford et al., 1990; Wood, 1991). 
Equine influenza virus, as well as causing pathology of the upper respiratory tract, 
also extensively damages the ciliated epithelial cells lining the conducting airways. This 
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leads to disruption of normal mucociliary clearance with consequent accumulation of 
mucus and bacteria in the airways and exposure of the larnma propria and irritant 
receptors, all leading to frequent coughing (Lucam e/ ol., 1974, O'Niell el til., 1984, 
Willoughby el al., 1992, Sutton el at, 1997). Figures 1.7a-c show a series of 3) scanning 
eletronmicrographs of equine tracheal ciliated epithelium at different stages of 
experimental influenza infection (courtesy of A. S. Blunden and J. A. Mumford). 
Figure 1.7a shows normal ciliated epithelium in a non-infected animal. Figure 1.7b, 
from a horse 2 days after infection, demonstrates disruption of the cilia and adherence of 
bacteria. Figure 1.7c shows complete loss ciliated epithelium with exposure ofthe lamina 
propria in a horse 6 days after infection. 
Figure 1.7a: Scanning electron m icrogra ph of normal equine tracheal ciliated 
epithelium 
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Figure 1.7b: Scanning electronmicrograph of equine tracheal ciliated epithelium 2 
days post-influenza infection 
Figure 1.7c: Scanning elect ronm icrograph of equine tracheal ciliated epithelium 6 
days post- infl u enza infection 
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Other viruses 
Coughing may be observed as a clinical sign in a number of other viral. respiratory 
infections of horses, including EHV-1 and EI-W-4 (Powell, 1975; Allen & Bryans, 1986; 
Chong & Duffus, 1992; Mair, 1994; Morley, 1995; Mair, 1996c; Allen el aL, 1998; 
Sutton et aL, 1998), and less frequently with EHV-2 (Borchers et aL, 1998), ERV-1 
(Plummer, 1962; Plummer & Kerry, 1962; Hofer et aL, 1973; Moraillon et aL, 1973) and 
EAV (Holyoak et aL, 1993). However, subclinical infections appear much more common 
with these infections than with influenza virus (Moraillon & Moraillon, 1978; Powell et 
aL, 1978; Studdert & Gleeson, 1978; Thomson, 1978; Gibson el aL, 1992; Gilkerson el 
aL, 1994; Wood et al, 1995; Burrell et aL, 1996; Newton et aL, 1999b). A case control 
study was recently conducted in racehorses around Sydney, Australia, with cases defined 
as horses that coughed at least 4 times in a 10 minute period during exercise (Christley et 
aL, 2001b). This study failed to demonstrate any association between coughing and 
infection with adenovirus, ERV-1, ERV-2 or undifferentiated EHV-1/4, each diagnosed 
serologically. 
1.2.3.3 Bacterial infections 
Streptococcus equ 
Although not the most widely reported sign in equine strangles, infection with S. 
equi may be associated with a soft, moist cough that in most cases is likely to come from 
inflarnmation and irritation of the larynx and trachea from purulent discharges originating 
in the upper respiratory tract (e. g. Mair, 1994; Newton el aL, 2000b). 
Streplococcus pneumoniae 
Prior to investigations of respiratory disease in racehorses involving tracheal endoscopic 
examination there had been only a few reports of S. pneumoniae being associated with 
coughing in horses (Hofer el aL, 1973; Benson & Sweeney, 1984; Huber el aL, 1988). 
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Large numbers of S. pneumoniae (10 
6 
-10 
8 
cfu/H), either as pure culture or mixed with S. 
zooepidemicus, have been isolated from tracheal washes taken from coughing racehorses 
(Burrell el aL, 1986b; Mackintosh et aL, 1988; Burrell ef aL, 1994). Consistent with this, 
intratracheal inoculation of 10ml of 109 cfu S. pneumoniaelml produced coughing among 
other clinical signs in experimental infections in Welsh mountain pony foals (Blunden el 
aL, 1991; 1994). More recently, the Australian case control study confirmed a significant 
dose-dependent association between S. pneumoniae in tracheal washes and coughing in 
racehorses (Christley ef aL, 2001b). 
Streplococcus zooei2idemictis and PasteurellalActinobacillus spp. 
The AHT and others have consistently demonstrated that S. zooepidemicus and 
PasteurellalActinobacillus spp. in tracheal washes are significantly associated with IAD in 
young racehorses (Wood et aL, 1993a; Burrell et aL, 1996; Wood et aL, 1998; Wood, 
1999; Chapman et aL, 2000). It has also been shown that coughing is a specific (84% of 
coughing horses had endoscopic and cytological evidence of IAD) but insensitive (only 
3 8% of horses with IAD were coughing) indicator of IAD, particularly when the condition 
had been present for at least 2 months. Corroborating these findings, Christley ef aL 
(200 1) recently demonstrated a significant association between isolation of > 10' cfu/ml of 
S. zooepidemicus or PasteurellalActinobacillus spp. from tracheal washes and coughing 
in Australian racehorses. 
Myc e Qplasma f 
An outbreak of IAD, including coughing, that was associated with M felis 
infection, occurred in a group of young Thoroughbred racehorses in Newmarket in 
November and December 1993 (Wood ef aL, 1997a). Isolation in pure culture in some 
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animals and seroconversion in a large proportion of affected horses, was strongly 
suggestive of a primary pathogenic role for M. felis in this outbreak. 
1.2. ý. 4 Pneumonialpleuropneumonia 
Various types of infectious pneumonia and pleuropneumonia may present with 
clinical signs of coughing among other respiratory signs (Mair, 1989; Mair & Lane, 1989; 
Mair, 1991; Chaffin et aL, 1994b; Mair, 1994). Pleuropneumonia is an extension of 
pneumonia or pulmonary abscessation to involve the visceral pleura and pleural space as 
well as the pulmonary parenchyma (Chaffin & Carter, 1993). For the purposes of this 
discussion 'pneumonia' will be used from here on in to refer to both pneumonia and 
pleuropneumonia. 
In foals infectious causes of pneumonia include Rhodococcus equi (Smith & 
Robinson, 1981; Falcon et aL, 1985; Varga et al., 1997) and various other bacterial 
species including Streptococcus spp. (Benson & Sweeney, 1984; Mair, 1989; Chaffin & 
Carter, 1993). Inhalation pneumonia may occur in foals secondary to congenital upper 
respiratory tract abnormalities (Stick & Boles, 1980; Riley et aL, 1991). 
Coughing with pneumonia, associated with infection with various different 
bacterial species, occurs secondary to influenza virus infection (Lucarn el al., 1974; Smith, 
1979), as a complication of Streplococcus equi infection known as 'bastard strangles' 
(Rooney, 1979; Ford & Lokai, 1980; Sweeney et al., 1987b) and following long-distance 
transport (Oikawa et al., 1994; 1995). Inhalation of food, saliva and other material 
frequently results in acute coughing and may culminate in pneumonia. This may occur, for 
example, because of oesophageal obstruction ('choke') or dysphagia of various causes 
(Mair, 1994). 
In racehorses it has been suggested that blood in the airways following intensive 
exercise (EIPH) may provide an ideal medium for bacterial replication and therefore 
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predispose to pneumonia (Raphel & Beech, 1982). Apparent differences in susceptibility 
to pneumonia between Thoroughbreds (increased risk) and Standardbreds (reduced risk) 
in America have been partially attributed to differences in prevalence of EIPH between 
these 2 breeds (Austin el aL, 1995). However, EIPH as an underlying factor in pneumonia 
is somewhat refuted by marked geographical differences in prevalence of pneumonia in 
racehorses between the UK and North America (Mair & Lane, 1989; Chaffin & Carter, 
1993) as EIPH is highly prevalent in both areas of the world (Clarke, '1985; Chaffin & 
Carter, 1993). It has been postulated that the reason for increased pneumonia among 
North American racehorses is more likely to be due to inhalation of kicked back track 
material while racing on 'dirt', which is common practice in America but relatively 
uncommon in the UK (Chaffin & Carter, 1993). In addition, it has been shown that a 
single bout of high intensity exercise contributes to increased bacterial contarnination of 
the lower respiratory tract in otherwise healthy Standardbred horses (i. e. no signs of lower 
airway disease) undergoing treadmill exercise (Raidal et aL, 1997b). However, these 
increased infectious burdens were rapidly cleared in these horses, which did not develop 
subsequent lower airway disease and the authors postulated that inhaled track debris and 
blood from EIPH may be additional contributory factors in overwhelming mucociliary 
clearance and predisposing to pneumonia in racehorses (Raidal el aL, 1997b). 
1.2.3.5 Lungworm infection 
The adult nematode Dictyocaulus arnfleldi resides in the bronchi and can be a 
cause of coughing in horses (Andersen & Fogh, 1981; Clayton & Duncan, 1981; George 
et aL, 198 1; Nielsen & Andersen, 198 1; Fischer et aL, 1982; Lyons et aL, 1982; Poncet, 
1983; Goetz, 1984; Whitwell & Greet, 1984; Lester, 1993; McGorum, 1994; Dixon el al., 
1995b; Ramachandran, 1995; Burks, 1998), a disease similar to parasitic bronchitis or 
'husk' in cattle (Urquhart el at, 1987). 
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D. arnfieldi infection is ubiquitous in donkeys, which are believed to be the natural 
reservoir host for the parasite, causing very few clinical signs. Without use of 
anthelmintics donkeys acquire infection as foals and tend to remain infected all their lives 
because with patent infections in this species there is frequent re-exposure to L3 stage 
larvae on pasture. Infection in horses is much less common as the infection is not patent 
and therefore requires co-grazing with donkeys, usually in the late-summer or autumn 
months. It is believed that Pilobilus fungi may play a role in disseminating infectious 
larvae away from faeces and onto the surrounding pasture as occurswrith D. vivipants in 
cattle (Urquhart et aL, 1987). Treatment -of lungworm. infection with ivermectin or 
benzimadazoles is straightforward but may elicit violent coughing for several days after 
treatment as the killed parasites are expelled (Fischer et aL, 1982). 
1.2.3.6 Upper respiratory tract conditions 
A number of conditions of the upper respiratory tract may be associated with 
clinical signs of coughing, particularly involving the epiglottis and/or soft palate. These 
conditions include soft palate ulceration (Norwood, 1983; Gille & Lavoie, 1996), 
epiglottitis (Hawkins & Tulleners,, 1994), soft palate hypoplasia (Riley el al., 1991), 
epiglottic entrapment (Honnas & Wheat, 1988; Honnas el al., 1990; Lumsden el al., 
1994) with or without dorsal displacement of the soft palate (Haynes 1981; Tate el aL, 
1990) and subepiglottic cysts (Stick & Boles, 1980). 
Neoplasia (Boulton, 1985; Elbert et aL, 1988; Tuckey et aL, 1995; Savage, 1998; 
Scarratt & Crisman., 1998; Tremaine'& Dixon,, 2001),, including progressive ethmoid 
haernatorna (Cook & Littlewort, 1974; Tremaine & Dixon, 2001) or foreign bodies 
(Arvidsson, 198 1; Urquhart et at, ý 198 1; Brown & Collier, 1983; Duckett el al., 1983; 
Mair, 1987; Scheidemann et al., 1993) in the upper respiratory tract may present with 
coughing. 
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Not surprisingly, coughing may also be a common sign following different types of 
surgery of the upper airway, particularly of the larynx in horses with left sided laryngeal 
hemiplegia (Huskamp, 1980; Speirs, 1986; Tulleners et aL, 1988; Hay et aL, 1993; 
Holcombe et aL, 1994; Russell & Slone, 1994; Hawkins et aL, 1997). 
1.2.3.7 Environmentalfactors 
Alleraic lunsz disease (RAO/SPAOLPD) 
Chronic and persistent coughing is frequently observed with the allergic 
respiratory diseases of recurrent airway obstruction (RAO) and summer pasture 
associated obstructive pulmonary disease (SPAOPD) (Cook, 1976; Robinson, 1987; 
Seahorn & Beadle, 1993; McGorum, 1994; Seahom & Beadle, 1994; Mair, 1996b; 
Robinson el aL, 1996; Robinson, 1997c; McGorum & Dixon, 1999; Robinson, 200 1). 
The common underlying pathological process behind both RAO and SPAOPD is a 
pulmonary hypersensitivity to different inhaled allergens (Cook, 1976; Derksen ef aL, 
1997; Robinson et aL, 1996). The notable differences between RAO and SPAOPD in 
seasonality and more specifically, the apparently dichotomous risk factors of housing 
predisposing to RAO and grazing to SPAOPD, are probably attributable to differences in 
the source of allergens to which horses are sensitive. 
RAO is triggered by exposure to inhaled organic dusts, usually from poor quality 
straw and hay which contain a mixture of species of moulds, spores, forage mites and 
endotoxins (McPherson et aL, 1979b; Derksen el aL, 1988; McGorum el al., 1993c; 
Robinson ef aL, 1996; McGorum et aL, 1998; Robinson, 2001). Results from several 
inhalation challenge studies conducted to identify important specific triggers (e. g. 
allergens/endotoxin) and controlled against natural challenge with exposure to hay/straw, 
suggest that naturally-occurring RAO is attributable to multiple factors within the 
environment (McGorum. el aL, 1993b; 1993c; Robinson et aL, 1996; Pirie et al, 2001a; 
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Robinson, 2001). The responses observed in extract challenges were uniformly less than 
those that occurred with exposure to hay/straw. 
In SPAOPD the allergens are believed to be moulds on grasses (Seahorn & 
Beadle, 1993; Derksen et aL, 1997; Robinson et aL, 1996) or inhaled pollens (McGorum, 
1994). The nature of allergens associated with SPAOPD has not been definitively 
determined, although some differences in nasal fungal isolates have been demonstrated 
between horses kept at pasture and those kept in stables (Seahom & Beadle, 1994). There 
are anecdotal suggestions that exposure to the pollen of oil seed rape (various Brassica 
species), an increasingly ubiquitous' summer field crop in the United Kingdom, is the 
underlying cause of respiratory disease in horses exposed to it (Dixon & McGorum, 1990; 
Mair, 1996b). However, preliminary investigations have suggested that although 
exposure to oil seed rape pollen may exacerbate underlying respiratory problems, it is not 
itself a significant primary cause of SPAOPD (McGorum & Dixon, 1992; McGorum, 
1994). ýIIýI, I 
Coughing vvith RAO and SPAOPD is most likely due to stimulation of irritant 
receptors in the epithelium of the conducting airways through several coinciding and 
probably synergistic mechanisms. These include chemical and physical irritation from 
inhaled foreign/allergen material found in the poor environments that predispose to these 
conditions (i. e. direct, non-immunogenic effects - of stable dust) as well as 
bronchoconstriction, mucus hypersecretion and consequent mucus accumulation through 
impaired mucus clearance'(Robinsoh, 1987; Robinson et aL, 1996 Robinson, 1997c; 
2001). 
Other environmental factors 
As previously discussed for pyrexia with respiratory disease, horses undergoing 
long distance travel may be at increased risk of coughing' (Oikawa et al., 1994; 1995), 
46 
Eqwne Infiw=atM Au"y Dmw Epi&molM 
which may be due to a combination of mucus accumulation, primarily as a result of 
prolonged raised head carriage and exposure to increased levels of toxic gases such as 
ammonia (Katayama et aL, 1995). 
Epidemiological studies are providing increasing evidence for a link between air 
pollution and respiratory disease in man, but although there are anecdotal reports that 
RAO is more prevalent in suburban than rural environments, to date there are no studies 
that confirm a similar association in horses (Mair, 1995). 
Acute onset coughing may be precipitated in racehorses during or immediately 
following racing due to inhalation of foreign track material kicked back from other horses 
further ahead in the field (Arthur, 1983; Sweeney et al., 1991; Chaffin & Carter, 1993; 
Austin el aL, 1995). This occurs particularly in horses using so-called 'all weather' or 
'dirt' surfaces, which in the UK are of various types and comprise a mixture of sand and 
water retardant materials. As already discussed, inhalation of and failure to clear inhaled 
'kickback' from the lungs has been implicated in causing pleuropneumonia in racehorses 
in North America (Arthur, 1983; Chaffin & Carter, 1993; Austin el aL, 1995; Raidal, 
1995; Raidal et aL, 1997b). The effects of kickback may be worse in the USA than in the 
UK because of the looser nature of the track surface. 'All weather' surfaces in the UK 
tend to be petroleum based for water resistance and consequently have reduced 'kickback' 
compared to the drier surfaces used in warmer climates. There may also be additional 
effects by longer distance travel in North America (Mair & Lane, 1989; Austin el al., 
1995). 
1.2.3.8 Otherfactors 
Me 
Coughing in young racehorses, as with nasal discharge, is most prevalent in 
younger animals. In North America coughing in conjunction with the presence of nasal 
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discharge (defined as cases of infectious upper respiratory disease; IURD) was inversely 
associated with age where horses were infected with influenza virus, equine herpesvirus or 
S. equi (Morley, 1995). A negative association between age and coughing was also 
demonstrated in horses with bacterial lower respiratory tract disease in Australia, in the 
absence of equine influenza virus infection (Christley el aL, 1999b; 2001 a). 
Trainina and racin 
The case control study conducted in Australia by Christley, using coughing as a 
clinical indicator of equine respiratory disease, demonstrated that this sign was most 
prevalent in horses in the early stages of training (Christley el aL, 1999b; 200 1 a). This was 
consistent with coughing being least prevalent in those animals that had been in the 
training yards for the longest time. Data from this study also suggested, having controlled 
for the effects of age, stage of training and time since last transported, that racing within 
the previous 7 days was associated with an increased risk of coughing compared to horses 
that had never previously raced. There was also evidence that horses that had been 
transported at least 14 days previously, were at increased risk of coughing compared to 
those transported less than one week previously. As the authors stated, this appeared 
somewhat anomalous as transport is recognised as a risk factor for respiratory disease 
(Raphel & Beech, 1982; Austin et al., 1995; Raidal el aL, 1997a). However, taking into 
account other significant variables in their analyses, this probably indicated a lag period 
between recent arrival in the training yard and the onset of coughing. 
In the Canadian study of IURD, the effect of previous racing, controlling for other 
significant factors, demonstrated a reduction in odds of disease (Morley, 1995). This 
indicated that for influenza related IURD, previous racing apparently conveyed a 
protective effect over and 'above that conveyed by the effects of increased age, male 
gender and raised antibody titres which had been identified as significant risk factors in 
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this particular study. The author speculated that this was most likely evidence of a 
'healthy worker' effect, i. e. only horses without clinical signs of disease would be sent 
racing rather than that the act of racing somehow conveyed protection. 
Miscellaneous 
Other miscellaneous causes of coughing in horses include blood in the airways 
with EIPH (McGorum, 1994) and physical tracheal abnormalities including collapse, 
usually in aged ponies, (Mair & Lane, 1990; Mair, 1994; McGorum, 1994) and more 
rarely obstruction from intraluminal masses (Wenger & Caron, 1988). Other rare causes 
are thoracic neoplasia (Mair & Brown, 1993; McGorum, 1994), Crofton weed 
(Eupatorium adenophanim) toxicity in Australia (O'Sullivan, 1979), eosinophilic 
interstitial pneumonia (Dixon et aL, 1992; Carrick, 1994), pulmonary infarction or 
oedema (Carr el aL, 1997), and cardiac diseases such as rupture of the rnitral chordae 
tendinae or bacterial endocarditis (Mair, 1994; Reef el aL, 1998). 
1.2.4 Dyspnoea 
Dyspnoea is the medical term used to describe the clinical presentation of laboured 
or exaggerated breathing and is principally an indication of inadequate ventilation and/or 
insufficient oxygenation of the circulating blood (Blood & Studdert, 1988). 
Physiologically, dyspnoea attempts to correct these insufficiencies and so clinically it may 
be manifested as an elevated respiratory rate (tachypnoea), exaggerated effort by 
intercostal and/or abdominal muscles (abdominal effort' or 'heaves'), flaring of the 
nostrils, extension of the head and neck, elbow abduction and abnormal sounds (usually 
stridor) (Mair & Lane, 1996). 
Dyspnoea may be thought of as having 4 classic subdivisions (Mair & Lane, 
1996). These are i) obstruction, ii) reduced thoracic capacity, iii) compromised gas 
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exchange and iv) physiological disorders. Table 1.1, adapted from Mair (1996), 
summarises conditions that cause dyspnoea in the horse according to each of these 4 
subdivisions. Some of these conditions, such as RAO, SPAOPD and pneumonia, may be 
classified in more than one category as they cause reduced gas exchange but are also 
'obstructive' diseases. 
In the majority of cases of dyspnoea there is likely to be both an increased rate and 
depth of respiration, with the effort used for both the inspiration and expiration phases of 
breathing being exaggerated to some extent (Mair & Lane, 1996). However, depending 
on the cause of dyspnoea or site of obstruction, either inspiratory or expiratory efforts 
may be more pronounced than the other. For example, upper respiratory tract (and by 
definition extra-thoracic) obstructions will tend to produce more pronounced inspiralory 
compromise and hence require additional effort at this stage of the breathing cycle. This is 
because respiratory obstruction will be exacerbated by dynamic airway collapse due to the 
reduced intraluminal pressure that occurs at this stage of respiration. Examples of this 
have been observed in horses with upper respiratory tract obstruction of various types. 
These include intralurninal tracheal obstruction (Wenger & Caron, 1988), tracheal 
compression by peri-tracheal abscess (Tessier et al., 1996), choanal atresia (Richardson el 
al., 1994a), persistent DDSP in foals (Altmaier & Morris, 1993), arytenoid chondritis 
(Haynes et al., 1980) and abnormalities of the nostrils (El Maghraby, 2000), false nostrils 
(Torre et al., 1993) and larynx (Haynes el aL, 1980; Duncan & Brook, 1985; Muylle, 
1988; Behrens & Pinero, 1990; Burba et aL, 1991; Dixon et al., 1993b). 
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In contrast, obstructions of the lower, intrathoracic respiratory tract (e. g. severe 
IAD, pneumonia, RAO, and SPAOPD) will produce more obvious expiratory dyspnoea 
because there is dynarnic collapse of these airways during expiration when intraluminal 
airway pressure is exceeded by extraluminal, pleural pressure (Mair & Lane, 1996; 
Robinson el aL, 1996; Robinson, 1997c). This results in the animal adopting a breathing 
strategy that allows it to exhale most of its tidal volume at an early stage in expiration which 
is then followed by an abdominal push that forces a relatively small volume of air through 
the obstructed and compressed airways (Robinson et al., 1996; Robinson, 1997c). 
Obstructions of the larger diameter upper airways, because their total cross sectional 
area is actually much smaller than that of the distal airways, may cause dyspnoea relatively 
easily (Robinson, 1997a). In order for obstructive lower respiratory tract diseases to cause 
signs of dyspnoea, obstruction of the bronchioles must be both diffuse and severe, i. e. a 
large proportion of the total cross sectional area of these airways must be obstructed 
(Robinson, 1997a). 
Inspiratory dyspnoea may also occur in diseases of the lower respiratory tract that 
inhibit expansion of the lungs, therefore requiring additional inspiratory effort to try and 
force air into the gas exchange regions (Mair & Lane, 1996). This type of dyspnoea occurs 
with interstitial pneumonia and alveolitis (Prescott ef aL, 1991; Whitwell, 1992; Ainsworth 
ef aL, 1993; Kelly et aL, 1995) and restrictive diseases affecting the pleura, including 
pneurnothorax (Boy & Sweeney, 2000), pyothorax/pleural effusion (Smith, 1977; Raphel & 
Beech, 1982; Ogilvie et aL, 1983; Collins et al., 1994, Carr et aL, 1997; Scarratt et al., 
1997; Quintavalla, 1998) and ruptured diiaphragm (Perdrizet el al., 1989; Ewart el aL, 
1992; Goehring el aL, 1999). 
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1.2.5 Lymph node enlargement 
The respiratory tract in the horse has associated lymphoid tissue throughout, which 
comprises series of multiple aggregated lymph nodes organised as anatomically discrete 
lymphocentres (Getty, 1975). The main equine lymphocentres relating to the respiratory 
tract are, from the nostrils caudally; the submandibular (SMLN or mandibuar), parotid, 
retropharyngeal (RPLN), superficial and deep cervical, mediastinal, axillary, dorsal and 
ventral thoracic, and bronchial (Getty, 1975). The vast majority of these lymphocentres, 
with the possible exception of the more superficial submandibular chain of nodes, are not 
normally palpable. 
Lymph node enlargement in association with respiratory disease in horses is most 
frequently seen with S. equi infection, with the disease colloquially referred to as 'strangles' 
because of the respiratory obstruction caused by lymph node abscessation in more severe 
cases. S. equi infection may affect all the lymphocentres of the head (submandibular, parotid 
and retropharyngeal), causing swelling, pain, abscessation and consequent disturbance to 
eating, swallowing and breathing. If left untreated lymph node abscesses usually discharge 
their purulent contents as a normal part of the course of the disease. In the case of 
submandibular lymph nodes there will be external discharge through the skin between the 
rami of the mandibles and for the parotid lymphocentre a discharge will be seen on the side 
of the face just below the ear (Sweeney, 1996). However, the RPLNs more commonly 
discharge internally through the ventral floor of the guttural pouch resulting in guttural 
pouch empyema, which when this drains via the pharyngeal pouch opening may be 
swallowed or appear as a purulent nasal discharge (Knight et aL, 1975; Sweeney, 1996; 
Newton et aL, 1997b; Fintl et aL, 2000). As mentioned for the derivation of the name 
'strangles', another major clinical sign associated with lymph node abscessation is dyspnoea 
due to physical respiratory obstruction, which may occur through occlusion of the pharynx 
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and larynx by the RPLNs or cranial deep cervical nodes or the trachea by the caudal cervical 
(Little et aL, 1985), mediastinal (Rigg et aL, 1985) or bronchial lymph nodes. 
Such a case of obstruction by peritracheal abscessation has also been reported 
associated with S. zooepidemicus infection of the caudal cervical lymph nodes (Tessier el 
aL, 1996). Lymph node enlargement with or without abscessation may be observed with 
other bacterial infections including Rhodococcus equi (Roberts et aL, 1980; Vyslouzil et aL, 
1984; Zinck et aL, 1986), S. pneumoniae (Blunden el aL, 1994) and Actinobacillus spp. 
(Zaharija el aL, 1979). Viral infections, including EHV-l (Allen & Bryans, 1986; Kydd el 
aL, 1994; Heldens et al., 2001) and ERV-1 (Plummer, 1962; Plummer & Kerry, 1962; 
Hofer et al., 1973), may also result in lymph node enlargement. 
1.2.6 Scoring of clinical disease 
Clinical scoring has been used in a number of studies of equine respiratory disease 
and these vary as to the range of signs that are assessed and the relative weights assigned to 
these individual parameters. 
There have been several studies that used clinical scoring on aspects of allergic 
respiratory disease such as RAO and SPAOPD. In some of these studies particular attention 
was paid to assessing the nature of the respiratory effort and this was done in a number of 
ways. in some studies this was by only scoring the extent of nasal flaring and abdominal lift 
(Seahorn et aL, 1997; Rush et aL, 1998; Costa et aL, 2000; Robinson et aL, 2000), which 
were given equivalent weighting. In other studies of RAO a wider range of clinical 
parameters were assessed. Tesarowski et aL (1996) used abdominal lift and nasal flaring in 
a complex 25-point scale, based on a system described by Hoffman el aL (1992b), that also 
included coughing, nasal discharge, respiratory rate, thoracic auscultation and percussion, 
and various sounds such as wheezes and crackles from the trachea, bronchi and lungs. In an 
assessment of the role of endotoxin in RAO, Pirie et aL (2001b) used a 13-point scale that 
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included coughing, nasal discharge, dyspnoea, respiratory rate, thoracic auscultation, pulse 
rate and pyrexia, with respiratory rate and dyspnoea being weighted the most heavily. In 
studies - of airway responsiveness and its attenuation Hare and co-workers described a 15- 
point scale based on cough, nasal discharge, respiratory rate, thoracic auscultation, 
bronchoscopy, expiratory effort and SMLN enlargement (Hare et aL, 1994; Hare & Viel, 
1998; Hare el aL, 1999). 
A number of studies of equine viral diseases including trials of vaccine efficacy have 
used clinical scoring systems, usually applied to much younger horses than in RAO studies 
and with less emphasis on characterising the degree of respiratory effort. The scoring 
systems adopted in these studies have been generally more consistent in the range of signs 
that are evaluated, although the weighting of these has differed. 
In a study of the efficacy of an inactivated EHV vaccine, Heldens et aL (2001) used 
a 29-point scale which included demeanour, appetite, respiratory rate, nasal and ocular 
discharge, coughing and SMLN enlargement. In this system, death or paralysis contributed 
10 points in the demeanour score and severe mucopurulent nasal and ocular discharges each 
scored 4.5 points. In a study of the effect of exercise on severity of signs in influenza 
infected horses, (Gross et aL, 1998) used a 6-point score that comprised equally weighted 
single scores each for fever, inappetance, depression, coughing, mucopurulent nasal 
discharges and abnormal lung sounds. In studies of a modified live equine influenza virus 
vaccine, Chambers et aL (2001) and Townsend et aL (2001) used a 7-point scale that 
scored coughing, nasal discharge, abnormal respiration and depression characterised by 
lethargy and inappetance. This score was most heavily weighted towards nasal discharge, 
which scored a possible maximum of 3 points and was least weighted towards abnormal 
respiration and depression which each scored a single point if observed. 
Many other studies, particularly on equine influenza virus infections, have evaluated 
a similar range of signs by allocation of scores for severity to each sign but rather than 
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generating aggregated summary scores for overall respiratory disease, they have evaluated 
each sign individually (Mumford et aL, 1983; 1988; 1990; Hoffman el aL, 1993a; Burrell el 
al., 1994; Mumford et aL, 1994b; 1994c; 1994d; Buffell et aL, 1996; Kastner el al, 1999; 
Morley et aL, 1999; Newton et aL, 1999b; Morley el al., 2000) 
In the majority of descriptions of scoring systems used to evaluate clinical severity 
of respiratory disease in horses the relative weighting assigned to different signs generally 
remains unjustified. However, it is usually evident from the scores used which signs are 
considered the most important by, the researchers involved although it is frequently not 
clearly stated that the scoring system was adopted prior to the conduct of the study and was 
not applied to data post hoc. 
1.3 Subelinical respiratory disease in horses 
Respiratory disease in horses may not necessarily be accompanied by overt clinical 
signs of disease as there may be pathology of the airways that remains effectively subclinical 
unless additional diagnostic investigations are carried out. 
1.3.1 Haematological investigations :I 
Although some veterinary surgeons and racehorse trainers hold store by the 
diagnostic benefit of haernatological investigations (Allen & Frank, 1982; Mason el at, 
1989a; 1989b; 1990), if changes to haematological parameters are detected these are often 
non-specific and may be seen in healthy as well as diseased individuals (Wood, 1999). The 
use of haernatology in the diagnosis of subýlinical respiratory disease is not discussed 
further here. 
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1.3.2 Respiratory endoscopy 
The advent of more widespread use of fibreoptic endoscopy in the examination of 
the respiratory tract of horses allowed hitherto inaccessible areas of the equine respiratory 
system to be assessed with respect to pathological conditions (Cook, 1974c; Burrell, 1985). 
As well as demonstrating that the lung was the source of bleeding for epistaxis (Cook, 
1974a) and that such bleeding (EIPH) was actually far more prevalent than epistaxis 
(Pascoe & Wheat, 1980, Pascoe & Raphel, 1982) because blood was more frequently 
swallowed than appeared at the nostrils, fibreoptic endoscopy revealed other 'pathological' 
phenomena of the equine respiratory tract. 
1.3.2.1 Pharyngeal lymphoid hyperplasia (PLH) 
One such 'pathological' condition was the presence of hyperplastic lymphoid 
follicles in the walls of the pharynx (pharyngeal lymphoid hyperplasia; PLH), particularly in 
young horses. PLH has been i) attributed to specific viral infections (Prickett, 1969; 
Blakeslee el aL, 1975), ii) cited as a reason for poor performance in some horses (Raker & 
Boles, 1978) and iii) observed to reduce following vaccination (Montgomery, 1981). 
However, a subsequent study in racehorses failed to demonstrate any significant 
associations between PLH and i) isolation of EHV-2 from the nasopharynx, ii) racing 
performance and iii) antibody titres raised to EHV-1 by vaccination (Buffell, 1985). This 
study did, however, clearly demonstrate a significant inverse correlation between decreasing 
severity of PLH and increasing age and time spent in the training yard, which was consistent 
with earlier age-related findings (Raphel, 1982). It is now generally accepted that this 
condition is a normal physiological phenomenon in young horses (Embertson, 1997). 
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1.3.2.2 Endoscopically visible tracheal mucus 
In addition to examination of. the upper respiratory tract, fibreoptic endoscopy has 
facilitated the exanýination of the airways distal to the larymx, particularly the distal trachea, 
allowing visible assessment of the presence of mucus (and/or blood) at this site (Burrell, 
1985). Different groups'have assessed the degree of mucus in the trachea using different 
scoring systems. One of the most widely adopted systems has been the 3-point score 
described by Burrell (1985) where grade 0 was no mucus observed, grade I was isolated 
globules, grade 2 was a thin continuous stream <15mm wide and grade 3 was a thick 
continuous stream >15mm wide (Burrell, 1985; Wood el aL, 1993a; Burrell el al,, 1994; 
1996; Wood et aI, 1997a; Wood, 1999; Chapman el aL, 2000). Others have used/use a 
similar system but based on a 5-point scale (Dixon el aL, 1995b; Holcombe el aI, 2001) 
(M. ' Shepherd and B.: Herinckx - personal communications). The 5-point scoring system 
was described by Holcombe et aL, (2001) as follows: 0- no visible mucus, I- singular 
small blobs, .2- multiple blobs only partly confluent, 3, - ventrally confluent, 4- large 
ventral pool and 5- profuse amounts occupying >24% of the tracheal lumen. Recently, a 
more complex scoring of tracheal, endoscopy -findings has been described with scores 
ranging between 2 and 20 (Hamm et aL. 2002). This system took 6 parameters into account 
amount ii) nature and iii) location of discharge, iv) whether or not there was discharge 
visible on insertion and v) withdrawal of the endoscope, and vi) clinician's overall rating. 
The timing' of examination relative to exercise would appear to be an important 
factor in whether or ýnot mucus'is visible in the trachea at endoscopy (Buffell, 1985; 
Lumsden ef al., , 1995; Wood, 1999). Several studies have concluded that endoscopy 
conducted after, exercise, increases . the likelihood . of , observing, tracheal mucus. 
Burrell 
(1985) observed that the prevalence of tracheal mucus was significantly greater (P<0.001) 
following cantering or galloping (62%) than after walking, trotting or no exercise (16%). In 
a series of referred cases of suspected upper respiratory tract disorders, 20% of horses were 
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only found to have increased levels of tracheal mucus following exercise (Lumsden et aL, 
1995). It is therefore important in critically considering the findings of studies using tracheal 
endoscopy of horses, to take into account whether or not the procedure has been conducted 
after exercise or not. In this thesis, in the study of respiratory disease in Thoroughbred 
racehorses, endoscopy was conducted after exercise but in the Welsh Mountain ponies 
endoscopy was performed following only the exercise required to bring the animals from the 
field to the adjacent examination area. 
1.3.2.3 Collection of tracheal aspirates 
As well as visible assessment of mucus and/or blood throughout the length of the 
trachea, endoscopy also facilitates collection of respiratory samples by instillation and 
aspiration of sterile fluid via catheter placed in the biopsy channel of the endoscope (Greet, 
1982; Whitwell & Greet, 1984; Dixon, 1995). Alternatively, collection of tracheal aspirates 
from horses may be conducted by transtracheal catheterisation techniques (Mansmann & 
Knight, 1972; Beech, 1981; Greet, 1982; Dixon, 1995). Although it avoids sample 
contamination by bypassing the upper respiratory tract, transtracheal aspiration does have 
some disadvantages compared to the transendoscopic technique. Transtracheal aspiration 
can be considered surgically invasive and as such requires good aseptic conditions to avoid 
subcutaneous infection (Dixon, 1995; Greet, 1982). Samples may become contaminated by 
blood from the stab incision and care is needed not to cut the catheter during vvithdrawal 
through the needle that is used to access the tracheal lumen through the skin (Dixon, 1995; 
Greet, 1982; Sweeney et aL, 1989). The procedure is also relatively time consuming, may 
require sedation of the horse to avoid undue movement and has limitations with respect to 
being frequently repeated. In addition, it has been shown that the degree of bacterial 
contamination from negotiating the upper respiratory tract in transendoscopically collected 
samples is not usually large (Sweeney el al, 1989; Darien et al., 1990; Christley et al., 
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1999a). This was particularly illustrated by the faure to isolate aerobic bacteria from a total 
of 341 of 551 (62%) transendoscopically collected tracheal wash samples in a study of IAD 
in young racehorses (Wood el aL, 1993a). Analysýis of data from this study also showed a 
hig)-dy statistically significant decreasing trend with increasing inflammation score for the 
proportions of samples from which aerobic bacteria were not isolated (Table 1.2). 
Table 1.2: Linear trend for decreasing proportion of samples with increasing 
inflammation score from which aerobic bacteria were not isolated for data 
presented by Wood et A (1993) 
Inflammation Sterile tracheal washes Total tracheal Odds Ratio* 
score n% washes examined 
0 155 76 205 1.00 (ref) 
1 120 69 174 0.72 
2 42 51 83 0.38 
3 24 27 89 0.12 
Total 341 11 62 * 551 
x2 for linear trend = 65.85 (P<0.00001) 
1.3.2.4 Cytological assessment of tracheal aspirates ,, 
Methods for detailed cytological assessment of transendoscopically or 
transtracheally collected tracheal washes from horses have been described (Beech, 1975; 
Whitwell & Greet, 1984; Mair, 1987; Sweeney et al., 1992; Freeman, 1997; Freeman & 
Roszel, 1997a; 1997b). As for assessment-of tracheal mucus there have been various 
systems used to score airway inflammation based on indices of tracheal wash cytological 
parameters (Sweeney et al., 1992), sometimes also incorporating a measure of visible 
tracheal mucus (Whitwell & Greet, 1984; Wood el al., 1993a; Burrell et al., 1996; 
Chapman et al., 2000). Sweeney et al. (1992) classified tracheobronchial aspirates from 
racehorses according to neutrophils as a proportion of the cells seen in a representative area 
of aspirate smear, with the baseline 'normal' group having :! ý20% neutrophils. Whitwell and 
Greet (1984) described a 3-point 'inflammation score' based on assigning a single point to 
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each of i) moderate or profuse tracheal mucus, ii) ýý103 nucleated cells/ml. of tracheal wash 
and iii) moderate or greater proportions of neutrophils in the tracheal wash. This system, 
with a minimum score of 0 and a maximum score of 3, has been used in a series of studies 
by the AHT (Wood et aL, 1993a; Burrell et al., 1996; Wood et aL, 1997b; Ward et aL, 
1998) including the longitudinal study of respiratory disease in racehorses (Wood, 1999). 
This system was slightly modified to a 5-point score in a study of experimental ozone- 
induced pulmonary oxidant injury in horses (Mills el aL, 1996). Definitions for each grade 
of inflammation were prescriptive but included the possibility of increasing scores by 0.5 to 
I according to certain criteria, including bronchoalveolar lavage characteristics. The 
Whitwell & Greet (1984) system was also recently adapted as a 9-point score by Chapman 
et aL (2000) in a retrospective study of IAD in racehorses. Scores comprised the sum of 3 
ordinal 0-3 scores for each of i) tracheal mucus, ii) cell count density and iii) neutrophil 
proportion as measured by percentage of cells on the smear. In their study Chapman et aL 
(2000) scored neutrophil proportions slightly differently to Sweeney et al. (1992), as those 
with <5% neutrophils were considered baseline 'normal' (score 0) and subsequent scores 
were assigned for 5-10% (score 1), 10-40% (score 2) and >40% neutrophils (score 3). 
1.3.3 Bronchoalveolar lavage (BAL) 
The use of bronchoalveolar lavage (BAL) to sample the distal airways of the equine 
lung has been used since the early 1980s and may be performed 'blindly' using appropriate 
catheter tubing or through a suitably long endoscope (>2 metres) that allows sufficient 
access to the narrower conducting airways (Fogarty, 1990; McGorum & Dixon, 1994; 
Moore, 1996). The relative merits of each of these BAL techniques have been discussed 
(McGorum & Dixon, 1994). 
Results of cytological examination of aspirates from BAL and tracheal lavage 
sampling have been compared but with no clear agreement across studies as to whether or 
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not there is good correlation between the 2 techniques (Mair, 1987; Mair el aL, 1987; 
Derksen el aL, 1989; Winder ef aL, 1991 Traub Dargatz el aL, 1992; Freeman el aL, 1993; 
Dixon et aL, 1995a). The relative merits of BAL and tracheal lavage have been debated 
with respect to i) their practicality in different types of horses (importantly among 
performance horses, endoscopic tracheal lavage does not require sedation), ii) their 
applicability in detecting focal pulmonary disease (BAL may miss focal disease whereas 
tracheal lavage samples all areas of the lung), iii) their relative clarity of cellular morphology 
(BAL generally has clearer cell morphology), iv) ease of differential cell counting (easier 
with BAL as less cellular clumping with mucus), v) degree of 'contamination' by 
degenerative cells, mucus and debris and subsequent ease of cytological interpretation 
(although BAL has less contamination, tracheal lavages are easily and accurately 
interpreted) (McGorurn & Dixon, 1994; Dixon et al., 1995a). 
To this end BAL has tended to become the technique of choice in studies of allergic 
respiratory disease (Naylor et aL, 1992; McGorum & Dixon, 1993; McGorum et aL, 1993a; 
1993b; 1993c; 1993d; Robinson et al, 1996; Robinson, 2001). BAL is also frequently used 
with other ancillary tests in referred cases of respiratory disease (Dixon el aL, 1995a; 
1995b; Dixon, 1997) and in EIPH pathogenesis research (D. Marlin - personal 
communication). 
Tracheal lavage is used much more frequently in clinical investigations and routine 
monitoring of IAD in racehorses that are frequently subjected to repeated sampling of the 
respiratory tract (Whitwell & Greet, 1984; Burrell, 1985; Burrell el aL, 1986b; Wood ef aL, 
1993a; Burrell et aL, 1994; 1996; Wood et aL, 1997a; Christley ef aL, 1999b; Wood, 1999; 
Chapman et aL, 2000; Christley et al., 2001a; 2001b). This is because it is very well 
tolerated by both horse and trainer and importantly does not require sedation and the need 
for a subsequent withdrawal period from competition (McGorum & Dixon, 1994; Dixon et 
aL, 1995a). 
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In the studies presented in this thesis tracheal lavage and not BAL sampling was 
used for various reasons. Tracheal lavage was considered a more appropriate technique 
when repeated sampling of the airways was being conducted, particularly when these were 
only one week apart as for the Welsh Mountain ponies, because localised trauma and 
inflammation induced by the procedure is more likely with BAL. Endoscopic tracheal lavage 
is also better tolerated by horses (and trainers) compared to BAL and importantly does not 
require administration of sedatives, which, as prohibited substances under the rules of 
racing, may affect subsequent race entries. Tracheal lavage, particularly if conducted after 
exercise, effectively samples the whole of the lung and is therefore much less likely to miss 
focal disease in more cranial and ventral regions of the lung than BAL, which samples only 
a small dorsal and caudal area of the lung. Although, several authors claim that BAL 
produces superior quality cytology, the pathology laboratories at the AHT have many years' 
experience in the preparation and interpretation of high quality cytological smears from 
tracheal lavage samples and these have been shown to be just as useful as BALs. 
1.4 Transferrin 
1.4.1 Bacterial iron acquisition 
Iron is both an essential requirement for bacterial cell growth and is toxic when 
present in sufficient concentration as free ions (Carter el aL, 1995). Host mammalian 
environments maintain toxic free iron at very low concentrations that is inhibitory to 
bacterial growth through specific complex metabolic mechanisms (Nixon, 2000). Iron 
metabolism, involving interplay of absorption, transport and storage, is conducted by many 
different enzymes and proteins, which ordinarily maintains a bacteriostatic and bacteriocidal 
environment by preferential chelation of iron (Ganzoni & Puschmann, 1975; Bezkorovainy, 
198 1; Bullen, 198 1; Ward el aL, 1996; Jurado, 1997). 
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The principal mammalian iron transport protein is transferfin, which binds iron 
strongly but reversibly, with iron being normally released within host cells via transferrin- 
receptor complexes following cellular endocytosis. However, some pathogenic bacteria 
have developed mechanisms for acquiring iron for growth from mammalian transferrin in 
these iron-restricted environments, by producing cell membrane-associated transferrin 
binding proteins (TBPs) that interact with transferrin and preferentially sequester iron 
(Comelissen & Sparling, 1994b; Guerinot, 1994; Jurado, 1997; Ratledge & Dover, 2000). 
Bacteria that demonstrate such TBP iron acquisition include members of the Neisseria 
(Cornelissen & Sparling, 1994a); Haemophilus (Schryvers & Gray-Owen, 1992), 
Pasteurella (Lo, 200 1; Ogunnariwo et aL, 1997) and A clinobacillus (Gerlach el aL, 1992) 
species, all of which are important pathogens of humans and domestic animals. Many 
pathogenic bacteria (such as Yersinia, Vibrio and Pseudomonas spp. and mycobacteria) use 
siderophore-mediated iron acquisition (reviewed by Ratledge & Dover, 2000). These 
organisms produce siderophores, which are iron binding agents, to preferentially chelate 
iron from some host molecules such as ferritin, transferrin and lactoferfin. However, as 
there is little evidence that the Streptococci or Pasteurellaceae use this mechanism to 
acquire iron, it will not be mentioned further here. 
It has been conceived that immunisation of animals against bacterial TBPs may be an 
effective means of protecting against these infections (Finkelstein el aL, 1983; Jurado, 
1997; Sparling et aL, 1994). Such a vaccination strategy has been shown to be effective for 
Mannheinfia haemolyfica in ruminants (Potter el aL, 1999) and inactivated vaccines with 
proven efficacy that incorporate M haemolytica propagated under iron restricted conditions 
(so called iron regulated protein or IRP vaccines) are now commercially available. Similar 
technology is being used in the development of vaccines against Actinobacillus 
pleuropneumoniae in pigs (Goethe el aL, 2000; Van Overbeke el al., 2001). 
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The restricted mammalian host ranges for some strains of TBP expressing bacterial 
species appear to be related to their ability to utilise only the transferrin of the specific host 
species (Schryvers & Gonzalez, 1990). Examples include Haemophilus influenzae 
(Schryvers & Gray-Owen, 1992) and N. meningitidis (Schryvers & Gonzalez, 1990) in 
humans, H. somnus in cattle (Yu et aL, 1992), Pasteurella spp. in ruminants (Ogunnariwo 
& Schryvers, 1990; Ogunnariwo et aL, 1991; Yu et aL, 1992) and A. pleuropneumoniae in 
pigs (Gonzalez et aL, 1990). This implies that there are important differences between 
transferrins of different mammalian species that preclude universal iron acquisition by 
bacteria with ability to express TBPs. 
In Streptococci, an important class of pathogenic -bacteria in both humans and 
animals, iron'acquisition mechanisms in iron restricted conditions have not been thought to 
involve direct iron sequestration from transferrin by TBPs (Chhatwal et al., 1985; 
Eichenbaum et aL, 1996;. Tai el aL, 1993). There is, however, evidence that lactoferrin, an 
iron binding protein closely related to transferrin, provides some innate immunity against 
infection with several streptococcal species by preferential chelation of iron. This has been 
demonstrated for S. mulans (Lassiter et aL, 1987; Arnold et aL, 1980; 1981) and S. 
pyogenes (Stenfors et aL, 200 1) in man and S. agalactiae (Rainard, 1992; 1993) in mastitis 
in cattle. There is litnited evidence that S. pneumoniae (Hakansson et aL, 2001; 
Hammerschmidt et aL, 1999) in man and S uberis (Fang &'Oliver, 1999) in mastitis in 
cattle may actually acquire iron from lactoferrin. Despite the lack of evidence for a direct 
role of transferrin in protection or predilection'to infection by Streptococci and disease, 
there are some intriguing suggestions that iron saturation of transferrin may be important in 
the pathogenesis of streptococcal infections. In a study of prognostic factors for S. 
pneumoniae pneumonia in people, Lambert & Hunter (1990) identified that only 14% of 
patients with low levels of unsaturated transferrin'and positive blood cultures survived 
compared to 80%-88% of people with negative blood culture and/or normal unbound iron 
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binding capacity. The authors suggest that insufficient unsaturated transferrin may have 
facilitated the bacteraemia and consequently contributed to fatal pneumococcal pneumonia. 
Brochu et aL (1998) demonstrated in vitro that S. intertnedius was able to acquire iron in 
iron restricted conditions by causing its release from transferrin by rapidly decreasing the pH 
of the culture medium. They confirmed that this was not associated with TBPs or 
proteolytic activity and was prevented when the buffering capacity of the medium was 
increased. 
1.4.2 Equine transferrin 
Transferrin is one of the serum proteins that are frequently characterised according 
to their electrophoretic properties in the blood typing and parentage testing of horses (Jones 
& Bogart, 1971). Equine transferrin is a highly polymorphic trait with 14 alleles (referred to 
as haplotypes from here) currently recognised for the single locus of the transferrin gene 
(Bowling, 1986). As each horse has 2 alleles, one from each parent, this means that there 
are 105 potential combinations (phenotypes) of these haplotypes, with heterozygous animals 
having 2 transferrin types in their blood corresponding to each separate haplotype (Jones & 
Bogart, 1971). The frequency of transferrin haplotypes among different horse breeds has 
been characterised (Table 7, page 86 in Bowlin [1986]) and shows that the most prevalent 19 
haplotypes in all breeds are transferrins D and F2. 
' 
Although the electrophoretic properties of equine transferrin are well recognised and 
utilised throughout the world for parentage testing and identification in horses, the 
relationship of different transferrin haplotypes and phenotype combinations with respect to 
differential release of iron to bacterial TBPs or through other mechanisms, and hence 
predisposing to bacterial disease, have not been reported in the horse. It is possible, 
however, that . differences in , electrophoretic properties 
between equine transferrin 
haplotypes might well be related to- differe, nces, in competitive binding of iron (Charlwood & 
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Jarritt, 1974) in the presence of either TBP or other bacterial iron chelating mechanisms, 
resulting in different manifestations of infection and disease in horses possessing different 
haplotypes. 
To this end, one aim of this thesis was to examine whether different transferrin 
haplotypes in Welsh Mountain pony foals were associated with differences in disease and 
infections of the respiratory tract. This would be presumed to involve infection with 
Pasteurella and Actinobacillus spp., which are known to be associated with equine 
inflammatory respiratory disease and are recognised as acquiring iron via TBPs. The 
background to how this came about is covered in the introduction to the study of naturally 
occurring respiratory disease in Welsh Mountain pony foals (Section 3; Chapter 6). 
1.5 Streptococcus zooepidemicus 
1.5.1 Association of S. zooepitlemicus infection with equine respiratory disease 
Streptococcus zooepidemicus is the bacterium most frequently isolated from cases of 
equine pneumonia and pleuropneurnonia (Raphel & Beech, 1982; Welsh, 1984; Sweeney et 
aL, 1985b; Mair & Lane, 1989; Sweeney et al., 1991; Chaffin & Carter, 1993) and has 
generally been regarded as the most important secondary pathogen of the respiratory tract 
of horses following primary viral infection (Gerber, 1970; Thomson, 1978; Allen & Bryans, 
1986; Wood & Chanter, 1994; Allpress, 1997). Although most frequently associated with 
horses, diseases in other species including man may be associated with infection with S 
zooepidemicus (Chanter, 1997). In man, unpastuerised milk from cows with mastitis may be 
the source of S. zooepidemicus associated sore-throats, septicaernia, meningitis and 
nephritis (Barnham et aL, 1983; Barnham et aL, 1987a; Bamham et aL, 1987b; Chanter, 
1997). In addition, S. zooepidemicus may be associated with metritis and mastitis in cattle; 
arthritis, abortion and septicaemia in pigs; pleuritis, pericarditis and pneumonia in lambs; 
fatal septicaemia in chickens (Carter et aL,, 1995) and mass mortality from pneumonia in 
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rodents such as coypu (Martino & Stanchi, 1998), guinea pigs (Weber & Bruner, 1979) and 
mice (Literak & Mraz, 199 1). 
Epidemiological studies have demonstrated significant associations between 
infection with S. zooepidemicus of the lower airways of racehorses and both IAD (Wood el 
aL, 1993a; Burrell et aL, 1996; Wood, 1999; Chapman el al., 2000) and coughing 
(Christley el aL, 2001b). These studies have also shown a strong association between these 
2 syndromes and demonstrated that coughing is a specific but insensitive indicator of IAD 
(Burrell el aL, 1996; Christley et aL, 2001a) and that IAD associated with bacteria is not 
dependent on prior viral infection (Wood, 1999). However, to date there has been only one 
limited report of an experimental infection demonstrating that S. zooepidemicus can act as a 
primary pathogen (Varma et aL, 1984). The reasons for the current and foreseeable lack of 
evidence for S. zooepidemicus satisfying Koch's postulates of infectious causality relate to 
this being a ubiquitous infection of equids and the non-availability of specific-pathogen-free 
(SPF) foals to this organism. Consequently,, early natural exposure of horses to S. 
zooepidemicus usually acts to confound experimental challenges (N. Chanter, unpublished 
observations). In addition, epidemiological studies have shown that whilst S. zooepidemicus 
infection may be the most important infectious factor in these disease syndromes, it is not 
absolutely exclusive. Other infections such as ActinobacilluslPasteurella spp., S 
pneumoniae (Wood et al., 1993a; Burrell el aL, 1996; Wood, 1999; Chapman et aL, 2000; 
Christley et aL, 2001b) and sometimes mycoplasmas and viruses may be involved in mixed 
infections (Wood, 1999). As an alternative to the 'gold standard' of experimental 
reproduction of disease with recovery of the, organism from lesions, Wood & Chanter 
(1994) examined the criteria proposed by Hill - (1965) ý for assessing whether the 
epidemiological association between IAD and S. zooepidemicus infection (in conjunction 
with S. pneumoniae and ActinobacilluslPasteurella spp. ) was likely to be causal. Re- 
assessing their arguments exclusively for S. 'zooepidemicus, - Wood & Chanter (1994) were 
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able to satisfy at least 7 (strength of association, consistency, biological gradient, biological 
plausibility, coherence, some limited experimental evidence, analogy with other species) of 
the 9 criteria for causal association with IAD (Hill, 1965). 
1.5.2 Subtyping of S. zooepidemicus isolates 
Detection of S. zooepidemicus and its differentiation from other beta-haemolytic 
streptococcal. species using standard bacteriological techniques is relatively straightforward 
(Cowan & Steel, 1993). The epidemiological studies described above have used these 
techniques in conjunction with standard quantification techniques (Wood et aL, 1993a; 
Wood, 1999) to identify and quantify S. zooepidemicus in tracheal washes and all analyses 
have considered this organism as an homogenous species. However, there have been several 
subtyping techniques described for isolates of S. zooepidemicus and these have used various 
technologies that have been available at different times. Such techniques provide the 
opportunity for more detailed molecular epidemiological investigations of the role of S. 
zooepidemicus in equine respiratory disease. 
Moore & Bryans (1969) described the serotyping of equine isolates of Lancefield 
group C beta haernolytic bacteria by immunodiffusion precipitation using antiserum raised in 
rabbits inoculated with acid extracts of equine isolates of S. zooepidemicus. In the initial 
description of this method, 13 specific antigenic types were characterised and 68 of 164 
(41%) equine isolates of S. zooepidemicus could be classified by this typing technique 
(Moore& Bryans, 1969) 
Barnham, et aL (1987a) described the characterisation of a panel of human 
(zoonotic) and animal isolates of S. zooepidemicus using various methods including the 
AP120STREP biochemical typing method, antibiotic susceptibility, bacteriocin production 
and sensitivity and susceptibility to a panel of 14 group C streptococcal bacteriophages. 
Results using this range of different techniques generally demonstrated that types isolated 
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from the same outbreaks were similar and could be discriminated from other outbreak 
strains, particularly by bacteriocin production and sensitivity and bacteriophage 
susceptibility typing. However, there was also evidence that multiple strains were involved 
in some outbreaks of human disease. Subsequent 'DNA fingerprinting' of these same 
isolates using nuclease digestion and agarose gel electrophoresis confirmed many of these 
findings including large number of different types, the specificity of bacteriocin and 
bacteriophage S. zooepidemicus typing and that isolates from clusters of outbreaks did have 
identical 'prints' (Skjold et aL, 1987). 
Other techniques such as random amplified polymorphic DNA analysis (RAPD), 
multilocus enzyme electrophoresis (MEE) and pulsed-field gel electrophoresis (PFGE) have 
also been applied to a restricted number of human and animal S. zooepidemicus isolates and 
have been found to discriminate different types (Bert et aL, 1996; Soedarmanto el aL, 1996; 
Bert el aL, 1997). 
Jorm et aL (1994) used MEE to type 70 isolates of S. equi and 177 isolates of S. 
zooepidemicus recovered from horses on 2 Thoroughbred studs in New South Wales, 
Australia. Results confirmed that there was a large number of types (n=41) of varying 
prevalence identified by this method and that S. equi appeared as a single clone apparently 
derived from the antigenically more diverse archetypal S. zooepidemicus species. 
Walker & Timoney (1998) investigated the molecular basis of variability in the M- 
proteins of S., zooepidemicus (SzP) isolates by sequencing and comparison of the M-protein 
genes of 14 of 15 different Moore and Bryans serovars. Two distinct M-protein types were 
identified on the basis of the amino acid sequences of the N-terminal corresponding to 
residues 27 to 48 and variability in the number of repeats of proline-glutamic acid-proline- 
lysine (PEPK) at the carboxy terminal. In addition, 5 distinct M-protein hypervariable 
regions (HVI-HV5) were identified corresponding to differences in arnino acid sequences 
between residues 106 and 166. These typing techniques have also been used to demonstrate 
70 
Equme hdWmatory Amway Dnease Epi&rniolW 
that horses without clinical signs could simultaneously harbour different subtypes of S. 
zooepidemicus in their tonsils but that separate isolates from the lower airways of cases of 
pneumonia in donkeys and foals were identical and consistent with infection by a single 
clone (Timoney et aL, 1997; Anzai et al., 2000). Further studies using typing by restriction 
fragment length polymorphism (RFLP) electrophoretic characteristics following digestion of 
SO by the restriction enzyme Dde I, have shown at least 19 different S. zooepidemicus 
types among 194 isolates from 29 foals and 2-year-olds (Anzai et al., 2001). 
Chanter el aL (1997) used the 16S-23S RNA gene intergenic spacer to characterise 
different members of the Lancefield group C streptococci of S. equi, S, zooepidemicus, S. 
equisimilis and S. dysgalactiae. Nine distinct regions of the spacer were identified and 
variations in spacer regions 1,3,5,6 and 7 were used to group all S. zooepidemicus and S. 
equi isolates into one of 8 possible intergenic spacer types (Al, A2, BI, B2, Cl, C2, DI 
and D2), with all S. equi being type DI clones. 
More recently Abdulmawjood & Lammler (2000) described using several 
differences in the V2 region of the 16S rRNA gene identified by RFLP using the HincII 
restriction enzyme and sequence comparison with S. equi, as well as variation in the size of 
the 16S-23S rRNA spacer gene to discriminate different strains of S. zooepidemicus. 
In this thesis the 2 PCR typing methods based on characterisation of the M-protein 
hypervariable region (5 possible types) described by Walker & Timoney (1998) and the 
16S-23S RNA gene intergenic spacer (8 possible types) reported by Chanter et aL (1997), 
were both applied to isolates of S. zooepidemicus from Welsh Mountain ponies suffering 
naturally occurring respiratory disease. Theoretically, the combination of these 2 typing 
systems would permit the allocation of each isolate to one of 40 (8x5) hypothetical types. 
Both typing techniques required similar PCR facilities and could be applied easily together 
under the same cycling conditions. The availability of published primer sequences meant 
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that this combined typing technique could be easily adopted by other laboratories and 
applied to S. zooepidemicus isolates recovered from any species, including man. 
1.6 Design & analysis of studies of respiratory disease in horses 
Although we believe that infections are important in the aetiology of equine 
respiratory disease, especially in young horses, to date the associations of bacterial 
infections with disease have not been universally accepted. In addition, data for modelling 
dynarnics of specific infections, with the notable exception of equine influenza (Glass el aL, 
2002), are not readily available. Therefore, methods for the specific modelling of infectious 
diseases have not been adopted in this thesis but are briefly mentioned here for 
completeness. These methods include a posteriori reasoning (Bregman & Langmuir, 1990) 
and various forms of a priori reasoning including the mass action concept (Fine, 1993; 
Anderson & May, 1991), Reed Frost models for acute contagious infections (Abbey, 1952; 
Fine, 1977) and complex multi-compartment models with deterministic or stochastic 
approaches (Anderson& May, 1985; 199 1). 
1.6.1 Cases series and outbreak investigations 
Many studies of respiratory disease in horses have been either case reports/case 
series or descriptions of outbreaks and their investigation. Case reports and series tend to 
describe animals with specific clinical signs, series of signs (syndromes) or diagnoses that 
have usually been referred to particular centres over a period of time or seen by individual 
clinicians. Outbreak reports normally describe respiratory diseases occurring in a discrete 
group of horses, clustering in time and with a specific, single and usually infectious 
aetiology. There are many examples of these types of studies on equine respiratory disease 
among the literature and whereas they collate information from cases/outbreaks and provide 
useful descriptive information, they are usually limited by their lack of quantitative 
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assessment of specific risk factors for equine respiratory disease. Exceptions to this have 
been some outbreak investigations that have subjected data to simple quantitative analyses 
to examine particular risk factors (e. g. Wood el aL, 1997a), particularly relating to the 
efficacy of respiratory vaccines (Jorm, 1990; Morley, 1995; Newton et aL, 1999a; 2000a). 
1.6.2 Cases control studies 
Case control studies have certain advantages and disadvantages compared with 
other types of study such as the cohort design (Schlesselman, 1982). On the positive side 
they are well suited to rare diseases and those with long latency, they are relatively quick 
and inexpensive to conduct, they require fewer individuals and frequently make use of 
existing data, they do not pose a risk to subjects and they allow multiple risk factors to be 
examined simultaneously. On the other hand they are frequently retrospective and as such 
rely on recall or on existing records and this may present problems with validation of data 
and control of confounding if data on potential confounders does not exist. In addition, 
there may be difficulties with control selection and rates of disease in exposed and non- 
exposed groups are not determinable (Schlesselman, 1982). 
The aim of case control studies is to quantify the associations between diseases and 
exposures of interest (risk factors) within a given population. This is achieved i) by making 
comparisons with respect to frequency of exposures among appropriately selected diseased 
(cases) and non-diseased (controls) individuals and ii) because 'frequency measures of 
disease among the exposed' are logically related to 'frequency measures of exposure among 
the diseased' (Schlesselman, 1982). 
The comparative measure (of either disease or exposure) underlying case control 
methodology is the 'odds ratio' (i. e. OR = 'odds of disease or exposure among casesTodds 
of disease or exposure among controls' with odds defined as 'number of diseased or 
exposedTnumber of non-diseased or non-exposed'). It can be shown mathematically, 
73 
EquLne InfWmatmy Amay Ihsease Epidmology 
assuming that the probability of cases and controls being selected is independent of their 
exposure status, that the 'exposure odds ratio' =' disease odds ratio' (Schlesselman, 1982):, 
Exposure Odds Ratio Disease Odds Ratio 
'odds of exposure among diseased' 'odds of disease among exposed' 
'odds of exposure among non-diseased' 'odds of disease among non-exposed' 
Importantly also, because 'odds' = 'risk'/(I -'risk'), it follows that where the 'risk' 
of disease is small because it is rare in the population (e. g. I in 1000 diseased; 'risk. = 
0.001), then the denominator for this equation is extremely close to 1 (i. e. 1-0.001 = 0.999) 
and consequently the 'odds of disease' closely approximate to the 'risk of disease'. In this 
situation the OR for a given exposure will also closely approximate to the risk ratio (RR) 
measure of relative risk between diseased and non-diseased individuals in the population. -. 
Risk of diseas Odds of diseas 
risk= 1/1000 risk/(I-risk) 
0.001 ltý 0.001/(1-0.001) = 0.001/0.999 
0.001 0.001001001 
This is the basis for the rare disease assumption of case control studies, which 
generally states that for rare disease (prevalence<l%) the odds ratio, risk ratio (for 
prevalence measures) and rate ratio (for incidence measures) are, for all practical purposes, 
equal. However, more recently it has been shown that the rare disease assumption is not a 
prerequisite for case control studies because, with a suitable choice of sampling scheme for 
controls, it is possible to obtain direct estimates of risk and rate ratios instead of relying on 
the OR as an indirect estimate (Rodrigues & Kirkwood, 1990). 
An important issue in case control studies is the use of 'matching', whereby controls 
are chosen from a subset of the available 'non-case' population with the subset of 'non- 
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cases' and the cases sharing a particular 'matching' variable. In human studies there is 
frequently use of age-matched controls i. e. the cases and controls come from a subset of the 
population that have the same age. The most important issues with respect to matching are 
that i) it may improve a study's precision, ii) it may help control confounding by factors that 
are difficult to measure (e. g. environmental factors), iii) it may be essential to overcome the 
rare disease assumption with more common disease (e. g. concurrent control selection 
described by Rodrigues & Kirkwood [1990]), iv) the effects of a matching variable cannot 
be evaluated in analyses, v) it makes cases and controls more similar and 'overmatching' 
may present problems, and vi) matched studies require statistical techniques that take 
appropriate account of the matching in analyses (e. g. conditional logistic regression). 
Although case control studies are now widely used in human medicine and are 
increasing in popularity in veterinary medicine, there have been very few examples to date in 
the area of equine respiratory disease. Three main examples have been reported since 1993 
(Hoffman et aL, 1993 a; Austin et al., 1995; Christley et aL, 1999b; 200 1 a; 200 1 b). 
An unmatched case control study of risk factors for pleuropneumonia was 
conducted among horses referred to the veterinary teaching hospital at the Univeristy of 
Illinois, USA, between 1980 and 1990 in which 45 eligible cases were recruited (Austin el 
aL, 1995). Although there were no details provided for the population from which these 
cases arose, it may be reasonable to assume that with only 45 cases over 10 years that 
pleuropneumoma satisfied the rare disease assuMption and the use of ordinary logistic 
regression analysis by these authors was valid (Austin et al., 1995). 
A small scale pilot study (8 cases and 8 controls) was conducted to establish a 
clinical definition of distal respiratory tract disease in foals on Thoroughbred breeding farms 
in'Ontario, Canada (Hoffman et aL, 1993a). In this limited study the'authors used the 
multiple matching criteria of farm, day of sampling, age, sex and weaning status and 
compared cases and controls for endoscopic, haernatological. and pulmonary cytological and 
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microbiological variables. Data were only presented for analyses at the univariable level by 
conventional statistical techniques and estimates of disease risk were not reported. 
As already described, a matched case control study of coughing among racehorses 
at 5 racetracks in and around Sydney, Australia was conducted (Christley el al., 1999b; 
2001a; 2001b). In designing this study the authors were conscious of the need for careful 
choice of controls because of the likely violation of the rare disease assumption by this 
prevalent condition among young racehorses. The choice of a matched design with use of 
concurrently selected controls (i. e. temporal matching with cases eligible as controls later in 
the study) allowed the rare disease assumption to be overcome. Matching on training stable 
also helped control for other factors that were difficult to measure, including the sensitivity 
of observation by trainers, environmental conditions and some stable management and 
training factors (Christley et aL, 1999b). Having used a matched design, the appropriate 
technique of conditional logistic regression to take account of the matching on time and 
training stable was used to analyse the data (Christley et aL, 1999b; 2001 a; 200 1 b). 
1.6.3 Studies with repeated measures 
It is important to state that this is not intended to be a comprehensive review of all 
the possible methodologies for dealing with the problems of repeated measures within all 
kinds of epidemiological studies. Rather it is a brief overview of the matters specifically 
relating to the nature of the data in a randomised, controlled trial in Welsh-Mountain ponies 
described later in this thesis. 
Approaches to analyses of longitudinal data are comprehensively reviewed by Diggle 
el aL (2002) and may take three different, forms of generalised linear models including 
marginal, random 
leffects 
and transition models. In marginal models the correlation between 
outcome and explanatory covariates is taken as an average across individuals in the 
population that share common covariate values. In random effeqts models variation between 
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all individuals is modelled randomly and reflects natural heterogeneity due to unmeasured 
factors. Finally, in transition (or Markov) models outcomes are modelled in terms of 
explanatory covariates that include outcomes (and covariates) for the same individuals at 
previous time points. Although there are various recent examples of studies using these 
approaches, the modelling of bovine herpesvirus type I on herd-level milk production by 
Van Schaik el aL (1999) describes the application of all three modelling methods to the 
same data. 
It is recognised that respiratory disease in horses, particularly in young animals with 
possible infectious aetiologies, clusters in both time and space (e. g. outbreaks of disease in 
training yards or groups of horses), and the infections change over time (Burrell et aL, 
1996; Wood, 1999). Consequently it has been recognised that one of the most appropriate 
methods for collecting accurate information on the occurrence of respiratory disease in such 
groups of horses is by using a longitudinal study design (Wood el aL, 1993b; Burrell et aL, 
1996; Wood et aL, 1997b; Wood, 1999). In longitudinal study designs individuals are 
followed over time with repeated observations made on them during the period of study. 
However, this does present specific issues with respect to the analysis of such data because 
the repeated measures effectively result in both clustering of data (i. e. observations) within 
individual animals and a consequent lack of independence between them. 
Methods have been developed to account for such clustering of data in order to 
overcome the problems of i) artificially small standard errors for what may be otherwise 
accurate regression coefficient estimates but with consequently reduced P-values (Curtis et 
al., 1988; Atwill el aL, 1995) or ii) inaccurate regression coefficients, reduced standard 
errors and P-values (Wood et aL, 1993b; Atwill et aL, 1995; Wood et aL, 1997b; Wood, 
1999), both of which may arise from methods such as ordinary logistic regression that 
ignore clustering. 
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Mixed effect logistic regression (MELR) with random effects are useful because 
they can be applied to unbalanced data where there are observations on different individuals 
at different time points and with variable numbers of observations per individual (Hedeker 
& Gibbons, 1997; EGRET, for Windows, 1999) and they provide some estimation of the 
strength of clustering (EGRET for Windows, 1999). MELR was used to analyse data from 
a longitudinal study of respiratory disease in young racehorses for the 3 binary outcomes of 
IAD, tracheal mucus and nasal discharge with random variation defined between (i. e. data 
were matched on) individual horses (Wood et aL, 1997b; Wood, 1999). It has been 
recommended that results of MELR should be presented retaining random effects terms 
even if these terms are not themselves statistically significant, as this provides the most 
accurate estimates for other effects having accounted for clustering of data (Mauritsen, 
1984). In these analyses there were significant random effects for final N1ELR models for 
IAD and for tracheal mucus but not for nasal discharge, although results for this model 
were presented retaining a random effects term (Wood, 1999). 
The MELR methods outlined above are available with various software packages 
including EGRET (EGRET for Windows, 1999) but although they are straightforward to 
apply they do have limitations., Such packages are only suited to binary outcome data from 
longitudinal/repeated measures studies and can only incorporate clustering at a single 
hierarchical level (e. g. observations within animals). However, there are also other statistical 
techniques and software available such as multilevel modelling in NILwiN (Multilevel 
Models project, Institute of Education), which are able to deal with either continuous or 
binary outcome variables and account for multiple hierarchical levels of clustering in data 
(Goldstein, 1999; Snijders & Bosker, 1999; Rasbash et aL, 2000). 
Much of the text and software development on multilevel modelling has its basis in 
social rather than medical sciences and particularly within educational assessment (Aitken et 
aL, 1981; Aitken & Longford, 1986; Goldstein, 1999; Snijders & Bosker, 1999; Rasbash et 
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al., 2000). However, because of the hierarchically structured nature of populations of most 
companion and particularly food producing species of animals (e. g. broilers within cages 
within sheds within farms), the considerable worth of multilevel modelling techniques are 
being increasingly recognised by veterinary epidemiologists as an appropriate means of 
dealing with complex patterns of variability within their data (e. g. Green & Morgan, 1993; 
Lancelot et al., 1995; Kadohira et al., 1997; Chriel el al., 1999; Grohn et al., 1999; 
Rattenborg et aL, 1999, Dohoo el al., 2001; Wood et aL, 2001; Green et al., 2002). Some 
of these studies used multilevel modelling to account for clustering in assessing risk factors 
and providing more accurate estimates of their effects (Green & Morgan, 1993; Lancelot et 
aL, 1995; Chriel et al., 1999; Grohn et aL, 1999; Rattenborg et aL, 1999, Green et aL, 
2002). Others use the technique to evaluate the relative contribution of different levels of 
the hierarchy to the total variability in the outcome of interest (Kadohira et aL, 1997; 
Dohoo et aL, 200 1; Wood et aL, 200 1). By doing this they are able to identify areas in 
which targeted interventions are likely to have the largest impact on disease or production. 
To the author's knowledge'multilevel modelling techniques of this nature have not 
previously been described for repeated measures on equine respiratory disease, although 
they were recently applied to assess the significance of different levels of clustering in 
fatalities of Thoroughbred horses on British racecourses (Wood et aL, 2001). One of the 
aims of this thesis was to explore data from a randomised, controlled trial of an 
experimental bacterial vaccine conducted in 29 Welsh Mountain ponies (Section 3). The 
techniques described were used to examine these data which comprised repeated clinical 
evaluations of signs of respiratory disease and results of microbiological sampling from the 
respiratory tract of all animals. 
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1.7 Context of this thesis 
The work presented in this thesis is a continuation of the AHT's more recent 
investigations of equine respiratory disease. However, unlike much of the work by Burrell 
and Wood (referred to above), which concentrated on epidemiological characterisation. of 
cases defined by largely subclinical IAD, this project concentrates mainly on the 
epidemiology relating to cases defined by clinically apparent respiratory disease. The change 
in case definition from earlier studies and subsequent comparison of factors associated with 
clinical and subclinical forms of respiratory disease, aims to determine whether these are 
different manifestations of the same condition or whether there are separate factors 
associated with each. 
Studies were conducted in 2 distinct equine populations and used different study 
designs and analytical methods to examine the associations of infectious and non-infectious 
risk factors with clinical disease. There were some differences in the non-infectious factors 
examined as a consequence of fundamental differences in the 2 populations. The studies that 
form the basis of this thesis are i) a case control study of clinically apparent respiratory 
disease that was nested within the longitudinal study previously referred to, and ii) a 
randomised, controlled trial of an experimental bacterial vaccine that was conducted in 
recently weaned Welsh Mountain pony foals monitored for naturally occurring respiratory 
disease. -, 
Appropriate case, control methodology were used to investigate risk factors for 
clinically apparent respiratory disease in Thoroughbred racehorses, with data nested within 
a longitudinal study (Wood, 1999). The study differs from that reported in Australian 
racehorses (Christley el aL, 1999b; 2001a; 2001b) because analyses were conducted to gain 
an insight into the similarities in risk factors associated with clinical and subclinical, 
presentations of respiratory disease. 
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The 2 PCR typing methods based on characterisation of the M-protein hypervariable 
region (5 possible types) described by Walker & Timoney (1998) and the 16S-23S RNA 
gene intergenic spacer (8 possible types) reported by Chanter et al. (1997), were both 
applied to isolates of S. zooepidemicus from Welsh Mountain ponies suffering naturally 
occurring respiratory disease. Theoretically, the combination of these 2 typing systems 
would permit the allocation of each isolate to one of 40 (8x5) hypothetical types. Both 
typing techniques required similar PCR facilities and could be applied easily together under 
the same cycling conditions. The availability of published primer sequences meant that this 
combined typing technique could be easily adopted by other laboratories and applied to S. 
zooepidemicus isolates recovered from any species, including man. 
1.7.1 A causal web for equine respiratory disease 
Figure 1.8 surnmarises a possible causal web for equine respiratory disease which 
attempts to bring together many different but inevitably related factors that may be 
contributing to different subclinical as well as clinical presentations of respiratory disease in 
the horse. 
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Figure 1.8: A causal web for equine respiratory disease 
Infections 
Viruses Bacteria Mycoplasma Unknown microorganisms 
Environment 
Dust/moulds/fungi K-ý Airway inflammation 
Endotoxin 
Ammonia/toxic gases 
Temperature r: ýý Mucociliary clearance 
Mucus secretion 
Ciliary damage 
Clinical signs of respiratory disease 
Pyrexia Nasal discharge Cough 
EIPH 
Dyspnoea 
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SECTION 2 
A CASE CONTROL STUDY OF CLINICALLY 
APPARENT RESPIRATORY DISEASE IN 
THOROUGHBRED RACEHORSES 
83 
Eqtune Mammatory Airway Disease Epideritiology 
CHAPTER2 
INTRODUCTION 
2.1 Background 
During the 1980s and early 1990s it was increasingly recognised that respiratory 
disease was a common and recurrent problem in young Thoroughbred racehorses and that 
whilst this may be clinically obvious it was more frequently subclinical, being characterised 
by the presence of airway mucus and inflammatory exudate (Burrell et aL, 1986; 1996). In 
order to estimate for the first time the incidence and prevalence of both clinical and sub- 
clinical forms of respiratory disease and the association between disease and various factors, 
including infections by different pathogens, a longitudinal study comprising repeated and 
regular sampling of individual Thoroughbred racehorses was conducted (Wood, 1999). 
Sampling and data collection for the study took place between November 1993 and 
December 1996 and involved a total of 148 horses in 6 different training yards with horses 
from only 5 yards being studied at any one time. For practical reasons and to ensure 
maximum co-operation from trainers and their staff for the duration of the study, a 
representative sample of between 10 and 15 horses in each yard were examined and 
sampled on a monthly basis irrespective of the respiratory health status of horses. 
This longitudinal study of respiratory disease in Thoroughbreds was funded by a 
grant awarded to the principal investigator, James Wood, by the Horserace Betting Levy 
Board. The majority of monthly examinations and sampling of horses was conducted by 
myself and I was responsible for collating and reporting of all results to racehorse trainers 
and their veterinary surgeons on a monthly basis. Bacterial and cytological examinations of 
tracheal wash samples and serological testing of blood samples were all conducted in the 
microbiology and pathology laboratories of the AHT. A commercial mycoplasma laboratory 
(Mycoplasma Experience) conducted examination of tracheal wash samples for 
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mycoplasmas. The longitudinal study was the basis of James Wood's PhD thesis, entitled 
'An Epidemiological Investigation of Respiratory Disease in Racehorses' (Wood, 1999), 
which is referenced in these methods and elsewhere in this thesis. The case control study of 
clinically apparent respiratory disease described here, although nested vvithin the 
longitudinal study, was planned and conducted by myself using a separate study design with 
a completely different case definition to that used in James Wood's analyses. 
2.2 Aims of the case control study 
The main aim of the study was to describe, quantify and test the significance of the 
associations of different infectious agents and other predisposing factors with clinically 
apparent respiratory disease in young Thoroughbred racehorses in training in the United 
Kingdom. 
During the study it was recognised that encloscopic examination of some outwardly 
healthy horses revealed the presence of subclinical IAD. Therefore, classification of horses 
already selected as outwardly healthy controls as either 'healthy' or 'subclinical' would 
allow additional investigation and comparison of factors associated with subclinical as well 
as clinically apparent respiratory disease. This would allow evaluation of whether these 
were likely to be separate disease entities with different aetiologies or merely the same 
disease manifested to different extents. 
More specifically the study aimed to determine whether both clinically apparent and 
subclinical respiratory diseases in young racehorses in training in the United Kingdom were 
associated with: 
i) infection of the lower respiratory tract (LRT) by certain species of bacteria (S. 
zooepidemicus, S. pneumoniae, Pasteurella and Actinohacillus spp. particularly) 
including Mycoplasma spp. (Mycoplasma felis and Mycoplasma equirhinis 
particularly) 
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ii) isolation of species of bacteria from the upper respiratory tract (URT) that are 
associated with LRT disease, 
iii) infection with known equine viruses, 
iv) horses' age, 
V) time since entry into the training yard, 
vi) recent racing. 
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CHAPTER 3 
MATERIALS AND METHODS 
3.1 Study design 
A matched case control study design with concurrent selection of controls 
(Rodrigues & Kirkwood, 1990) was used. This case control study was nested within a 
longitudinal study of respiratory disease (Wood, 1999). In addition to cases of clinically 
apparent respiratory disease in routinely monitored horses, other horses with clinical 
respiratory signs were also investigated during the study period if requested by the trainer. 
Controls were selected from horses that were routinely monitored in the study yards close 
to the time of the case and which did not have clinical signs of respiratory disease. 
3.1.1 Longitudinal study of respiratory disease in Thoroughbred racehorses 
3.1.1. ]Racingyards 
A convenience sample of 6 Thoroughbred training yards was used for the study, 
with horses from only 5 yards being studied at any one time. A convenience rather than 
random sample of trainers was used in order to ensure that there would be a high degree of 
co-operation from the yards for a considerable part of the 3 years of the study, thus 
ensuring the highest possible quality of repeated measures data. Yards were, therefore, 
recruited on the basis of likely good co-operation based on known previous interest in 
equine respiratory disease from both the trainers and their veterinary surgeons, although 
before recruitment there was no reason to believe that these yards suffered any worse than 
others with respiratory disease. 
Of the 6 training yards involved in the study, 4 were situated in Newmarket in 
Suffolk and one each in Epsom in Surrey and Lambourn. in Berkshire. Although 6 training 
yards were involved in the study, a total of 7 trainers provided data for their horses. This 
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was because of the untimely death of trainer 7 who was replaced on the study by his 
successor at the yard (trainer 5) .A summary of details of the location, size, age structure 
and aspects of construction and management of the different yards under each trainer is 
outlined in Table 3.1, (adapted from Wood [ 1999]). 
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3.1.1.2 7horoughbred racehorses 
At the time of recruitment to the study, trainers were asked to select at random 
between 10 and 15 Thoroughbred racehorses that were representative of the age, sex and 
general management structure within each yard and which were not intended to be sold 
midway through the year. Trainers were specifically requested not to select horses on the 
basis of their previous respiratory disease and horses that were known to be 
temperamentally difficult with respect to respiratory sampling were excluded on the grounds 
of safety. Horses that were sold or left the yard for prolonged periods during the year were 
replaced by another horse. 
3.1.1.3 Routine monthly examination and sampling 
Simple clinical examination was performed on horses at the time of the monthly visit 
to the training yard immediately prior to samples being collected. The presence or absence 
of abnormal and obvious serous or mucopurulent nasal discharge and coughing was noted. 
A blood sample was then collected from the jugular vein into a silicon coated 
evacuated blood collection tube (Vacutaineflm; Becton-Dickinson). After the blood had 
clotted, serum was poured off and used for viral serological testing. 
An unguarded wire-mounted gauze swab was passed via the ventral nasal meatus to 
the level of the common pharynx and soft palate. The swab was then gently moved around 
several times to slightly abrade the mucosa before being removed. The gauze swab was 
immediately placed and sealed in transport medium (isotonic phosphate buffered saline 
(PBS), pH 7.2, containing 2% (v/v) foetal calf serum and 0.0005% (w/v) amphotericin B 
(Sigma-Aldrich) (Newton et al, 1997b). Nasopharyngeal swabs were transported to the 
AHT laboratories on ice blocks in polystyrene boxes and were submitted for bacteriological 
exanunation. 
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The respiratory tracts of the horses were then evaluated for the amount of mucus 
and/or blood visible in the trachea and this was recorded as either absent (score = 0), slight 
(score = 1), moderate (score = 2) or severe (score = 3), as illustrated in Figure 3.1 (from 
Wood [1999]). Examination took place to the level of the tracheal bifurcation (carina) using 
a flexible I. Om-1.7m endoscope (various makes used) which was passed rapidly but 
carefully through the ventral nasal meatus, nasopharynx, larynx and then into the trachea. 
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Tracheal wash samples were collected transendoscopically by the instillation and 
aspiration of 30n-d of sterile phosphate buffered saline (PBS) just anterior to the bifurcation 
using a flexible, sterile polythene catheter passed through the biopsy channel of the 
endoscope (Greet, 1982; Whitwell & Greet, 1984; Dixon et aL, 1995b). Immediately 
following collection and thorough mixing, tracheal wash samples were divided into 3 
aliquots. One aliquot went into 15% (v/v) ethylene diamine tetra-acetic acid (EDTA) for 
nucleated and red blood cell counts, another was fixed with an equal volume of 10% (v/v) 
saline buffered formalin for cytological examination and the remaining neat sample was 
transported to the laboratory on ice blocks for quantitative bacteriological examination. 
After each examination the endoscope was wiped clean and disinfected by 
immersion in liquid disinfectant (10% (v/v) TriGeneTm, MediChern International, Sevenoaks, 
Kent, LTK), with particular care taken to make sure that the biopsy channel was cleaned. 
Following disinfection the endoscope, including the biopsy channel, was thoroughly rinsed 
using sterile saline. 
3.1.1.4 Examination and sampling of other horses 
In addition to the routine monthly sampling of horses selected by trainers for the 
longitudinal study, which was conducted irrespective of the presence of respiratory signs, 
other horses in the yards that showed signs of clinically obvious respiratory disease were 
also examined. Horses that had sudden onset coughing, an obvious, abnormal nasal 
discharge or a high rectal temperature (ý! 38.6'C/101.5'fl were examined when requested 
by the trainer. These additional examinations were conducted both separately from and at 
the same time as the routine monthly yard visits. 
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3.1.2 Sample size calculations 
As this study was nested within the 3 year longitudinal study of inflammatory 
respiratory disease (Wood, 1999) it was, therefore, largely reliant on the sampling 
conducted for that study. No formal sample size calculations were performed prior to the 
collation of data for this case control study. After collating case data from within the 
completed longitudinal study, sample size calculations were performed post hoc using 
standard epidemiological methods for matched case control studies (Breslow & Day, 1980) 
in order to estimate the likely strengths of effect that might be required for a given level of 
significance and power. It was estimated that using a casexontrol ratio of 1: 4, and an 80% 
chance (power) of detecting the effects of an exposure with 30% prevalence and an OR of 
2.0 with 95% confidence, 74 matched case control sets were required. However, as we had 
many more cases than matched sets this was likely to be a conservative estimate of the 
expected significant OR at this exposure level. However, estimates of sample size 
requirements for matched case control studies are imprecise because they are profoundly 
affected by the closeness of matching and hence the correlation between exposure status of 
matched cases and controls (Dupont, 1988). 
3.1.3 Matching 
Matching was used in this case control study to overcome several potential 
confounders. All cases and controls with the same matching criteria were treated as a 
matched set for purposes of analysis. All cases of clinically apparent respiratory disease 
were matched to controls: 
i) by trainer (and hence training yard as no trainers moved yards during the course of 
the longitudinal study) and 
ii) to within a period of 6 weeks of sampling of the case and other controls in the set. 
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Matching by trainer controlled for factors that were unique to each training yard and 
trainer and which were difficult to measure and adjust for by other methods such as 
stratification or regression. Such factors included those related to the general management 
of horses, including housing (and hence ventilation, bedding etc. ), feeding, daily routine, 
training regime, contact with other horses and hence their infections (clustering in space) 
and likelihood of receiving veterinary investigation and treatment and being notified as a 
case. 
Matching of cases and controls to within a6 week period satisfied the requirement 
for concurrent control selection in the use of a case control study design (Rodrigues & 
Kirkwood, 1990). A period of 6 weeks (approximately 1.5 times the routine sampling 
interval) for time matching cases and controls was used pragmatically to allow maximum 
recruitment of controls as cases were not necessarily sampled at the same time as the 
routine sampling in the longitudinal study. A shorter period was considered to prohibitively 
restrict the number of matched sets. Matching on time also controlled the effects of season 
and related factors such as the variable introduction of new horses and variations in intensity 
of training and racing. An important consideration in the study of respiratory disease of 
probable infectious aetiology among horses is the possible confounding by clustering in 
time. Matching on time was designed to control this. 
Matching was restricted to trainer and time period to avoid the risk of overmatching. 
There was no need to match on covariates such as age as these could be measured and their 
effect estimated. 
3.2 Outcome variable: definition and selection of cases 
Cases of clinically apparent respiratory disease were defined as all horses that were 
resident in study yards during the period of the longitudinal study, which on examination 
demonstrated at least one of the following signs: 
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i) sudden onset coughing at exercise or rest 
ii) abnormal and obvious serous or mucopurulent nasal discharge 
iii) high rectal temperature/pyrexia (ý: 38.6*C [101.5F]). 
Clinically apparent cases of respiratory disease were identified irrespective of 
endoscopic findings or cytological interpretation of tracheal washes. Some cases were being 
routinely monitored and others were presented by the trainer for examination. 
3.3 Outcome variable: definition and selection of controls 
3.3.1 Selection of 'all' controls 
Where possible and subject to restrictions required for matching, up to 4 matched 
controls were initially selected at random 'out of a hat' for each case from eligible horses 
routinely sampled during the longitudinal study. Horses were eligible as controls if i) they 
did not have clinical signs of respiratory disease (coughing, nasal discharge or pyrexia) at 
the time of sampling, ii) they were under the same trainer and iii) they had been sampled 
within 6 weeks of examination of the case. This selection was made irrespective of 
endoscopic findings or cytological interpretation of tracheal washes. All sets of cases and 
controls matched by trainer and time period were assigned a unique identifying number (set 
matching). The binary variable CASE took the value of 'one' for clinically apparent cases 
and 'zero' for 'all' controls. 
3.3.2 Subdivision of controls 
3.3.2.1 Inflammation score 
A summary measure of airway inflammation was made using an aggregated scoring 
system comprising 3 equally weighted parameters (Whitwell & Greet, 1984). A score of one 
was given for each of 
i) moderate or severe amounts of endoscopically visible tracheal mucopus 
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ii) ý: 1000 nucleated cells/ml of tracheal wash 
iii) moderate or predominant amounts of neutrophils in the tracheal wash. 
Under this scoring system the degree of inflammation ranged from zero to a 
maximum score of 3, with a score of zero indicating no evidence of airway inflammation. 
The detailed definition of each component is given with the description of the laboratory 
methods (see 3.4 Laboratory methods). 
3.3.2.2 Definition and selection of 'healthy'controls 
Control horses were defined as 'healthy' if endoscopic findings and tracheal wash 
cytological parameters demonstrated no evidence of lower respiratory tract disease, i. e. as 
indicated by an inflammation score of zero out of a possible maximum score of 3. The 
binary variable CASE2 took the value of one for clinically apparent cases and of zero for 
'healthy' controls (subclinical controls were classified as 'missing' values) and variable 
CASE4 took the value of one for 'subclinical' controls (dealt with as 'cases' in this 
comparison) and of zero for 'healthy' controls. 
3.3.2.3 Definition and selection of 'subclinical'controls 
Control horses were defined as having 'subclinical' respiratory disease if encloscopic 
findings and tracheal wash cytological parameters demonstrated evidence of airway 
inflammation, as indicated by an inflammation score of one or more (Table 3.2). The binary 
variable CASE3 took the value of one for clinically apparent cases and of zero for 
'subclinical' controls (healthy controls were classified as 'missing' values) and variable 
CASE4 took the value of one for 'subclinical' controls (dealt with as 'cases' in this 
comparison) and of zero for 'healthy' controls. 
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Table 3.2: Summary of inflammation scores used to define the 2 control classifications 
Control Inflammation score 
Classification 
0123 
Healthy +-- 
Subdinical 
+ score used in control selection 
- score used in control exclusion 
3.4 Laboratory methods 
3.4.1 Cytology 
Cytological examinations of tracheal wash samples, including nucleated and red 
blood cell counts, were conducted in the AHT laboratories by appropriately trained 
technicians and pathologists according to standard methods by Whitwell and Greet (1984). 
Samples for cell counts were submitted in potassium EDTA tubes and where 
specimens were visibly mucoid, trypsin was added to break down mucus. A Neubauer 
counting chamber was used to separately count nucleated and red blood cells. Cell counts 
were expressed as the number of cells per ml of wash. 
Samples for cytological examination were submitted mixed in equal volumes with 
10% formal buffered saline as a fixative. The samples' visual characteristics of clarity and 
flocculation were recorded. Trypsin was added to markedly mucoid specimens. Samples 
were then centrifuged at 1200 rpm for 5 minutes to sediment the cells. All but I ml of the 
supernatant fluid was then discarded. The pellet was re-suspended with the remaining Iml 
of supernatant and 1-2 drops were smeared onto 2 gelatinised slides. The smears were fixed 
with polyethylene glycol, one was stained with haernatoxylin and eosin (H&E) stain and the 
other with Perle's stain prior to examination under the microscope. 
The fixed and stained tracheal wash smears were examined for the presence of 
inflammatory and degenerative changes using the techniques described by Whitwell and 
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Greet (1984). Records were made of the smear cell density, mucus quantity and 
characteristics, relative proportions of different cell types including haernosiderophages (i. e. 
alveolar macrophages containing Perle-positive, erythrocyte derived haernosiderin deposits) 
as well as other endogenous and exogenous material. Categories of recorded cytological 
characteristics are summarised in Table 3.3. 
Table 3.3: Summary of cytological variable categories 
Cytological variable Categories 
Appearance of tracheal wash clear, translucent, opaque 
Flocculation of tracheal wash slight, moderate, heavy 
Nucleated & red blood cell counts cells/ml of tracheal wash 
Smear cell density low, medium-low, medium, medium-high, high 
Cell types: 
Neutrophils, macrophages, predominant cell type 
Mononuclear cells, epithelial cells ++ present in moderate proportions 
& eosinophils + small proportion of cells 
occasional cells only 
no cells seen 
Haemosiderophages relative quantity on smear measured as ++, +++ or 
Multinucleated. macrophages presence noted or not 
Foamy macrophages presence noted or not 
Mucus quantity scant, copious 
Mucus characteristics fine, inspissated 
Plant material presence noted or not 
'Fungal material presence noted or not Bacteria presence noted or not 
Filamentous structures presence noted or not 
Debris presence noted or not 
Degenerate epithelium presence noted or not 
Free ciliary tufts presence noted or not 
Squarnes none, small or large quantity noted 
Inflammation score (out of 3) 0,1,2,3 
summary measure of airway inflammation was made using an aggregated scoring 
system comprising 3 equally weighted parameters. A score of one was given for each of 
i) moderate or severe endoscopically visible tracheal mucopus, 
ý1000 nucleated cells/ml of tracheal wash and 
iii) moderate or predominant amounts of neutrophils in the tracheal wash. 
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Under this scoring system the degree of inflammation ranged from zero to a maximum score 
of 3, with a score of zero indicating no evidence of airway inflammation. 
3.4.2 Serology 
Serological tests were conducted by trained and experienced AHT laboratory 
technicians according to established standard operating procedures (Thomson et aL, 1976; 
Powell et aL, 1978). Blood samples were collected into silicon-coated plain tubes and after 
clotting and centrifugation serum was collected into a separate tube and stored frozen at - 
20"C. At the end of the data collection phase of the study all samples for each horse were 
batch tested in parallel to quantify antibodies to equine respiratory viruses. Samples were 
tested for equine herpesvirus-I (EHV-1), equine herpesvirus4 (EHV4) and equine 
rhinovirus-I (ERV-1) and equine rhinovirus-I (ERV-2) by complement fixation (CF) test. 
Samples were also tested for equine adenovirus, the recent European-like equine influenza 
virus strain A/Newmarket2/93 (H3N8) and the prototype A/Prague/56 (H7N7) strain by 
haernagglutination inhibition (HI) test. 
As repeated samples had been taken at monthly intervals from horses in the study, 
examination of rises in antibody titres between consecutive months would indicate likely 
infection (or vaccination in the case of influenza virus) around the time of the first of the 2 
samples. A 4-fold or greater rise in antibody titres between consecutive montWy samples 
was used to deterrnine serological evidence of infection for all viruses other than influenza. 
In the case of influenza virus, a 4-fold or greater rise in both the H7N7 and H3N8 subtypes 
of virus indicated probable vaccination around the time of the first sample. As H7N7 
subrtypes were included in vaccines used at the time and had not been shown to be the 
cause of infection in horses anywhere in the world since the early 1980s, a 4-fold or greater 
rise in titre for the H3N8 subtype only, in the absence of recent vaccination was indicative 
of infection with the virus at around the time of the first sample. 
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3.4.2.1 Complementfixalion (CF) test 
Complement fixation, based on established methods for equine sera (Thomson et aL 
1976), was used to measure antibodies to EHV-1, EHV-4, ERV-1 and ERV-2. Sera were 
diluted I in 5 with CF diluent (5 complement fixation tablets (ICN Flow) per 500 ml 
distilled water) and inactivated in a waterbath for 30 rninutes at 60'C. Further 2-fold serial 
dilutions of these diluted sera were made across 8 wells of a 96-well microtitre plate. 
Appropriately diluted antigens were added to each well in equal volume (25 pl) to the 
diluted serum and the plates were cooled to 4'C for ý30 minutes. Freshly thawed Guinea- 
pig complement (25 pl) was then added to each well and the plates were stored overnight at 
4"C. Fresh, washed sheep red blood cells diluted to a 4% (v/v) concentration in CF diluent 
and mixed with an equal volume of rabbit haernolysin solution (Serotec Ltd, Oxford, LJK) 
were also stored at 4*C overnight. The red blood cells were then sensitised the following 
morning by warming to 37'C for 30 minutes and a 25ýd aliquot was then added to each 
well, the plates were shaken and re-incubated at 37'C for 15 rninutes twice. The plates were 
then shaken a third time and placed in the fridge at 37*C for 24 hours and read by visually 
assessing the degree of lysis of the red blood cells in each well and hence for each serum 
dilution. Controls for complement, all antigens and corresponding antiserurn were used in 
every test and results outside acceptable limits were discarded. Anti-complementary activity 
(i. e. non-specific fixation of complement giving rise to a false positive result) was assessed 
for each sera by performing the tests in the absence of antigen. 
If virus-specific antibody is present in serum, when antigen is added an immune- 
complex forms. Complement is then added and is fixed by adsorption to the immune- 
complex. When sensitised sheep red blood cells are added they will not be lysed due to the 
lack of free complement. In the absence of virus-specific antibody in the serum, immune- 
complexes will not form, complement is not fixed and is available to lyse the red blood cells. 
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3.4.2.2 Haemagglutination inhibition (HI) test 
Antibodies to equine influenza virus and equine adenovirus were measured by 
haemagglutination inhibition, based on established methods for equine sera (Powell el aL, 
1978). Aliquots of serum samples were diluted serially 2-fold across a 96 well microtitre 
plate in phosphate buffered saline (PBS). A standard virus antigen dose of 4 
haemagglutination units (HAU) was then added to each well and the plates were incubated 
at room temperature for 30 minutes. A 1% (v/v) suspension of chicken red blood cells in 
PBS for the influenza HI test and a 1% (v/v) suspension of human 0 red blood cells for the 
adenovirus HI test were added to each well and the plates were shaken. After 45 minutes at 
room temperature the plates were read. Red blood cells cross-linked by virus 
haernagglutinin are unable to sediment and form a button of cells in the bottom of the V- 
bottomed well. Antibody is detected by absence of agglutination due to inhibition of cross- 
linkage and consequent formation of a clearly visible button in the bottom of the well. The 
end point titre was the highest dilution of serum that gave a >90% inhibition of 
haernagglutination in the well. Antigen and antiserum controls were tested on each plate and 
results discarded if the virus back-titration was not standard or if the control antiserum was 
not within a 2-fold dilution of that expected. 
3.4.3 Bacteriology 
Bacteriological assays were conducted by AHT laboratory staff according to 
standard operating procedures on non-fixed tracheal wash samples and nasopharyngeal 
swabs stored and transported in transport medium. 
After vortexing, tracheal washes were diluted serially in PBS to produce subsamples 
diluted to 10-1,10-2,10"' and 10-4. Volumes of 0.1 ml of each dilution were aseptically spread 
on various types of solid bacteriological media, including Wilkins-Chalgren 5% (v/v) horse 
blood agar (Oxoid), selective streptococcal agar (Strepselect; Mast Diagnostics), 
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MacConkey agar (Oxoid) and Wilkins-Chalgren 10% (v/v) horse blood agar and neomycin 
(Oxoid). All 4 agar types were used to inoculate samples neat and diluted 10-3 . 
Horse blood 
and MacConkey agars were inoculated with samples diluted 10-1 and Strepselect was 
inoculated with samples diluted 10'2 and 10-4. 
Primary inoculations of nasopharyngeal swabs onto Strepselect, horse blood, cystine 
lactose electrolyte deficient (CLED: Oxoid) and G20 agar (Oxoid) plates for the selective 
culture of Bordetella bronchiseptica (Smith & Baskerville, 1979), were spread with a sterile 
loop to obtain single colonies of bacteria after incubation. ' 
Horse blood, Strepselect and MacConkey agars were all incubated overnight at 
37*C. Horse blood and Strepselect were incubated in an atmosphere of 5%(V/V) C02- 
Neomycin blood agar plates were incubated anaerobically at 37'C for 4/5 days after the 
addition of a metronidazole sensitivity disc to the primary part of the swab inoculation. 
Following incubation, plates of diluted tracheal wash samples were examined and 
separate counts were made of colonies of the different types of bacteria that could be 
presumptively identified by the type of media they grew on and by their colony morphology. 
The plates inoculated with a sample dilution with between 30 and 330 colonies were used 
for counting. The numbers of each species present were estimated and expressed as colony 
forming units per ml (cfu/ml) of neat tracheal wash sample. 
Species of bacteria were identified using standard bacteriological techniques (Cowan 
& Steel, 1993). ActinohacilluslPasteurella spp. were presumptively identified on the basis 
of reactions in the API 20NE test strip identification system (BioMerieux). Those growing 
on MacConkey agar with a bi-polar staining, pleomorphic, Gram-negative cellular 
morphology and whose colony growth was sticky to the touch were presumptively 
identified as Actinobacillus equu1i. Colonies with the same general morphology that did not 
grow on MacConkey agar and were not sticky were referred to as miscellaneous 
ActinobacilluslPasteurelia spp. 
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3.4.4 Mycoplasmology 
Mycoplasnia spp. were isolated from tracheal wash, samples by the laboratories of 
Mycoplasma Experience Ltd in Reigate, Surrey. Tracheal wash samples from yard 4 in 
Epsom were generally delivered directly to the laboratory shortly after collection. Aliquots 
of washes from horses in the other yards had foetal calf serum added to a concentration of 
10% (v/v) and samples were then stored frozen at -70'C. Batches of stored samples were 
periodically couriered overnight to Mycoplasma Experience on ice blocks in sealed, 
insulated polystyrene boxes. 
On arrival at Mycoplasma, Experience samples were thawed to room temperature 
and then 0.1ml of each wash was inoculated on ME Mycoplasma agar plates, which were 
then incubated in 95% (v/v) N2and 5%(V/V) C02for up to 28 days. Plates were inspected 
microscopically at least twice weekly during the first 4teen days and again at 28 days. 
Media batches were validated for their ability to grow low numbers of pre-counted, frozen 
suspensions of a low-passage equine isolate of M felis. Isolates with variations in colony 
morphology were sub-cultured. 
Isolates were grouped according to their growth characteristics, their ability to 
metabolise arginine and ferment glucose in ME liquid media, inhibition of their growth by 
species-specific antisera and their sensitivity to digitonin (Mycoplasma spp. are digitonin 
sensitive and Acholeplasma spp. are not). Isolates were stored at -70*C. 
Isolates were consequently identified as one of 7 types: 
i) serologically identified M. felis 
ii) serologically identified M. equirhinis and presumptive M. equirhinis based on 
growth characteristics, arginine metabolism and colony morphology 
iii) Acholeplasma spp. based on insensitivity to digitonin 
iv) slow growing, non-M. felis glucose fermenting Mycoplasma spp. 
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V) other arginine metabolising Mycoplasma spp. 
vi) so-called 'D87-like' colonies based on morphology and biochemistry identical to a 
previous isolate which did not fit any classically described species 
vii) other isolates. 
3.5 Explanatory variables 
The variables used in the analyses are described below in broad categories. The 
methods to derive microbiological and cytological variables have already been described in 
the description of the longitudinal methods. The variable names as used in the analyses and 
the values of their different levels are shown in parentheses. 
3.5.1 Matching variables 
Cases and 'all' controls were matched to one of the 7 trainers which contributed to 
the longitudinal study and to within 6 weeks of the date of sampling of the case. The trainer 
variable was categorical and all matched cases and controls were identified by a matching- 
set variable. Due to requirements for concurrent control selection and in order to maximise 
sample size, matching in this study was not I: n but m: n (i. e. cases and control numbers 
varied between matched sets). 
3.5.2 Time-associated, racing and sex variables 
3.5.2.1 Age 
The ages of horses at the time of examination were recorded as the age in years from 
January I"' of the year of birth up to January I" of the year examination. All horses were 
between one (yearling) and eight years old, with the majority being 2 or 3 years old. 
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Age was classified as a categorical variable (AGECODE; 14) to broadly reflect the 
distribution of different age groups in these flat-training yards. The 4 categories were: (1) 
yearlings, (2) 2-year-olds, (3) 3-year-olds and (4) 4-year-olds and older. 
Two-year-olds were treated as the referent group for the purposes of analyses since 
they had the largest numbers. Horses did not remain in the yearling category for long after 
entering training in the autumn of their yearling year and there was wastage of older horses 
(i. e. horses leaving study yards for any reason). 
3.5.2.2 Time since entering training 
The Racing Division of Weatherbys supplied dates of entry into training with the 
particular trainer for each horse on the study. Subtracting the date of entry into training 
from the date of sampling provided the period in days (ENTDD) that the horse had been in 
training with that trainer. Risk of disease and different periods of time in training were 
examined graphically to assess the most suitable way to express levels of this variable 
(Figure Al. I in Appendix 1). There was evidence of a non-linear relationship between the 
logit of disease risk and period of time in training, as the risk of disease decreased initially 
with time and then levelled off. Therefore this continuous variable was transformed into a 
categorical variable (ENTDCOI; 0-2) to reflect time measured in months. The 3 categories 
were for horses that entered training less than one month ago (0), between one and 3 
months ago (1) and more than 3 months ago (2). 
3.5.2.3 Previous racing 
The Racing Division of Weatherbys also supplied details of racing history for horses 
on the study where this was available. Horses were classified according to whether they had 
raced previously at the time of sampling (PREVRACE; 0-1). Where horses had raced 
previously, the date of their last race was subtracted from the sampling date to generate the 
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number of days since last raced (RACEDD). The relationship between risk of disease and 
time since last raced was again examined graphically to assess the best method of 
representing these data (Figure A1.2 in Appendix 1). Data examination showed that the 
logit of disease risk was not linear in relation to time since previous race and this variable 
was transformed into a categorical variable (RACDCOD; 0-2). Horses that had never raced 
before sampling were used as the referent group (0) with the other groups comprising 
horses that had raced within 7 days of sampling (1) and those that had raced more than a 
week previously (2). These data were represented in the same categories as those used by 
Christley et aL (1999; 2001 a;, 200 1 b). 
3.5.2.4 Sex 
The exact dates that colts were gelded were not recorded so the sex of horses were 
classified as male or female only (SEXCODE; 0-1), with females used as the referent group 
(0). 
3.5.3 Microbiological variables 
3.5.3.1 Bacteria 
Tracheal wash bacteriology results were classified on the basis of total bacterial 
numbers isolated as well as numbers of individual species of bacteria. Total bacterial count, 
expressed as loglo colony forming units (cfia) per n-A of tracheal wash was used as an 
ordered categorical variable with logio cfu/H bacteria rounded down to the nearest whole 
logio. Counts greater than 6 logslo were pooled in a single group because of low numbers of 
individuals in these categories. 
Risk of disease and loglo cfu/ml numbers of individual bacterial species including 
mycoplasmas were examined graphically to assess the most suitable way to express variable 
levels for the purposes of logistic modelling (Figures AIA - Al. 10 in Appendix 1). 
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There was a satisfactory linear relationship between the logit of disease risk and 
loglo cfulml bacteria for Streplococcus zooepidemicus (SZOOC) and 
AclinobacilluslPasteurella spp. (PASTALLC) and the risk of disease was expressed per 
logio cfu/ml increase relative to no bacterial culture for these variables. The relationship 
between logit disease risk and non-haernolytic Streptococcus spp. (NHSGP3; 0-2), 
Staphylococcus spp. (STAPHGP; 0-2) and Acinelobacter spp. (ACINETOG; 0-2) was best 
reflected by ordered categories (Table 4-2). Due to too few individuals within different 
categories, the remaining tracheal wash bacterial isolates were classified as binary variables, 
irrespective of bacterial numbers. No bacterial culture (0) was used as the referent group 
against culture of the organism (1) from the tracheal wash sample. 
3.5.3.2Mycoplasma 
Three species of Mycoplasma, Mycoplasma felis (MFELIS), non-felis glucose 
fermenting Mycoplasma spp. (MNFGF) and Mycoplasma equirhinis (MEQUIR), were also 
classified as binary variables, cultured (1) or not cultured (0), because there were few 
individuals with different logio cfii/ml numbers of these bacteria. 
3.5.3.3 Nasopharyngeal swabs 
Results of nasopharyngeal swab cultures were classified as binary variables 
according to presence (1) or absence (0) of bacterial species cultured from swabs. 
3.5.3.4 Serology 
Seroconversion between paired blood samples taken at the time of initial 
examination and then several weeks later, was taken to indicate the presence of viral 
infection around the time of first sampling. Viral infection variables (equine herpesvirus 
(EHV), equine rhinovirus infection (ERV), equine adenovirus (ADENO) and equine 
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influenza (INFLUENZ)) were expressed as binary variables with seroconversion (1) 
compared with no seroconversion (0). 
3.5.4 Endoscopy and cytology variables 
3.5.4.1 Tracheal mucopus 
Endoscopically visible tracheal mucopus was classified as an ordered categorical 
variable (MP; 0-3) with no mucopus visible (0), slight (1), moderate (2) or severe visible 
mucopus (3) (Figure 3.1; 3.1.1.3 Routine monthly examination and sampling). 
3.5.4.2 Tracheal haemorrhage 
Tracheal haernorrhage was classified as a binary variable (HAEMTRGP; 0-1) with 
presence (1) or absence of any visible haernorrhage (0) noted. 
3.5.4.3 Inflammation score 
Inflammation score as a measure of airway inflammation aggregated from 
endoscopic and cytological parameters has been described earlier (3.3.2.1 Inflammation 
score and 3.4.1 Cytology). 
3.6 Data management 
Following collation from the various laboratory and other sources, data from cases 
of clinically apparent respiratory disease were entered into a computer database using Epi 
Info 6 version 6.04b software (Dean el aL, 1994). The case database was designed to only 
allow entry of meaningful data by use of legal field limits through use of Epi Info CBECK 
files. Following entry, completed case data were checked for inconsistencies using 
appropriate frequency tabulations for variable values. Controls were randomly selected 
(subject to restrictions required for matching) from an existing longitudinal study dataset 
(Wood, 1999), which had already been validated and checked for inconsistencies. The 
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dataset for the case control study was then created by merging the datasets of clinically 
apparent cases and all selected controls, irrespective of endoscopic findings or cytological 
interpretation of tracheal washes. Merging of datasets was achieved using the 
CONCATENATE function from the MERGE menu in Epi Info. 
Data were exported to Stat9m 5.0 software (Stata Corporation). Continuous and 
ordered categorical variables were transformed as appropriate into ordered categorical or 
binary variables. 'Healthy' and 'subclinical' controls were identified according to their 
inflanimation score and 3 additional case variables (CASE2, CASE3 and CASE4) were 
created with horses being appropriately assigned to either of 2 levels for each variable, 
according to the status of horses being compared. 
3.7 Statistical methods 
3.7.1 Overview 
Conditional logistic regression (CLR) is the appropriate regression technique for 
analysis of matched case control studies. In this type of analysis the probability of being a 
case is calculated in each stratum or matched set relative to the controls to which the 
case(s) is (are) matched i. e. a conditional probability or likelihood of being a case is 
calculated. The summary coefficient or relative risk measure for all cases is then calculated 
as the sum of probabilities over all strata that are concordant for exposure (i. e. strata that 
have all individuals classified the same way for exposure do not contribute to results). The 
conditional likelihood, L,, where there are a variable number of controls per case in different 
strata may be represented as follows (Breslow & Day, 1980): 
Lc =11M, 
KI 
j=1 I+ ZeXPfL, 8k(X, 
k -X, Ok)) 
j=l k=l 
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Here the th of I matched sets contains A controls in addition to the cases and xjok 
denotes the K-vector of exposures for the cases in this set and X#k denotes the k' exposure 
for the t control (j= 1,2 . ..... 
M). It is clear from this conditional model that there is no 
estimate of an intercept term and there is no contribution to the likelihood estimate when all 
components of strata are concordant with respect to outcome status. 
Classification of controls into 2 subgroups according to their tracheal inflammation 
scores meant that factors associated with different case and control definitions (datasets) 
could be determined. Comparison of the factors associated with each dataset would 
establish whether different factors were likely to be associated with clinically apparent and 
subclinical presentation of respiratory disease in this population of racehorses. The different 
datasets are briefly described below with the statistical approaches used. All statistical 
analyses were conducted using StataTm 5.0 software (Stata Corporation). 
3.7.2 Case control datasets 
3.7.2.1 Cases vs 'all' controls 
'All' controls ('healthy' and 'subclinical' taken together) were compared with cases 
in the largest dataset. This approach would have the advantage of using a maximum sample 
size thus maximising the power of the study but controls, none of which had clinically 
apparent disease, were not differentiated according to tracheal inflammation score. This 
would mean that factors associated with a spectrum of clinical and subclinical disease would 
have the size of their effect reduced and possibly to the extent that that they would no 
longer be statistically significantly associated with clinically apparent disease. 
3.7.2.2 Cases vs 'healthy'controls 
Use of a 'healthy' control group that included only horses without signs of airway 
inflammation, as measured by the aggregated inflammation score, would allow removal of 
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the effects of factors associated with subelinical respiratory disease. More clearly defined 
comparison groups would allow more reliable biological interpretation of findings but the 
exclusion of data, however, would reduce power and increase the size of an effect needed 
to be found statistically significant. 
3.7.2.3 Cases vs 'suhchnical' controls 
Use of a 'subclinical' control group that included only horses with signs of airway 
inflammation, as measured by the aggregated inflammation score, would allow direct 
evaluation of what factors were associated with clinical disease over and above those 
associated with the subclinical form. Again, more clearly defined comparison groups would 
maximise biological interpretation but with the cost of reducing power. 
3.7.2.4 'Healthy' controls vs 'suhchnical'controls 
'Subclinical' controls were here coded as cases and 'healthy' controls were used as 
the control group. This would determine which factors were associated with the presence of 
subclinical airway inflammation among the non-clinically affected horses and in turn allow 
better interpretation of earlier comparisons involving clinically apparent cases and both 
subgroups of controls. 
3.7.3 Univariable analyses 
All explanatory variables were exarnined for their univariable (crude) association 
with the probability of being a clinically apparent case by inclusion in a simple conditional 
logistic regression (CLR) model in which cases and controls were matched by set (trainer 
and time period). The association between outcome and each explanatory variable was 
expressed as a logistic regression coefficient (0) and standard error (S. E. P), an estimated 
crude odds ratio (OR) with 95% confidence intervals around the estimate (derived from 
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S. E. 0), and corresponding Wald X2 P-value. When the results of these analyses were cross- 
checked with those of conventional Mantel Haenszel methods used to adjust for the effects 
of matching, they were found to be very similar. Consequently only the results of the CLR 
models are presented. 
3.7.4 Multivariable, analyses 
3.7.4.1 Regression modelling strategy 
Following univariate analyses, 4 separate models were developed using multivariable 
conditional logistic regression modelling with the 4 different case and control definitions. 
This was undertaken to provide valid estimates of the strength of associations between 
significant explanatory variables and disease, having adjusted for the effects of other 
v. ariables. 
Variables believed a priori to be associated with disease and others that were 
associated with outcome in univariate analysis at a significance level P<0.25 were entered in 
conditional regression models during the model building process. An inclusion criteria of 
P<0.25 was chosen to allow variables that may be truly associated with diseases but were 
confounded by others at the univariate level, to be included in final models. Cytological 
markers of inflammation, including tracheal mucopus, inflammatory cell predominance, 
nucleated cell count and aggregated inflammation score and tracheal haemorrhage, were 
considered likely to be part of a causal pathway between infections and disease and were, 
therefore, not included as their inclusion in models with microbiological variables was likely 
to modify any effect towards unity. The matching process controlled factors confounding 
the association between clinically apparent disease and tracheal isolate variables. Due to the 
similarity of most housing and management of horses within training yards, most but not all 
factors related to housing, horse management and training were controlled by matching on 
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trainer and factors related to season and disease or infection clustering, were controlled by 
matching on time period. 
A forward stepwise approach was adopted for multivariable analyses with systematic 
addition of a priori and significant main effects variables in descending order of their 
strength of association with the outcome. Variables were only retained if they were 
associated with disease (Wald X2: P :! ý 0.05) or if their inclusion resulted in a significant 
reduction in model deviance as measuredby the likelihood ratio statistic (LRS X2: p :50.05) 
(Hosmer & Lemeshow, 1989). To ensure that statistically significant associations had not 
been inadvertently rejected, the final parsimonious model was checked by systematic 
addition of rejected variables one at a time. 
Infection with influenza virus was extremely rare in this well vaccinated population 
and was not detected among 'healthy' controls. This presented particular problems with its 
inclusion in multivariable analyses involving this control group. In order to maximise 
available sample size and minimise the confounding effects from rare influenza infection, all 
analyses were conducted after exclusion of the 2 matched sets in which influenza 
seroconversions occurred. 
Statistical interaction was examined by the addition of biologically meaningful, 2- 
way interaction terms between main effect variables. Interaction terms that provided a 
significant improvement to model fit as measured by likelihood ratio statistic (LRS X2: p 
0.05) were retained. 
3.7.4.2 Postfit diagnostic procedures 
Final multivariable models were examined for goodness-of-fit using the Hosmer- 
Lemeshow technique (Hosmer & Lemeshow, 1989). The estimated probabilities from the 
models for each observation and the corresponding observed outcomes (taking the value 
one if a case and zero if a control) were ranked in ascending order of their estimated value 
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and split into ten groups corresponding to deciles of ascending risk. The sum of observed 
and predicted values for observations in each decile group were then calculated and the 2x 
10 contingency table tested for statistically significant differences across deciles using the 
modified chi-squared test with 8 degrees of freedom as described by Hosmer & Lemeshow 
(1989). A statistically significant result with P<0.05 in this test would indicate that there 
was poor prediction of outcome by the regression model. 
In addition, final multivariable models were evaluated for their robustness by 
refitting of models following sequential exclusion of the observations with the largest delta- 
beta values (i. e. those observations whose exclusion were predicted to have the largest 
influence on each coefficient) for each variable included in the final model (Pregibon, 1981). 
Models were considered stable and robust when there was no significant effect on the fit of 
the model with exclusion of these observations as judged by the value and significance of 
coefficient estimates. 
Finally, individual observations with the largest residual values, i. e. those 
observations whose outcomes were not well predicted by final models, were examined with 
respect to the variables included in these models. Contingency tables of case control status 
versus categories of included variables were generated for observations with absolute 
residual values >0.5 and the relative distribution of observations among these categories 
was examined. 
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CHAPTER 4 
RESULTS 
4.1 Description of data 
Numbers and prevalence proportions of different categories of variables in clinically 
apparent cases, 'all' controls and subgroups of 'healthy' and 'subclinical' controls are 
presented in Tables 4.1 - 4.3. 
Table 4.1 sununarises the trainer details, age group, sex, encloscopic findings, 
inflammation score categories, time since entering yards and previous racing status for 
clinically apparent cases and 'all' controls, 'healthy' controls and 'subclinical' controls. 
Compared with 'all' controls a higher proportion of cases had positive grades of visible 
tracheal mucopus, had inflammation scores of 2 or 3 out of 3, were yearlings or 2-years- 
olds, female, had been in the yards less than 3 months and had not raced previously. 
Although numbers were small, a larger proportion of cases had visible tracheal haemorrhage 
compared to 'all' controls. Due to the requirements for matching, the relative proportions 
of cases and 'all' controls contributed by each trainer were very similar. However, the 
variation in relative proportions of subgroups of 'healthy' and 'subclinical' controls 
comprising 'all' controls contributed by each trainer reflected the overall prevalence of 
subclinical disease in each yard. As such, this would contribute a yard effect that was 
controlled for in matching by trainer. Predictably, the overall number of cases presented by 
each yard was correlated with the period that the yard was studied and the total number of 
horses in the yard. There were lower numbers of cases from the 2 yards in Lamboum and 
Epsom, due to the additional logistics involved in collecting samples from these yards 
because of their distance from the laboratories at the AHT. There was a slight seasonal 
variation in the presentation of cases, with fewer being seen between August and October 
than in the rest of the year when cases were more evenly presented. There was an increased 
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proportion of 'subclinical' controls seen between February and April compared to other 
periods. 
e ,1 Table 4.2 summarises the isolation of bacterial species from tracheal washes and 
their numbers. Results show that the proportion of horses with ý! 10' cfu/nil of total bacteria, 
PasteurellalActinobacillus spp., S. zooepidemicus and non-haernolytic Streptococcus spp. 
was larger amongst cases compared to 'all' controls and amongst 'subclinical' controls 
compared to 'healthy' controls. S. pneumoniae was isolated from a larger proportion of 
cases compared to 'all' controls and 'subclinical' controls compared to 'healthy' controls. 
In contrast, <102 CfU/ml (coagulase negative) Slaphylococcus spp. were isolated from a 
larger proportion of 'all' controls compared to cases but in similar proportions from 
'healthy' and 'subclinical' controls. Relatively few horses amongst both cases and controls 
had other species of bacteria isolated from tracheal washes. 
Table 4.3 shows results of mycoplasma culture of tracheal washes available from 
129 cases and 564 controls. There were relatively few horses from which mycoplasma, were 
isolated from tracheal washes, although the proportion of horses from which Mycoplasma 
ftfis was isolated was higher amongst cases compared to 'all' controls. Mycoplasma 
equirhinis was the most frequently isolated Mycoplasma spp., from approximately equal 
proportions of cases and 'all' controls. Amongst controls, however, M equirhinis was 
isolated more frequently from 'subclinical' controls. 
Table 4.3 also includes nasopharyngeal swab bacterial culture and serology results for 
clinically apparent cases and the 3 control groups. Results of bacterial culture of 
nasopharyngeal swabs were available from 124 cases and 610 controls. The proportions of 
horses with bacteria isolated amongst all groups were broadly similar, although S. 
zOOepidemicus was isolated from a marginally higher proportion of cases compared to 'all' 
controls and from more 'subclinical' controls than 'healthy' controls. Non-haemolytic 
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Streptococcus spp. and Staphylococcus spp. were isolated from more than 80% of all swabs 
from all groups. 
Complement fixation (CF) tests were performed on samples from 141 cases and all 632 
controls for equine herpes- and rhino viruses. Haernagglutination inhibition (111) tests for 
equine adenovirus and equine influenza were performed on samples from 126 cases and all 
632 controls. There were relatively few positive diagnoses of viral infection made, with less 
than 6 percent of horses in any group seroconverting to any single virus. Equine herpesvirus 
was the most common serologically diagnosed viral infection but was found in 
approximately equal proportions of acute cases and 'all' controls. Equine rhinovirus was 
diagnosed more frequently among cases than controls. Influenza was an extremely rare 
infection in this vaccinated population and was not diagnosed in 'healthy' controls 
throughout the duration of the study. 
It may be seen that there were more missing data from cases than controls, especially 
for samples submitted for laboratory testing'such as bacterial and mycoplasma culture and 
serology. This arose because clinical cases but not controls included horses that were 
sampled at times other than routine monthly yard visits usually by the yard's own veterinary 
surgeon. Consequently a larger proportion of these animals did not have a full set of 
samples submitted, despite attempts by study staff to encourage as complete sampling as 
possible. 
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Table 4.1: Numbers and percentages of cases and controls for non-infectious 
explanatory variables 
A ll 'Healthy' 'Suhclinical' 
Explanatory variable Cases Controls Controls Con trols 
n r1o) n r1o) n r1o) n r1o) 
Totalnumhers 170 (100) 632 (100) 304 (100) 328 (100) 
Trainer Period Total No. Location 
studied Horses 
1 14 mths 55-65 Larnboum 8 (5) 31 (5) 17 (6) 14 (4) 
12 34 mths 100-125 Newmarket 49 (29) 177 (28) 95 (31) 82 (25) 
i3 36 mths 65 Newmarket 39 (23) 127 (20) 49 (16) 78 (24) 
4 36 mths 55-70 Epsom 13 (8) 52 (8) 35 (12) 17 (5) 
5 27 mths 70 Newmarket 32 (19) 125 (20) 68 (22) 57 (17) 
6 12 mths 175 Newmarket 15 (9) 60 (9) 15 (5) 45 (14) 
76 mths 90 Newmarket 14 (8) 60 (9) 25 (8) 35 (11) 
Season 
November - January Winter 47 (27) 169 (27) 84 (28) 
85 (26) 
February - April Spring 46 (27) 196 (31) 80 (26) 
116 (35) 
May - July Summer 47 (28) 162 (26) 85 (28) 
77 (23) 
August - October Autumn 30 (18) 105 (17) 55 (18) 
50 (15) 
'Agegroup* Yearlings 15 (9) 12 (2) 6 (2) 6 (2) 
2 ycar-olds 98 (58) 326 (52) 151 (50) 175 (53) 
3 year-olds 39 (23) 226 (36) 114 (38) 112 (34) 
; _>4 year-olds 
18 (11) 68 (11) 33 (11) 35 (11) 
Sex Female 68 (40) 177 (28) 78 (26) 99 (30) 
Male 102 (60) 455 (72) 226 (74) 229 (70) 
Endoscopic examination 
Visible tracheal mucopus none visible 45 (29) 414 (66) 238 (78) 176 (54) 
slight 55 (36) 149 (24) 66 (22) 83 (25) 
moderate 43 (28) 61 (10) 0 (0) 61 (19) 
severe 10 (7) 8 (1) 0 (0) 8 (2) 
Visible tracheal haemorrhage none visible 139 (92) 620 (98) 298 (98) 322 (98) 
visible 12 (8) 12 (2) 6 (2) 6 (2) 
ý Inflammation score* 0 44 (27) 304 (48) 304 (100) 0 (0) 
(out of 3) 1 55 (34) 238 (38) 0 (0) 238 (73) 
2 37 (23) 52 (8) 0 (0) 52 (16) 
3 28 (17) 38 (6) 0 (0) 38 (12) 
Time since entering training <1 month 21 (13) 27 (4) 10 (3) 17 (5) 
yard* 1-3 months 34 (21) 76 (12) 30 (10) 46 (14) 
>3 months 110 (67) 517 (83) 259 (97) 258 (80) 
Racedpreviously No 107 (63) 323 (51) 136 (45) 187 (57) 
Yes 63 (37) 309 (49) 168 (55) 141 (43) 
Time since last race Never raccd 107 (63) 323 (51) 136 (45) 187 (57) 
1-7 days 8 (5) 52 (8) 26 (9) 26 (8) 
>7 davs 55 (32) 257 (41) 142 (47) 115 (35) 
*missing data values explain departures from totals 
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Table 4.2: Numbers and percentages of cases and controls for tracheal wash (TW), 
bacterial culture explanatory variables 
All 'Healthy' 'Subclinical' 
Explanatory variable Cases 
n (016) 
Controls 
n (01ý6) 
Controls 
n (01o) 
Controls 
n (1/0) 
TWbacterial culture TW submitted 157 (92) 632 (100) 304 (100) 328 (100) 
no TW submitted 13 (8) 0 (0) 0 (0) 0 (0) 
Total bacterial count none isolated 22 (14) 149 (24) 90 (30) 59 (18) 
<102 CftVMI 15 (10) 122 (19) 59 (19) 63 (19) 
101-101 cfu/ml 23 (15) 140 (22) 72 (24) 68 (21) 
103_104 CfU/Ml 31 (20) 107 (17) 49 (16) 58 (18) 
104_105 CftL/Ml 28 (18) 70 (11) 26 (9) 44 (13) 
101-10, cfu/ml 21 (13) 29 (5) 8 (3) 21 (6) 
ý;. 106 CfU/nIl 17 (11) 15 (2) 0 (0) 15 (5) 
ActinobacillusIPasteurelia none isolated 95 (61) 477 (75) 251 (83) 226 (69) 
SPP. <102 CfU/Ml 3 (2) 36 (6) 15 (5) 21 (60 
102_103 CfU/Ml 16 (10) 41 (6) 16 (5) 25 (8) 
103.104 CfU/nll 11 (7) 37 (6) 12 (4) 25 (8) 
104_105 CfU/ml 9 (6) 28 (4) 9 (3) 20 (6) 
105_106 CfU/nIl 13 (8) 8 (1) 2 (<I) 6 (2) 
> 106 CfU/ml 10 (6) 5 (<I) 0 (0) 5 (2) 
Streptococcus zooepidemicus none isolated 85 (54) 446 (71) 240 (79) 206 (63) 
<102 CfU/ml 18 (11) 77 (12) 31 (10) 46 (14) 
102_103 CfU/ral 15 (10) 53 (8) 21 (7) 32 (10) 
103_104 CfU/Ml 11 (7) 28 (4) 9 (3) 19 (6) 
104_105 CfU/ml 9 (6) 18 (3) 3 (1) 15 (5) 
105_106 CfU/Ml 11 (7) 7 (1) 0 (0) 7 (2) 
> 106 CfU/ml 8 (5) 3 (<I) 0 (0) 3 (1) 
Streptococcuspneumoniae not isolated 135 (86) 580 (92) 289 (95) 291 (89) 
isolated 22 (14) 52 (8) 15 (5) 37 (11) 
Streptococcus equisimilis not isolated 150 (96) 621 (98) 298 (98) 323 (98) 
isolated 7 (4) 11 (2) 6 (2) 5 (2) 
Non-hacm. Streptococcus <103 CfU/Ml 103 (66) 490 (78) 250 (82) 240 (73) 
SPI). 
103_104 CfU/ml 37 (24) 123 (19) 50 (16) 73 (22) 
>104 CfU/ml 17 (11) 19 (3) 4 (1) 15 (5) 
Acinetobacter spp. not isolated 149 (95) 581 (92) 288 (95) 293 (89) 
<102 cfU/ml 4 (3) 37 (6) 12 (4) 25 (8) 
>I 01 cfu/ml 4 (3) 14 (2) 4 (1) 10 (3) 
Bacillus spp. not isolated 147 (94) 597 (94) 290 (95) 307 (94) 
isolated 10 (6) 35 (6) 14 (5) 21 (6) 
Bordetella bronchiseptica not isolated 156 (>99) 627 (>99) 301 (>99) 326 (>99) 
isolated I (<I) 5 (<I) 3 (<I) 2 (<l) 
Enterobacter spp. not isolated 155 (99) 624 (99) 299 (98) 325 (99) 
isolated 2 (1) 8 (1) 50 (2) 3 (1) 
Escherichia coli not isolated 148 (94) 603 (95) 293 (96) 310 (95) 
isolated 9 (6) 29 (5) 11 (4) 18 (5) 
Pseudomonas spp. not isolated 156 (>99) 631 (>99) 303 (>99) 328 (100) 
isolated I (<I) I (< 1) 1 (<I) 0 (0) 
Serratia spp. not isolated 156 (>99) 627 (>99) 303 (>99) 324 (99) 
isolated 1 (<l) 5 (<l) I (<I) 4 (1) 
Staphylococcus spp. not isolated 113 (72) 371 (59) 183 (60) 188 (57) 
* 102 CfU/Ml 15 (10) 136 (22) 70 (23) 66 (20) 
* 102 Cffi/ml 29 (18) 
_125 
(20) 51 (17) 74 (23) 
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Table 4.3: Numbers and percentages of cases and controls for tracheal wash (TW) 
mycoplasma and nasopharyngeal swab bacterial culture and serological 
explanatory variables 
All 'Healthy' 'Subclinical' 
Explanatory variable Cases Controls Controls Controls 
n r1o) n r1o) n r1q) n r1o) 
TWMvcoplasma culture TW submitted 129 (76) 564 (89) 271 (89) 293 (89) 
no TW submitted 41 (24) 68 (11) 33 (11) 35 (11) 
Mycoplasmafelis not isolated 119 (92) 557 (99) 270 (>99) 287 (98) 
isolated 10 (8) 7 (1) 1 (<I) 6 (2) 
NFGF Mycoplasma spp. not isolated 122 (95) 555 (98) 266 (98) 289 (99) 
isolated 7 (5) 9 (2) 5 (2) 4 (1) 
Afycoplasma equirhinis not isolated 111 (86) 494 (88) 250 (92) 246 (84) 
isolated 18 (14) 68 (12) 21 (8) 47 (16) 
NP swab bacterial swab submitted 124 (73) 610 (97) 298 (98) 312 (95) 
culture 
no swab 46 (27) 22 (3) 6 (2) 16 (5) 
submitted 
Pasteurella spp. not isolated 80 (65) 428 (70) 213 (71) 215 (69) 
isolated 44 (35) 182 (30) 85 (29) 97 (31) 
S. zooepidemicus not isolated 76 (61) 438 (72) 224 (75) 214 (69) 
isolated 48 (39) 172 (28) 74 (25) 98 (31) 
S. pneumoniae not isolated 109 (88) 537 (88) 269 (90) 268 (86) 
isolated 15 (12) 73 (12) 29 (10) 44 (14) 
Non-haem. Strep. spp. not isolated 22 (18) 71 (12) 30 (10) 41 (13) 
isolated 102 (82) 539 (88) 268 (90) 271 (87) 
A cinetobacter spp. not isolated 99 (80) 460 (75) 231 (78) 229 (73) 
isolated 25 (20) 150 (25) 67 (22) 83 (27) 
Bacillus spp. not isolated 109 (87) 523 (86) 255 (86) 268 (86) 
isolated 16 (13) 87 (14) 43 (14) 44 (14) 
Enterohacter spp. not isolated 122 (98) 598 (98) 292 (98) 306 (98) 
isolated 2 (2) 12 (2) 6 (2) 6 (2) 
Escherichia coli not isolated 120 (97) 597 (98) 291 (98) 306 (98) 
isolated 4 (3) 13 (2) 7 (2) 6 (2) 
Serratia spp. not isolated 123 (>99) 603 (99) 293 (98) 310 (>99) 
isolated I (<I) 7 (1) 5 (2) 2 (<I) 
Staphylococcus spp. not isolated 20 (16) 93 (15) 45 (15) 48 (15) 
isolated 104 (84) 517 (85) 253 (85) 264 (85) 
Sero pairs CF tested 141 (83) 632 (100) 304 (100) 328 (100) 
pairs HI tested 126 (74) 632 (100) 304 (100) 328 (100) 
EHV-1 & EHV4 (CF) no scroconversion 133 (94) 609 (96) 294 (97) 315 (96) 
scroconversion 8 (6) 23 (4) 10 (3) 13 (4) 
ERV-1 (CF) no scroconversion 137 (96) 623 (99) 301 (99) 322 (98) 
scroconversion 4 (4) 9 (1) 3 (1) 6 (2) 
Equine adenovirus (HI) no seroconvcrsion 125 (>99) 627 (>99) 302 (>99) 325 (>99) 
scroconvcrsion I (<I) 5 (<I) 2 (<I) 3 (<l) 
Equine influenza virus (HI) no seroconvcrsion 123 (98) 630 (>99) 304 (100) 326 (>99) 
scroconversion 3 (2) 2 (<I) 0 (0) 2 (<I) 
NFGF = Non-felis glucose fermenting 
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4.2 Cases vs 'all' controls 
4.2.1 Univariable analyses 
Table 4.4 surnmarises univariable associations between clinically apparent respiratory 
disease and non-infectious explanatory variables using 'all' controls. Horses were at 
significantly increased risk of being a case with younger age, being female, increasing 
mucopus and inflammation scores and presence of tracheal haemorrhage. Risk was 
increased in horses that had never raced previously but decreased with the time they had 
been in the training yard. 
Table 4.4: Univariable associations between clinically apparent cases and non- 
infectious explanatory variables using 'all' controls 
Explanatory variable Crude OR 95% C1 PLvalue 
Age group Yearlings 11.6 3.5-38.0 <0.001 
2 ycar-olds referent 
3 year-olds 0.5 0.3-0.8 0.002 
ý-4 year-olds 0.8 0.4-1.5 0.458 
Sex Female referent 
Male 0.6 0.4-0.8 0.002 
risible tracheal mucopus none visible referent 
slight 4.3 2.7-6.9 <0.001 
moderate 9.9 5.6-17.6 <0.001 
severe 24.3 8.2-71.8 <0.001 
risible tracheal haemorrhage none visible referent 
visible 4.7 2.0-11.1 <0.001 
Inflammation score 0 referent 
(out of 3) 1 1.6 1.0-2.5 0.037 
2 6.6 3.7-11.7 <0.001 
3 7.2 3.8-13.7 <0.001 
Time since entering training yard <1 month 4.5 2.3-9.1 <0.00 1 
1-3 months 3.3 1.8-5.8 <0.001 
>3 months referent 
Racedpreviously No referent 
Yes 0.6 0.4-0.8 0.004 
Time since last race Never raccd referent 
1-7 days 0.4 0.2-1.0 0.040 
>7 days 0.6 0.4-0.9 0.010 
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Table 4.5 shows that clinically apparent respiratory disease was associated with several 
n&robiological variables in univariable analyses. The risk of being a case increased with 
Pasteurella greater logio cfu/ml of tracheal wash for total bacterial count, Actinobacillusl, 
spp. and S. zooepidemicus. Non-haernolytic Streplococcus spp. at > 104 CfU/ml of tracheal 
wash was significantly associated with clinical disease as was the presence of S. 
pneumoniae, M ftfis and non-felis glucose fermenting (NFGF) Mycoplasma spp.. 
Staphylococcus spp. at <102 cfu/ml of tracheal wash was inversely associated with the risk 
of clinically apparent respiratory disease. Infections with known equine viruses were not 
significantly associated with clinical disease other than equine influenza, which had the 
largest OR of 7.0 being marginally significant (P = 0.051). The presence of non-haernolytic 
Streptococcus spp in NP swabs was inversely associated with disease. 
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Table 4.5: Univariable associations between clinically apparent cases and 
microbiological explanatory variables using 'all' controls 
-II 
Explanatory variable Crude OR 95% CI P-value 
Tracheal wash bacterial isolates 
Total bacterial count none isolated referent 
<102 cuira 0.9 0.4-1.8 0.668 
102_103 CfU/nIl 1.2 0.6-2.3 0.610 
103.104 CfU/Ml 2.1 1.1-4.0 0.023 
104_105 cfU/nIl 3.3 1.7-6.4 0.001 
105_106 CfU/ml 6.1 2.8-13.5 <0.001 
>106 CfU/Ml 9.2 3.8-22.6 <0.00 I 
PasteurellalActinobacillus spp. log cfU/ml-' 1.4 1.3-1.6 <0.001 
Streptococcus zooepidemicus log cfU/ml-' 1.4 1.3-1.6 <0.001 
Streptococcuspneumoniae not isolated referent 
isolated 1.8 1.0-3.2 0.034 
Streptococcus equisimilis not isolated referent 
isolated 2.4 0.9-6.5 0.074 
Non-haemolytic Streptococcus spp. <103 CfU/Ml referent 
103_104 CfU/nfl 1.4 0.9-2.2 0.141 
>104 CfU/ml 4.2 2.0-8.6 <0.001 
Acinetobacter spp. not isolated referent 
< 102 CfU/ml 0.4 0.1-1.1 0.087 
> 102 CfU/Ml 1.0 0.3-3.4 0.937 
Bacillus spp. not isolated referent 
isolated 1.2 0.6-2.5 0.651 
Bordetella bronchiseptica not isolated referent 
isolated 0.6 0.06-6.2 0.680 
Enterobacter spp. not isolated referent 
isolated 0.9 0.2-4.7 0.886 
Escherichia coli not isolated referent 
isolated 1.3 0.6-2.8 0.563 
Pseudomonas spp. not isolated referent 
isolated 3.6 0.2-57.4 0.368 
Serratia spp. not isolated referent 
isolated 0.8 0.1-6.9 0.837 
Staphylococcus spp. not isolated referent 
< 02 cfu/ml 0.3 0.2-0.6 <0.001 
> 102 cfU/nd 0.7 0.5-1.2 0.181 
Tracheal wash Mrcoplasma isolates 
Afycoplasmafelis not isolated referent 
isolated 5.3 1.7-17.1 0.005 
NFGF Afycoplasma spp. not isolated referent 
isolated 3.6 1.2-10.3 0.019 
Afycoplasma equirhinis not isolated referent 
isolated 1.2 0.7-2.1 0.578 
NFGF = Non-felis glucose fermenting 
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Table 4.5 continued 
Variable Crude OR 95% CI Avalue 
Serological evidence of viral infection 
Equine herpcsvirus no seroconversion referent 
seroconversion 1.5 0.5-4.0 0.440 
Equine rhinovirus no scroconversion referent 
scroconversion 2.1 0.6-7.2 0.239 
Adenovirus no seroconversion referent 
seroconversion 1.0 0.1-9.4 0.978 
Influenza no scroconvcrsion referent 
scroconvcrsion 7.0 1.0-50.2 0.051 
Nasopharmpeal sivab bacterial isolates 
Pasteurella spp. not isolated referent 
isolated 1.4 0.9-2.4 0.168 
Streptococcus zooepidemicus not isolated referent 
isolated 1.5 1.0-2.3 0.068 
Streptococcuspneumoniae not isolated referent 
isolated 0.9 0.5-1.6 0.633 
Non-haemolytic Streptococcus spp. not isolated referent 
isolated 0.6 0.3-1.0 0.037 
Acinetobacter spp. not isolated referent 
isolated 0.73 0.4-1.3 0.258 
Bacillus spp. not isolated referent 
isolated 0.9 0.5-1.6 0.600 
Enterobacter spp. not isolated referent 
isolated 0.8 0.2-3.9 0.789 
Escherichia coli not isolated referent 
isolated 2.0 0.6-6.8 0.286 
Serratia spp. not isolated referent 
isolated 0.6 0.07-4.7 0.613 
Staphylococcus spp. not isolated referent 
isolated 1.0 0.6-1.7 0.949 
4.2.2 Multivariable analyses 
Table 4.6 summarises the final multivariable CLR model for clinically apparent 
respiratory disease using 'all' controls, excluding the 2 matched sets in which influenza 
infections occurred. Afler controlling for microbiological variables, clinical respiratory 
disease remained significantly associated with age and time since entry into the training 
yard; with younger horses and those that had been in training less than 3 months at 
increased risk. Risk of being a case was significantly and positively associated with presence 
of ActinobacilluslPasteurella spp. and M felis in tracheal washes but was inversely 
associated with Slaphylococcus and Acinelobacter spp.. No statistically significant 
interactions were identified in this model. 
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Table 4.6: Final multivariable CLR model for associations between clinically 
apparent respiratory disease and explanatory variables using 'all' controls 
Explanatory variable 0 S. E, 0 Adjusted OR 95% CI P-value 
Age group Yearlings 2.55 1.17 12.8 1.3-128 0.029 
2 year-olds referent 1.0 
3 year-olds -0.51 0.31 0.6 0.3-1.1 0.098 
Z-4 year-olds -0.24 0.43 0.8 0.3-1.8 0.576 
*0.028 
Time since entering training yard <1 month 1.71 0.59 5.5 1.7-17.6 0.004 
1-3 months 0.89 0.39 2.4 1.1-5.2 0.022 
>3 months referent 1.0 
*0.005 
TW PasteurellalActinobacillus spp. log cfU/ml-, 0.26 0.08 1.3 1.1-1.5 0.001 
*0.0006 
TW Staphylococcus spp. not isolated referent 1.0 
* 102 CfU/Ml -0.97 0.38 0.4 0.2-0.8 0.010 
* 102 CfU/n-d -0.01 0.28 1.0 0.6-1.7 0.981 
*0- 020 
TWA cinetobacter spp. not isolated referent 1.0 
< 102 CfU/Ml -1.25 0.06 0.3 0.1-0.9 0.030 
>102 CfU/nlj -0.04 0.69 1.0 0.3-3.6 0.956 
*0.048 
TWALfelis not isolated referent 1.0 
isolated 1.44 0.67 4.2 1.1-15.9 0.033 
*0.029 
*Likelihood ratio statistic X2 P-value TW = tracheal wash isolate 
Hosmer-Lemeshow X2 = 3.45; P=0.90 
4.3 Cases vs 'healthy' controls 
4.3.1 Univariable analyses 
Table 4.7 surnmarises univariable associations between clinically apparent respiratory 
disease and non-infectious explanatory variables using 304 'healthy' controls. Using this set 
of controls, horses were at increased risk of being a clinical case for the same factors as for 
tall' controls (younger age, female, tracheal haemorrhage, less time in training yard and not 
raced previously). However, the strengths of the associations were generally larger than 
when 'all' controls were used. 
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Table 4.7: Univariable associations between clinically apparent cases and non- 
infectious explanatory variables using 'healthy' controls 
Variable Crude OR 95% CI P-value 
Age group Yearlings 13.4 3.3-54.3 <0.001 
2 year-olds referent 
3 year-olds 0.4 0.3-0.7 0.001 
ýA ycar-olds 0.9 0.4-1.8 0.702 
Sew Female referent 
Male 0.5 0.3-0.8 0.002 
rhible trach eal haemorrhage none visible referent 
visible 5.3 1.8-15.4 0.002 
Time since entering training yard <1 month 5.9 2.5-14.1 <0.001 
1-3 months 4.1 2.0-8.3 <0.001 
>3 months referent 
Racedpreviously No referent 
Yes 0.5 0.3-0.7 0.001 
Time since last race Never raced referent 
1-7 days 0.5 0.2-1.1 0.084 
>7 days 0.5 0.3-0.7 0.001 
Table 4.8 shows that with univariable analysis, clinically apparent cases of respiratory 
disease compared to 'healthy' controls were significantly associated with the same tracheal 
wash bacterial variables as 'all' controls, but the strength of the associations were increased. 
The association between M. felis and clinical disease was increased compared to 'all' 
controls although smaller sample numbers gave rise to very wide confidence intervals. 
NFGF Mycoplasma spp. and M equirhinis were not associated with disease. 
Staphylococcus spp. in tracheal washes at <102 cfu/ml demonstrated an inverse association 
with disease. In this analysis the presence of S. zooepidemicus in nasopharyngeal swabs was 
associated with disease but non-haernolytic Streptococcus spp. in swabs was inversely 
associated with clinical disease. There was again no association with viral infections and no 
L 
diagnoses of influenza were made amongst 'healthy' controls. 
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Table 4.8: Univariable associations between clinically apparent cases and 
microbiological explanatory variables using 'healthy' controls 
Erplanatory variable Crude OR 95% CI P-value 
Tracheal wash bacterial isolates 
Total bacterial count none isolated referent 
<102 CfU/nIl 1.1 0.5-2.3 0.874 
102_103 CfU/Ml 1.4 0.7-2.9 0.304 
103.104 CfU/nll 2.2 1.1-4.6 0.025 
104_105 CfU/Ml 4.3 2.0-9.3 <0.00 1 
105_106 CfU/Ml 8.7 3.2-23.8 <0.001 
>106 CfU/n-d 00 - 
PasteurellalActinobacillus spp. log CUMI-I 1.6 1.3-1.8 <0.00 I 
Streptococcus zooepidemicus log cfti/Ml-I 1.7 1.4-2.0 <0.001 
Streptococcuspneumoniae not isolated referent 
isolated 3.0 1.5-6.3 0.002 
Streptococcus equisimilis not isolated referent 
isolated 2.3 0.7-7.3 0.149 
Non-haernolytic Streptococcus spp. <103 CfU/Ml referent 
103_104 CfU/nIl 1.6 1.0-2.7 0.067 
> 104 CfU/Ml 9.4 2.9-30.5 <0.001 
A cinelobacter spp. not isolated referent 
* 102 CfU/Ml 0.6 0.2-1.9 0.373 
* 102 cfu/inI 1.6 0.3-7.5 0.561 
Bacillus spp. not isolated referent 
isolated 1.9 0.8-4.8 0.162 
Bordetella bronchiseptica not isolated referent 
isolated 0.4 0.03-4.6 0.437 
Enterobacter spp. not isolated referent 
isolated 0.6 0.1-3.5 0.555 
Escherichia coli not isolated referent 
isolated 1.8 0.7-4.6 0.241 
Pseudomonas spp. not isolated referent 
isolated 1.7 0.1-27.0 0.717 
Serratia spp. not isolated referent 
isolated 1.2 0.1-18.9 0.92 
Staphylococcus spp. not isolated referent 
<102 CfU/nll 0.3 0.2-0.6 0.001 
> 102 CfU/Ml 0.8 0.5-1.4 0.432 
Tracheal wash Mvcoplasma isolates 
Afycoplasmafelis not isolated referent 
isolated 11.6 1.3-102.4 0.028 
NFGF Afycoplasma spp. not isolated referent 
isolated 3.0 0.9-10.7 0.086 
Mycoplasma equirkinis not isolated referent 
isolated 1.9 0.9-4.0 0.101 
NFGF = Non-felis glucose fermenting 
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Table 4.8 continued 
Variable Crude OR 95% CI P-value 
Serolorical evidence of viral infection 
Equine herpesvirus no seroconversion referent 
seroconversion 1.8 0.6-5.7 0.305 
Equine rhinovirus no seroconversion referent 
seroconversion 4.0 0.8-20.3 0.090 
Adenovirus no seroconversion referent 
seroconversion 0.8 0.1-9.5 0.894 
Influenza no seroconversion referent 
seroconversion 00 
'-'Nasopharvn, veal swab bacterial isolates 
Pasteurella spp. not isolated referent 
isolated 1.6 0.9-2.7 0.128 
Streptococcus zooepidemicus not isolated referent 
11'ý isolated 1.8 1.1-2.9 0.019 
Streptococcuspneumoniae not isolated referent 
isolated 1.1 0.5-2.2 0.890 
Non-haernolytic Streptococcus spp. not isolated referent 
isolated 0.5 0.2-0.9 0.028 
A cinelobacter spp. not isolated referent 
isolated 0.8 0.4-1.5 0.522 
Bacillus spp. not isolated referent 
isolated 1.0 0.5-1.9 0.928 
Enterobacter spp. not isolated referent 
isolated 0.9 0.2-5.0 0.929 
Escherichia coli not isolated referent 
isolated 2.2 0.5-10.1 0.326 
Serratia spp. not isolated referent 
isolated 0.4 0.05-3.8 0.451 
Staphylococcus spp. not isolated referent 
isolated 0.9 0.5-1.8 0.862 
4.3.2 Multivariable analyses 
Table 4.9 summarises the final multivariable CLR model for clinically apparent 
respiratory disease using only 'healthy' controls, excluding the 2 matched sets in which 
influenza infections occurred. After controlling for microbiological variables, clinical 
respiratory disease remained significantly associated with age and time since entry into the 
training yard; with younger horses and those that had been in training less than 3 months at 
increased risk. Risk of being a case was significantly and positively associated with presence 
of ActinobacilluslPasteurella spp. and S. zooepidemicus in tracheal washes, and 
ActinobacilluslPasteurella spp. in nasopharyngeal swabs but was inversely associated with 
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Staphylococcus spp. in washes and non-haemolytic Streplococcus spp. in swabs. No 
statistically significant interactions were identified in this model. 
Table 4.9: Final multivariable CLR model for associations between clinically 
apparent respiratory disease and explanatory variables using 'healthy' 
controls 
Explanatory variable P SEP Adjusted OR 95% CI P-value 
Age group Yearlings 2.64 1.30 14.0 1.1-179 0.042 
2 year-olds referent 1.0 
3 year-olds -0.74 0.39 0.5 0.2-1.0 0.057 
ýA year-olds 0.10 0.53 1.1 0.4-3.1 0.849 
Time sincc entcring training yard <1 month 1.23 0.67 
1-3 months 1.47 0.51 
>3 months rcfercnt 
TW PasteurellalActinobacillus spp. log cfu/mr, 
TW S. zooepidemicus log cfu/ml-I 
TW Staphylococcus spp. not isolated 
<102 CfU/Ml 
> 102 cfu/ml 
0.38 0.12 
0.28 0.13 
referent 
-0.96 0.45 
-0.07 0.35 
NP non-haemolytic Streptococcus not isolated referent 
SPP. Isolated -0.86 0.42 
3.4 0.9-12.6 
4.3 1.6-11.7 
1.0 
1.5 1.1-1.9 
1.3 1.0-1.7 
1.0 
0.4 0.2-0.9 
0.9 0.5-1.9 
1.0 
0.4 0.2-1.0 
*0.020 
0.065 
0.004 
*0.006 
0.002 
*0.0017 
0.029 
*0.024 
0.032 
0.839 
*0.077 
0.039 
*0.041 
NPActinobacilluslPasteurella spp. not isolated referent 1.0 
Isolated 0.74 0.36 2.1 1.0-4.3 0.039 
*0- 038 
*Likelihood ratio statistic X2 P-value TW = tracheal wash isolate 
NP = nasopharyngeal swab isolate Hosmer-Lemeshow X2 = 7.10; P=0.53 
4.4 Cases vs 'subelinical' controls 
4.4.1 Univariable analyses 
Table 4.10 summarises univariable associations between clinically apparent respiratory 
disease and non-infectious explanatory variables using 328 'subclinical' controls. Using this 
set of controls, horses were at increased risk of being a clinical case with younger age, being 
female, increasing tracheal mucopus, presence of tracheal haemorrhage and less time since 
entering the training yard. Previous racing was marginally inversely associated with clinical 
disease. 
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-Table 4.10: Univariable associations between clinically apparent cases and non- 
infectious explanatory variables using 'subclinical' controls 
ExplanatorY variable Crude OR 95% Cl P-value 
Age group Yearlings 9.1 2.4-34.9 0.001 
2 year-olds referent 
3 year-olds 0.6 0.3-0.9 0.024 
ý: 4 year-olds 0.8 0.4-1.6 0.489 
Sex Female referent 
Male 0.6 0.4-0.9 0.022 
KsihIe tracheal mucopus none visible referent 
slight 3.0 1.7-5.0 <0.001 
moderate 4.0 2.2-7.3 <0.001 
severe 9.3 3.1-28.1 <0.001 
risible tracheal haemorrhage none visible referent 
visible 4.5 1.5-13.3 0.006 
Time since entering training yard <1 month 3.8 1.7-8.4 0.001 
1-3 months 2.8 1.5-5.1 0.001 
>3 months referent 
Racedpreviously No referent 
Yes 0.7 0.5-1.1 0.090 
Time since last race Never raced referent 
1-7 days 0.4 0.2-1.1 0.083 
>7 days 0.7 0.5-1.2 0.195 
Table 4.11 shows that with univariable analysis, clinically apparent cases of respiratory 
disease compared to 'subclinical' controls were significantly associated with tracheal washes 
containing >104 cfu/ml total bacteria and non-haemolytic Streptococcus spp. and with logio 
cfu/ml increases of PasleurellalAclinobacillus spp. and S. zooepidemicus. The strengths of 
these associations were generally lower than for the analyses with 'healthy' controls or 'all' 
controls combined. Presence of Acinelobacter spp. and Staphylococcus spp. in tracheal 
washes were inversely associated with clinical disease. The presence of S. pneumoniae in 
tracheal washes was not associated with disease in this analysis. Both M. felis and NFGF 
Mycoplasma spp. present in tracheal washes were associated with clinical disease but M 
equirhinis was not. There was no association between clinically apparent disease and viral 
infection or presence of any individual bacterial species in nasopharyngeal swabs. 
131 
Equine Inflarninatory Airway Disease Epidemiology 
Table 4.11: Univariable associations between clinically apparent cases and 
microbiological explanatory variables using Isubclinical' controls 
Explanatory variable Crude OR 95% C1 Avalue 
Tracheal wash bacterial isolates 
Total bacterial count none isolated referent 
<102 CfU/Ml 0.6 0.3-1.4 0.222 
102_103 CfU/Ml 0.9 0.4-1.7 0.661 
103_104 CfU/Ml 1.5 0.7-3.1 0.283 
104_105 CfU/ml 2.2 1.0-4.8 0.044 
101_106 CfU/Ml 3.4 1.4-8.2 0.006 
>106 CfU/Ml 4.0 1.6-10.4 0.004 
PasteurellalActinobacillus spp. log cfu/ml-1 1.3 1.1-1.4 <0.001 
Streptococcus zooepidemicus log Curar, 1.3 1.1-1.4 <0.00 I 
Streptococcuspneumoniae not isolated referent 
isolated 1.3 0.7-2.4 0.420 
Streptococcus equisimilis not isolated referent 
isolated 2.6 0.8-8.5 0.109 
Non-haemolytic Streptococcus spp. <103 CfU/ml referent 
103_104 CfU/nIl 1.2 0.7-1.9 0.551 
> 104 CfU/Ml 2.6 1.2-5.6 0.015 
A cinetobacter spp. not isolated referent 
<102 CfU/ml 0.3 0.1-0.9 0.025 
> 101 cfu/ml 0.8 0.2-2.7 0.675 1 
Bacillus spp. not isolated referent 
isolated 0.9 0.4-2.0 0.717 
Bordetella bronchiseptica not isolated referent 
isolated 0.9 0.1-10.9 0.953 
Enterobacter spp. not isolated referent 
isolated 1.3 0.2-10.1 0.792 
Escherichia coli not isolated referent 
isolated 0.7 0.3-1.8 0.489 
Pseudomonas spp. not isolated referent 
isolated 00 - 
Serratia spp. not isolated referent 
isolated 0.5 0.05-4.5 0.527 
Staphylococcus spp. not isolated referent 
<10'cfu/nil 0.3 0.2-0.6 0.001 
>102 CfU/jw 0.6 0.4-1.1 0.092 
Tracheal wash Mvcopla. vma isolates 
Afycoplasmafelis not isolated referent 
isolated 4.0 1.2-13.0 0.024 
NFGF Alycoplasma spp. not isolated referent 
isolated 4.5 1.2-16.9 0.025 
Afycoplasma equirhinis not isolated referent 
isolated 0.9 0.5-1.6 0.631 
NFGF = Non-felis glucose fermenting 
132 
Equine Inflammatovy Affway Mease Epidemiology 
Table 4.11 continued 
Variable Crude OR 95% ci P-value 
Serolo--ical evidence of viral infection 
Equine herpesvirus no scroconversion referent 
scroconversion 1.3 0.4-4.2 0.643 
Equine rhinovirus no scroconvcrsion referent 
scroconvcrsion 1.6 0.4-5.9 0.493 
Adenovirus no scroconversion referent 
scroconvcrsion 1.6 0.1-17.5 0,722 
Influenza no seroconversion referent 
scroconvcrsion 4.0 0.5-29.2 0.174 
ý, Nasopharvneeal swab bacterial isolates 
Pasteurella spp. not isolated referent 
isolated 1.2 0.7-2.1 0.522 
Streptococcus zooepidemicus not isolated referent 
isolated 1.3 0.8-2.1 0.328 
Streptococcuspneumoniae not isolated referent 
isolated 0.7 0.4-1.5 0.376 
Non-haemolytic Streptococcus spp. not isolated referent 
isolated 0.6 0.3-1.2 0.141 
Acinetobacter spp. not isolated referent 
isolated 0.6 0.3-1.1 0.119 
Bacillus spp. not isolated referent 
isolated 0.9 0.4-1.6 0.637 
Enterobacter spp. not isolated referent 
isolated 0.4 0.04-3.2 0.368 
Escherichia coli not isolated referent 
isolated 1.8 0.4-7.8 0.463 
Serratia spp. not isolated referent 
isolated 0.8 0.1-8.9 0.835 
Staphylococcus spp. not isolated referent 
isolated 0.9 0.5-1.7 0.685 
4.2.3 Multivariable analyses 
Table 4.12 summarises the final multivariable CLR model for clinically apparent 
respiratory disease using only 'subclinical' controls, excluding the 2 matched sets in which 
influenza infections occurred. After controlling for microbiological variables, clinical 
respiratory disease remained significantly associated with age and time since entry into the 
training yard; with younger horses and those that had been in training less than one month at 
increased risk. Risk of being a case was significantly and positively associated with presence 
of ActinobacilluslPasteurella spp. and M felis in tracheal washes but was inversely 
associated with Staphylococcus and Acinelobacter spp. in washes. No statistically 
significant interactions were identified in this model. 
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Table 4.12: Final multivariable CLR model for associations between clinically 
apparent respiratory disease and explanatory variables using 'subclinical' 
controls 
Explanatory variable P S. E. P AdjustedOR 95% CI P- 
value 
Age group Yearlings 2.26 1.20 9.5 0.9-100 0.060 
2 year-olds referent 1.0 
3 year-olds -0.48 0.35 0.6 0.3-1.2 0.172 
; ->4 year-olds -0.17 0.50 0.8 0.3-2.2 0.732 *a 089 
Time since entering training yard <1 month 1.32 0.62 3.8 1.1-12.7 0.033 
1-3 months 0.62 0.42 1.9 0.8-4.2 0.134 
>3 months referent 1.0 
*0.065 
TW PasteurellalActinobacillus spp. log cfu/ml-l 0.16 0.09 1.2 1.0-1.4 0.050 
*0.047 
TW Staphylococcus spp. not isolated referent 1.0 
* 102 CfU/Ml -1.06 0.45 0.3 0.1-0.8 0.019 
* 102 CfU/Ml -0.09 0.30 0.9 0.5-1.6 0.755 
*0- 041 
TWAcinelobacter spp. not isolated referent 1.0 
* 102 cfu/nil -1.34 0.58 0.3 0.1-0.8 0.022 
* 102 CfU/Ml -0.23 0.69 0.8 0.2-3.1 0.739 
*0.038 
TWAL fefis not isolated referent 1.0 
Isolated 1.30 0.68 3.7 1.0-13.8 0.056 
*0.051 
*Likelihood ratio statistic X2 P-value TW = tracheal wash isolate 
Hosmer-Lerneshow X2 = 4.86; P=0.77 
4.5 Subdinical cases vs 'healthy' controls 
4.5.1 Univariable analyses 
Table 4.13 summarises univariable associations between subclinical. respiratory disease 
in controls with airway inflammation (cases in this analysis) and non-infectious explanatory 
variables using 'healthy' controls that had no evidence of airway inflammation. Using this 
definition of cases and controls, subclinical respiratory disease was not significantly 
associated with any of the non-infectious explanatory variables that were associated with 
clinically apparent respiratory disease. 
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Table 4.13: Univariable associations between subelinical respiratory disease in 
I controls and non-infectious explanatory variables using 'healthy' controls 
Explanatory variable Crude OR 95% CI P-value 
Age group Ycarlings 1.1 0.3-3.8 0.903 
2 ycar-olds refcrcnt 
3 ycar-olds 0.8 0.5-1.2 0.807 
; ->4 year-olds 
1.1 0.6-2.1 0.243 
Sex Female referent 
Malc 0.7 0.5-1.1 0.129 
risible tracheal haemorrhage none visible referent 
visible 1.4 0.4-5.3 0.624 
Time since entering training yard <1 month 2.1 0.8-5.4 0.123 
1-3 months 1.4 0.8-2.6 0.285 
>3 months referent 
Racedpreviously No referent 
Yes 0.7 0.4-1.0 0.072 
Time since last race Never raced referent 
1-7 days 1.0 0.5-2.0 0.921 
>7 days 0.7 0.5-1.0 0.046 
Table 4.14 shows that with univariable analysis, subclinical disease in controls 
compared to 'healthy' controls was significantly associated with increasing total bacterial 
count, PasleurellalActinobacillus spp. and S. zooepidemicus and >104 cfu/ml non- 
haemolytic Streplococcus spp. Presence of S. pneumoniae and M equirhinis in tracheal 
washes were also associated with subclinical disease, whereas M ftlis and NFGF 
Mycoplasma spp. were not. There was no association between subclinical disease and viral 
infection or presence of any individual bacterial species in nasopharyngeal swabs. 
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Table 4.14: Univariable associations between subclinical respiratory disease in 
controls and microbiological explanatory variables using 'healthy' controls 
Explanatory variable Crude OR 95% CI P-value 
Tracheal wash bacterial isolates 
Total bacterial count none isolated referent 
PasteurellalActinobacillus spp. 
Streptococcus zooepidemicus 
Streptococcuspneumoniae 
Streptococcus equisimilis 
Non-haemolytic Streptococcus spp. 
Acinetobacter spp. 
Bacillus spp. 
Bordetella hronchiseptica 
Enterobacter Spp. 
Escherichia coli 
Pseudomonas spp. 
Serratia spp. 
Staphylococcus spp. 
Tracheal wash Mvcoplasma isolates 
Alycoplasmafelis 
NFGF Afycoplasma spp. 
Afycoplasma equirhinis 
<10' cfti/n-d 
102_103 CfU/ml 
103_104 CfU/Ml 
104_105 CfU/Ml 
105_106 CfU/Ml 
>106 CfU/Ml 
log cfu/ml-I 
log cfu/ml-I 
not isolated 
isolated 
not isolated 
isolated 
<103 CfU/nIl 
103_104 CfU/ml 
>104 CfU/Ml 
not isolated 
< 102 cfulml 
> 101 cfu/ml 
not isolated 
isolated 
not isolated 
isolated 
not isolated 
isolated 
not isolated 
isolated 
not isolated 
isolated 
not isolated 
isolated 
not isolated 
<102 cfu/mI 
> 102 cfu/ml 
not isolated 
isolated 
not isolated 
isolated 
not isolated 
isolated 
1.8 
1.7 
1.8 
2.7 
4.1 
00 
1.3 
1.5 
referent 
2.2 
referent 
0.9 
referent 
1.4 
3.7 
referent 
2.0 
4.0 
referent 
1.5 
referent 
0.5 
referent 
0.5 
referent 
1.9 
referent 
1/00 
referent 
3.7 
referent 
1.0 
1.3 
referent 
2.9 
referent 
0.7 
referent 
2.5 
1.1-3.2 
1.0-2.9 
1.0-3.1 
1.4-5.2 
1.5-11.0 
1.1-1.5 
1.2-1.8 
1.1-4.3 
0.3-3.2 
0.9-2.2 
1.1-12.3 
0.9-4.1 
1.0-16.8 
0.7-3.4 
0.1-3.4 
0.1-2.3 
0.9-4.5 
0.4-37.6 
0.6-1.6 
0.8-2.0 
0.3-25.8 
0.2-2.7 
1.4-4.6 
0.026 
0.038 
0.048 
0.004 
0.005 
0.001 
<0.00 I 
0.022 
0.859 
0.135 
0.032 
0.077 
0.058 
0.356 
0.467 
0.355 
0.135 
0.264 
0.991 
0.335 
0.349 
0.566 
0.004 
NFGF = Non-felis glucose fermenting 
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Table 4.14 continued 
Variable Crude OR 95% CI P-value 
Serolorical evidence of viral infection 
Equine herpesvirus no seroconversion referent 
seroconversion 1.9 0.6-5.9 0.249 
Equine rhinovirus no scroconversion referent 
seroconversion 1.8 0.4-7.6 0.404 
Adenovirus no scroconversion , referent 
seroconvcrsion 1.3 0.2-8.4 0.792 
Influenza no seroconversion referent 
seroconversion 00 - 
Nasopharvnzeal nvab bacterial isolates 
Pasteurella spp. not isolated referent 
isolated 1.3 0.8-2.0 0.337 
Streptococcus zooepidemicus not isolated referent 
isolated 1.2 0.8-1.9 0.277 
Streptococcuspneumoniae not isolated referent 
isolated 1.3 0.8-2.4 0.302 
Non-hacmolytic Streptococcus spp. not isolated referent 
isolated 0.7 0.4-1.3 0.296 
Acinetobacter spp. not isolated referent 
isolated 1.0 0.6-1.6 0.952 
Bacillus spp. not isolated referent 
isolated 1.3 0.7-2.1 0.396 
Enterobacter spp. not isolated referent 
isolated 1.2 0.3-4.2 0.807 
Escherichia coli not isolated referent 
isolated 1.1 0.3-4.3 0.868 
Serratia spp. not isolated referent 
isolated 0.6 0.1-3.3 0.522 
Staphylococcus spp. not isolated referent 
isolated 1.0 0.6-1.7 0.985 
4.5.2 Multivariable analyses 
Table 4.15 summarises 2 final multivariable CLR models for subclinical respiratory 
disease compared with 'healthy' controls, excluding the 2 matched sets in which influenza 
infections occurred. After controlling for other variables, subclinical respiratory disease was 
only significantly associated with increasing S. zooepidemicus in tracheal washes. S. 
pneumoniae was forced into model I and ActinobacilluslPasteurella spp. forced into model 
2 as they each approached statistical si0ficance (Wald P-values = 0.069 & 0.073, 
respectively), but once one of them had been included, then the other lost significance. In 
neither of these models was subclinical inflammatory airway disease associated with age or 
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time since entering training. No statistically significant interactions were identified in these 
models. 
Table 4.15: 2 final multivariable CLR models for associations between subclinical 
respiratory disease and explanatory variables using 'healthy' controls 
Explanatory variable 0 S. E. 0 Adjusted OR 95% CI P- 
value 
Model I 
TW & zooepidemicus log cfUlml-, 0.35 0.09 
TW S. pneumoniae not isolated referent 
Isolated 0.68 0.37 
LRS)? P-value=0.062, Hosmer-LemeshowX2= 2.71; P= 
0.95 
Model 2 
TW S. zooepidemicus log cfti/ml-I 0.31 0.10 
1.4 1.2-1.7 <0.00 I 
1.0 
2.0 0.9-4.1 0.069 
1.4 1.1-1.7 0.002 
TW PasteurellalActinobacillus spp. log cfu/ml-1 0.16 0.09 1.2 1.0-1.4 0.073 
LRS X2 P-value = 0.070, Hosmer-Lemeshow j2 = 4.73; P 
0.79 
4.6 Post-fit diagnostics of final conditional logistic regression models 
4.6.1 Goodness of fit of final models (Hosmer-Lemeshow statistics) 
The observed and expected numbers of cases predicted by final multivariable 
conditional logistic regression models for the different case and control definitions in each 
decile of risk are summarised in Table 4.16. All final regression models demonstrated 
adequate goodness of fit as measured by non-significant Hosmer-Lemeshow statistics 
(Hosmer & Lemeshow, 1989). Although there are considerable limitations in the 
interpretation of non-statistically significant results in this sort of evaluation, results do 
confirm that there were no serious discrepancies between the fitted models and the 
distribution of cases in the study. 
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Table 4.16: Observed and expected numbers of cases by decile of risk for each final 
multivariable conditional logistic regression analysis 
Decile of risk 
Model 123456789 10 Total 
Cases vs 'all' controls 
Observed cases (n) 2247 10 13 13 12 19 39 121 
Expected cases (n) 1.2 3.2 4.9 6.7 8.5 10.4 12.7 15.4 19.9 38.1 121.0 
Total cases & controls 59 59 59 59 59 59 59 59 59 65 596 
(n) 
Hosmer-Lemeshow istatistic (8 d. f. ) = 3.45; P=0.90 
Cases vs 'healthv' controls 
Observed cases (n) 13277 10 15 10 20 36 111 
Expected cases (n) 0.8 2.6 4.0 5.3 6.8 9.3 12.0 15.3 20.5 34.3 110.9 
Total cases & controls 34 35 35 35 35 35 35 35 35 39 353 
(n) 
Hosmer-Lemeshow istatistic (8 d. f. ) = 7.10; P=a 53 
Cases vs 'subclinical'controls 
Observed cases (n) 2 3 6 10 11 11 10 14 21 28 116 
Expected cases (n) 1.6 4.0 5.5 7.6 9.7 11.8 13.8 16.4 19.5 26.1 116.0 
Total cases & controls 36 36 36 36 36 36 36 36 36 35 359 
(n) 
Hosmer-Lemeshow istatistic (8 d. f) = 4.86; P=0.77 
Subclinical cases vs 'healthv' controls: model I including S. Pneumonige 
Observed cases (n) 13 20 21 27 27 32 32 38 44 48 302 
Expected cases (n) 12.9 17.9 21.1 24.7 27.1 31.9 36.1 40.1 43.8 46.3 301.9 
Total cases & controls 59 59 59 59 59 59 59 59 59 54 585 
(n) 
Hosmer-Lemeshow istatistic (8 d. f. ) = 2.71; P=0.95 
Subclinical cases vs 'healthy'controls: model 2 including PasteurellalActinobacillus srpm 
Observed cases (n) 10 20 20 - 26 32 28 33 41 45 47 302 
Expected cases (n) 12.9 17.7 21.1 24.9 27.4 31.9 35.8 40.0 44.0 46.2 301.9 
Total cases & controls 59 59 59 59 59 59 59 59 59 54 585 
(n) 
Hosmer-Lemeshow istatistic (8 d. f) = 4.73; P = 0.79 
4.6.2 Exclusion of observations with the largest delta-beta values 
Examination of each final conditional logistic regression analysis model by sequential 
exclusion of observations with the largest delta-beta values i. e. those observations predicted 
to have the largest influence on the fit of models, demonstrated that all models were 
generally stable and robust. There was only one situation where the exclusion of a single k 
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observation had a significant effect on the fit of a final model. Examination of observations 
with the largest delta-beta values for each model term showed that for the yearling category 
of AGECODE there was one observation (1659) with a very large delta-beta value and 
following its exclusion, models failed to converge. Closer examination of the data showed - 
that this was because among the strata with yearling cases, observation 1659 was the only 
2-year-old control i. e. member of the referent category. This was because of the small 
number of yearlings in the data (horses entered training in November and were re-classified 
as 2-year-olds the following January) such that exclusion of observation 1659 effectively 
meant that yearlings had an infinite OR due to the absence of any individuals in the referent 
group for the few relevant strata. 
4.6.3 Examination of model residuals 
For the largest final regression model using cases and 'all' controls (n=596) there 
were 99 observations with residuals with absolute values >0.5, which comprised 8 controls 
and 91 cases. Table 4.17 summarises the distribution of controls and cases with absolute 
residuals >0.5 between categories of the statistically significant variables retained in the final 
multivariable regression model. The distribution among categories of significantly retained 
variables indicated why the model most poorly predicts the clinical disease outcome status 
of these observations. 
Among the 8 controls with high residual values, 3 were yearlings (the highest risk 
age group for clinical respiratory disease), 7 had entered training <3 months previously, 4 
had >103 cfu/ml ActinobacilluslPasteurella spp. in tracheal washes, 7 had no 
Staphylococcus or Acinefobacter spp. isolated from tracheal washes and one had M felis 
isolated. Among the group of cases most poorly predicted by the model, all were 2-year- 
olds or older (i. e. not yearlings), 71 (78%) had entered training more than 3 month 
previously, 72 (79%) had <103 cfu/rnl ActinobacilluslPasteurella spp. in tracheal washes, 
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and 89 (98%) were negative for M. felis in their tracheal washes. These results indicate that 
a large proportion of the cases in this analysis were apparently not well predicted by the 
final model. This may be consistent with either i) the effects of factors that were not 
measured (e. g. stable dust or other unidentified infections), ii) the use of 3 clinical signs in 
the case definition provided a mixture of case types that actually had different risk factors or 
iii) although each of the risk factors identified were significantly associated with disease, 
only a small proportion of animals were positive for all of them. 
Table 4.17: Distribution of controls and cases with absolute residual values >0.5 
between categories of significantly retained variables from the final 
multivariable regression model of cases vs 'all' controls 
Risk factor Category 
n 
Controls 
% 
Cases 
n % 
Overall 8 100 91 100 
Age group Yearlings 3 37.5 0 0 
2 year-olds 3 37.5 57 63 
3 year-olds 2 25 24 26 
; _>4 year-olds 
0 0 10 11 
Time since entering training yard <1 month 4 50 1 1 
1-3 months 3 37.5 19 21 
>3 months 1 12.5 71 78 
TWActinobacilluslPasteurella spp. none isolated 4 50 56 62 
<102 CfU/Ml 0 0 2 2 
10'-10' cfu/nil 0 0 14 15 
103_104 CfU/Ml 2 25 9 10 
101-10, cfu/ml 0 0 5 5 
105_106 CfU/ml 0 0 3 3 
>106 CfU/nll 2 25 2 2 
TW Staphylococcus spp, None isolated 7 87.5 58 64 
< 102 cfu/ml 1 12.5 11 12 
> 102 CfU/" 0 0 22 24 
TWA cinetobacter spp. None isolated 7 87.5 83 91 
< 102 CfU/nIl 0 0 4 4 
> 102 CfU/Ml 1 12.5 4 4 
TWM. felis None isolated 
Isolated 
7 
1 
87.5 
12.5 
89 
2 
98 
2 
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CHAPTER 5 
DISCUSSION 
5.1 Discussion of multivariable analyses findings 
Use of different case and control definitions in 4 separate analyses provided a better 
understanding of risk factors for this complex respiratory disease syndrome of young 
horses. There is probably a spectrum of severity of presentation of respiratory disease in 
horses and this includes subclinical inflammatory airway disease (IAD), which is not 
evidenced by any overt clinical signs, being diagnosed only with endoscopy and lavage of 
the trachea after exercise. This subclinical condition is being increasingly recognised in 
athletic young horses (Burrell, 1985; Wood et aL, 1993 a; Burrell et aL, 1994; Moore ef aL, 
I 
1995; Burrell et aL, 1996; Moore, 1996; Christley et aL, 1999b; Chapman et aL, 2000; 
Christley el aL, 200 1 a; 200 1 b) and so an important and unique aspect of this study was the 
consideration of the occurrence and possible influence of subclinical IAD on the risk factors 
for clinically apparent respiratory disease. The findings of the multivariable analyses for 
cases presenting clinically were therefore compared with separate healthy and subc1inical, 
control subgroups in the first instance and then the factors accounting for differences 
between healthy and subclinical controls were considered. Finally, the risk factors for 
clinically apparent respiratory disease that arose in an overall large model using 'all' 
controls together, irrespective of IAD status, were considered in light of the findings from 
the 3 smaller models. 
5.1.1 Cases vs 'healtby' controls 
Controls in this analysis did not have signs of IAD as defined by endoscopic and 
cytological parameters (Whitwell & Greet, 1984; Burrell ef aL, 1996). However, in contrast 
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to previous studies (Buffell el al., 1996; Wood, 1999) the definition of controls here was 
that these horses had inflammation scores of zero out of 3- so a very stringent definition of 
respiratory health was used. Multivariable analysis showed that after controlling for other 
factors, clinical respiratory disease was significantly associated with younger age and recent 
entry into the racing yard. This was consistent with, but not proof of, an infectious aetiology 
as would be expected with acquisition of immunity against infection in young horses or 
recent arrivals experiencing novel infectious challenge. In the event that horses entered 
training at exactly the same time e. g. as yearlings, then these variables would have measured 
the same thing. However, as there was a wide variation in the time since entry into training 
within each 'Thoroughbred' age category, it is more likely that there was an overlap 
between these variables. After controlling for these factors, horses were at increased risk of 
clinical disease with recovery of ActinohacilluslPasteurella spp. and S. zooepidemicus from 
tracheal washes and ActinohacilluslPasteurella spp. from nasopharyngeal swabs. There was 
a significant inverse association found with low numbers (<102 CfU/ml) of Staphylococcus 
spp. in washes and non-haemolytic Streplococcus spp. in swabs. This may have reflected the 
dynamic nature of colonisation by micro-organisms in the respiratory tract, in that as the 
more pathogenic bacteria such as AclinobacilluslPasteurella spp and S. zooepidemicus 
increased in number they replaced transient or commensal bacteria such as Staphylococcus 
spp. and non-haernolytic Streplococcus spp.. However, although culture techniques were 
designed to attempt to detect species of bacteria even in small numbers by use of different 
selective media, it was still possible that in certain circumstances small numbers of transient 
or commensal bacteria from all horses may have been masked by larger numbers of other 
bacteria growing on the same media when large numbers of others overgrew them. So 
whether these findings represent a true phenomenon is unknown but worthy of further 
study. It is of note that when ActinobacilluslPasleurella spp. were found in both the trachea 
and nasopharynx they were associated with disease without apparently confounding each 
143 
Equm In&mmatmy Auway Mem EpidengoloV 
other. The issue of contamination of tracheal samples collected via an endoscope passed 
through the upper respiratory tract is discussed in further detail in Section 5.2.4. 
5.1.2 Cases vs Isubdinical' controls 
Controls in this analysis were defined on the basis of having signs of IAD based on 
endoscopic and cytological parameters. Importantly, in contrast with earlier AHT studies in 
which horses with inflammation scores of one were defined as non-diseased controls 
(Burrell el aL, 1996; Wood, 1999), in this thesis outwardly healthy horses with 
inflammation scores of one or greater out of 3 were defined as 'subclinically' affected 
controls. Multivariable analysis using 'subclinical' controls showed that, after controlling for 
the effects of other variables, clinical disease was still significantly associated with younger 
age, recent entry into the yard, presence of ActinobacilluslPasteurella spp. in tracheal wash 
samples and relative absence of small numbers of Slaphylococcus spp. In addition, horses 
were at increased risk of clinically apparent disease with the isolation of M. felis from 
tracheal washes but at decreased risk with isolation of small numbers of Acinelobacter spp. 
in washes. In contrast to the analysis with 'healthy' controls (i. e. no pathology detected on 
endoscopy and tracheal wash), S. zooepidemicus in tracheal washes and nasopharyngeal 
bacterial factors were not significantly associated with clinical respiratory disease. 
5.1.3 Subdinical cases vs 'healthy' controls 
Cases in this analysis were taken as those horses that had been defined as 
'subclinical' controls in the previous analysis and they were compared with horses that were 
selected as 'healthy' controls. Both groups of horses had been selected as controls for the 
main study and were later subdivided according to endoscopic and cytological evidence of 
IAD; neither group had outward signs of respiratory disease at the time of sampling. 
Multivariable analysis conducted with the same criteria as previous analyses showed that all 
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other variables were confounded by the presence of S. zooepidemicus in tracheal washes. 
There was also an apparently increased risk with S. pneumoniae or 
ActinobacilluslPasteurella spp. isolated from tracheal washes having controlled for S. 
zooepidemicus. These infections, which were forced into 2 final models as their presence 
after controlling for S. zooepidemicus, were nearly significant at the 5% level (Wald X2 p 
values = 0.069'and 0.073, respectively and LRS X2 p values = 0.062 and 0.07, respectively). 
In contrast to the analyses using clinically apparent respiratory disease cases, 'subclinical' 
disease was not significantly associated with younger age or time since entry into the yard. 
This suggests that horses may have at least slight airway inflammation, irrespective of their 
age and time in training, and would be consistent with immunity that increases with age and 
time in training but which is not complete or with an underlying problem that is largely 
unrelated to infection. This finding should be considered in the context that horses with an 
inflammation score of one out of 3 (probably indicating only slight airway inflammation) 
were allocated to the 'subclinical' case/control group in this study. 
In order to investigate whether any factors were associated with 'subclinical' disease 
among controls with inflammation scores of one, and because this level of inflammation had 
arbitrarily been considered 'normal' in previous studies (Burrell el aL, 1996; Wood, 1999), 
additional post hoc analyses were conducted. Analyses were performed comparing horses 
with inflammation scores of one with 'healthy' controls (zero inflammation scores, n--304), 
after exclusion of all controls with inflammation scores of 2 or 3. 
Of 328 horses with evidence of 'subclinical' respiratory disease, 238 (73%) of these 
had an inflammation score of one out of a possible score of 3. These 238 animals were 
assigned a single inflammation score on the basis of i) moderate or severe visible mucopus 
in eight animals (3.4%), ii) ý! 1000 nucleated cells/ml. tracheal wash in 14 horses (5.9%) and 
iii) moderate or predominant amounts of tracheal wash neutrophils in 216 controls (90.7%). 
Results indicated that compared with horses with inflammation scores of zero, 'subclinical' 
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disease as evidenced by an inflammation score of one out of 3 was significantly associated 
with being female and the presence of S. zooepidemicus in tracheal washes. 
5.1.4 Clinically apparent cases vs 'all' controls 
Having considered 3 previous analyses with more specific definitions of cases and 
controls, the results of the main analysis used clinically apparent cases compared with 'all', 
controls, irrespective of their IAD status. In this multivariable CLR model clinical disease 
was significantly associated with age group, time since entry into the yard, 
ActinobacilluslPasteurella spp. and M felis isolated in tracheal washes and inversely with 
low numbers of Staphylococcus and Acinelobacter spp. in washes. Tracheal S. 
zooepidemicus and nasopharyngeal swab bacterial variables were not significantly 
associated with clinical respiratory disease in this model, although they had been associated 
with clinical disease in the analysis using 'healthy' controls. 
It is clear that the final model using 'all' controls (i. e. 'healthy' and 'subclinical' 
controls together), when considered in relation to each of the separate models, is likely to 
reflect a composite of factors from these other models. This is most clearly demonstrated by 
infection with S. zooepidemicus, which was shown to be associated with both clinical and 
tsubclinical' disease, including disease defined by an inflammation score of one, when each 
was compared with only 'healthy' controls but was absent from the all and 'subclinical' only 
control models. This was because S. zooepidemicus in tracheal washes was significantly 
associated with 'subclinical' disease, evidenced predominantly by tracheal neutrophilia, 
among the controls as well as being associated with clinical disease among cases. Overall, 
there was no apparent significant net effect from S. zooepidemicus in favour of clinically 
apparent respiratory disease when horses with 'subclinical' IAD were used as or included in 
the control group. Similarly the effects of nasopharyngeal bacterial isolates of 
ActinobacilluslPasteurella spp. and non-haernolytic Streplococcus spp. that were 
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I associated with clinical disease compared with 'healthy' controls were not retained in the 
final model. In contrast, ActinobacilluslPasteurella spp. in tracheal washes, although nearly 
significantly associated with 'subclinical' disease among controls, retained a significant 
association with clinically apparent respiratory disease when compared with only 
'subclinical' controls as well as 'all' controls- considered together. In multivariable analyses 
M felis in tracheal washes was associated with clinical disease compared to 'subclinical' but 
not 'healthy' controls and this significant association was retained in the overall model with 
call' controls. Age, time since entry into the training yard and Staphylococcus spp. in low 
numbers in tracheal washes were significantly inversely associated with clinical but not 
'subclinical' disease in these analyses. 
Examination of observations with residual values >0.5 in the final main analysis (i. e. 
cases and 'all' controls) indicated that a large proportion of the cases in this analysis were 
apparently not well predicted by the variables included in the final model. The distribution of 
numbers of these cases between categories of retained variables showed that this was 
because large proportions of these cases were not yearlings and/or had been in training >3 
months and/or did not have >10' cfu/nil ActinobacilluslPasteurella spp. and/or Mfelis 
isolated from their tracheal washes. This suggests that there are other significant factors 
associated with respiratory signs in these cases that were not included in the final model. It 
is possible that there were effects from other unidentified infectious agents or from non- 
infectious factors such as stable dust, which is a recognised factor in triggering respiratory 
signs, particularly in older animals. In the absence of appropriate assays it is always possible 
that there are infections that remain undetected, the outbreak of M felis-associated 
respiratory disease described by Wood et aL (1997a) illustrated this. The use of matching by 
trainer in this study was intended to help control for the immeasurable effects of such non- 
infectious factors as stable dust. However, we would expect inevitable variation of factors 
such as the effect of stable dust within training yards and particularly between individual 
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horses of different ages. There may also have been inadequate account taken of the effect of 
airway inflammation in the horses in this analysis. Although 'all' controls included animals 
with and without airway inflammation and it was known that cases had a much higher 
proportion of horses with inflammation scores >-2 compared to controls, the final model did 
not include any specific factors (other than infections associated with IAD) to account for 
differences in the severity of airway inflammation between cases and controls. Related to 
this there may have been some additional influence from the exclusion of S. zooepidemictis 
infection from this analysis as >10' cfu/n-A of S. zooepidemicus in tracheal washes was more 
prevalent in cases than controls and may have been the only infection identified in sorne 
cases. There may also have been problems related to the case definition used in this study in 
that horses were defined as a case if they presented with one or a combination of 3 signs 
(cough, nasal discharge, pyrexia). This may have made prediction more difficult if different 
signs were related to different factors. I' ý, I 
5.1.5 Conclusions 
Taken together the analyses. conducted in this study using different case and control 
definitions provide considerable evidence that bacterial infections of the trachea, sometimes 
in conjunction with other factors, are predominantly associated with a range of 
presentations of respiratory disease in young horses in training. The milder end of the 
disease spectrum includes slight inflammation attributed predominantly to tracheal 
neutrophilia (inflammation score 1/3) in the absence of overt clinical signs and detected only 
by cytology of tracheal wash samples. The more severe end of the spectrum includes 
obvious signs of disease such as coughing, nasal discharge and pyrexia and this is associated 
with marked airway inflammation (inflammation score ýt2/3) as evidenced by visible tracheal 
mucopus, neutrophilia and high nucleated cell count. The study identified that tracheal 
infection with S. zooepidemicus was associated with an increased risk of clinically apparent 
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as well as subclinical respiratory disease when compared with 'healthy' horses that had no 
clinical, endoscopic or cytological evidence of disease (inflammation score 0/3). This 
remained true for horses that had a cytologically detectable airway neutrophilia but were 
otherwise considered to have a healthy respiratory tract. There was evidence that tracheal 
infections with ActinobacilluslPasteurella spp. and M felis were associated with clinically 
more apparent disease and that younger horses and those that had arrived more recently in 
the yards were at increased risk of clinical disease. 
5.2 Current study findings in the context of existing knowledge 
The current study is one of a few conducted by separate research groups in recent 
years that are starting to contribute to a better understanding of the epidemiology of 
respiratory disease in young horses. There have to date been relatively 'few studies 
conducted to investigate the association between respiratory disease in horses and a wide 
range of possible infectious agents, including viruses, bacteria and mycoplasmas and other 
non-infectious factors. It is recognised that the true biological credibility of the conclusions 
of individual studies is enhanced when they demonstrate broadly similar findings to other 
separate studies. This was referred to as 'consistency of association' by Bradford IFEII 
(1965) in his criteria for assessing causality. The findings of this study are discussed 
particularly in the context of similar racehorse studies conducted in Sydney, Australia 
(Christley et aL, 1999b; 2001a; 2001b) and by 2 groups in the United Kingdom (Buffell, 
'1985; Wood et aL, '1993a; Burrell et aL, 1994; 1996; Chapman et aL, 2000). Where 
relevant, findings are also compared with work conducted on infectious causes of 
inflammatory respiratory disease in foals by Andy Hoffman (Hoffman et aL, 1993 a; 1993 c). 
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5.2.1 The effects of age and sex 
The current study conducted in young flat-trained Thoroughbred racehorses is in 
general agreement with previous studies in demonstrating that the risk of clinically apparent 
respiratory disease decreased with increasing age in horses. In the current study the inverse 
association with age remained even after controlling for other factors including infections 
and time since entering training. 
The AHT group has shown previously that the risk of infection with S. 
zooepidemicus, S. pneumoniae and Pasteurella spp. associated with airway inflammation 
was statistically significantly lower in horses 4 years or older compared with 3-year-olds and 
younger (Wood et aL, 1993a). Similarly, in 2 longitudinal studies, the risk of inflammatory 
airway disease associated with bacterial infection, particularly S. zooepidemicus, decreased 
with age (Burrell et aL, 1996; Wood, 1999). The prevalence of several bacterial infections 
and different disease presentations, including inflammatory lower airway disease, also 
.1 
decreased with increasing age in 2 recent studies (Wood el aL, 1998; Wood, 1999; 
Chapman et aL, 2000). The longitudinal study by Wood el al, (1998) also demonstrated 
that the incidence of specific infections decreased between 2 and 4 years of age and this was 
particularly marked for S. pneumoniae. A recent case control study conducted in 
Thoroughbred racehorses in Sydney, Australia also showed that the risk of coughing 
decreased significantly with increasing age, with yearlings and 2-year-olds being at greatest 
risk (Christley el aL, 1999b; 2001 a; 200 1 b). 
These multiple studies all demonstrate similar inverse associations between risk of 
infectious inflammatory respiratory disease and increasing age. This is most likely explained 
by immunity increasing with age in young horses with increased exposure to a wide range of 
species and different subtypes of organisms. This situation is analogous to that of young 
children acquiring immunity to common childhood infections during their early 
nursery/school years. It has been suggested that this time dependent (age and time in 
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training) decrease in clinically apparent respiratory disease, particularly coughing, may be 
due to an induced tolerance to airborne irritants, such as endotoxin (Christley et aL, 1999b; 
2001a). It is likely that because endotoxin (lipopolysaccharide) is an integral part of gram 
negative bacteria such as Pasteurella spp., then it probably does play a role in the 
inflammatory processes seen in clinical infectious lower airway disease in young horses. To 
date several studies have demonstrated short-term tolerance to endotoxin in horses (Allen el 
aL, 1996; Barton el aL, 1996). In other species this phenomenon has been shown to lead to 
moderation of inflammatory processes such as reduction of the activation and recruitment of 
neutrophils and production of chemokines and cytokines (Shimada et aL, 2000). It is not 
clear at the moment, however, whether endotoxin tolerance can be maintained for the time 
scales (i. e. months) over which signs of respiratory disease persist before reducing in the 
horse (Wood, 1999). Further detailed studies are oWously required to better understand 
the exact role of bacterial as well as environmental endotoxin in clinical respiratory disease 
syndrome in young horses. 
To date very few studies have considered the effect of gender or sex on risk of 
respiratory disease in horses. In the Australian study of risk factors for coughing, gender 
was not found to be significantly associated with disease after controlling for other factors, 
although at a univariable level colts and females were at apparently increased risk compared 
to geldings (Christley et aL, 1999b). In the larger current study, although differentiation 
between colts and geldings was not made and male horses at the univariate level appeared at 
decreased risk of clinically apparent respiratory disease compared to females, sex was not a 
significant risk factor in the final models. 
5.2.2 The effects of training & racing 
The simultaneous examination of the effects of previous racing and stage of training 
with other factors including age and infections, have not been reported previously, although 
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Christley el aL (1999b; 2001 a) did examine recent racing and stage of training among non-- 
infectious risk factors for coughing in Australian Thoroughbred racehorses. In the 
Australian study, multivariable analysis showed that the risk of coughing decreased with 
stage of training but horses that had raced within the last week were approximately II times 
more likely to cough than those that had never raced previously (Christley el aL, 1999b; 
2001 a). The variable 'time since entering training yard' used in the current UK study may be 
considered analogous to 'stage of training' used by Christley el al. because horses that had 
more recently entered training would be automatically at an earlier stage of training than 
those that had been in training longer. In agreement with Christley el aL (1999b; 2001a), 
this study found that horses that had entered training more recently were at significantly 
increased risk of clinically apparent respiratory disease, even after controlling for the effects 
of age and other factors. A study of both flat and national hunt racehorses in the UK also 
showed that 4-year-old flat trained horses were at significantly lower risk of airway 
inflammation than the same aged horses in national hunt yards (Chapman el aL, 2000). The 
difference between the 2 types of horses was most likely related to the time that they had 
been in training and, therefore, the time they had been encountering infections and 
developing immunity. The 4-year-old flat horses had generally been in training for at least 2 
years and were much more likely to have'developed immunity to infections. In contrast the 
4-year-old NH horses would include horses from the flat and NH stores the latter having 
only just entered training and would be more likely to be suffering respiratory infections for 
the first time. The current data, when examined at a univariable level, showed that horses 
that had never raced previously were at increased risk of clinical respiratory disease 
compared with those that had raced before. However, when other factors including age, 
time in training and infections were simultaneously considered, racing at any time previously 
or within the last week were not found to be associated with clinical disease. The 
univariable effect had probably been confounded by these other factors. This contrasts with 
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the findings of Christley et aL (1999b; 2001 a), where controlling of confounding resulted in 
a highly significant association between recent racing and the occurrence of coughing. 
Differences in the amount of inhaled debris experienced by horses during racing has 
previously been proposed as a cause for markedly different rates of pleuropneumonia in 
American and British racing Thoroughbreds (Mair & Lane, 1989; Chaffin & Carter, 1993; 
Austin et al., 1995; Raidal, 1995; Raidal et aL, 1997b). That is that dirt tracks, which are 
commonly used in North America, produce more inhaled debris than turf tracks that are 
more widely used in the UK and may be watered. Therefore, any fundamental differences in 
the commonly used racing surfaces in the respective countries may have accounted for this 
difference. Although horses in Sydney train predominantly on a non-turf surface, they do 
race on turf. The nearest track surfaces to dirt in the UK are the sand and petroleum based 
'all-weather' surfaces, which are recognised as having increased 'kickback' compared with 
turf. The younger horses in the yards we studied did not generally use this type of surface in 
the early stages of their racing careers. Indeed, the only 2-year-old horse that was raced on 
such a surface in this study was a clinical case that showed signs within one week of racing 
on an 'all-weather' track. However, examination of horses that recently raced did not 
demonstrate an increased risk of clinical respiratory disease among the few horses (n--10) 
that had raced on an all-weather surfaces in the past week compared with those that had 
raced on turf in this study. Further work is obviously required to establish whether racing on 
all-weather surfaces is associated with an increased risk of clinically apparent respiratory 
disease in UK racehorses and whether this differs compared to other countries. 
5.2.3 The effect of bacterial and mycoplasma infections of the trachea 
As with previous studies of different forms of respiratory disease in young horses 
this study provides evidence for an association between S. zooepidemicus and 
ActinobacilluslPasteurella spp. and clinically apparent respiratory disease (Burrell, 1985; 
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Wood el at, 1993a; Burrell et al., 1994; 1996; Christley et aL, 1999b; Chapman el aL, - 
2000; Christley el aL, 2001b). An important difference between this study and others 
previously reported is that many factors, including non-infectious as well as infectious 
variables were considered simultaneously for their association with clinical respiratory 
disease. In addition, the possible effect of subclinical inflammatory airway disease (IAD) 
was also considered and controlled for in examination of the data. This study was consistent 
with earlier findings of associations between bacterial infections and pyrexia (Burrell et aL, 
1994) and coughing (Christley el aL, 1999b; 2001a; 2001b) both of which were included in 
the case definition used here. The study also confirmed the close association between non- 
specific signs of clinical respiratory disease (pyrexia, nasal discharge and coughing) and the 
likely presence of inflammatory airway disease (IAD) (Burrell el aL, 1996) and bacterial 
lower airway infection (Wood et aL, 1993a; 1998; Wood, 1999; Chapman el aL, 2000). ,, 
This study demonstrated that the group of organisms referred to as 
ActinohacilluslPasteurella spp. were significantly associated with clinically apparent 
respiratory disease when compared with any classification of controls, including those with 
subclinical airway inflammation. Comparison of 'subclinical' with 'healthy' controls also 
showed that infection with this group of organisms was almost statistically significantly 
associated with subclinical IAD. Together this suggests that not only might 
AclinohacilluslPasleurella spp. contribute to subclinical IAD but they might also have a 
role in contributing to clinically apparent respiratory disease. The association with clinically 
apparent disease was more robust for ActinohacilluslPastellrella spp. than for S. 
zooepidemicus and might suggest a relatively more important role in clinical disease for 
some members of this group of organisms. Previous work on the PastellrellalActinohacillus 
spp. group has shown that specific identification of these species by colony morphology 
alone is difficult because of the similarity between them (Ward et aL, 1998). Accurate 
identification of species within the group requires study of detailed fermentation reactions to 
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different sugars but this is complicated, expensive and too time-consuming to carry out on 
large numbers of diagnostic samples. It is likely that grouping of these bacterial species 
resulted in an underestimation of the true extent of the effect of several specific pathogenic 
species within the group (such as A. equuli, A. suis and A. fignieresh), although some of the 
more pathogenic bacteria may have been uncommon (A. suis and A. lignieresii) (Ward et 
aL, 1998). Further detailed epiderniological studies are required to elucidate which species 
in the PasteurellalActinobacillus spp. group are associated with clinical presentation of 
respiratory disease in horses. 
Streplococcus zooepidemicus is an important equine pathogen and is commonly 
associated with pneumonia, 'shipping fever' and inflammatory airway disease in young 
horses (Chanter, 1997). Detailed studies have shown that respiratory infections are common 
in' weaned foals (Hoffman et aL, 1993a; 1993c) and young Thoroughbred racehorses 
(Wood et aL, 1993a) and that they are frequently protracted and recurrent. Age-specific 
decreases in incidence and prevalence of specific bacterial lower respiratory tract infections 
in racehorses, including S. zooepidemicus, have been demonstrated (Wood et aL, 1998) and 
this is consistent with gradual development of immunity. The exact reasons for this, 
however, are not known but may be due to cumulative and sequential infections (clonal 
succession) with non-cross immunising subtypes of S. zooepidemicus. In support of this 
there is evidence that equine sera can be highly discriminating in their ability to opsonise S. 
zooepidemicus isolates (Causey el aL, 1995) and which suggests that there are antigenic 
and immunogenic differences between strains of this bacterium. Therefore specific subtypes 
of S. zooepidemicus may be found to be particularly associated with respiratory disease in 
horses and this may also have resulted in an underestimation of the overall association of 
this species in this study. 
Previous studies have shown significant association between S. pneumoniae tracheal 
infection and equine upper and lower respiratory tract disease, particularly in young horses 
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(Burrell et al., 1986b; Mackintosh et aL, 1988) and experimental tracheal inoculation has 
reproduced disease (Blunden el aL, 1994). A statistically significant univariable association 
between infection with S. pneumoniae and both clinically apparent disease and subclinical 
IAD was also identified in this study and there was almost a significant association 
demonstrable with subclinical IAD when tracheal wash S. pneumoniae was included with 
tracheal wash S. zooepidemicus in a multivariable analysis. The failure to achieve statistical 
significance in multivariable analyses most likely reflected the low power of this study due 
to the low prevalence of S. pneumoniae compared to other infections. Equine S. 
pneumoniae isolates have to date all been of the same capsule type (type 3) (Mackintosh et 
aL, 1988). The marked reduction in risk of disease from S. pieumoniae with increasing age 
in young horses (Wood el aL, 1998; Wood, 1999) may be due to the rapid acquisition of 
immunity against this single capsule type. This appears to be in contrast to the situation with 
S. zooepidemicus and PasteurellalActinobaciffits spp. for which solid immunity may be 
acquired only following serial infections by several non cross-protective subtypes (S. 
zooepidemicus) or even species (ActinobacilluslPasteurella) (Wood et aL, 1993a; Wood, 
1999). 1 
In the current study multivariable analyses showed that M. felis was statistically 
significantly associated with clinical disease when compared with 'all' controls as well as 
only controls with subdinical IAD. However, at the univariable level tracheal M felis 
infection was significantly associated with clinical respiratory disease when compared with 
each classification of controls (i. e. all, 'healthy' and 'subclinical') but was not associated 
with subclinical IAD compared with 'healthy' controls. Controlling for the combination of 
other factors, particularly tracheal S. zooepidemicus infection, probably accounted for why 
M felis in the trachea did not remain significantly associated with clinical disease at the 
multivariable level in the model using 'healthy' controls as the comparison group. There 
was no association identified between clinical disease and tracheal isolation of other species 
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of mycoplasma at the multivariable level including M equirhinis. However, non-felis 
glucose fermenting Mycoplasma spp. was significantly associated with clinically apparent 
respiratory disease at the univariable level. These results are in agreement with earlier 
reports of the potential for M felis to produce clinical signs of respiratory disease including 
pleuritis (Ogilvie et aL, 1983; Rosendal et aL, 1986; Hoffman et aL, 1992a), pericarditis 
(Morley el aL, 1996) and lower respiratory tract inflammatory disease (Wood et al., 
1997a). 
From this and other studies, there is a significant and strong association between 
presence of certain presumptively pathogenic species of bacteria, particularly S. 
zooepidemicus, A clinobacilluslPasteurella spp. and M felis and a. range of severity of IAD 
in horses, as measured by inflammation score and clinical signs (Wood et aL, 1993a; Burrell 
et aL, 1994; Chapman et aL, 2000). Therefore, an additional post hoc analysis was 
conducted to investigate the nature of the association between tracheal infection with these 
bacterial species and different classifications of respiratory disease. An analysis was 
perfonned to investigate a possible linear trend in proportions of tracheal washes positive 
for any of these bacterial species across disease categories ordered according to increasing 
severity by chi-square test for linear trend under the STATCALC command in Epi-Info 6 
(Dean et al., 1994). 
Tracheal washes were classified as positive if either S. zooepidemicus, 
ActinobacilluslPasteurella spp. or M felis were isolated from them and negative if none of 
the 3 bacterial species was recovered. As not all washes were examined for mycoplasma, 
those that were negative for S. zooepidemicus and A clinobacilluslPasteurella spp. and were 
not submitted for mycoplasma culture were also classified as negative (rather than missing) 
in order to maximise sample size. Categories of disease outcome were classified and 
ordered according to inflammation score (0,1 and ý: 2 out of possible maximum of 3) in the 
first instance and these levels were subdivided according to whether horses had been 
157 
Eq=e Murtrtiatmy Airway Dmease Epi&-rraology 
recruited to the study as cases or controls. Hence, disease categories were logically ordered 
from healthy controls with zero inflammation score as the baseline referent group, through 
to clinical cases with inflammation score of 2 or greater at the highest disease level (Table 
5.1). Analysis output provided chi square value for linear trend, corresponding probability 
value as well as ORs as a measure of risk of a positive outcome at each disease level relative 
to the baseline group. 
Results are summarised in Table 5.1 and showed that there was a highly statistically 
significant linear trend for increasing proportions (and hence trend of increasing ORs) of 
tracheal washes positive for S. zooepidemicus, ActinobacilluslPasteurella spp. or M. felis 
as inflammation score increased. In addition, for horses with a given inflammation score, 
those presenting with clinical signs of respiratory disease (cases) had an increased 
proportion of positive washes and OR compared with controls not demonstrating overt 
clinical signs but with the same level of inflammation. 
These data apparently confirm that inflammation score is an appropriate means of 
classifying respiratory disease status with respect to likely tracheal bacterial infection with 
presumptive pathogens. However, they also highlight that there was a moderate proportion 
of horses (24 of 157 cases (15%) that had tracheal washes examined for bacteria) that were 
classified as clinical cases but in which there was no evidence of tracheal inflammation or 
infection with S. zooepidemicus, ActinobacilluslPasteurella spp. or M ftfis. It is possible 
that other early stage bacterial, viral or mycoplasma infections were responsible for some of 
these cases, particularly prior to the development of marked inflammatory responses or that 
there was possibly some misclassification of cases or that there were other causes. 
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Table 5.1: Proportions of tracheal washes (TWs) positive for S. zooepidemicus, 
ActinobacilluslPasteurella spp. or M. felis * among horses ordered 
according to inflammation score and presence (cases) or absence (controls) 
of clinical signs 
Case/Control Inflammation 
score 
TWs (%) positive 
for bacterial spp. 
Total TWs 
examined (100%) 
Odds Ratio 
Control 0 91(30%) 304 1.00 (ref) 
Case 0 18(43%) 42 1.76 
Control 1 88(37%) 238 1.37 
Case 1 25(51%) 49 2.44 
Control ý! 2 71(79%) 90 8.75 
Case ý! 2 53(80%) 66 9.54 
2 for linear trend = 92.43 (P:: ý0.00001) 
In this and sirnilar previous studies tracheal washes were collected 
transendoscopically, which means that there was the potential for transfer of bacteria on the 
endoscope between consecutively sampled animals. However, all reasonable and practical 
precautions were taken to thoroughly disinfect the endoscope by immersion between 
animals, with disinfectant freshly made up between batches of animals. Although not 
specifically recorded for data analyses, it would be possible to examine the effect of the 
order in which animals were sampled on the quantitative bacteriology of tracheal wash 
samples to see whether horses sampled later tended to have higher bacterial counts due to 
cross contamination from earlier samplings due to inadequate disinfection between horses. 
Although quantitative bacteriological techniques were applied in this study, for 
analytical purposes these were rounded down to the nearest whole logio colony forming unit 
count and depending on their relative frequency these were subsequently treated as 
continuous, ordered categorical or even binary outcomes. This rounding and categorisation 
of bacterial counts meant that there was a loss of precision of colony count estimation, 
which would have inevitably lead to reductions in the significance of any trends in 
association, particulalry where infections were relatively rare and were consequently treated 
I 
as binary outcomes. 
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5.2.4 The effect of nasopharyngeal bacterial infections 
There have been several studies to evaluate the relative benefits of transtracheal 
aspiration and endoscopy for collection of distal tracheal samples (Sweeney el al., 1989; 
Darien et al., 1990; Christley et aL, 1999a). It is generally considered that whereas_ 
endoscopy does increase the likelihood of contamination of tracheal samples with bacteria_ 
of URT origin, a large proportion of non-contaminated samples can be obtained using this 
method (Wood et aL, 1993 a). In addition endoscopy has the advantage that it can be readily 
repeated, does not require sedation in the majority of animals and has a much lower risk of 
serious adverse effects than the invasive transtracheal technique. To this end, tracheal 
endoscopy is still considered the technique of choice for obtaining post exercise tracheal 
wash samples from valuable Thoroughbred racehorses, that are undergoing routine 
respiratory health monitoring and which may or may not have subclinical IAD. The 
influence of different catheter designs on degree of oropharyngeal contamination during 
endoscopic collection of tracheal wash samples has not been directly assessed, although 
several studies have been conducted comparing endoscopic collection of tracheal samples 
with transtracheal aspiration, considered to be the 'gold standard' with respect to 
representative bacterial sampling as it bypasses contamination from the upper respiratory 
tract (Darien et al, 1990; Christley et al., 1999a). It is possible, however, that differences in 
the design of sterile catheters preplaced in the biopsy channel of the endoscope but 
withdrawn several inches from the end of the endoscope during introduction to the distal 
trachea, may not make a significant difference to the degree of oropharyngeal 
contamination. It is likely that contamination will occur to the outside of the end of thý 
endoscope, irrespective of the design of catheter shielded in the biopsy channel. The degree 
of contamination is most likely to be dictated by the time spent negotiating the upper 
respiratory tract, particularly the pharynx and the density of pharyngeal infection, which is 
likely to vary between cases and controls. Cases with large numbers of LRT bacteria that 
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are coughing or have a nasal discharge would produce more URT contamination than 
controls that have smaller LRT bacterial numbers. 
To investigate whether oropharyngeal/URT contamination was likely to be 
responsible for the presence of specific bacterial species in tracheal washes taken during the 
same sampling session and was, therefore, the explanation for the association between 
disease and tracheal bacterial infection, further post hoc analyses were conducted. To do 
this pathogen-specific analyses were conducted on data that were restricted to only those 
horses for which the specific bacteria had been recovered from a nasopharyngeal swab. For 
each of 3 presumptively pathogenic bacteria (S. zooepidemicus, ActinobacilluslPasteurella 
spp and S. pneumoniae) and 2 non-pathogenic species (Staphylococcus spp. and 
Acinetobacter spp. ), the proportions of tracheal washes that were positive for these bacteria 
were investigated at different levels of respiratory disease. As previously described (Table 
5.1), disease categories were ordered according to inflammation score and presence/absence 
of clinical signs and data were analysed by chi square test for linear trend for increasing or 
decreasing proportions. 
Results are summarised in Table 5.2 and showed that for all of the presumptively 
pathogenic species of bacteria there was a highly statistically significant linear trend for 
increasing proportions (and hence trend of increasing odds ratios) of positive isolation from 
tracheal washes as disease severity increased. However there was no evidence whatsoever 
of a similar trend for the transient, non-pathogenic bacterial species. As data were restricted 
to only those samplings when bacteria were recovered from the URT, these results indicate 
that it was highly unlikely that contamination of the trachea by bacteria from the URT was 
the only explanation for the presence of presumptively pathogenic bacteria in the trachea in 
diseased horses. 
Several studies using different sampling techniques have apparently identified a 
proportion of horses that have low numbers or scanty growths of non-pathogenic bacteria in 
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the distal trachea or more caudal sites of the lung (Whitwell & Greet, 1984; Sweeney et al., 
1985a; Blunden & Mackintosh, 1991). Using transtracheal aspirates, one study found that 
24% of 50 Thoroughbred racehorses and 64% of 36 pastured, non-racing animals in 
Philadelphia, USA had so called 'transient' non-pathogenic bacteria isolated from tracheal 
samples with Staphylococcus spp. and Acinelobacter spp. both isolated (Sweeney el aL, 
1985a). 
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Table 5.2: Proportions of tracheal washes (TWs) positive for bacterial species among 
only horses positive for the same organism on nasopharyngeal swab and 
ordered according to inflammation score and presence (cases) or absence 
(controls) of clinical signs 
Case/Control Inflammation TWs (*/o) positive for 
score bacterial spp. * 
Total TWs examined 
(100%) 
Odds Ratio 
Streptococcus zooepidemicus 
Control 0 21(28%) 74 1.00 (ref) 
Case 0 3(301/o) 10 1.08 
Control I 28(451/o) 62 2.08 
Case 1 6(60%) 10 3.79 
Control ý: 2 30(831/o) 36 12.6 
Case >2 20(71%) 28 6.31 
)? for linear trend = 33.25 (P-! ý0.00001) 
ActinobacilluslPasteurella spp. 
Control 0 19 (22%) 85 1.00 (ref) 
Case 0 4 (3 1 'Yo) 13 1.54 
Control I 25(321/o) 77 1.67 
Case 1 6(43%) 14 2.61 
Control -? -2 16(80%) 
20 13.9 
Case ý1 13(761/o) 17 11.3 
Xý for linear trend = 30.28 (P--! ý0.0000 1) 
Streptococcus pneumonige 
Control 0 7(241/o) 29 1.00 (ref) 
Case 0 1 (33%) 3 1.57 
Control 1 9 (3 2 'Yo) 28 1.49 
Case 1 2(67%) 3 6.29 
Control ; ->2 11(69%) 16 
6.91 
Case ; ->2 7(70%) 10 
7.33 
)? for linear trend = 11.85 (P=0.00058) 
Staphylococcus spp. 
Control 0 110 (43%) 253 1.00 (ref) 
Case 0 8(28%) 29 0.50 
Control 1 88 (45%) 197 1.05 
Case 1 15 (45%) 33 1.08 
Control ý: 2 32(481/o) 67 1.19 
Case ý-> 2 12 (29%) 42 0.52 
x2 for linear trend = 0.238 (P--0.63) 
Adnetobacter spp. 
Control 0 8(121/o) 67 1.00 (ref) 
Case 0 1 (14%) 7 1.23 
Control 1 7(11%) 63 0.92 
Case I 1 (110/0) 9 0.82 
Control ý1 10(14%) 74 1.15 
Case ; >-2 1 (50/0) 21 0.37 
)? for linear trend = 0.07 (P=0.80) 
Another study also considered that tracheal washes collected by endoscopy 
contained bacteria that were unlikely to be of pathogenic significance (Whitwell & Greet, 
1984) and in a carefully conducted post mortem study, Staphylococcus spp. and 
Acinelobacter spp. were isolated from distal lung sites in 37% and 12% of horses 
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respectively (Blunden & Mackintosh, 1991). A difference was noted between different 
breeds of horses, with Thoroughbreds having a higher proportion positive for these bacteria 
than non-Thoroughbreds. This was thought to be attributable to differences in management 
practices between the breeds, but the important confounding effect of age was not 
considered. Together these studies suggest that the lower airways at least to the level of the 
carina and including the distal trachea, are not entirely sterile in all horses at all times aný 
they do harbour transient, non-pathogenic bacteria periodically. It is likely that these 
bacteria are cleared naturally by normal mucociliary clearance mechanisms but they may be 
influenced by the presence of other pathogenic bacteria during the course of an infectious 
disease process. It is of note that in this study there was a strong inverse association 
between clinical respiratory disease and the presence of low numbers of some species of 
non-pathogenic bacteria in tracheal washes, including Staphylococcus spp. '.; and 
Acinetobacter spp. The prevalence of non-sterile tracheal washes appears to vary according 
to sampling technique, with oropharyngeal contamination probably increasing the 
proportion of non-sterile samples when endoscopy is used. However, the methods used in 
quantification of bacteria in washes in this study were specifically designed to quantify all 
bacteria present in samples, including those that were likely to be acquired from 
contamination of the endoscope during its passage through the URT. Assuming that if cases 
were associated with increased URT bacterial numbers, then there would - be 
correspondingly more contamination of tracheal washes in clinically affected horses than 
controls and the risk of being a case would increase with detection of transient bacterial 
species, which is contrary to the actual finding of this study. 
Isolation of most bacterial species from the URT on nasopharyngeal swabs has not 
been shown to be associated with respiratory disease in horses, with the exceptions of S. 
equi and possibly S. 'pneumoniae. ActinobacilluslPasteurella spp. and S. zooepidemicus 
are, therefore, generally considered to be normal URT commensal organisms and 
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considerable care is needed in interpreting their presence on URT swabs taken during 
clinical disease. In its overall findings this study failed to demonstrate a significant 
association between URT infection with bacteria and clinical respiratory disease. However, 
it is of note that in the final multivariable analysis using only 'healthy' controls, the presence 
of ActinobacilluslPasteurella spp. on swabs as well as in tracheal washes was significantly 
associated with disease. Similarly to the situation in the trachea, there was also an inverse 
association shown with a non-pathogenic bacteria at the same time, this time with non- 
haemolytic Streplococcus spp.. We nýght suppose that the A clinobacilluslPasteurella spp. 
isolated from the URT reflected increased numbers of the organism in the lower respiratory 
tract that were cleared 'by mucociliary mechanisms. However, further molecular 
epidemiological research is required to demonstrate that isolates of the same pathogenic 
bacteria recovered from both the upper and lower respiratory tract concurrently in horses 
suffering respiratory disease, are the same and therefore of common origin. It must be 
considered that the case definition used in this study also included signs of URT disease 
(Wood, 1999) and these URT bacteria may have been associated with this syndrome. 
5.2.5 The effect of viral infections 
This study failed to demonstrate a significant association between clinically apparent 
respiratory disease in young racehorses and infection with several species of viruses, as 
diagnosed by subsequent seroconversion. These infections included equine herpesvirus-I 
(EHV-1), equine herpesvirus-4 (EHV-4), equine rhinovirus-I (ERV-1) and equine 
adenovirus. Previous observational studies have found an apparent association between 
EHV-1 infection and URT disease as defined as nasal discharge (Powell et aL, 1978; 
Thomson, 1978; Morley, 1995; Burrell ef aL, 1996). However, one study demonstrated that 
only around 10% of clinical cases had virus isolated and viruses were not found to be 
associated with subclinical outbreaks (Thomson, 1978). The results here agreed with a 
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recent Australian case control study that also failed to demonstrate any association between 
coughing and viral infections (Christley et al., 1999b; 2001b). 
The current study did identify that infection with equine influenza virus was 
significantly associated with clinical respiratory disease at a univariable level, although the 
prevalence of infection was extremely low among study animals (<I% prevalence overall). 
This very low prevalence among this population of horses was probably directly attributable 
to mandatory vaccination against the disease, which is required under the Jockey Club Rules 
of Racing for Thoroughbreds in the UK. However, influenza infection under the cover of 
vaccination does occur, particularly in young Thoroughbred racehorses, and produces both 
clinicallY apparent but mild as well as subclinical infections (Newton et aL, 1999a; 2000a). 
Serological diagnosis of influenza is possible in vaccinated horses (Newton et aL, 1999a; 
2000a) and we assumed failure to seroconvert was a reliable indicator of non-infection and 
that the majority of horses in this study probably remained free of influenza infection. For 
the purposes of maximising available data and minimising the confounding effects of 
influenza infection in a very small number of horses in this well vaccinated population, all 
analyses in this study were conducted after exclusion of the only 2 matched sets in which 
seroconversion to influenza occurred. 
5.3 Choice of study design 
This case control study used a matched design to investigate the associations 
between clinically apparent respiratory disease and different infectious agents and other 
factors in young Thoroughbred racehorses in training in 3 training centres in the United 
Kingdom. As this study was designed to investigate associations between clinically 
presenting respiratory disease and a wide range of potential risk factors, particularly 
different infections, a conventional prospective cohort design would not have been 
appropriate. In such a cohort study, subjects of known exposure status to a limited number 
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of risk factors are followed over time to assess disease outcomes. In this case control study 
the exposure status of horses to many risk factors (i. e. the infections) changed over the 
study pefiod. 
Clinically apparent respiratory disease in young racehorses is recognised as a 
common and recurrent disease that does not confer solid immunity after a single episode 
(Burrell, 1985; Sweeney et aL, 1992). The restricted traditional epidemiological paradigm 
that the case control design was only useful for the study of risk factors for rare diseases is 
no longer accepted (Greenland & Thomas, 1982; Rodrigues & Kirkwood, 1990). In order 
for the case control design to be appropriate for the investigation of a prevalent disease such 
as respiratory disease in young racehorses, concurrent selection of controls was, therefore, 
necessary (Rodrigues & Kirkwood, 1990). Concurrent selection meant that subjects that 
had been cases at one time could also have been recruited as controls at a later stage 
(Rodrigues & Kirkwood, 1990). The longitudinal study of respiratory disease (Wood et al., 
1997b; Wood, 1999) allowed concurrent recruitment and investigation of horses that did 
(cases) and did not (controls) satisfy the case definition of clinically apparent respiratory 
disease. The design used was therefore similar to a nested case control study inwhich cases 
were recruited from a large cohort and compared to a restricted number of selected controls 
chosen from the same cohort (White et aL, 1998). As cases and controls were recruited 
from the same limited population (cohort) of horses in the participating training yards, this 
would help limit the chance that the selection of cases and controls was biased. The use of 
nested matched case control studies in the investigation of equine infectious respiratory 
disease has not been widespread to date although recent studies have used case control 
methods to investigate risk factors for pleuropneumonia (Austin et aL, 1995) and coughing 
(Christley et aL, 1999b; 2001a; 2001b) in horses. The study of risk factors for 
pleuropneumonia in American horses was somewhat different to the study reported here 
because it was retrospective in nature and was conducted among cases referred to 'a 
167 
Equ= lifflanunatmy Amway Dmase Eptd=ology 
teaching hospital (Austin et aL, 1995). However, the study of coughing among 
Thoroughbred racehorses in Sydney, Australia was much more similar in design to this 
study as it used prospective and concurrent recruitment of cases and controls with coughing 
cases being observed by the trainer or veterinary surgeon (Christley et aL, 1999b; 2001 a; 
200 1 b). Both this study and that conducted in Australia used an appropriate matched design 
with cases and controls being matched on trainer (and hence management factors) and time 
of sampling (i. e. concurrent selection). 
5.4 Bias and confounding 
There were several aspects of the design and conduct of this study that potentially 
introduced bias and confounding. The choice of case control study design, as discussed 
above, had considerable potential for the introduction of bias into this study. As the name 
indicates, case control studies require differentiation and comparison of cases and controls, 
therefore careful definition and classification of subjects into these groups was essential to 
minirrýise bias. 
5.4.1 Definition and selection of cases 
The definition of clinically apparent cases of respiratory disease in this study was 
based on any of 3 clinical parameters; coughing, nasal discharge or pyrexia, which in 
previous studies have been either strongly correlated with or used as a definition of 
respiratory disease (Wood & Mumford, 1992; Burrell ef aL, 1994; Morley, 1995; Moore, 
1996). However, this may be considered to be a non-specific definition, and although 
pyrexia may have a number of non-respiratory underlying causes (e. g. Mair & Lane, 1989), 
respiratory infection is generally considered to be the most likely cause of raised 
temperature in young horses. Case recruitment was not complete in this study because of 
the problems of ensuring compliance in busy training yards. This meant that missed cases 
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had the potential to be recruited as controls leading to bias and underestimation of the size 
of true effects. This was ýninimised by selecting participating yards where the trainer and 
veterinary surgeons were enlightened and concerned about respiratory disease and where 
there was a strong veterinary input. 
There were differential case reporting rates between yards. There were probably 
many reasons for this including differences between trainers, veterinary surgeons, times of 
the year, the proximity of yards to the AHT and the convenience of deploying study 
investigators to sample 'clinically apparent cases. Matching on trainer and time of sampling 
helped control this. Within each yard there was possibly some bias in case selection due to 
trainers monitoring horses differently during critical periods of training such as in the build- 
up to races. This was considered a non-differential bias, however, as it was assumed that the 
trainer would generally apply the same investigation criteria to all horses irrespective of 
whether they were being routinely monitored. 
It was apparent from results that there were more missing laboratory data from cases 
than controls because these animals were sampled at times other than routine monthly yard 
visits, usually by the yard's own veterinary surgeon who did not always submit a complete 
set of appropriate samples. Having cases but not controls examined by different veterinary 
surgeons may have contributed to a differential bias, although cases with missing data were 
more likely to be subsequently excluded in later analyses, thereby reducing the effect of this 
bias. 
5.4.2 Definition and selection of controls 
As only a sample of horses were selected for routine longitudinal monitoring of 
respiratory disease in each yard, there was the potential that the choice of these horses, 
which would be used as the source of controls, would introduce a bias. The sample of 
horses was chosen by the trainer to be broadly representative of the age structure, housing 
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and general management of the yard. Although their initial selection was not necessarily 
random it was probable that this effect would diminish over time as recurrent disease 
occurred. As cases were recruited from the entire yard and controls only from the 
longitudinal sample of horses there was potential for biased selection of cases and controls if 
unmeasured factors within yards were influencing the occurrence of disease differently in 
each group. As the longitudinal sample of horses was generally representative of the whole 
yard, the within-yard effects, which would not be controlled by matching for trainer, were 
not likely to be significant. 
The allocation into subgroups of controls, classified as 'healthy' or 'subclinical', was 
done after the random selection, subject to the requirements for matching, of the entire 
control group, which in turn was done irrespective of respiratory health status. Therefore, 
there was no additional bias introduced by the selection of these control subgroups. 
There was an absence of strict exclusion criteria for controls in this case control 
study because the investigation was essentially undertaken after all the examinations and 
sampling had been conducted. Therefore horses were not classified as cases or controls 
prospectively acording to strictly applied criteria. Case identification was, therefore, reliant 
on later checking records of clinical signs kept at the time of sampling to identify animals 
that were subsequently classified as cases. In the absence of clinical signs being recorded the 
remainder of horses were automatically classified as controls. This might inevitably have 
lead to some misclassification of both cases and controls in this study. 
5.5 Conclusions 
This matched case control study demonstrated that clinically apparent respiratory 
disease in young Thoroughbred racehorses was statistically associated with several 
infectious and non-infectious risk factors. Younger horses and those that had entered. 
training within the last 3 months and those that had ActinobacilluslPasteurella spp. or 
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Mycoplasma ftlis isolated from the trachea were at increased risk of suffering clinical 
respiratory disease. Streplococcus zooepidemicus in the trachea was significantly associated 
with both subclinical IAD in controls and clinical respiratory disease in cases when 
compared with controls with no endoscopic or cytological evidence of IAD. There was 
evidence for an inverse association between clinical disease and the presence of small 
numbers of transient, probably non-pathogenic bacteria in the trachea, although the true 
significance of this is not clear. There was no significant association found between viral 
infections and clinical disease other than for equine influenza, which was an extremely rare 
infection in this well vaccinated and managed population. After controlling for other factors, 
no significant association was identified between previous or recent racing and clinical 
disease. The only significant upper respiratory tract bacterial infection associated with 
respiratory disease was AclinobacilluslPasteurella spp., which was identified only when 
clinical cases were compared with horses with no endoscopic or cytological evidence of 
IAD. This study demonstrates that the horse's age, its time since entry into training and 
bacterial and mycoplasma infections of the trachea are important factors in clinically 
presenting respiratory disease in flat trained racehorses. Several aspects of these factors 
require further investigation to better understand their role in the epiderniology of equine 
inflammatory respiratory disease. 
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SECTION 3 
A STUDY OF NATURALLY OCCURRING 
RESPIRATORY DISEASE IN WELSH MOUNTAIN 
PONY FOALS 
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CHAPTER 6 
INTRODUCTION 
6.1 Background 
During many years of the AHT acquiring recently weaned Welsh Mountain pony 
foals for use in various types of studies, it was clear that these young animals consistently 
suffered a significant burden of natural respiratory disease that was not associated with 
infection by known equine viruses (AHT unpublished observations). The disease, which 
occurred soon after ponies were mixed and transported from Wales to Suffolk, was 
characterised by both obvious clinical signs and lower respiratory tract inflammation. The 
disease was invariably associated with bacterial infections, particularly with Streptococcus 
zooepidemicus, Streplococcus pneumoniae and AclinobacilluslPasteurella spp. and in most 
cases apparently persisted for several weeks. 
In order to study this respiratory disease phenomenon in young Welsh Mountain 
ponies in more detail, a study was conducted by Dr. Neil Chanter in collaboration with the 
research and development arm of a commercial pharmaceutical company (Hoechst Roussel 
Vet). 
6.2 Aims of the study 
The overall aim of the study was to test the efficacy of a multiple strain experimental 
bacterial vaccine against naturally occurring respiratory disease in recently weaned pony 
foals following mixing and transportation to the AHT. Although Dr. Chanter had conducted 
simple descriptions of study data in terms of the proportion of ponies affected by clinical 
signs and infections over the study period, more detailed analyses of the data were required 
and these are presented here. 
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After the study was unblinded it seemed to Dr Chanter that some ponies 
encountered less disease whereas others were clearly more susceptible, irrespective of 
vaccination status. Stimulated by Dr Chanter's impressions of a difference in susceptibility 
to respiratory disease among these ponies, discussions were conducted with 
immunogeneticists at the Eighth Equine Infectious Diseases Conference in Dubai in March 
1998 regarding equine transferrin as a source of iron for growth of Actinobacillus equuh. 
This led to the suggestion that variations in transferrin haplotypes may influence the ability 
of A. equuli to acquire iron and hence to differences in the susceptibilities of individual 
ponies to respiratory. disease. The transferrin haplotypes of ponies were consequently 
determined and these, with protease inhibitor haplotypes as a 'control' variable (i. e. as they 
are also used during equine blood typing but have no obvious biological basis for inclusion), 
were exatnined as pony-level risk factors in analyses. Other variables; including 
autoregressive outcomes, tracheal and nasopharyngeal infections, sex and vaccination status 
were also evaluated. 
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CHAPTER 7 
MATERIALS AND METHODS 
7.1 Study design 
The study was a randornised, double blinded, placebo controlled trial of an alum 
adjuvanted vaccine containing 2 killed strains of S. zooepidemicus and 2 killed strains of A. 
equitli. The sterile placebo was identical to the vaccine in all aspects other than it did not 
contain bacteria. Study ponies, selected from a single location in Wales, each received 2 
doses of intramuscularly administered vaccine or placebo at 4-week intervals whilst at an 
interim holding site in Shropshire. Several days after the second dose, the study ponies were 
mixed with 5 other ponies from 5 distinct sites across Wales and transported together in a 
single batch by road to the study site near Newmarket, Suffolk. All ponies were then 
monitored by twice weekly detailed clinical examination and sampled once a week by 
nasopharyngeal swab, endoscopy and tracheal wash sampling. Blood samples for viral 
serology were taken at monthly intervals. Examinations and sampling continued for 10 
consecutive weeks after ponies were moved to the study site and a final examination and 
sampling was conducted 16 weeks later (i. e. 26 weeks after mixing and transportation). 
conducted all vaccinations and these were blinded from Dr. Neil Chanter, the principal 
investigator, who conducted all clinical examinations and samplings during the study. The 
study was conducted under appropriate Home Office licences. 
7.1.1 Welsh Mountain ponies 
A group of 24 recently weaned, 4 to 6 month old, Welsh Mountain pony foals, 
comprising 10 males and 14 females, were recruited for the study. Ponies were randomly 
allocated to 2 equally sized groups (n=12) to receive either vaccine or placebo and the 
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principal investigator remained blinded to the randomisation code throughout the duration 
of the study. 
All 24 ponies were acquired from a geographically very small area i. e. they ran 
.I together on the same Welsh hill, which would theoretically reduce confounding from 
immunity from previous infections. Selecting vaccinates and controls from the same small 
geographic area would mean they were likely to have had less exposure to multiple 
pathogens and that any measurable difference in disease between the groups would be 
attributable to vaccination rather than immunity acquired by previous infection. Horses from 
a geographically small area would theoretically reduce the number of subtypes of bacterial 
--strains that ponies would have been exposed to prior to vaccination and increase the 
chances of meeting new subtypes when mixed and transported with other ponies from other 
geographically diverse areas. Mixing of vaccinates/controls with a third group of ponies 
from diverse locations was intended to increase the likelihood that they would encounter 
markedly different infections following vaccination. Any subsequent measurable differences 
-, - 
in disease severity between the vaccine and placebo groups rnight then be attributable to 
immunity from vaccination. Use of ponies from diverse locations would have increased the 
likelihood of them having markedly different previous infections and any measurable 
differences in disease severity between the vaccine and placebo groups might be attributable 
to differences in previously acquired immunity rather than to immunity from vaccination. 
A third group of 5 Welsh Mountain ponies from 5 separate and geographically 
diverse locations within Wales was mixed with the vaccine and placebo groups after 
vaccination but several days before all 29 ponies were transported together by road to 
Newmarket. Detailed examination and sampling of all ponies over the next 10 weeks would 
test whether the vaccinated ponies had increased immunity to these novel infections 
compared with the placebo group. 
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7.1.2 Twice weekly clinical examinations 
Clinical examinations followed a standard protocol which included measurement of 
rectal temperature, nasal and ocular discharges, coughing, abnormal breathing pattern and 
submandibular lymphadenopathy. Individual clinical parameters (signs) were assigned a 
score according to severity and these were recorded on an individual record sheet for each 
pony at each exanýnation (Table 7.1). 
Table 7.1: Summary of scoring recorded at the time of clinical assessment for 
individual clinical parameters 
.1 
Clinical parameter Scoring allocation Possible maximurn 
Nasal discharge Normal=O, serous= 1, unilateral= I, mucopurulent=2, bilatcral=2 4 
Ocular discharge Normal=O, serous= 1, unilateral= 1, mucopurulent--2, bilatcral=2 4 
Coughing Absent during exarnination=0, present during examination--2 2 
Breathing pattern Normal=O, dyspnoca/abdominal breathing=2 2 
Submandibular LNs Normal=O, swollen= 1 
7.1.3 Weekly sampling 
On a single occasion during each week of the study all ponies were sampled and 
visual examination of the trachea was made using an endoscope. Similar samples were taken 
as those described for the longitudinal study of respiratory disease in Thoroughbred 
racehorses. 
Blood samples were taken prior to vaccination and at 2,6 and 10 weeks after 
transportation for serological testing for antibodies against equine respiratory viruses. 
Nasopharyngeal swabs were taken for bacteriological testing including PCR typing of 
isolates of S. zooepidemicus. Swabs were immediately placed in transport medium and were 
kept cool on ice blocks in a polystyrene box for transportation over the short distance to the 
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laboratory. A I. Orn flexible endoscope was used to evaluate the amount of mucus visible in 
the trachea and this was recorded on a dedicated recording sheet as either absent (score = 
0), slight (score = 1), moderate (score = 2) or severe (score = 3). A tracheal wash sample 
using PBS was collected and transported to the laboratory on ice blocks. Thoroughly 
mixed aliquots were used for nucleated and red blood cell counts (EDTA sample), 
cytological examination (formalin fixed sample) and quantitative bacteriology and S. 
zooepidemicus typing PCR. The endoscope was thoroughly cleaned and disinfected 
between each pony. 
7.2 Data 
The data consisted of II weekly (repeated) observations (i. e. week of observation 
after mixing with the non-vaccinated group) for all 29 ponies, giving a total of 319 
observations. The ponies were categorised according to whether they received vaccine, 
placebo or were introduced later. 
7.2.1 Pony level variables 
There were several variables which resided at the pony level and which, therefore, 
did not alter over the weeks of observation. These variables included sex, vaccine group and 
each pony's transferrin and protease inhibitor haplotype derived from typing of blood 
samples from each pony. 
Sex was recorded as a binary variable with male (1) and female (0) categories and 
vaccine group as a categorical variable with vaccine (1), control (2) and introduced later (3) 
categories. Variables corresponding to each of the transferrin (D, F2, HI, H2,0 & R) and 
protease inhibitor (1, L, L2, R& S) haplotypes were recorded as binary variables, i. e. 
corresponding to the presence (1) or absence (0) of that particular haplotype, independent 
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of the presence or absence of any other haplotype in that individual. Table 7.2 summarises 
the distribution of these pony level variables among each sex and in total. 
Table 7.2: Overall and sex-specific distribution of pony level variables and frequency 
of specific transferrin and protease inhibitor phenotypes 
Pony level variable Female Male Total Frequency of specific phenotypes 
(n) (n) 
Total 15 14 29 Trmsferrin PI type N qpe n 
Vaccine group D0 5 L L 10 
Vaccine (V) 6 6 12 D F2 4 L 1 10 
Placebo (P) 8 4 12 F2 F2 4 L S 4 
introduced later (I/L) 1 4 5 DR 3 1 1 2 
Transferrin D H2 3 L L2 I 
haplotype positive F2 0 3 L R I 
D 9 9 18 DD 2 1 S I 
F2 9 5 14 F2 HI 2 
HI 2 1 3 D III I 
H2 1 3 4 H2 0 1 
0 5 4 9 F2 R I 
R 3 1 4 
By vaccine group V P I/L Total 29 29 
D 9 8 1 
F2 5 4 5 
HI 1 2 0 
H2 2 2 0 
0 3 6 0 
R 2 2 0 
Protease inhibitor 
haplotype positive 
1 8 5 13 
L 13 13 26 
L2 1 0 1 
R 0 1 1 
S 1 4 5 
PI = protease inhibitor 
7.2.2 Observation level variables 
There were a series of both outcome and explanatory variables that were specific to 
each time of observation for each pony. 
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7.2.2.1 Outcome variables 
The outcome variables of interest corresponded to individual and aggregated clinical 
scores allocated to severity of particular signs of disease. Individual clinical parameter 
scores were recorded on dedicated scoring sheets at the time of clinical evaluation (Table 
7.1) for nasal and ocular discharges, coughing, abnormal breathing/dyspnoea and 
submandibular lymph node (SMILN) enlargement. 
Aggregated clinical and airway inflammation scores 
Two aggregated clinical scores were used as overall summary measures of severity 
of clinical respiratory disease. Clinical score was the term used for the sum of all 5 
individual clinical parameters whereas CDNS score was the sum of coughing (C), abnormal 
breathing/dyspnoea (D), nasal discharge (N) and SMLN enlargement (S) but excluded 
ocular discharge. The altemative score of CDNS was also used because ocular discharge 
may not have reflected respiratory diseaseper se, but possibly some environmental influence 
such as hay dust encountered whilst ponies fed from hay racks. Comparison of analyses 
including and excluding ocular discharge in aggregated scores might allow this possibility to 
be evaluated. 
Although clinical observations were conducted twice weekly, respiratory sampling 
was only conducted once a week and this was always done at the time of the first clinical 
assessment. Therefore in order that numbers of clinical and sampling observations 
corresponded, a single weekly average (mean) was calculated for clinical parameters. For 
the purposes of this study the weekly average was considered the most appropriate measure 
of the weekly clinical severity of respiratory disease, with each of the 2 examinations being 
weighted equally. 
Table 7.3 summarises the scoring system used for analysis purposes for individual 
and aggregated clinical parameters. In order that scores for nasal and ocular discharges 
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were not overly weighted in the aggregated clinical scores (each originally counting for a 
score of up to 4 compared to 2 or I for other clinical signs Table 7.1), the scoring 
allocations for these 2 clinical parameters were halved. This, therefore, gave a possible 
maximum score of 2 for nasal and ocular discharges that were mucopurulent and bilateral, 
with the possibility of lower scores for serous and/or unilateral discharges. The clinical signs 
of coughing and abnormal breathing/dyspnoea were considered to be clinically equivalent in 
their contribution to respiratory signs to bilateral, mucopurulent discharges and were each 
scored 2 when present. Enlargement of the submandibular lymph nodes was considered less 
clinically significant than coughing, abnormal breathing/dyspnoea and bilateral, 
mucopurulent discharges and was consequently attributed a score of one when present. "'- 
Overall individual observation scores (n=319) were taken as the average of 2 weekly 
examination scores and aggregated weekly clinical scores were equivalent to the sum of the 
relevant average individual parameter scores. This averaging over the 2 clinical 
exarninations increased the precision of aggregated scores because of the possibility of 
fractional scores. For example, a pony that had clinical scores of 5 and 6 during 
exan-ýinations in a particular week, would have an averaged weekly clinical score of (5+6)/2 
= 5.5 and this would be out of a possible maximum of 9 (i. e. (9+9)/2). 
Table 7.3: Summary of scoring used for analyses for individual and aggregated 
clinical parameters 
Clinical parameter Scoring allocation per clinical examination Maximum 
possible score 
Individual parameters 
1. Nasal discharge* normal=0, scrous=0.5, unilateral=0.5, mucopurulcnt=l, bilateral=1 2 
2. Ocular discharge* normal=O, serous=0.5, unilateral=0.5, mucopurulcnt--I, bilateral=1 2 
3. Coughing absent during examination--0, present during cxamination--2 2 
4. Breathing normal=O, dyspnoea/abdominal breathing--2 2 
5. SMLN normal=O, cnlarged/swollen-- 1 1 
Aggregated scores 
Clinical score sum of scores for all 5 clinical parameters 9 
CDNS score sum of scores for cough, breathing, nasal discharge & SMLNs only 7 
*modified nasal and ocular discharge scores from those recorded, SNILN = submandibular lymph nodes 
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In addition to the outcome measures of clinical and CDNS scores, another outcome 
measuring airway inflammation was derived from 3 component observations. Airway 
inflammation score was derived from the sum of scores for i) mucus visible in the trachea on 
endoscopy, ii) the density of cells on a smear of tracheal wash examined cytologically and 
iii) the relative proportion of all cells that were neutrophils on the same smear. Table 7.4 
summarises the allocation of scores to different categories of the component observation 
scores, which have been in common usage by clinicians and pathologists at the AHT over 
many years and have proved reliable semi-quantitative measures. In analyses airway 
- inflammation score was treated as an ordinal variable. 
Table 7.4: Summary of component observation scores for airway inflammation score 
Tracheal mucus score Tracheal wash smear Neutrophil proportion in 
(Mucus) cell density (SCD) tracheal wash (Neutrophil) 
0 no mucus visible 0 low density 0 no cells observed 
I slight mucus visible 0 medium-low density 0 few cells seen 
2 moderate mucus visible I medium density 0 small numbers and diffuse 
3 severe mucus visible 2 medium-high density I small numbers but aggregated 
3 high density 2 moderate proportion of cells 
3 predominant cell type seen 
Airway inflammation score = Mucus + SCD + Neutrophil 
Individual clinical signs 
For each individual clinical parameter, a binary outcome was generated 
corresponding to whether the clinical sign was considered present during the week of 
observation (1) or not (0). For coughing, abnormal breathing and submandibular lymph 
nodes, ponies possessing the sign at either of the clinical exanýnations during the week were 
classified as having that sign and this corresponded to an average parameter score >0. 
However, a more discretionary cut-off was used for nasal and ocular discharges as these 
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parameters were scored for their nature (absent, serous or mucoid) and extent (absent, 
unilateral and bilateral) rather than simply just presence or absence. 
Table 7.5 summarises the derivation of binary outcomes for both nasal and ocular 
discharges from all of the possible combinations of discharge scores from 2 weekly 
examinations (weekly average scores). 
Table 7.5: Summary of the derivation of binary outcome scores for nasal and ocular 
discharges from combinations of discharge scores from 2 weekly 
examinations 
Examination 1 
Normal Unilateral Bilateral serous Unilateral mucoid Bilateral mucoid 
serous 
Examination 2 WAS Binary WAS Binary WAS Binary WAS Binary WAS Binary 
Normal 0.0 0 0.5 0 0.75 1 0.75 1 1.0 1 
Unilateral serous 0.5 0 1.0 0 1.25 1 1.25 1 1.5 1 
Bilateral serous 0.75 1 1.25 1 1.5 1 1.5 1 1.75 1 
Unilateral mucoid 0.75 1 1.25 1 1.5 1 1.5 1 1.75 1 
Bilateral mucoid 1.0 1 1.5 1 1.75 1 1.75 1 2.0 1 
WAS - Weekly Average Score, Binary = Binary Outcome Score 
Animals that were normal on both examinations (weekly average score=O) or had a 
unilateral, serous discharge on one (weekly average score--0.5) or both (weekly average 
score=1.0) occasions were all considered not to have had a nasal or ocular discharge during 
that week. Ponies with all other combinations of signs were classified as having had nasal or 
ocular discharge. 
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7.2.2.2 Explanatory variables 
The explanatory variables of interest at the observation level corresponded to results 
of microbiological examination of tracheal wash and nasopharyngeal swabs taken at the 
time of observation/sampling. 
Tracheal washes had individual species of bacteria enumerated and expressed as 
colony forming units (cfu) per ml of sample and total bacterial count was the sum of the 
total counts of each species, also expressed as cfu/n-A. Quantitative data were available at 
each sampling for total bacteria, S. zooepidemicus, A. equu1i, Pasteurella spp., Bordetella 
bronchiseplica and non-haemolytic Streptococcus spp. For analytical purposes, quantitative 
bacteriology results (cfu/ml) for all samples were transformed by taking the logio of their 
value plus one. 
In addition, autoregressive variables, corresponding to the clinical outcome of 
interest (i. e. aggregated scores or individual clinical binary outcomes) at previous sampling 
points (1,2 and 3 weeks previously), were generated. Inclusion of these variables, however, 
did limit the amount of available data for analyses. For example, autoregressive variables for 
the outcome the previous week were only available from the second sampling onwards, for 
outcomes 2 weeks previously from the third week onwards and for outcomes 3 weeks 
previously from the 4th week onwards. In addition, autoregressive variables for the 
sampling at week 26 were not deemed relevant, as this would refer to samplings at least 16 
weeks earlier. 
For analytical purposes bacterial isolate data for nasopharyngeal. swab samples were 
expressed in a binary manner, corresponding to whether individual species of bacteria were 
isolated (1) or not (0) from swabs. Bacteria isolated from nasopharyngeal swabs included 
S. zooepidemicus, Pasteurella spp., Bordefella bronchiseptica, non-haemolytic 
Streplococcus spp. and Staphylococcus spp.. However, A. epuft was not isolated from 
nasopharyngeal swabs during the course of the study. 
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7.2.3 Pony level cumulative summary measures for repeated observations 
In order to conduct a preliminary examination of data at the pony level (prior to 
analysis of individual observations, which considered repeated observations from specific 
ponies), cumulative summary measures of outcome and explanatory variables were derived 
from the data as explained in Table 7.6. Cumulative summary measures for each individual 
clinical outcome were the sum of scores for each clinical sign and were treated as 
continuous data. Similarly, cumulative aggregated scores were also generated and were also 
treated as continuous data. Various cumulative summary measures for infectious 
explanatory variables were derived for different infections and also took the form of 
continuous data. These included the total, maximum and geometric mean loglo count for 
specific bacterial species in tracheal wash samples and the loglo count at week 26 of the 
study. In addition, the total number of weeks that each horse had counts of specific bacteria 
in washes at greater than 103,104 and 10' cfu/rnl were calculated. 
It was considered valid to include clinical and infectious examination results at week 
26 in the cumulative summary measures as all animals had been examined at this time and 
analyses of these data would investigate differences between ponies (n--29) and not 
observations (n--319) within the cumulative data. 
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Table 7.6: Details of pony level cumulative summary measures for clinical and 
infectious variables 
Pony level summary measure Derivation 
Clinical outcome variables 
Nasal discharge (ndavg) Sum of II average weekly scores 
Ocular discharge (odavg) Sum of II average weekly scores 
Coughing (coughavg) Sum of 11 average weekly scores 
Breathing (dyspavg) Sum of 11 average weekly scores 
SMLN (smlnavg) Sum of II avcraRc weekly scores 
Clinical score (clinsc) Sum of all scores for all weeks 
CDNS score (cdns) Sum of cough, breathing, nasal discharge & SMLN scores for all weeks 
Infectious explanatory variables (each for S. zooepidemicus, A. epuli, Pasteurella spp., B. 
Bronchiseptica and non-haemolytic Streptococcus spp. ) 
Total log, 0 cfu/ml Log, 0 of sum of II weekly arithmetic cfu/ml counts 
Maximum log, 0 cfu/ml Maximum log, 0 count encountered through the study period 
Geometric mean log, 0 cfti/mI Mean of log, 0 weekly counts 
Total weeks with 103 CfU/Ml Sum of number of weeks with equal to or greater than 103 Cfti/Ml 
Total weeks with 104 CfU/Ml Sum of number of weeks with equal to or greater than 104 Cfti/ml 
ý: 105CfU/ I Total weeks with - in 
Sum of number of weeks with equal to or greater than 105 CfU/Ml 
Week 26 log, 0 cfti/ml Log, 0 cfu/ml in sample taken at week 26 
7.3 Statistical analyses 
7.3.1 Pony level analyses 
Data were examined to see whether there were any statistically significant 
differences between measures of clinical outcome (continuous clinical score data) among 
different categories of individual explanatory variables. 
The distribution of data for pony level clinical scores (Figure 7.1) and CDNS scores 
(Figure 7.2) were examined by normal quantile-quantile (QQ) plots and were considered 
satisfactorily normally distributed and did not require transformation. 
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Figure 7.1: Normal quantile-quantile plot for pony level clinical scores 
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Figure 7.2: Normal quantile-quantile plot for pony level CDNS scores 
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The more conservative non-parametric ranking methods of the Wilcoxon rank sum 
test (for binary variables such as sex and possession of each transferrin and protease 
inhibitor haplotype) and the Kruskal-Wallis test (for categorical variables such as vaccine 
group) were used. Statistical significance was arbitrarily set at the 5% level. Where 
significant differences were identified, the direction of the difference in cumulative clinical 
outcome score in relation to the categories of the explanatory variable was examined. 
Continuous summary measures of infectious explanatory variables were examined 
for their association with continuous cumulative clinical outcomes using simple linear 
regression. Linear regression was used to describe data by the following equation: 
outcome Ypony Ct + PlponyXI 
where cc= intercept estimate 
pip., 
Iy = slope estimate 
for variable x, 
Where results indicated a significant association between multiple variables, 
stratified analyses were then performed in order to examine the nature of the relationship 
between variables according to the different levels of another parameter. For example, to 
investigate whether the variation in scores between sexes was explained by the effect of a 
particular transferrin group or vice versa, a stratified analysis was conducted. In this 
stratified approach, the effect of sex for each category of a particular transferrin haplotype 
(present or absent) and the effect of transferrin haplotype for each sex were estimated. 
Having examined the relationship between pony-level outcome and explanatory 
variables, the relationship between several of the explanatory variables was further 
investigated. In particular, data were examined for any significant differences between 
cumulative summary measures of infectious variables and sex, vaccine group and possession 
of transferrin and protease inhibitor haplotypes. Again the more conservative non- 
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parametric techniques of the Wilcoxon rank sum test and the Kruskal-Wallis test were used. 
All pony level analyses were conducted using Stata5.0 computer software (Stata 
Corporation). 
There were no missing data for clinical outcomes in this study as all ponies were 
clinically examined on all occasions and hence there were no missing values for cumulative 
outcome variables. However, there were 5 occasions when tracheal wash samples could not 
be taken and these missing infectious data were ignored in generating cumulative 
explanatory variables for all parameters except the week 26 bacterial counts i. e. variables 
were generated for the number of weeks for which there were data available. This was 
considered preferable to excluding all pony-level data for ponies that had missing tracheal 
washes as this would considerably reduce the effective sample size. It was also considered 
that the missing samples occurred randomly and as such were unlikely to introduce a 
significant bias by underestimation of variable values. There was no tracheal wash taken 
from pony 21 on week 26 and so the week 26 bacterial counts for this pony were set as 
missing values and all analyses using these variables were based on 28 rather than 29 
observations (ponies). 
7.3.2 Observation level analyses 
7.3.2.1 Aggregated clinical sign and airway inflammation scores 
Three aggregated outcome measures of respiratory disease were generated for each 
observation (n=319), with an observation corresponding to a week of the study (n7-1 1) for 
each pony (n7-29). Clirdical score was the sum of each of the weekly average scores for the 5 
individual clinical signs of nasal and ocular discharges, coughing, abnonnal 
breathing/dyspnoea and submandibular lymph node enlargement. CDNS score was the sum 
of the same individual sign scores but excluding the score for ocular discharge. Airway 
inflammation score was the sum of scores for endoscopically visible tracheal mucopus, 
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cytological smear cell density and neutrophil predominance in tracheal wash smears. 
Aggregated clinical sign and airway inflammation scores were treated as continuous 
variables. 
The distribution of data for clinical scores (Figure 7.3), CDNS scores (Figure 7.4) 
and inflammation scores (Figure 7.5) were examined by normal quantile-quantile (QQ) 
plots. Although these data were not perfectly normally distributed due to an excess of zero 
values at the lower end of the distributions, the use of logarithmic transformations, usually 
applied to positively skewed data such as these, did not make sufficient differences to the 
distributions to merit using transformed data. 
Figure 7.3: Normal quantile-quantile plot for observation level clinical scores 
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Figure 7.4: Normal quantile-quantile plot for observation level CDNS scores 
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Figure 7.5: Normal quantile-quantile plot for observation level airway inflammation 
scores 
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Uniýariable analyse 
As for the pony level analyses, data were examined in the first instance to determine 
whether there were any statistically significant relationships between outcome scores and 
different possible explanatory variables. Explanatory variables fell into several discrete 
groups and took different forms. These included logio transformed counts (cfu/ml + 1) of 
total and individual species of bacteria in tracheal washes (continuous), species of bacteria 
isolated on nasopharyngeal. swabs (binary), clinical scores for the same pony from previous 
or earlier weeks (continuous autoregressive), sex (binary), vaccine group (categorical) and 
transferrin and protease inhibitor haplotypes (binary). 
Linear regression was used to examine separately the relationship of each of the 
tracheal wash bacterial counts and autoregressive score variables with the aggregated 
scores. In addition polynomial forms for fitting the data were also evaluated using the 
FRACPOLY and COMPARE commands available for linear regression analysis in Stata5.0 
software. Outcome variables were regressed using the following equation and this was 
compared with the linear regression result to examine whether it provided statistically 
significant improvement to the fit of data as measured by deviance reduction based on 
appropriate degrees of freedom on a X2 distribution: 
outcome YObservation --"' OC + pl[Xlla+ P2 [XI]b ...... + pm[XI]n 
where (x =intercept estimate 
PI [xi ]' = slope estimate for variable x, raised to power a 
i -', 
PAXII b= slope estimate for variable x, raised to power b 
slope estimate for variable x, raised to power n 
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Polynomial regression analyses represented the best fitting regression mo de is 
containing 2 or more power terms tested from combinations of ýC2, ýCl, X-0.5, XO. 
5, 
x 
1, 
x 
2, 
X3 
and log, x and including products of log. x with all other powers including itself. Higher 
order models containing 3 or more power terms were also investigated. 
Wilcoxon rank sum and Kruskal-Wallis methods were used to examine whether 
there were any statistically significant differences in aggregated clinical and airway 
inflammation scores between the categories of binary and categorical explanatory variables. 
Where significant differences were identified, the direction of the difference in clinical 
outcome score in relation to the categories of the explanatory variable was examined. All 
univariable analyses were conducted using Stata5.0 computer software (Stata Corporation). 
Ordinary multiple linear regression modelling 
Multiple linear and polynomial regression modelling was conducted initially using 
Stata5.0 computer software (Stata Corporation). These analyses would be able to take 
account of some of the temporal clustering of observations over relatively short time 
periods (weeks) by inclusion of autoregressive variables, which for an individual pony 
related outcome scores in previous weeks to that being modelled. Inclusion of these 
variables would necessarily reduce the effective sample size and this type of modelling 
would not account for all the within-pony relationships that may be present. 
Model development was conducted in a stepwise manner with the sequential 
addition of variables that achieved a significance of P: 50.3 in univariable analysis in 
descending order of the proportion of the variability (W value) in the outcome that they 
accounted for. Final regression models were those that accounted for the most variability 
and contained statistically significant variables. Statistical significance was arbitrarily set at 
the 5% level but as final models were intended to be biologically meaningful, attention was 
also paid to results that were approaching statistical significant (<10%). 
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Multilevel linear repression modelling 
Although ordinary linear and polynomial regression modelling included 
autoregressive variables that would take account of some of the important temporal 
clustering of these data, these analyses did not take account of the within-pony 
relationships. Such relationships in repeated observations in ponies might have important 
implications in the level of significance and estimated values of model parameters. To 
overcome this, multilevel regression modelling was used in which the hierarchical structure 
of the data (i. e. observations within ponies) was specified and random effect terms (in 
addition to the other fixed effect terms) included to model the random variability between 
ponies and observations. Multilevel regression modelling was conducted using MLwiNI. 10 
(Multilevel Models Project, Institute of Education; Rasbah et aL, 2000), with care taken to 
ensure that data were correctly ordered with respect to the hierarchical structure prior to 
analyses. 
Model development was conducted in a similar manner to that used for ordinary 
multiple linear and polynomial regression with sequential addition of variables that achieved 
a significance of P: 50.3 in univariable analysis. Improvement in the fit of models of the same 
sample size was evaluated by the reduction of model deviance and likelihood ratio test. 
Final models were those in which parameters were either significantly associated with the 
outcome (Wald X2 test P:! ý0.05) or the inclusion of which had significantly improved the fit 
X2 fi of the model (Likelihood ratio . test 
P: 50.05). All mal models included random effect 
tenns to account for variability in the data attributable to both ponies and observations and 
these were retained even if they were not shown to be statistically significant. 
Each multilevel regression model was represented by fixed effect and random effect 
-pI 
ortions, with the following example for inclusion of a single fixed effect variable (xj): 
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outcome Yobservation, pony ý-- 60observation, ponyXO + J61 XI observation, pony 
where j6Oobservation, pony ý j6O+ popony 
+ eoobservation, pony 
xo = constant taking a value of I 
AXI 
observation, pony ---: slope estimate 
for variable XIobservation, pony 
, 
60 = intercept estimate 
Ap ... y= pony-level random coefficient (mean = 0, variance = a2.,,,, ) 
eoobsmation, pony : -, = observation-level random coefficient (mean = 0, variance = 
CY 0) 
The fixed effects are represented by the relevant 0 estimates and their standard 
wors (S. E. ) for the intercept (flo) and slopes (, 81) for the explanatory variable(s) included 
in the model. The random effects are represented by variance estimates at each hierarchical 
level within the data. The hierarchical structure of these data was repeated observations 
(known as level I in the hierarchy) clustered within each pony (level 2). This meant that the 
level 2 random effects represented the variability between different ponies (pony level 
random departures or residuals, Apy, were normally distributed with mean of zero and 
variance cy 2 , o). The 
level I random effects represented the variability between individual 
observations within ponies (observation level random departures or residuals, eo obscivation, ponyv 
were normally distributed with mean of zero and variance Cy2 eo). It was possible that the 
random variability between ponies might have been best modelled by differences in both 
their intercepts and their slopes (so called random intercept and slope models) or it may 
have been more appropriate to only model variation in intercepts (random intercept only 
models). 
196 
Equine hfflammatmy Auway Dmeme EpulemokV 
The intra-pony correlation, which was the proportion (%) of the total variance of 
observations and ponies attributable to variation between ponies, was also calculated for 
individual multilevel models: 
Intra-pony Level 2 (pony-level) variance 
x 100 correlation Level I (observation-level) variance + Level 2 (pony-level) variance 
Therefore, the more similar ponies were to each other, as measured by a lower level 
2 variance, then the lower the intra-pony correlation. 
After final models were derived, the fits to the data were investigated by 
examination of residual values at different levels within the data. Ranking and plotting of 
residual values and their 95% confidence intervals for data at both pony and observation 
levels, in so-called 'caterpillar plots', allowed the identification of animals, and observations 
from these individuals, whose outcomes were poorly predicted by the model in question. 
Models were also re-analysed with specified poorly fitting observations or ponies (large 
value residuals) fitted with separate intercepts (and slopes if necessary) in the fixed effect 
part of the model and not contributing to the estimation of the random effects. 
7.3.2.2 Individual clinical signs 
As described previously, each pony had a weekly binary outcome for each of the 5 
individual clinical parameters of nasal discharge, ocular discharge, coughing, abnormal 
breathing and submandibular lymph node enlargement. 
Univafiable analyse 
Data were initially examined for the univariable association of the probability of 
presence of each individual clinical sign with explanatory variables (same variables as for 
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aggregated clinical sign and airway inflammation scores) by inclusion in a simple ordinary 
logistic regression (OLR) model. 
109it (Pobsex-vation) --` 10ge[Pobservation/(I-Pobservation)I CC + PIXIobservation 
Where the logit of probability (D. b,, e,. ti., ) is the natural logarithm of the odds of the 
binary outcome being observed ([p. b. r,. tjd(l-p. b. evtj. )]), cc is an estimate of the population 
intercept and P, is the slope estimate for variable 
The association between outcome and each explanatory variable was expressed as a 
beta estimate and standard error (p and S. E. 0), an estimated unadjusted (crude) OR with 
95% confidence intervals around the estimate and corresponding Wald )? P-value. 
The risks of each outcome with logio cfu/ml S. zooepidemicus in tracheal washes 
were examined graphically to assess the most suitable way to express the levels of this 
variable in further multivariable analyses. Where there was not a satisfactory linear 
relationship between the logit of outcome risk and loglo cfu/ml S. zooepidemicus, the square 
and cube of logio cfa/ml S. zooepidemicus were examined for their suitability of fitting data 
by inclusion as quadratic (i. e. logio cfii/ml and [logio cfii/H]2 included as model terms) or 
cubic (i. e. logio cfu/ml and [logio cfu/ml]' included) model terms. If these terms were also 
considered unsuitable for modelling the risk of outcome with logio cfu/n-A S. zooepidemicus 
then an appropriate categorical summary of the data was chosen. 
Multivariable loeistic repression analyses ignofing pony-level random effects 
As for analyses for the aggregated clinical sign and airway inflammation scores, 
multivariable analyses of individual binary clinical outcomes were conducted initially using 
logistic regression with inclusion of autoregressive variables. This would take account of 
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some of the temporal associations between repeated observations in the data but would not 
account for the within-pony relationships. 
A forward stepwise approach was adopted with systematic addition of explanatory 
variables that achieved a significance of P: 50.3 in univariable analysis and in descending 
order of their strength of association with the outcome. Variables were only retained if they 
were associated with disease (Wald X2: P : ýý 0.05) or if their inclusion resulted in a significant 
improvement in model fit as measured by the likelihood ratio statistic (LRS X 2: p :50.05) 
(Hosmer & Lemeshow, 1989). To ensure that statistically significant associations had not 
11 '' 
been inadvertently rejected, the final parsimonious model was checked by systematic 
II 
addition of rejected variables one at a time. 
I 
Statistical interaction was examined by the addition of biologically meaningful, 2- 
way interaction terms between main effect variables. Interaction terms that provided a 
significant improvement to model fit as measured by likelihood ratio statistic (LRS X2: P: 5, 
0.05) were retained. Multivariable logistic regression analyses were conducted using the 
'Logistic regression' analysis option in Egret software (Cytel Software Corporation). 
Multivariable loizistic repression analyses accounting for pony-level random effects 
In order to account for the clustering of repeated observations within individual 
ponies in these data, 2 separate software packages were used and compared to conduct 
multivariable logistic regression modelling that included specific terms for random 
variability between ponies (pony-level random effects). 
Egret software (Cytel Software Corporation), which provides maximum likelihood 
estimates for regression parameter estimates, was used to extend the multivariable models 
produced with no account taken of random variation between ponies. Logistic regression 
models were extended by inclusion of a random effects term matched on pony using the 
'Logistic regression with distinguishable binomial random effect' analysis option. 
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109it (Pobservation, 
pony) 
10ge[Pobsffvatiori, 
pony/(I -Pobsmation, pony)] + CyponyU 
where 10ge[Pobservation, pony/(l -Pobservationpony)] 
+ CTponyU : -- (X +0 IXI observation, pony 
(TponyU 
f,, 
Where the logit of probability (p. b., p.,, y) is the sum of the natural logarithm of 
the odds of the binary outcome being observed ([p. b,,,,., i, p. ý(l-p. b,,,,,., j, p.. y)]) and the 
random variable ap.,, yu, which has a mean of zero and variance of one. The term ap.. y is a 
positive scalar (expressed as %SCL in EGRET output) equivalent to the coefficient of the 
pony (group) effect and u is a standardised binomial random variable which is always equal 
to one. The term cc is an intercept term (expressed as %GM in Egret output) and 01 is the 
slope estimate for variableXIobservation, pony. 
Results were presented as beta estimates and standard errors (P & S. E. 0), estimated 
adjusted OR with 95% confidence intervals around the estimates and corresponding Wald 
X2 P-values. Due to the lack of approximation of differences in deviances between models 
with and without a random effect term to a chi-squared distribution and consequent 
difficulty in their interpretation, formal likelihood ratio statistics and corresponding P-values 
were not presented. 
NiLwiNI. 10 (Multilevel Models Project, Institute of Education) software was also 
used to exan-ýine factors associated with presence of individual clinical signs. As for 
multilevel linear regression modelling, the hierarchical structure of observations within 
individual ponies was specified and model building was conducted in a forward stepwise 
manner similar to that used for ordinary multivariable logistic regression. 
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outcome Yobservation, pony --` 7Cobservation, pony + eOobservation, ponyXO 
where 109it OC-blemti., pony) =0 lponyXI 
+ 02X2observation, 
pony 
e0observation, pony " observation-level random coefficient (mean = 0, variance 
=1) 
X0 -*: -- 
I* [7Cobservation, 
pony( 
I -7Cobservation, pony)/nobservation, pony]0*5 
01 
ponyX I=PI+ PI pony 
02X2observation, 
pony slopeestimate 
for variableX2observation, pony 
PI= intercept estimate 
x, = constant taking a value of I 
-I 
Pipony --ý pony-level random coefficient (mean = 0, variance = cýpi) 
Modelling was conducted using the second order penalised quasilikelihood (PQL) 
estimation technique with model estimates derived by both iterative generalised least 
squares (IGLS) and the less biased restricted iterative generalised least squares (RIGLS) 
methods. The results from these 2 methods were compared with those produced for the 
maximum likelihood estimation techniques of Egret software. As previously, the fit of final 
models was investigated by the examination of residual values, particularly at the level of 
individual ponies within the data. 
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CHAPTER 8 
RESULTS 
8.1 Description of pony level data 
Table A2.1 (Appendix 2) summarises details of pony level explanatory variables and 
cumulative summary outcome measures for each of the 29 ponies grouped according to 
their vaccine status along with details of whether they possessed D and/or F2 transferrin 
haplotypes. The cumulative summary outcome measures are the sum of weekly average 
scores for individual signs of nasal and ocular discharges, cough, abnormal 
breathing/dyspnoea and SMLN enlargement over the study period. Clinical and CDNS 
scores are the sum of the cumulative scores of each of the individual signs including and 
excluding ocular discharge, respectively. Results of the summary statistics (mean, S. D., S. E. 
and median; bottom 4 rows of Table A2.1) show that coughing was the least frequently 
observed individual clinical sign, with some animals not being observed to cough at all 
during the period of the study. 
Tables A2.2a -e surnmarises details of pony level explanatory variables and 
cumulative summary measures (logio total cfu/ml, maximum loglo cfii/ml, mean logio cfu/n-d, 
>104 total weeks with 2! 10', _ and ý! 
10' cfu/ml and loglo cfu/n-d at week 26) for specific 
bacterial infections in tracheal wash samples, including S. zooepidemicus, A. equu1i, 
Pasteurella spp., B. bronchiseptica and non-haemolytic Streplococcus spp., respectively. 
Results also include summary statistics for each cumulative parameter and demonstrate that 
A. equuli was the least prevalent infection in tracheal washes with respect to the quantities 
of bacteria isolated from tracheal washes. 
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8.1.1 Scrologyresults 
Serology results were not available for all observations but were taken at 
approximately monthly intervals during the study. The first sample was taken immediately 
prior to vaccination (week -4) and subsequent samples were collected at weeks 2,6 and 10 
after transportation to Newmarket. 
Although there was no serological evidence of influenza virus infection during the 
study there were seroconversions to other equine viral infections. Figure 8.1 summarises the 
number of seroconversions detected to EHV, equine adenovirus and ERV for each of 3 sets 
of paired sera (Le. weeks -4 and 2, weeks 2 and 6 and weeks 6 and 10). 
Figure 8.1: Summary of numbers of seroconversions to EHV, equine adenovirus and 
ERV for different paired sera 
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The 5 ponies in the late introduction group were not available for blood sampling at the 
time of vaccination and so the first set of paired sera (weeks -4 and 2) only apply to the 24 
vaccine and placebo administered ponies. The 2 subsequent sets of paired sera (weeks 2 and 
6 and weeks 6 and 10) apply to all 29 ponies. 
There were only 2 ponies that seroconverted to ERV and both of these occurred 
between weeks 2 and 6 and 5 ponies seroconverted to equine adenovirus, all between 
weeks -4 and 2. Of the 24 ponies with paired sera available between weeks -4 and 2,15 
(62.5%) seroconverted to EHV. Of the 14 ponies with samples available between weeks 2 
and 6 which had either not seroconverted earlier (n--9) or were late introductions (n=5),, 9 
(64.3%) seroconverted to EHV, with 4 of these being late introductions. There were 3 
seroconversions to EHV between weeks 6 and 10. These included 2 ponies that had 
seroconverted previously between weeks -4 and 2 and the remaining late introduction pony 
that had not seroconverted between weeks 2 and 6. These serological results show that 
within 6 weeks of being transported, 83% of all ponies had seroconverted to EHV and 
during the entire study period 4 animals (14%) did not seroconvert. 
The large proportion of animals either seroconverting to EHV within a short period 
of being transported or not seroconverting to ERV or adenovirus and the absence of firm 
dates on which to accurately pinpoint infections relative to the weekly sampling and clinical 
examinations, meant that serological, results were not incorporated in further analyses. 
Therefore, it is important to note that the following pony and observation-level analyses are 
performed in ponies with a history of recent transport and associated seroconversion to 
EHV. 
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8.2 Pony level analyses 
8.2.1 Relationship between clinical disease scores and pony level explanatory 
variables 
Table A2.3 summarises the results of non-parametric tests to examine whether there 
were significant differences in clinical disease scores between the pony level variables of 
sex, vaccine group and each of the transferrin and protease inhibitor haplotypes. 
It can be seen that overall there were no statistically significant differences between 
any of the individual or aggregated clinical parameters and the sexes, vaccine groups or 
those ponies with and without any of the protease inhibitor haplotypes. However, between 
the sexes there were differences in scores for CDNS, nasal discharge and abnormal 
breathing/dyspnoea that approached statistical significance (0.05<P<0.1). For all 3 of these 
parameters female ponies had higher scores than expected and males had lower scores, i. e. 
there was consistency in the direction of this effect. 
.1 
Among 2 of the transferrin haplotypes (D and F2) there were consistently 
statistically significant differences in clinical scores between ponies that possessed particular 
haplotypes and those that did not. The 18 ponies that had transferrin haplotype D ranked 
I- 
significantly lower scores for both aggregated clinical parameters and for the abnormal 
breathing/dyspnoea score, compared to the II ponies that did not possess this haplotype. 
The 14 ponies that had transferrin haplotype F2 ranked significantly higher scores for both 
aggregated clinical parameter scores as well as for the scores for nasal discharge, cough and 
abnormal breathing/dyspnoea, compared with 15 ponies not possessing this haplotype. 
Table A2.4 gives specific details of data ordered by increasing measures of each 
cumulative aggregated and individual clinical sign score for individual horses. Statistically 
significant differences using the non-parametric Wilcoxon ranked sum test were found 
between rankings of clinical, CDNS, nasal discharge, cough and abnormal 
breathing/dyspnoea scores between ponies that did and did not possess transferrin D 
(without F2 as a DF2 phenotype) or transferrin F2 haplotypes. Ponies with the transferrin 
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F2 haplotype (including DF2 phenotypes) have been highlighted. It can be seen that for 
clinical, CDNS, nasal discharge, cough and abnormal breathing/dyspnoea scores where 
there was a statistically significant difference between transferrin haplotypes, the majority of 
F2 ponies appear in the lower halves of the tables. This indicated that ponies possessing the 
F2 haplotype suffered cumulatively more signs over the study period than those that did not. 
All the other ponies except pony 23 possessed the transferrin D haplotype as either a 
homozygote or as a heterozygote and this accounted for significant differences between 
ponies with and without the D haplotype. 
Four ponies possessed both the D and F2 haplotypes (i. e. DF2 phenotypes) and 
examination of raw clinical score data (Tables A2.4) suggested that these individuals were 
more like most F2 haplotypes than D haplotypes, i. e. they tended to have higher clinical 
parameter scores. Therefore, further analyses were conducted to examine the effect of the 
transferrin D haplotype on clinical parameters in the absence of possible dominance from the 
F2 haplotype. Analyses were repeated with exclusion of the 4 DF2 phenotype ponies. When 
these ponies were excluded from the analyses there was now a statistically significant 
difference in scores for nasal discharge (P=0.04) and cough (P=0.02) where previously 
these were not significant, with horses possessing the D haplotype having lower scores. In 
addition, exclusion of the 4 DF2 phenotype ponies from the earlier analyses that had yielded 
statistically significant results, all resulted in lower P-values. The changes in P-values were 
for clinical score, P=0.002 from P=0.01; CDNS score, P=0.003 from P=0.02 and abnormal 
breathing/dyspnoea score, P=0.0003 from 0.008. 
Additional analyses were also conducted to examine whether inclusion in the 
analyses of the 5 non-vaccinated ponies from other parts of Wales (Late intro group) had an 
effect on the strong association between clinical disease and D and F2 transferrin 
haplotypes. Analyses were repeated excluding these 5 ponies. Results showed that the 
relationship between transferrin groups D and F2 and clinical outcomes remained 
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statistically significant and in the same'direction when only the vaccinated and placebo 
adrninistered control ponies (n--24) were included in the analyses. The lack of apparent 
effect of vaccine group in this and earlier analyses, was taken to justify that data from all 29 
ponies be included in all analyses. 
These results indicated that clinical scores varied most significantly with the 
transferrin haplotypes of D and F2 but there was also some evidence of variation according 
to sex. In order to investigate whether the variation in scores between sexes was explained 
by the effect of transferrin group or vice versa, a stratified analysis was conducted. In this 
stratified approach, the effect of sex for each category of transferrin F2 haplotype (present 
and absent) and the effect of F2 for each sex category (male and female) were examined. 
Data for the 3 outcome variables of CDNS score, nasal discharge score and abnormal 
breathing/dyspnoea score, which were all approaching statistical significance for the effect 
of sex were used in the stratified analysis. Results for the stratified analyses are summarised 
in Table 8.1. 
Table 8.1: Summary of non-parametric analyses examining differences in clinical 
scores according to sex and transferrin F2 haplotype stratified by levels of 
the other category 
Outcome variable Explanatory variable by Stratum Total n P-value 
stratification variable 
CDNS score Sex by transferrin F2 
Transferrin F2 by sex 
Nasal discharge score Sex by transferrin F2 
Transferrin F2 by sex 
F2 negative 15 0.175 
F2 positive 14 0.386 
male 14 0.072 
female 15 0.013 
F2 negative 15 0.156 
F2 positive 14 0.257 
male 14 0.095 
female 15 0.025 
Abnormal breathing Sex by transferrin F2 F2 negative 15 0.622 
F2 positive 14 0.201 
Transferrin F2 by sex male 14 0.056 
female 15 0.002 
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Results indicated that overall there was still an approaching significant difference 
(P<O. I with sample size reduced by -501/a in each stratum) in clinical outcome scores for all 
3 tested variables between those ponies with and without transferrin F2 haplotype even 
when tested for (i. e. stratified by) each sex separately. In contrast, %Vhcn stratificd by 
transferrin F2 haplotype, there was no longer any evidence for a significant difference in 
clinical score ranking between the 2 sexes. Examination of the distribution of transfcrrin 
haplotypes between the sexes explained this result if the true explanation %%2s transferrin 
haplotype. 9 females possessed haplotype F2 compared with only 5 maim and 6 females 
possessed haplotype D in the absence of F2 compared with 8 males. 
8.2.1.1 Summary 
in conclusion, the results of these analyses using various different individual and 
aggregated clinical outcome measures suggested that there was a difference in the outward 
demonstration of clinical respiratory disease between horses possessing particular transferrin 
haplotypes. This was consistent with a genetically based variation in susceptibility to clinical 
respiratory disease in equids. 
In these 29 ponies monitored intensively and rcpcatedly over a 10 wcck period, the 
14 ponies that possessed homozygote or non-F2 hcterozygote transferrin D haplotype 
demonstrated statistically significantly less cumulative clinical disease as measured by a sum 
of clinical scores and analysed using non-parametric ranking techniques. Using the same 
techniques, 14 ponies possessing the F2 transfcrrin haplotype and including 4 DF2 
phenotype ponies, demonstrated statistically significantly more cumulative clinical disease. 
8.2.2 Relationship between clinical disease scores and inrectious summary variables 
Tables A2.5 - A2.9 summarise the results of linear regression analyses conducted to 
assess any linear relationship between different cumulative clinical paramctcr scares and 
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different pony level infectious summary variables for tracheal isolations. The tables (A2.5 - 
A2.9) are for S. -(xvj)idemicus, A. equitli, Pasteurella spp., R brmichiseplica and non- 
hacmolytic Strepococcus spp., respectively. For each analysis there were a total of 29 
observations corresponding to cumulative summary measures for each individual pony for 
the period of the study. In each regression, the relevant clinical score was regressed on a 
single infection variable. 
8.2. ZIS. : mwpidemicus 
The results of the regression analyses show that for most of the summary measures 
for S. -mwiWenficus in tracheal washes (except loglo cfu/mI count at week 26), there was a 
statistically significant positive linear relationship between increasing infectious burden and 
increasing clinical parameter scores (except ocular discharge). In general this indicated that 
the higher the overall clinical score that ponies exhibited the more likely they were to have 
higher burdens of S. : (x)ej)idemicus infection, which was measured in a variety of ways (e. g. 
logio total cfia/ml, maximum or mean loglo cfu/ml or number of weeks with Aogio cfiL/ml). 
This rather crude analysis simply tells us that the more severely affected horses tended to 
have greater overall burdens of S. : mwpidemicus in their tracheas and for longer periods but 
does not reveal very much about the dynamics or distribution of infection over the course of 
the study period. 
For illustration, Figures A2.1 - A2.5 show the distribution of cumulative CDNS 
scores and various corresponding S. -mwlvdemicus parameter measures, with points 
identified as to the ponies' transferrin D and F2 haplotype status. Graphs for the total week 
count parameters were plotted incorporating 5% spherical random noise around plotted 
points to avoid loss of information with overlaying of points. This was particularly 
important for graphs plotting CDNS score with autoregressive scores. It can be clearly seen 
that the majority of ponies with transferrin D haplotype (but without F2 haplotype) occupy 
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the lower points to the left and those with F2 haplot)-pc (including DP. phcnotypes) occupy 
the higher points to the right. 
8.2.2.2 A. equidi 
There was evidence for a positive linear relationship between several summary 
measures of tracheal A. equu1i infection and clinical parameter scores, although involving 
fewer parameters than had been the case for S. -owpidemicus. The aggregated parameters 
of clinical score and CDNS score as well as cough and abnormal breathing scores 
demonstrated a statistically significant association with logio total cfu/n-d and maximum 
logio cfu/ml and total weeks with Z--105 cfu/n-J. 
8.2.2.3 Pasleurella spp. 
There was evidence for a positive linear relationship bctwcen several summary 
measures of tracheal Pasteurella spp. infection and clinical parameter scores, although again 
involving fewer parameters than had been the case for S. zooepidenticus. The aggregated 
parameters of clinical score and CDNS score as well as nasal discharge and abnormal 
breathing scores demonstrated a statistically significant association %%ith logto total cfu/mi 
and maximum logio cfu/ml and total weeks with 2t 10" and ?. 105 cfu/ml. 
8.2.2.4B. bronchiseplica 
In the summary data examined here there were no obviously dcmonstrable overall 
linear relationships between summary measures of tracheal B. branchiseptica infection and 
any biologically meaningful cumulative clinical parameter scorcs. Analyses for the 
relationship between the loglo cfu/n-d tracheal wash count of B. bronchiseptica at week 26 
and each outcome measure were not possible as B. bronchiseptica was not isolated from 
any tracheal washes at this point in the study. 
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8. ZZJ Non-liaeinolyic StrelVococcus sly). 
There was evidence for a negative linear relationship between several surnmary 
measures of tracheal non-haemolytic Streplococcus spp. infection and clinical parameter 
scores, although this involved fewer parameters than had been the case for S. 
'00epidenficus. The aggregated parameters of clinical score and CDNS score and nasal 
discharge and abnormal breathing scores demonstrated a statistically significant inverse 
association %krith both geometric mean logio cfu/n-d and total weeks with 2: 10' cfu/n-A and 
SMLN score was inversely associated with the latter. In addition, nasal discharge and 
SNILN scores were also significantly negatively associated with the count of non-haernolytic 
Strel)f0coccus spp. in tracheal washes sampled at week 26. 
8. ZZ6 Ammar), 
In conclusion, results indicated that at the pony level there were statistically 
significant positive linear relationships between various cumulative clinical parameter scores 
and summary measures of infectious burden in the trachea for S. zooepidemicus, A. equu1i 
and Pasteurella spp. and negative ones for non-haemolytic Strepwoccus spp.. 
8.2.3 Relationship between infectious summary variables and sex, vaccine group, 
transferrin anti protease inhibitor haplotypes 
Tables A2. I Oa/b - A. 2.14 (Appendix 2) summarise the results of non-parametric tests 
to examine whether there were significant differences in infectious summary measures 
between the pony level variables of sex, vaccine group and transferrin and protease inhibitor 
haplotypes for S. : ocw1fidenticus. A. eqnuli, Pasteurella spp., B. bronchiseptica and non- 
haemolytic Sjrej)j()cOCcjj. T spp. respectively. 
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8.2.3.1 S. zooepidemicits 
It can be seen that overall there was no statistically significant differences in any of 
the summary parameters for tracheal & zooepidemicus between the vaccine groups or those 
ponies with and without any of the protease inhibitor haplotypes. However. between the 
sexes there were differences in total, maximum, mean logja cfu/ml and total weeks with 
2ý 104 CfU/Ml scores that approached statistical significance (0.05<P<0.1). For all these 
parameters female ponies had higher rank sum scores than expected and maks had lower 
rank sum scores, i. e. there was consistency in the direction of this cffcct. However, as 
previously explained the distribution of D and F2 haploqýpes between the sexes was 
sufficient to provide an alternative explanation for the strength of association with sex. 
Among 2 of the transferrin haplotypes (D and F2) there was consistency in 
statistically significant differences in tracheal S. : owpidemicus summary measures between 
ponies that possessed particular haplotypes and those that did not (Tables A2. I Oa/b). In the 
analyses for transferrin D haplotype, results are presented with the 4 ponies that possessed 
DF2 phenotype excluded from the analyses. The 14 ponies that had transferrin haplotype D 
in the absence of F2 ranked significantly lower scores for total, maximum, mean loglo cfUlml 
ý: 104 and total weeks with - and ý: 105 cfu/ml, compared to the II ponies that did not possess 
this haplotype. The 14 ponies that had transfcrrin haplotype F2 ranked significantly higher 
scores for these measures, compared with 15 ponies not possessing this haplotype. Table 
A2. I Ob summarises the relative distribution of transfcrrin D and F2 haplotypes, in ascending 
order of magnitude of various cumulative measures of tracheal & -mwpkkmiC11S infection. 
Given the relationship between bacteria and clinical scores, these results were 
consistent with the earlier findings that transferrin haplotypes D and F2 were associated 
with significant differences in cumulative clinical parameter scores. In addition, the direction 
of the ranking scores were also consistent and biologically meaningful i. e. that transferrin D 
haplotypes not heterozygous with F2 resulted in both lower clinical scores and infectious 
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parameter measures and possession of F2 haplotype, even if heterozygous vAth D, gave 
higher scores. 
8.2.3.2 A. equidi 
There was no evidence from these data for any significant association between the 
different tracheal A. equitli summary outcome measures and any of the pony level variables 
examined. 
8. Z 3.3 Pasteurellaspl). 
There was some consistency in statistically significant differences in tracheal 
Pasteurella spp. summary measures between ponies that possessed transferrin haplotype 0 
and those that did not. The 9 ponies that possessed transferrin haplotype 0 ranked 
statistically significantly lower scores for logio total cfu/ml, maximum logio cfu/ml, mean 
, ý104 logio cfu/mI and total weeks with 2: 10' and, cfu/ml, compared to the 20 ponies that did 
not possess this haplotype. 
8. Z3.4B. bronchiseplica 
There was no evidence from these data for any significant association between 
different tracheal B. hroncidsepica summary outcome measures and any of the pony level 
variabics cxamincd, 
8.2.3.5 Non-haentolpic Streplococcus spi). 
There was some consistency in statistically significant differences in tracheal non- 
haemolytic Strepococcus spp. summary measures between ponies that possessed either 
transferrin F2 or 0 haplotypes and those that did not and between different vaccine groups. 
The 14 ponies that possessed transferrin haplotype F2 ranked statistically significantly lower 
scores for mean logio cfu/ml and total weeks with 2: 10' and Z: 104 CfU/ml, compared to the 15 
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ponies that did not possess this haplotype. Similarly the 9 ponies that possessed transferrin 
haplotype 0 ranked statistically significantly higher scores for the same 3 parameters 
compared to the 20 ponies that did not possess this haplotype. There was C%idence that the 
5 non-vaccinated ponies that were introduced later had statistically significantly lower 
scores for mean logio cfu/n-3 and total weeks with 2: W cfu/ml. These results, when taken 
together with the results for S. : ooepidemicus, arc consistent with an inverse reciprocal 
relationship between non-haemolytic Streplococcus spp. and & : (x)epidemicus in tracheal 
washes. That is factors such as transferin F2 haplotypc or increased clinical scores that were 
positively associated with different measures of & : mwpid-emicus infection in tracheal 
washes, were inversely associated with some measures of non-haemol)-tic StrelVococcits 
spp. in the same washes. This is consistent with the findings of the case control study of 
clinically apparent respiratory disease in Thoroughbred racehorses (Section 2), and as with 
that study, it is not clear whether this is biologically meaningful or %hether it is due to some 
artificial sampling error that results in reduced detection of bacteria such as non-haemolytic 
Streptococci in the presence of larger numbers of presumptively pathogenic bacteria. 
8.2.3.6 Summary 
The results of these analyses using various diffcrent trachcal & ztwpidenticus. 
Pasleurella spp. and non-haemolytic Streptococcus spp. summary outcome measures 
suggest that there was a difference in the overall infectious burden sufficred by horses 
possessing particular transferrin haplotypes. This may be consistent with a genetically based 
variation in susceptibility to bacterial respiratory infection in horses. It may be no surprise 
that different organisms demonstrate significant differences according to %vhcthcr ponies 
possess different transferrin haplotypcs as this may reflect differences in the mechanisms of 
acquisition of iron by the different bacterial species. For species of bacteria possessin' 
transferrin binding proteins (TBPs) such as 11demolAilus, Actinobticiffiss and PiLsleurelit, 
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spp., transferrin is a recognised source of iron with mechanisms well described for its 
acquisition. To date, no mechanism for iron acquisition from transferrin has been recognised 
for Strcptococci. Therefore, the findings for Streptococci in this study may be consistent 
with either linkage to some other disease susceptibility factor, acquisition of iron from 
particular transferrin haplotypes or use of transferrin for some other purpose. 
8.2.4 Preliminary discussion of findings and conclusions from pony level analyses 
Data in this study of naturally occurring respiratory disease in recently weaned 
Welsh Mountain ponies were relatively complete and consistent compared to many field 
studies. Detailed clinical and infectious data were collected at regular intervals during the 
study from all 29 study subjects (ponies). Certain variables including sex, vaccine group and 
transferrin and protease inhibitor haplotypes were available for each pony and these were 
set at the pony level. Twice weekly clinical observations were averaged so as to correspond 
to weekly infectious sampling data. These were observation level data and were clustered 
within individual ponies. 
To examine preliminary univariable associations between parameters at the pony 
level, summary measures were generated for clinical outcome and infectious parameters. 
There was no evidence for a statistically significant effect on any aggregated or individual 
clinical summary parameters according to vaccine group. There was some limited evidence 
for a statistically significant effect on some aggregated or individual clinical summary 
parameters according to sex. There was evidence for statistically significant differences in 
various aggregated and individual clinical summary parameters between ponies possessing 
, 
either the D or F2 transferrin haplotypes. Ponies with the D haplotype in the absence of F2 
suffered significantly less severe disease whereas ponies with F2 suffered more severe 
disease. Stratification of this small dataset to examine whether sex or transferrin group were 
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associated with differences in clinical parameters, suggested that this was due to transferrin 
haplotype. 
At the pony level there was evidence that indi%iduals that had higher overall clittical 
disease scores tended to have higher overall infectious burdens. This was most marked for 
S. zooepidemicus and less marked for A. e(puli and Pasteurelliz spp. and was not evident 
for B. bronchiseptica. There was some evidence for a negative relationship between non- 
haernolytic Sireplococcus spp. in tracheal washes and overall clinical disease scores. 
There was evidence for statistically significant diffcrences in various summary 
measures for tracheal S. : ooepidemicus infection between ponies possessing either the D -or 
F2 transferrin haplotypes. Ponies with the D haplotype in the absence of F2 had significantly 
less infectious burden whereas ponies with F2 had greater burdens. There was also c%idcnce 
for significant differences in burden of tracheal I'asteurella spp. infection between ponies 
with and without transferrin 0 haplotype. Ponies with the 0 h3plotype had significantly less 
infectious burden than those without it and this may be consistent Mth iron from transferrin 
0 being less usable by Pasteurella spp.. 
Caution is required in interpretating the multiple statistical comparisons performed in 
these pony-level analyses (e. g. Table A2.3) because as the number of comparisons increaseS 
the possibility of a chance occurrence of a 'statistically significant' result similarly goes up. 
There is currently much debate as to whether such results should be automatically 
accompanied by some form of coff cction, such as using Donferroni's method, to help in 
identifying true rather than chance occurrences (Perneger, 1998). Such corrections have not 
been applied here, although I am aware of the issues suff ounding such multiple 
comparisons. I would argue that in considering consistency of results for difficrent outcomes 
and an unwillingness to over interpret occasionally significant results I have imposed 
gcorrection', whilst at the same time have not stuck to a strict corrected Nvalue paradigm. 
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In conclusion, these data preliminarily suggest that there might be a genetic basis for 
variation in susceptibility to clinical respiratory disease. This may be manifested by a 
variability in susceptibility to infection with bacteria such as S. zooepidemicus and 
Pasteurella spp., which have been shown to be significantly associated writh both clinical 
and subclinical (IAD) respiratory disease. 
The lack of association between cumulative ocular discharge score and any of the 
explanatory variables that were examined suggested that this was not a useful sign with 
which to evaluate clinical severity of respiratory disease. This was confirmed by the 
increased statistical significance of associations between cumulative CDNS score (which did 
not include ocular discharge) and the vast majority of explanatory variables compared with 
their associations with cumulative clinical score (which did include ocular discharge). 
8.3 Description of observation level data 
Figure A2.6 summaries the average weekly scores for individual clinical signs 
(different shading/colour for each sign) for each individual pony in a graphical format as 
stacked bars, with the peak of the stacked bar corresponding to the overall average clinical 
score for that week. Each graph also represents the loglo colony forming units per n-A of 
tracheal wash of different bacterial species, with A. equitli and Pasteurella spp. being 
combined and referred to as Pasteurella-like spp.. 
8.4 Observation level analyses 
8.4.1 Aggregated clinical and airway inflammation scores 
8.4. LI Univariable analyses 
Table A2.15 summariscs the results and comparisons of linear and best fitting 
polynomial regression analyses of clinical, CDNS and airway inflammation scores with logio 
cfu/ml for total bacterial and species specific tracheal wash counts and autoregressive, 
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variable scores. The results of polynomial regression analyses represented the best fitting 
regression models containing 2 power terms tested from combinations of xý. x7l, 
es, xý-3, 
x', xý, xý and log. x and including products of log. x with all other powers including itself. 
Higher order models containing 3 or more power terms were investigated but found not to 
significantly improve the fit of the data. 
Comparison of the respective linear and polynomial model W values showed that in 
all cases the fitting of a 2-powcr polynomial regression model increased the amount of 
variability in the data explained by the models. The last 2 columns of Table A2.15 
represented the decrease in deviance by the polynomial model compared to the linear 
regression and the corresponding P-value based on 3 degrees of freedom in a chi-squared 
distribution. This indicated whether the polynomial model pro%ided a significantly improved 
fit of the data compared to the linear model. 
Results indicated that there was no evidence of a significant linear relationship 
between increasing scores of each of the 3 outcome measures and logja cfU/mI counts of A. 
equu1i and B. bronchiseptica and use of a best fitting. 2-power term polynomial regression 
model did not provide significant improvement. 
Results indicated that there was a significant linear relationship between increasing 
score for all 3 outcome measures and logio cfu/n-J S. : Mwpidemicus and use of a best fitting, 
2-power term polynomial regression model only provided significant improvement over a 
linear model for CDNS score. Figure 8.2 illustrates the distribution of CDNS scores versus 
corresponding logio cUn-d. S. : ooepidemicus counts with linear and best fitting polynomial 
regression lines plotted. Graphs were plotted incorporating 3% spherical random noise 
around plotted points in order to avoid loss of information caused by overlaýing of points. 
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Figure 8.2: CDNS score vs. logle cfu/nil S zooepi(lemicus in tracheal wash with data 
fitted front significant a) linear and b) best fitting polynomial regression 
models and including 3% spherical random noise. The deviance benefit 
between regression models was statistically significant (P<0.001) 
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Results indicated that for logio cfu/ml Pasteurella spp. in tracheal washes there was 
no significant linear relationship with increasing clinical and CDNS scores but there was 
with airway inflammation score. The use of a best fitting, 2-power term polynomial 
regression model provided significant improvement over linear models for each of the 3 
outcome measures. Figure 8.3 illustrates the distribution of CDNS scores versus, 
corresponding logio cfu/ml. PiLvIeurelliz spp. counts with linear and best fitting polynomial 
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regression lines plotted. Graphs again incorporated 30,0 splicrical random noisc around 
plotted points. 
Figure 8.3: CDNS score vs. logie cfu/ml Pasteu"Ila spp. in tracheal wash with data 
fitted from non-significant a) linear and signiricant b) best rating 
polynomial regression models and including 3% spherical random noise. 
The deviance benefit between regression models Was Statistically 
significant (P<0.001) 
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Results indicated that for logio cfu/ml non-haernolytic Streplococcus spp. in tracheal 
washes there was a significant inverse linear relationship with increasing clinical and CDNS 
scores and a marginally significant inverse relationship with airway inflammation score. The 
use of a best fitting, 2-power term polynomial regression model provided significant 
improvement over linear models for each of the 3 outcome measures. Figure 8.4, 
incorporating 3% spherical random noise around plotted points, illustrates the distribution 
of CDNS scores versus corresponding logio cfu/ml. non-haemolytic Streplococcus spp 
counts with linear and best fitting polynomial regression lines plotted. 
221 
Eqtnm hdImundmy Armw Damm EpWwm*W 
Figure 8.4: CDNS score vs. logie cfulml non-haemolyticSfrept""cus spp. in tracheal 
wash with data fitted from significant a) linear and b) best fitting 
polynomial regression models and including 3% spherical random noise. 
The deviance benerit between regression models was statistically 
significant (P<0.001) 
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There was a significant linear relationship between increasing score for all 3 
outcome measures and all levels of autoregressive variables. This confirmed, not 
surprisingly, that higher outcome scores were predicted for ponies that had higher outcome 
scores in the previous weeks of sampling. Use of a best fitting, 2-power term polynomial 
regression model only provided significant improvement over a linear model for the 
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autorcgrcssive variables for CDNS score 3 weeks previously and airway inflammation score 
the previous week. Figures 8.5 and 8.6 illustrate the distribution of CDNS scores versus 
corresponding one week and 3 week previously autoregrcssive CDNS scores with linear 
and best fitting polynomial regression lines plotted. 
Figure 8.5: CDNS score vs. CDNS score the previous week with data fitted from 
significant a) linear and b) best fitting polynomial regression models and 
including 3% spherical random noise. The deviance benefit between 
regression models was not statistically significant (P--0.936) 
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Figure 8.6: CDNS score vs. CDNS score 3 weeks previously with data fitted from 
significant a) linear and b) best fitting polynomial regression models and 
including 3% spherical random noise. The deviance benefit between 
regression models was statistically significant (P=0.034) 
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CONS score 3 meeks previousty 
Examination of W values demonstrated that the amount of variability in the 
outcomes that were explained by successive previous weeks' scores decreased over time. 
That is that the outcome score 3 weeks previously explained less variation in the current 
outcome score than the score 2 weeks previously, which in turn explained less than the 
score from the week immediately preceeding it. 
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Table A2.16 summarises the results of non-parametric tests to examine whether 
there were any significant differences in clinical and airway inflammation scores between the 
pony level variables of sex, vaccine group and each of the transferrin and protease inhibitor 
haplotypes. The observation level binary variables of isolation of different bacterial species 
from nasopharyngeal swabs were also examined. 
I Results indicated that'for the aggregated clinical outcome measures there were 
statistically significant differences between the sexes, vaccine groups, transferrin D and F2 
haplotypes, protease inhibitor L and L2 haplotypes and S. zooepidemicus isolates from 
nasopharyngeal swabs. Observations from female ponies and from those that did not receive 
vaccine or placebo but were introduced later, had significantly higher clinical score ranks. 
There was no significant difference between observations from vaccinates and controls 
when these observations were analysed alone (Wilcoxon rank sum test P>0.28). 
Observations from ponies either not possessing D or F2 transferrin haplotypes had 
significantly higher score ranks. Those without L or with L2 protease inhibitor haplotypes 
also had significantly higher clinical outcome ranks, although there were only observations 
from one and 3 ponies in these respective categories. Observations from ponies with 
protease inhibitor haplotype S had higher scores than those without. Those observations 
when S. zooepidemicus was isolated from the nasopharyngeal. swab sample also had 
significantly higher clinical scores. 
For airway inflammation score there were statistically significant differences 
between the sexes, transferrin F and HI haplotypes, protease inhibitor L and L2 haplotypes 
and isolates of both S. zooepidemicus and Pasteurella spp. on nasopharyngeal swabs. For 
the appropriate variables the direction of the ranking was the same for airway inflammation 
score as it had been for the clinical outcomes. Observations when Pasteurella spp. was 
isolated from the nasopharyngeal swab sample and those from ponies without transferrin 
haplotype HI both ranked significantly higher inflammation scores. 
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8.4.1.2 Ordinary multiple linear regression modelling 
Table 8.2 summarises the results from the final ordinary multiple linear regression 
models for the outcome variables of clinical score, CDNS score and airway inflammation 
score. Whilst all models included significant autoregressive variables there was no explicit 
controlling of within-pony relationships in these models. Two final models (Models I and 2) 
for both clinical and CDNS scores are presented. These represent respective models with 
transferrin D (Models 1) and transferrin F2 (Models 2) haplotypes retained as explanatory 
variables. Transferrin HI was retained as a marginally significant in the final airway 
inflammation score model. 
All final models were very similar with respect to the explanatory variables included 
in them. They all retained one or 2 autoregressive variables corresponding to the outcome 
parameter scores from the week and/or 2 weeks previously. This confirmed the importance 
of temporally related, repeated measure observations in these data. However, with inclusion 
of one or 2 autoregressive variables it was found that the variable corresponding to the 
outcome score from 3 weeks previously was not statistically significant in any model. 
Inclusion of autoregressive variables reduced the sample size from the original n--3 19. to 
n--229 for clinical score, to n=257 for CDNS score and to n--225 for airway inflammation 
score. All models also contained various terms for loglo cfu/n-d counts of tracheal wash 
bacteria as significant explanatory factors and pony level factors relating to transferrin 
haplotypes were also retained. In the clinical score and CDNS score models, non- 
haemolytic Streplococcus spp. and Pasteurella spp. were both significant when expressed as 
quadratic terms and logio cfuln-A S. zooepidemicus was retained as a significant linear term. 
Results for clinical and CDNS scores were consistent with those seen for the pony level 
analyses in that both transferrin D and F2 haplotypes were retained as potentially important 
predictive factors, particularly in the CDNS score model. In the airway inflammation score 
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model, non-haernolytic Streptococcus spp. as a quadratic term and S. zooepidemicus 
expressed as a linear term, were both significant and were retained. 
Table 8.2: Results of multivariable linear and polynomial regression of clinical, CDNS 
and airway inflammation parameter scores 
Outcome Explanatory variables Regression 95% CI of R2 value P-value 
variable / Model in the models (n) coefficient coefficient (%) 
Clinical score (n--229) 
Model I Intercept 1.66 0.78-2.55 50.3 <0.001 
Clinical score I week previously 0.41 0.28-0.54 <0.001 
Clinical score 2 weeks previously 0.14 0.02-0.27 0.023 
Logio cfuhnI non-haem. Strep. -0.43 -0.78 - -0.08 0.016 
[Logio cfu/ml non-haem. Strep. ]2 0.07 0.01-0.12 0.025 
Logio cfu/ml Pasteurella spp. -0.47 -0.76 - -0.18 0.002 
[Logio cfu/mI Pasteurella Spp. ]2 0.08 0.03-0.13 0.002 
Loglo cfu/n-d S. zooepidemicus 0.15 0.02-0.27 0.019 
Transferrin D haplotype -0.40 -0.79 - -0.002 0.051 
Model 2 Intercept 1.20 0.39-2.02 50.1 0.004 
Clinical score I week previously 0.42 0.29-0.55 <0.001 
Clinical score 2 weeks previously 0.14 0.01-0.26 0.028 
Logio cfu/ml non-haem. Strep. -0.42 -0.77 - -0.07 0.019 
[Logio cfu/nil non-haem. Strep. ]2 0.07 0.01-0.13 0.018 
Loglo cfu/ml Pasteurella spp. -0.49 -0.78 --0.20 0.001 
[Logio cfu/ml Pasteurella Spp. ]2 0.08 0.03-0.13 0.002 
Loglo cfu/ml S. zooepidemicus 0.13 0.01-0.26 0.037 
Transferrin F2 haplotype 0.40 -0.04-0.83 0.075 
CDNS score (n--257) 
Model I Intercept 1.51 0.89-2.14 53.3 <0.001 
CDNS score I week previously 0.49 0.38-0.59 <0.001 
Logio cfu/mI non-haern. Strep. -0.42 -0.68 --0.15 0.002 
[Loglo cfu/mI non-haern. Strep. ]2 0.05 0.01-0.10 0.017 
Loglo cfb/mI Pasteurella spp. -0.38 -0.60 - -0.16 0.001 
[Logio cfb/ml Pasteurella Spp. ]2 0.07 0.03-0.10 0.001 
Logio cfuhnl S. zooepidemicus 0.11 0.01-0.20 0.028 
Transferrin D haplotype -0.39 -0.69 - -0.09 0.010 
Model 2 Intercept 1.05 0.44-1.65 53.3 0.001 
CDNS score I week previously 0.49 0.38-0.59 <0.001 
Logio cfu/ml non-haem. Strep. -0.40 -0.67 - -0.13 0.004 
[Logjo cfu/ml non-haern. Strep. ]2 0.06 0.01-0.10 0.012 
Log Io cfu/nd Pasteurella spp. -0.40 -0.61 - -0.18 <0.001 
[Logio cfb/ml Pasteurella Spp. ]2 0.07 0.03-0.10 0.001 
Logio cfu/ml S. zooepidemicus 0.10 0.0003 - 0.19 0.049 
Transferrin F2 haplotype 0.41 0.10-0.73 0.011 
Airwa 
inflammation (n--225) 
(AD score Intercept 3.06 2.03-4.09 41.9 <0.001 
Al score I week previously 0.23 0.11-0.35 <0.001 
AI score 2 weeks previously 0.17 0.07-0.27 0.001 
Logio cfu/ml non-haern. Strep. -0.37 -0.71 --0.03 0.034 
[Logio cfu/ml non-haern. Strep. ]2 0.06 0.006-0.12 0.030 
Logio cfuhnl S. zooepidemicus 0.33 0.20-0.46 <0.001 
Transferrin HI haplotype -0.63 -1.24 - -0.02 0.044 
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Examination of W values for these models demonstrated that >50% of the 
variability in clinical and CDNS scores appeared to be explained by the factors retained in 
the final models. The corresponding figure for the airway inflammation score was around 
42%. 
8.4.1.3 Multilevel linear regression modelling 
Table 8.3 summarises the results from the multilevel linear and polynomial 
regression modelling process for the outcome variables of clinical score, CDNS score and 
airway inflammation score. Results represent the important stages of the model building 
process with the first models (Model 1) being those with significant autoregressive, 
variables and a linear term for S. zooepidemicus included. There was no significant 
improvement with the use of a quadratic or polynomial term for S. zooepidemicus over the 
linear term. The autoregressive variables corresponding to outcomes 2 weeks previously 
were not significant for clinical and CDNS scores when included with the previous week 
autoregressive variable and the linear S zooepidemicus term. Subsequent models illustrated 
results for the addition of other significant variables through to the final models (Models 4a. 
and 4b for clinical and CDNS score and Model 3 for airway inflammation score). 
Although it was possible that the random variability between ponies might have 
been due to differences in both their intercepts and their slopes (so called random interce -pIt 
and slope models), multivariable modelling of these limited data showed that a random 
intercept only model was appropriate as their was no significant improvement by inclusion 
of random slope parameters. Also represented in the tables were the deviances 
2*loglikelihood) for each model. Where appropriate (same n), assessment of statistically 
significant improvement in the fit of models was made by calculation of the difference 
(reduction) in their deviances (likelihood ratio statistic LRS). The LRS followed a chi- 
squared distribution, with degrees of freedom equal to the difference in numbers of 
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parameters in models being compared and P: ý0.05 was used as the criterion for significant 
improvement. Also represented for models were the intra-pony correlation, which was the 
proportion (%) of the total model variance attributable to variation between ponies. 
Therefore, the more similar ponies were to each other then the lower the intra-pony 
correlation. 
Table 8.3: Summary of multilevel linear and polynomial regression modelling of 
clinical, CDNS and airway inflammation scores 
Outcome variable / Effectiype Estimate Estimate Estimate Estimate Estimate 
Explanatory variable in model (S. E. ) (S. E. ) (S. E. ) (S. E. ) (S. E. ) 
Clinical score Model I Model 2 Model 3 Model 4a Model 4h 
n--257 n--257 n--257 n--257 n--257 
Fixed effect 
Intercept 0.79(0.25) 1.52(0.38) 1.76(0.38) 2.20(0.42) 1.46(0.39) 
Clinical score I week previously 0.35(0.05) 0.34(0.05) 0.36(0.05) 0.35(0.05) 0.35(0.05) 
Log10 cfu/ml S. zooepidemicus 0.27(0.05) 0.21(0.06) 0.17(0.06) 0.16(0.06) 0.15(0.06) 
Logio cfu/n-d non-haern. Strep. -0.43 (0.16) -0.40 (0.16) -0.40 (0.16) -0.38 (0.16) 
[Logio cfh/mI non-haem. Strep. ]2 0.06(0.03) 0.06(0.03) 0.06(0.03) 0.06(0.03) 
Loglo cfu/ml Pasteurella spp. -0.45 (0.13) -0.44 (0.13) -0.45 (0.13) 
[Logio cfu/H Pasteurella Spp. ]2 0.08(0.02) 0.08(0.02) 0.08(0.02) 
Transferrin D haplotype -0.63 (0.27) 
Tranfseffin F2 haplotype 0.68(0.27) 
Random effect 
Level 2 variance: Pony 0.48(0.18) 0.41(0.16) 0.36(0.14) 0.27(0.12) 0.27(0.12) 
Level I variance: Observation 1.71(0.16) 1.68(0.16) 1.61(0.15) 1.61(0.15) 1.61(0.15) 
-2*loglikelihood 903.20 896.09 883.88 878.49 877.80 
LRS -2 (d. f) 7.11(2) 12.2](2) 5.39(l) 6.08(l) 
P-value 0.029 0.002 0.020 0.014 
Intra-pony correlation (016) 21.9 19.6 18.3 14.4 14.4 
CDNS score Model I Model 2 Model 3 Model 4a Model 4b 
n--257 n--257 n--257 n=257 n--257 
Fixed effect 
Intercept 0.17(0.20) 1.02(0.30) 1.24(0.30) 1.56(0.33) 1.03(0.31) 
CDNS score I week previously 0.43(0.05) 0.37(0.05) 0.39(0.05) 0.39(0.05) 0.39(0.05) 
Logio cfiu/ml S. zooepidemicus 0.23(0.05) 0.18(0.05) 0.15(0.05) 0.14(0.05) 0.14(0.05) 
Logio cfu/mI non-haem. Strep. -0.38 (0.13) -0.34 (0.13) -0.35 (0.13) -0.33 (0.13) 
[Logio cfb/ml non-haem. Strep. ]2 0.04(0.02) 0.04(0.02) 0.04(0.02) 0.04(0.02) 
Logio cfuhnl Pasteurella spp. -0.37 (0.11) -0.36 (0.11) -0.37 (0.11) 
[Loglo cfu/ml Pasteurella Spp. ]2 0.06(0.02) 0.06(0.02) 0.06(0.02) 
Transferrin D haplotype -0.46 (0.21) 
Transferrin F2 haplotype 0.48(0.21) 
Random effect 
Level 2 variance: Pony 0.26(0.10) 0.23(0.10) 0.20(0.09) 0.16(0.07) 0.16(0.08) 
Level I variance: Observation 1.20(0.11) 1.14(0.11) 1.10(0.10) 1.10(0.10) 1.10(0.10) 
-2*loglikelihood 806.58 792.96 781.38 776.70 776.50 
LRS J (I d. f) 13.62(2) 11.58(2) 4.68(l) 4.88(l) 
P-value 0.001 0.003 0.031 0.027 
Intra-pony correlation r1q) 17.8 16.8 15.4 JZ7 12.7 
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Table 8.3 continued 
Outcome variable / Effect typ 
Explanatory variable in model 
Estimate 
(S. E. ) 
Estimate 
(S. E. ) 
Estimate Estimate Estimate 
(S. E. ) (S. E. ) (S. E. ) 
Airwav inflammation (Ab Model I Model 2 Model 3 
score 
n--225 n=225 n=225 
Fixed effec: 
Intercept 2.43(0.39) 2.88(0.51) 3.06(0.52) 
AI score I week previously 0.24(0.06) 0.25(0.06) 0.23(0.06) 
Al score 2 weeks previously 0.17(0.05) 0.17(0.05) 0.17(0.05) 
Loglo cfu/mI S. zooepidemicus 0.39(0.06) 0.33(0.06) 0.33(0.06) 
Logio cfu/ml non-haem. Strep. -0.36 (9.17) -0.37 (0.17) 
[Loglo cfu/nil non-haern. Strep. ]2 0.06(0.03) 0.06(0.03) 
Transferrin HI haplotype -0.63 (0.31) 
Random effec 
Level 2 variance: Pony 0.02(0.08) 0.02(0.08) 0.00(0.00) 
Level I variance: Observation 1.98(0.20) 1.94(0.20) 1.94(0.20) 
-2*loglikelihood 794.27 789.77 785.66 
LRS J (Idf. ) 4.50(2) 4.11(l) 
P-value 0.105 0.043 
Intra-pony correlation ('16) 1.0 1.2 0.0 
Sequential inclusion of quadratic terms for non-haemolytic StreptOCOCCIjs spp.. 
(Model 2) and Pasteurella spp. (Model 3) significantly improved the fit of models as 
measured by reduction of model deviance and likelihood ratio statistics. The values of the 
quadratic terms for these bacterial species demonstrated that there was a positive 
association only between outcome scores at the higher levels of bacterial counts (>106 loglo 
cfu/ml) in tracheal washes but there was a negative association with low to moderate counts 
(102_105 logio cfu/n-d). The final stage of model building for clinical and CDNS scores was 
the addition of variables for transferrin haplotypes. The separate inclusion of transferrin D 
(Models 4a) and F2 (Models 4b) haplotypes resulted in 2 largely equivalent final models for 
each of clinical and CDNS scores. Comparison of Models 4a and 4b with Model 3, which 
had the same sample size (n--257), showed that addition of the transferrin haplotypp 
I 
variables resulted in significant improvement in the fit of models as measured by reduction 
in deviance. This also resulted in a reduction in the pony level variance among the random 
effects and a consequent reduction in the intra-pony correlation. Therefore, inclusion of the 
pony-level variable for transferrin haplotype was explaining some of the difference betweeý 
individual ponies that was being modelled as random variation. Inclusion of transferrin F2 
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haplotype resulted in a positive association, indicating that ponies with this haplotype had 
increased clinical and CDNS scores compared with those without this haplotype. 
Conversely, those ponies with the D haplotype had a negative association indicating that 
these ponies had lower outcome scores. For both the clinical and CDNS score models 
inclusion of transferrin F2 haplotype resulted in a marginal and non-significant improvement 
in model fit and reduction in deviance and intra-pony correlation compared with the model 
with transferrin D haplotype included. 
In the multilevel linear regression modelling process for airway inflammation the 
autoregressive variable for outcome score 2 weeks previously remained statistically 
significantly associated with the outcome (Wald X 2, ld. f = 11.56; P<0.001) with inclusion 
of other significant variables. In addition, there was no evidence for a significant pony-level 
random effect in these models. This was such that in the final model in which transferrin HI 
'haplotype was included, the level 2 variance was zero and the model was exactly equivalent 
to the final model produced from ordinary multiple linear regression analysis (Table 8.2). 
Examination of poLiy level residuals 
Using M1LwiN software it was possible to examine the pony level residuals (n--29) 
'of final fitted models and these were ranked and plotted with their 95% confidence intervals 
in so-called 'caterpillar' plots. Figures A2.7 and A2.8 represented caterpillar plots of the 
pony level residuals for the final models for clinical score including transferrin D and 
transferrin F2 haplotypes, respectively. Ponies with the largest residuals and with 95% 
ý, confidence intervals that did not include or just included zero (hatched line representing 
, zero residual is equivalent to the mean prediction from the fixed effects model) appeared at 
the extremes of the plots. Ponies 21 and 29 have been identified on Figure A2.7 as having 
'the largest positive residuals, i. e. these ponies had higher clinical scores than was predicted 
'-by the final model including transferrin D haplotype. Also pony 28 was identified as the only 
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pony with a significantly negative residual value (95% confidence intervals for residual does 
not include zero), i. e. had lower clinical scores than was predicted by the final model. In the 
final model that included transferrin F2 haplotype, ponies 23 and 24 were identified, as 
having the largest positive pony level residual and pony 28 again had the largest negative 
residual. Figures A2.9 and A2.10 represented caterpillar plots of the pony level residuals for 
the final models for CDNS score including transferrin D and transferrin F2 haplotypes, 
respectively. In these plots, there were no ponies in the transferrin D haplotype model with 
significantly positive residuals although pony 28 had a significant negative value residual in 
this model. In the transferrin F2 haplotype model pony 23 was identified as having the 
largest significant positive residual and pony 28 again had the residual with largest negative 
value. 
Results of each stage in the further modelling of clinical score (Table A2.17) showed 
that as the ponies with largest value residuals were reassigned in the models there was a 
sequential decrease in deviance and the overall fit of models improved significantly at each 
stage. In all except one modelling stage (addition of pony 24 to Model 7b of clinical score 
with transferrin F2) there was an increase in the value (but in a negative direction for 
transferrin D) of the fixed effect slope estimates for the transferrin parameters. This was 
accompanied by a corresponding decrease in the standard errors for these estimates and 
hence the significance of their association with clinical score also increased. In addition, 
there was a notable decrease in both the estimates and significance of pony level variances 
across the sequential modelling, which also resulted in a sequential decrease in intra-pony 
correlation. The estimates and standard errors for the autoregressive and S. zooepidemicus 
fixed effect parameters and observation level variances remained largely unaltered during this 
modelling process. 
Examination of the transferrin haplotype status of the ponies that had the largest 
value residuals revealed why these were likely to have had the largest influence on the 
I 
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goodness of fit of the final clinical score models. In the model which included transferrin D 
haplotype, ponies 21 and 29 had the largest positive residuals, i. e. they had higher clinical 
scores than was predicted by the model. As these 2 ponies were each of the transferrin DF2 
haplotype, they were consequently predicted by the model to have lower scores as they were 
positive for transferrin D (due to the negative fixed effect slope estimate for this parameter). 
In the case of pony 28, atypically for a transferrin F2 haplotype, the model predicted higher 
clinical scores than were actually observed for this individual which had a low clinical score 
and low S. zooepidemicus counts (Figure A2.6). Examination of the additional modelling of 
data for the clinical score model with transferrin F2 haplotype showed that pony 23 had the 
largest positive value residual and the greatest influence on model fit when reassigned in the 
model. Examination of data (Figure A2.6) showed that this was likely to be due to relatively 
low loglo cfu/mI S. zooepidemicus counts in tracheal washes compared to other ponies with 
comparatively high clinical scores. In this model the influence of pony 23 was exacerbated as 
this individual was also negative for transferrin F2 haplotype and hence the clinical scores 
observed were much higher than predicted by the model. 
Table A2.18 summarises a similar further modelling of 2 final models for CDNS 
score, each including transferrin D (Model 4a) and transferrin F2 (Model 4b) haplotypes. 
For the transferrin D model, no ponies had significantly large positive value residuals and 
pony 28 had the only significant negative value residual, which was reassigned in re- 
modelling (Model 5a). In the transferrin F2 model, pony 23 had the largest positive and 
pony 28 the largest negative residual values. Results were very similar to those seen for the 
clinical score models with respect to decreasing pony level variances and intra-pony 
correlations, and, increasing estimate values and significances (due to decreasing standard 
error estimates) with exclusion of ponies with large value residuals from the random effect 
parts of models. 
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The final multilevel model (Model 3; Table 8.3) for airway inflammation had 
identical fixed effects (estimates and variables) to the multiple linear regression model 
(Table 8.2) and had zero pony-level variance. Consequently, this final model did not have 
pony-level residuals that varied from zero. The model that did not include the transferrin 
parameter (Model 2) did have a small amount of non-significant pony-level variance but all 
pony-level residuals for this model had 95% confidence intervals that did include zero 
(Figure A2.1 1). 
8.4.2 Individual clinical signs 
8.4.2.1 Univariable analyses 
Tables A2.19a -e summarise the results of each univariable logistic regression 
analysis of individual clinical signs with explanatory variables, including the linear and 
categorical terms for counts of individual bacterial species in tracheal washes, 
autoregressive outcomes from previous weeks, sex, vaccine group, transferrin and protease 
inhibitor haplotypes and nasopharyngeal swab bacterial isolates. 
Other than ocular discharge, which with the exceptions of Pasteurella spp. on swabs 
and 103 _ 105 cfu/ml B. bronchiseptica in tracheal washes, did not show significant 
association with explanatory variables, the other clinical parameters were largely consistent 
in the variables with which they were significantly associated. 
Nasal discharge, coughing, abnormal breathing/dyspnoea and SMLN enlargement 
were all significantly positively associated with increasing total tracheal wash bacterial 
counts and all measures (linear and categorical measures in tracheal washes and isolation 
from nasopharyngeal swab) of S. zooepidemicus infection. The same 4 signs were also 
significantly negatively associated with linear and categorical measures of non-haemolytic 
Streplococcus spp. in tracheal washes. Ponies with Pasteurella spp. >10 6 cfu/ml in tracheal 
washes had significantly increased risk of abnormal breathing/dyspnoea (OR 2.7, P=0.026), 
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and SMLN enlargement (OR 2.6, P=0.036), compared with ponies with <10 4 cfu/ml. 
There was no evidence of a significant association of Pasteurella spp. with these signs at 
counts in tracheal washes between 104 and 106 CfU/Ml. 
The majority of autoregressive outcome variables were highly statistically 
significantly associated (P<0.001) with the 4 clinical parameters of nasal discharge, 
coughing, abnormal breathing/dyspnoea and SN1LN enlargement. With the exceptions of 
nasal discharge 3 weeks previously and abnormal breathing/dyspnoea 2 weeks previously 
that had the highest risk associated with them, there was a general trend towards reducing 
risk of demonstrating a clinical sign with increasing time period between previous week and 
time of observation. This was illustrated by coughing. Ponies that had coughed the previous 
week were 6.2 times more likely to cough in the current week whereas ponies that had 
coughed 2 and 3 weeks previously were 4.3 times and 2.9 times respectively, more likely to 
cough. 
For nasal discharge, coughing and abnormal breathing/dyspnoea there was a 
significant negative association between clinical outcome and being male and possession of 
transferrin D haplotype. In contrast, there was a significant positive association between 
these 3 outcomes and possession of transferrin F2 haplotype. 
The categorical variable of vaccine group was significantly positively associated with 
coughing and SMLN enlargement in these univariable analyses. Ponies that received 
placebo were at approximately 3 times the risk of coughing than those ponies that were 
vaccinated and the late introduction animals were at almost 5 times the risk of SMLN 
enlargement compared to both vaccinates or controls. 
There were other occasionally significant associations, particularly involving 
transferrin HI haplotype, and protease inhibitor L and L2 haplotypes. Exan-ýination of the 
frequency of these haplotypes in the dataset (Table 7.2), showed that they occurred or were 
absent in relatively very few animals and their association with disease was consequently 
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strongly influenced by the frequent presence or absence of signs in certain of these 
individuals. 
An example of this is the significant association between possession of transferrin 
HI haplotype and coughing (OR 3.3, P=0.004). Examination of the frequency of 
transferrin haplotypes in Table 7.2 shows that there were only 3 ponies with transferrin HI 
haplotype. One of these, pony 24, had the highest cumulative cough score (Table A2.4) 
indicating that of all the ponies it suffered the most coughing over the study period. Results 
of a logistic regression analysis for coughing with all results from pony 24 excluded showed 
that there was no longer any association between coughing and transferrin HI haplotype 
(OR 1.0, P=0.963). This confirms that extreme caution is required in interpreting the 
findings of these analyses where small numbers of individuals comprise categories of 
explanatory variables. I 
Logistic regression analysis was unable to fit models (i. e. there was non- 
convergence) for the association of isolation of Pasteurelia-like spp. from nasopharyngeal 
swab extracts with ocular discharge, coughing or abnormal breathing/dyspnoea. This was 
because in all of these outcomes there were no cases (i. e. ponies demonstrating the clinical 
sign in question) from which Pasteurella-like spp. were not isolated and therefore the 
presence of these bacteria on swabs predicted each outcome perfectly. In order to allow 
examination of the effect of Pasteurella-like spp. isolated from nasopharyngeal. swabs in 
univariable and later multivariable analyses, data were slightly modified to create a single, 
artificial negative nasopharyngeal swab isolation of Pasteurella-like spp. from a clinical 
case. The nasopharyngeal Pasteurella-like spp. culture result for pony 14 on week 5 was 
modified (i. e. binary classification of one changed to zero). This pony at this time was 
positive for ocular discharge, coughing and abnormal breathing/dyspnoea and being an 
observation from week 5 (rather than weeks one, 2,3 or 26) would allow its inclusion with 
all levels of autoregressive variables. Results of univariable analyses using the modified data 
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showed that isolation of Pasteurella-like spp. from the nasopharynx was significantly 
associated with both ocular discharge and abnonnal breathing/dyspnoea but was not 
significantly associated with coughing. 
8.4.2.2 Mullivariable analyses 
Table 8.4 summarises the final multivariable logistic regression models that include 
pony-level random effects for each of the individual clinical outcomes of nasal discharge, 
coughing, abnormal breathing/dyspnoea and SMLN enlargement. Results of multivariable 
logistic regression analyses incorporating pony-level random effects are now discussed for 
each of the individual clinical signs. 
Ocular discharp- 
Multivariable logistic regression modelling of ocular discharge resulted in no 
significant improvement of association of any explanatory variable with this outcome, 
therefore results are not presented. This demonstrated that ocular discharge was not well 
predicted by any of the factors examined in this study, including autoregressive variables. 
The results of univariable and multivariable logistic regression analyses were consistent with 
ocular discharge not being part of the complex of clinical signs normally associated with 
clinical equine respiratory disease. The lack of association between ocular discharge and the 
majority of risk factors examined was in contrast to other signs. In keeping with the absence 
of significant results in earlier pony-level analyses for this sign, this suggested strongly that 
inclusion of ocular discharge was not warranted or necessary in a summary measure of 
respiratory disease. This was consistent with the summary measure of clinical score 
(including ocular discharge) compared to CDNS score (excluding ocular discharge) 
showing no difference in the variables with which it was significantly associated but 
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possessing more variability or 'noise', as evidenced by decreased W values in both 
univariable and multivariable analyses. 
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Nasal discharsze 
The final logistic regression model for nasal discharge included all 3 autoregressive 
variabl , es, terms for a categorical classification of S. zooepidemicus isolated in tracheal 
washes, a binary term for the isolation of Bordefella bronchiseptica from the nasopharynx 
and a pony-level random effect term. 
Examination of the final model showed that among the autoregressive variables, a 
nasal discharge 3 weeks previously was significantly associated with increased risk of the 
same sign in any given week (adjusted OR 2.9, P=0.012). It was possible that there might 
have been correlation between clinical signs and outcomes during any of the 3 weeks 
immediately preceeding it. Therefore, where there was a significant autoregressive variable 
corresponding to 2 or 3 weeks previously (thus reducing the effective sample size), the 
autoregressive variable(s) for the closer weeks would be retained a priori, irrespective of 
whether they themselves were significantly associated with the clinical outcome. This would 
not further affect the sample size in these models but would best allow for control of 
potential confounding effects from coffelated outcomes. 
Examination graphically of how the risk of nasal discharge changed with increasing 
logio cfu/ml S. zooepidemicus in tracheal washes (Figure A2.12a) revealed there was not a 
satisfactory linear relationship between the logit of disease risk and loglo cfu/H S. 
zooepidemicus. In order to represent most accurately the plateau of non-increased risk up to 
104 cfu/ný followed by a steep rise in risk with increasing S. zooepidemicus counts, a 
categorical representation of logio cfla/ml S zooepidemicus was used. The baseline group 
corresponded to washes with <104 cfu/ml with further categories for 104_105 CfU/ml, 105_ 
106 cfu/ml and > 106 CfU/Ml. Inclusion of this categorical variable showed that increasing 
numbers of S. zooepidemicus in tracheal washes was associated with a significant increased 
risk of nasal discharge. There was some evidence that this increase in risk was dose 
dependent above 10' cfu/ml. 
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Controlling for the other variables in the final model, isolation of Bordetella 
bronchiseplica was found to be associated with an increased risk of nasal discharge 
(adjusted OR 3.0, P=0.024), even though it had not been statistically significant in 
univariable analysis (unadjusted OR 1.4, P=0.188). Similarly, terms for non-haemolytic 
Streplococcus spp. in tracheal washes were no longer significantly associated with nasal 
discharge after controlling for other variables. 
As these data were highly correlated within individual ponies all final models were 
produced a priori including a pony-level random effects term in order to account for 
random variability between ponies. Due to the lack of approximation to a chi-squared 
distribution of differences in deviances between models with and without a random effect 
terms and consequent difficulty in their interpretation, formal likelihood ratio statistics and 
coff esponding P-values were not presented. However, there was evidence from the 
relatively larger coefficient estimate compared to its standard error (i. e. 0: S. E. 0 ratio ýt 2.1) 
that for the nasal discharge model the random effect term was likely to be statistically 
si0ficant and its inclusion had improved the fit of the model. 
As described in the methods, 3 different estimation techniques were used in 
different software packages and their results compared. Table 8.4 provides the beta 
coefficient estimates and corresponding standard errors for restricted and non-restricted 
iterative generalised least squares (RIGLS and IGLS) algorithms using second order 
penalised quasilikelihood (PQL) estimation in MLwiN and maximum likelihood estimation 
(MLE) using a modified Newton-Raphson algorithm in Egret. The pony-level variance 
estimates and standard errors presented in Table 8.4 for the ML estimates from Egret have 
been modified so as to be consistent with those produced by MLwiN. The modifications 
were performed according to the relationship between different outputs as described by 
Snijders & Bosker (1999). The estimated adjusted odds ratios (OR) with 95% confidence 
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intervals around the estimates and corresponding Wald X2 P-values produced by Egret are 
also presented. 
Generally for all models there was very good agreement in the coefficient estimates 
and their standard errors for each of the 3 estimation techniques, vvith the second order 
PQL IGLS estimates and the maximum likelihood estimates producing almost identical 
results for most model components. No statistically significant interaction terms were 
identified. 
Using MILwiN software it was possible to exarnine the pony level residuals (n=29) of 
final fitted logistic regression models with random effects and these were ranked and plotted 
with their 95% confidence intervals in 'caterpillar' plots. Figures A2.13 and A2.14 
represented caterpillar plots of the pony level residuals for the final models for nasal 
discharge calculated by IGLS and RIGLS algorithms, respectively. It can be seen that the 
11 plots were virtually identical and that although all RIGLS estimated residuals were in the 
same direction (i. e. positive or negative) as the corresponding IGLS estimates, they were of 
consistently greater magnitude. Examination of the pony level residuals demonstrated that 
residuals for 2 ponies (ponies 5 and 28) had 95% confidence intervals that did not include 
zero. 
,i Ponies with the largest residuals and with 95% confidence intervals that did not 
include or just included zero (hatched line representing zero residual is equivalent to perfect 
I prediction by the model) appear at the extremes of the plots. Ponies 5 and 25 have been 
identified on Figures A2.13 and A2.14 as having the largest positive residuals, i. e. these 
ponies had more nasal discharges than were predicted by the final model. Also pony 28 was 
identified as the only pony with a significantly (95% confidence intervals for residual does 
not include zero) negative residual value, i. e. this pony had less nasal discharge than the 
i final model predicted. 
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Examination of data (Figure A2.6) from ponies 5 and 25 that had the largest positive 
value residuals revealed why these animals were likely to have had an influence on the 
goodness of fit of the nasal discharge model. These ponies for several of the study weeks 
had nasal discharges but had low logio cfu/ml S. zooepidemicus, lacked positive 
autoregressive outcomes 3 weeks previously and did not have B. hronchiseptica isolated 
from nasopharyngeal swabs. Examination of data (Figure A2.6) from pony 28 that had the 
largest negative value residual, revealed that for several of the study weeks this animal had 
no nasal discharge but had high logio cfii/ml S. zooepidemicus, had positive autoregressive, 
outcomes 3 weeks previously and had B. bronchiseptica isolated from nasopharyngeal, 
swabs. 
Coup-hin 
As with the results of multivariable analyses of aggregated clinical outcome scores, 2 
final models, corresponding to inclusion of either transferrin D (Model 1) or F2 (Model 2) 
haplotypes, were derived for the logistic regression analysis of the binary clinical outcome 
of coughing. Other significant or marginally significant and/or a priori variables in the final 
coughing models included the autoregressive variable of coughing the previous week 
(marginal), vaccine group category, the categorical classification of S. zooepidemicus in 
tracheal washes and pony-level random effect term (apriori). 
In order to control for some of the temporal association between repeated weekly 
sampling and subsequent observation of the clinical sign, the autoregressive variable of 
coughing the previous week was retained in both models. Although only marginally 
statistically significant, there was evidence for a greater than 2-fold increase in risk of 
coughing when coughing had been present the previous week. 
The categorical variable of vaccine group was retained as a statistically significant 
variable in both final coughing models. Results showed that there was an increased risk of 
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coughing among ponies that had received placebo compared to those that had been 
vaccinated but there was no statistically significant difference in risk of coughing between 
vaccinates and the 5 non-vaccinated ponies that were introduced later. 
Examination graphically of how the risk of coughing changed with increasing logio 
cfu/ml S. zooepidemicus in tracheal washes (Figure A2.12b) showed there was not a 
satisfactory linear relationship between the logit of disease risk and logio cfii/nil S. 
zooepidemicus. However, the same categorical classification of logio cfu/n-A S. 
zooepidemicus used for nasal discharge (4 categories) was considered -appropriate to 
represent the non-linearity of the logit of risk of coughing with increasing bacterial counts. 
Inclusion of this categorical variable showed that increasing numbers of S. zooepidemicus in 
tracheal washes was associated with a significant increased risk of coughing and again there 
was some evidence that this increase in risk was dose dependent above 10' cfu/ml. 
Binary variables for possession of either of 2 transferrin haplotypes (type D in Model 
I and type F2 in Model 2) remained significantly associated with coughing in these final 
models. The direction of the effect of each of these variables was the same as had been 
observed in previous analyses of aggregated clinical outcome scores. That is that possession 
of the transferrin D haplotype was associated with reduced risk of coughing (adjusted OR 
0.4, P=0.047) whereas possession of the F2 haplotype was associated with significantly 
increased risk (adjusted OR 3.7, P=0.03 1). 
Examination of the pony-level variance estimate and its standard error showed that 
these variables were unlikely to be statistically significant (i. e. P: S. E. P ratio :51.94) in the 2 
coughing models. However, this variable was retained a priori to account for the 
hierarchical structure of repeated measures data within ponies in the dataset. No statistically 
significant interaction terms were identified. 
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Figures A2.15 and A2.16 represent caterpillar plots of the pony level residuals for 
the final coughing models calculated by RIGLS algorithms, which include transferrin D and 
F2 haplotypes, respectively. 
Residuals for IGLS estimates (not shown), as for those demonstrated previously for 
nasal discharge, were more conservative in that they had smaller absolute values and the 
95% confidence intervals for all pony level residuals included zero. 
Exatnýination of the RIGLS pony level residuals and their 95% confidence intervals 
for the final coughing model including transferrin D haplotype showed that the confidence 
intervals for only one pony (pony 12) did not include zero. The residual for pony 12 had a 
positive value indicating that this animal coughed on more occasions than was predicted by 
the model. Examination of data (Figure A2.6) revealed that pony 12, which as well as being 
in the vaccinated group and being positive for transferrin D haplotype (by virtue of being 
DF2 phenotype) also lacked positive autocorrelated outcomes from the previous week on 3 
occasions. 
Exarnination of the RIGLS pony level residuals and their 95% confidence intervals 
for the final coughing model that included transferrin F2 haplotype showed that the 
confidence intervals for only one pony (pony 23) did not include zero. The residual for pony 
23 also had a positive value indicating that this animal coughed on more occasions than was 
predicted by the model. Examination of data (Figure A2.6) revealed that pony 23, which, 
despite being in the placebo group, was negative for the F2 haplotype (by virtue of being 
OH2 phenotype), lacked positive autocorrelated outcomes from the previous week on 2 
occasions and had relatively low logio cfu/ml S. zooepidemicus in tracheal washes. 
Abnormal breathingidyspnoe 
As with the results for coughing, 2 final models that included different transferrin 
haplotypes (type D in Model I and type F2 in Model 2) were produced for the logistic 
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regression analysis of the binary outcome variable of abnormal breathing/dyspnoea. Other 
variables included in these models were autoregressive, variables for abnormal . o, 
breathing/dyspnoea one week and 2 weeks previously, logio cfuln-A S. zooepidemicus in 
tracheal washes and pony-level random effects term, 
Inclusion of the autoregressive variable for abnormal breathing/dyspnoea 2 weeks 
previously was significantly associated with increased disease risk (adjusted OR 2.3, P= 101 
0.041) in the transferrin D model and was marginally associated with an increased risk of 
similar magnitude (adjusted OR 2.1, P=0.068) in the transferrin F2 model. As discussed 
for the modelling of nasal discharge, in order to best control for temporal association 
between outcomes without unnecessary reduction of the sample size, the autoregressive 
variable for the week previously was included a priori in the final model, even though it was 
itself not significantly associated with the outcome. 
Examination graphically of how the risk of abnormal breathing/dyspnoea changed 
with increasing logio cfu/ml S. zooepidemicus in tracheal washes (Figure A2.12c) showed 
there was a satisfactory, although not perfect linear relationship between the logit of disease 
risk and logio cfu/mI S. zooepidemicus. Abnormal breathing/dyspnoea was, therefore, 
modelled, using the continuous variable of logio cfu/ml S. zooepidemicus in tracheal washes. 
Results showed that an incremental increase in logio cfu/ml S. zooepidemicus was 
associated with a significant increase in risk of abnormal breathing/dyspnoea in the 
transferrin D model (adjusted OR 1.3 per logio cfu/n-A increase, P=0.017) and a marginally 
significant increase in risk in the transferrin F2 model (adjusted OR 1.2 per loglo cfu/ml 
increase, P=0.076). 
Binary variables for possession of either of 2 transferrin haplotypes (type D in Model 
', 1 and type F2 in Model 2) were strongly significantly associated with abnormal 
breathing/dyspnoea. The direction of the effect of each of these variables was the same as 
had been observed in previous linear regression analyses of aggregated clinical outcome 
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scores and for logistic regression analysis of coughing. Possession of the transferrin D 
haplotype significantly reduced the risk of abnormal breathing/dyspnoea (adjusted OR=0.2, 
P=0.005) whereas possession of the F2 haplotype significantly increased the risk (adjusted 
OR=5.7, P=0.003). 
Examination of pony-level variance estimates and their standard errors showed that 
they were likely to be at least marginally statistically significant in the 2 abnormal 
breathing/dyspnoea models, depending on the estimation method used. The MILE and 
second order PQL RIGLS estimates (0: S. E. 0 ratio ý! 1.99) were higher than those of the 
second order PQL IGLS estimates (0: S. E. 0 ratio :51.71). As vvith other analYses the 
variable was retained a priori to account for the hierarchical structure of repeated measures 
data within ponies in the dataset. No statistically significant interaction terms were 
identified. 
Figures A2.17 and A2.18 represent caterpillar plots of the pony level residuals for 
the final abnormal breathing/dyspnoea models calculated by RIGLS methods, which include 
transferrin D and F2 haplotypes, respectively. 
Examination of the RIGLS pony level residuals and their 95% confidence intervals 
for the final abnormal breathing/dyspnoea model including transferrin D haplotype showed 
that the confidence intervals for 2 ponies either did not include zero (pony 29) or just 
included zero (pony 28). The residual for pony 29 had a positive value indicating that this 
animal had more abnormal breathing/dyspnoea than was predicted by the model. 
Examination of data (Figure A2.6) revealed that pony 29, which as well as being Positive 
for transferrin D -haplotype (by virtue of being DF2 phenotype) also lacked Positive 
autocoffelated outcomes from 2 weeks previously and had relatively low loglo c S. fu/ml 
zooepidemicus in tracheal, washes on 3 occasions when there was abnormal 
breathing/dyspnoea. Pony 28, with the largest negative value residual, did not Possess 
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transferrin D haplotype and had no abnormal breathing/dyspnoea, but had high logio cfu/rnl 
S. zooepidemicus for several weeks of the study. 
Examination of the RIGLS pony level residuals and their 95% confidence intervals 
for the final coughing model that included transferrin F2 haplotype showed that the 
confidence intervals for only one pony (pony 23) did not include zero. The residual for pony 
23 also had a positive value indicating that this animal had more abnormal 
breathing/dyspnoea than was predicted by the model. Examination of data (Figure A2.6) 
revealed that pony 23 was negative for the F2 haplotype (by virtue of being OH2 
phenotype), lacked positive autocorrelated outcomes from 2 weeks previously on 3 
occasions and had relatively low logio cfu/ml S. zooepidemicus in tracheal washes. 
SMLN enlarRement 
The final logistic regression model for SMLN enlargement included the 
I 
autoregressive variable for clinical outcome the previous week, vaccine group category and 
a pony-level random effect term. 
The autoregressive variable for SMLN enlargement the previous week was 
significantly associated with increased risk of enlarged lymph nodes in the current week 
(adjusted OR 4.5, P<0.001). This variable was important as it completely confounded the 
significant associations with S. zooepidemicus infection in the trachea. 
The other significant variable in the final logistic regression model of SNIELN 
enlargement was that of vaccine group. Results showed that ponies that were introduced 
later were at significantly greater risk of SMLN enlargement compared to vaccinated 
animals (adjusted OR 7.4, P=0.014) but that ponies that received placebo were at no 
significantly increased risk. No statistically significant interaction terms were identified. 
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There was evidence from the relatively larger coefficient estimates compared to their 
standard errors (i. e. 0: S. E. 0 ratio ýt 2.1) that for the SMLN model the random effect 
variance was likely to be significantly >0. 
Exarnination of the RIGLS pony level residuals and their 95% confidence intervals 
for the final SNILN enlargement model (Figure A2.19) showed that the confidence intervals 
for only one pony (pony 23) did not include zero. The residual for pony 23 had a Positive 
value indicating that this animal had more SMLN enlargement than was predicted by the 
model and the main reason for this was that it was in the placebo and not the late 
introduction vaccine group category. 
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CHAPTER 9 
DISCUSSION 
9.1 Discussion of overall study aims and design 
This was a randornised, blinded, placebo-controlled study to evaluate an 
experimental inactivated, multivalent, adjuvanted bacterial vaccine in you I ng Welsh 
Mountain ponies suffering natural respiratory disease. 
The study had been conceived after several years of repeated clinical observations in 
young Welsh Mountain ponies brought to the AHT shortly after weaning for use in various 
studies, particularly those involving trials of respiratory virus vaccines. It was consistently 
noted by AHT clinicians and scientists that these young ponies suffered a considerable 
burden of clinical respiratory disease, characterised by mucoid nasal discharge, coughing 
and in some instances pyrexia, dyspnoea and pneumonia. This disease syndrome would 
frequently persist for many months in groups of animals that were kept predominantly 
. outdoors at pasture. 
Animals that were particularly badly affected were often treated for pneumonia with 
anti-inflammatory and antimicrobial therapy. The large proportion of positive responses to 
treatment seen in these cases, along with post mortem investigations in those ponies that 
died despite treatment, was consistent with this disease syndrome being closely associated 
with bacterial infection of the airways, which were affected with mucoid inflammatory 
exudate. The bacterial species most commonly isolated from the lungs of affected ponies 
included S. zooepidemicus, S. pneumoniae, A. epuli, Pasteurella spp. and B. 
bronchiseptica. Together with the detailed studies conducted by researchers at the AHT 
into inflammatory airway disease in young racehorses in training (Burrell, 1985; Burrell ef 
aL, 1986b; Wood et aL, 1993a; Burrell et aL, 1994; 1996; Wood et aL, 1997b; Wood, 
1 1999), these observations suggested that non-Thoroughbreds maintained as a herd outdoors 
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underwent a clinically similar form of respiratory disease as housed, young Thoroughbred 
racehorses in the early part of their training careers. On the basis of epidemiological studies 
in Thoroughbreds and the observation in ponies, a multivalent vaccine containing 2 strains 
each of A. equuli and S. zooepidemicus was developed by a commercial collaborator for 
evaluation in an appropriately conducted clinical trial. Observations in several challenge 
studies (Blunden el al., 1994) (N. Chanter, unpublished observations) suggested that 
experimental infection with the more common presumptive pathogens such as S. 
zooepidemicus and A. equuh, was most often confounded by natural disease. A natural 
disease challenge was considered the only available and appropriate infectious setting for 
the vaccine trial, particularly due to the predictable occurrence and nature of the disease 
process in ponies. 
In considering the most appropriate method of evaluating the vaccine within a 
natural disease challenge setting, it was deemed important that ponies should be vaccinated 
prior to the time of highest risk of natural disease challenge. This had been frequently 
observed to be soon after the stress of weaning, mbdng with other ponies and hence their 
infections, and transportation to the AHT from different locations. Ponies in this study that 
were assigned to receive either vaccine (n=12) or placebo (n--12) were, therefore, 
vaccinated immediately prior to weaning and before mixing and transportation with other 
ponies (n--5) from geographically distinct areas. In order to try and minimise the amount of 
natural infection transrnitted between ponies prior to vaccination, ponies receiving vaccine 
or placebo were chosen from as small a geographical area as possible, in this case the same 
Welsh hillside. 
It was considered essential that a blinded, randornised and controlled study design 
was used in the evaluation of effectiveness of vaccination in reducing respiratory disease, in 
order to avoid observer bias. Treatment allocation was done randomly using a random 
permuted block design. In order to maximise the blinding, a placebo control was used, 
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which like the vaccine, was injected in the middle third of the neck on the left-hand side in 
each pony. Therefore, administration of a placebo in this study rather than non- 
administration had the advantage that it would not subsequently be obvious from any signs 
of injection such as blood leakage or swelling in this area which animals had received 
vaccine and which had not (i. e. signs caused by the action of intramuscular injection, 
irrespective of likely reaction to bacterial vaccine components). In addition, the use of a 
placebo consisting of alum adjuvant without the bacterial antigens would ensure that any 
significant differences observed were, therefore, more likely attributable to the antigenic 
portion rather than from any effect from adjuvant. 
In considering the endpoints of interest in this study it was recognised. that-repeated 
measures in individual animals would be warranted because of the dynamic and time-varying 
nature of respiratory disease in young horses. In addition, detailed clinical, endoscopic and 
microbiological investigations were required at each sampling point to best characterise the 
disease and infection status of the animal over an extended period of time. 
For practical logistical reasons, weekly intervals were selected for repeated sampling 
of the airways and summary clinical measures were produced to correspond with these. 
Each pony was exarnined clinically in detail on 2 occasions during each week and this was 
combined with endoscopic assessment of mucus in the trachea, collection of tracheal wash 
and nasopharyngeal swabs on a single occasion each week. Results of microbiological 
culture of wash and swab samples were then conducted immediately and completed before 
the next sampling occasion. 
To our knowledge this was the first intensive and repeated clinical and 
microbiological investigation of naturally occurring respiratory disease in such young non- 
Thoroughbred horses combined with a clinical trial of a bacterial vaccine. 
Although a detailed longitudinal study involving repeated sampling using endoscopy, 
tracheal wash and nasopharyngeal swabbing had been conducted in Thoroughbreds in 
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training (Wood, 1999), the current study used more intensive weekly sampling over a 
shorter period of 10 weeks compared to monthly sampling over a longer period. The 
current study therefore allowed a detailed 'snapshot' of the dynamics of respiratory disease 
in recently weaned Welsh Mountain ponies maintained outdoors, shortly after weaning, 
mixing and transporting. It was very important that the likely strong correlation between 
repeated samples from the same individual animals was considered carefully in the analysis 
of data from this study and this is discussed in detail later. 
9.2 Evaluation of vaccine efficacy 
The main purpose of this study was to evaluate the efficacy of a bacterial vaccine 
under conditions of natural respiratory disease in young Welsh Mountain pony foals. The 
vaccine was an inactivated, alum adjuvanted vaccine containing each of 2 strains of S. 
zooepidemicus and A. equuh, both recognised previously as being strongly associated with 
lower respiratory disease in young horses (Wood el al., 1993a; Ward el al., 1998; Chapman 
el aL, 2000; Christley el aL, 200 1 b). 
Preliminary univariable analyses of pony-level summary data indicated that there was 
no evidence for statistically significant differences in clinical respiratory disease or infectious 
burdens between pony groups that received vaccine, placebo or were introduced later. This 
was in contrast to an apparently strong effect of transferrin haplotype. It had been Dr. 
Chanter's impression immediately after the study that ponies tended to fall into 2 clinically 
distinct groups, those with severe respiratory signs and high infectious burdens and those 
that were much less severely clinically affected and had lower infectious burdens. Formal 
analysis of pony-level data apparently confirmed this clinical impression and suggested that 
it was not attributable to vaccine but appeared closely linked to the genetically determined 
transferrin haplotype of the ponies. 
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Closer examination of observation-level data, taking particular care to control for 
temporally correlated outcomes within individual ponies and random variation between 
them, indicated that there was evidence for statistically significant differences in some 
individual clinical signs between the vaccine groups after controlling for other significant 
factors. Consistent with the pony-level analyses, however, there was no evidence for a 
significant effect from vaccination when aggregated clinical and airway inflammation scores 
were used as outcomes. 
Among individual clinical outcomes, coughing and SMLN enlargement 
demonstrated statistically significant differences between vaccine groups when examined in 
univariable and multivariable analyses. Compared to ponies that were adminstered vaccine 
the placebo group had significantly more coughing and the late introduction group 
significantly more SMELN enlargement. 
After controlling for the effects of coughing the previous week, S. zooepidemicus 
infection in the trachea, transferrin haplotype and random variation between ponies, ponies 
that received placebo remained at significantly increased risk of coughing compared to those 
that received vaccine. Although the estimate of risk of coughing varied between final 
logistic regression models that included different transferrin haplotypes (transferrin D model 
OR 4.5; P=0.007 & transferrin F2 model OR 7.1; P=0.002), confidence limits overlapped 
and results indicated that vaccinated ponies were significantly less likely to cough than those 
that received placebo. 
It has been observed previously that coughing is an insensitive but specific measure 
of respiratory disease in horses (Burrell et aL, 1996; Head & Wood, 2001) The finding that 
cough was the least prevalent clinical sign (cough score summary, Table A2.1) in this study 
was consistent with coughing being a relatively poor predictor of respiratory disease. It is 
unclear at the moment what mechanism of action might be responsible for the significant 
reduction in coughing' among vaccinated ponies compared to adjuvant (placebo) 
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administered controls, but this finding suggests there may be some link between bacterial 
infection of the airways and coughing. 
After controlling for SMLN enlargement the previous week and random variation 
between ponies there was an increased risk of SNILN enlargement among the late 
introduction group (OR 7.4; P=0.014) and no significant difference in risk in the placebo 
group (OR 1.4; P=0.608) compared with vaccinated ponies. Vaccination did not 
significantly affect SMLN enlargement but there was a difference between the late 
introduction group and the other ponies with respect to SMLN enlargement. It is not clear 
to what specific factors this difference may have been attributable, although it is likely that 
differences in disease and management between these groups prior to the study. may have 
been important. 
9.3 Discussion of findings on naturally occurring respiratory disease 
As well as providing a means of evaluating the efficacy of a killed bacterial vaccine 
this study also provided an opportunity to make detailed clinical and microbiological 
observations on naturally occurring respiratory disease in recently weaned Welsh Mountain 
ponies. Multivariable analyses of observation-level data have provided an insight into 
various risk factors associated with this respiratory disease. 
9.3.1 Risk factors associated with individual clinical signs 
In this study the same observer (Dr. Neil Chanter), who remained blinded as to the 
vaccination status of ponies until after completion of the study, conducted all clinical 
examinations. Clinical examinations were reasonably detailed and assessed 5 separate 
clinical parameters (nasal and ocular discharges, coughing, abnormal breathing/dyspnoea 
and SMLN enlargement), with allocation of a score according to the severity of each sign. 
In order that results of respiratory sampling that was conducted only once a week, could be 
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matched with results of twice weekly clinical examinations, mean weekly scores for 
individual clinical parameters were calculated. The weekly average rather than, for example, 
the maximum score from the week, was considered the most suitable and discriminatory 
way of representing the overall weekly burden of clinical respiratory signs. Using this 
method, ponies that had maximum clinical severity at both examinations would score a 
higher weekly average score than a pony that had only shown the maximum severity at one 
examination. 
In this study the clinical sign of ocular discharge was not well predicted by any of 
the factors exarnined, including autoregressive variables. This was consistent with this sign 
not being an important part of the respiratory disease syndrome demonstrated by young 
Welsh Mountain ponies. Given that ponies were fed from elevated hay racks it is probable 
and consistent with previous observations in other ponies managed in the same way that the 
ocular discharges observed were due to irritation from airborne dust released during 
communal feeding rather than respiratory disease per se. 
9.3.1.1 Infections 
Among nasopharyngeal infections, isolation of B. hronchiseptica, was found to be 
associated with a significantly increased risk of nasal discharge after controlling for other 
factors. Bordelella bronchiseplica has been reported from cases of respiratory disease in 
young horses previously, including from nasal discharges (Cockram et aL, 1981; Bayly et 
al., 1982; Vandevenne et aL, 1995). Although previous case reports have suggested a 
primary role for B. bronchiseptica in respiratory disease in young horses, particularly 
shortly after weaning and there was a notable temporal clustering of isolations from ponies 
during this study (weeks 3-5), there was actually very little evidence to show that this 
infection was associated with signs of respiratory disease. 
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After controlling for the effects of other factors, infection of the trachea with S. 
zooepidemicus was found to be significantly associated with an increased risk of nasal 
discharge, coughing and abnormal breathing/dyspnoea. There was evidence with all 3 signs 
of a dose response relationship between the risk of the sign and the level of S. 
zooepidemicus infection in the trachea as measured by logio colony forming units per ml. of 
tracheal wash. Tracheal infection with S. zooepidemicus has been previously shown to 
demonstrate a dose dependent association with increasing risk of coughing (Christley el aL, 
1999b; 2001b) and inflammatory airway disease (IAD) (Wood el aL, 1993a; Burrell et aL, 
1996; Wood, 1999; Chapman ef aL, 2000) as defined by increased tracheal mucus and 
airway neutrophilic inflammation. 
The finding of significant association between tracheal S. zooepidemicus infection 
and increased risk of nasal discharge appears contrary to the results of Burrell el aL (1996), 
who found no such association in racehorses in training, although they did show a 
significant association with infection with S. pneumoniae. Differences in the age of horses, 
definitions of disease, frequency of sampling and study duration may account for these 
apparently dichotomous findings, and the non-significant findings of Burrell el aL (1996) 
may have been due to a small sample size. In a follow-up longitudinal study of respiratory 
disease in Thoroughbreds, Wood (1999) recognised that concurrent IAD was a significant 
risk factor for nasal discharge and that adjusting for IAD accounted for the effects of 
infections such as S. zooepidemicus, that were associated with both IAD and nasal 
discharge. In the current study extremely detailed clinical and endoscopic examinations 
were performed concurrently and analyses for individual clinical signs were conducted using 
tracheal and nasopharyngeal infections as risk factors. Although nasopharyngeal isolation of 
S. zooepidemicus was associated with increased risk of nasal discharge in univariable 
analysis, it was not statistically significant in multivariable analyses. Results here indicate 
that tracheal S. zooepidemicus infection of the lower airway was a significant risk factor for 
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nasal discharge and should be considered consistent with the observations of Wood (1999). 
This was probably because this infection was associated with increased tracheal mucus and 
inflammation, as in young Thoroughbreds, which after natural tracheal mucociliary 
clearance appeared as a nasal discharge. This would suggest that at least in the young Welsh 
Mountain ponies studied here that the distinction between IAD and nasal discharge is not as 
clear-cut as that defined in Thoroughbreds in training by Wood (1999). This might be 
consistent with an age-related change in the relationship between S. zooepidemicus 
associated tracheal and nasal pathology and immunology (i. e. mucoid inflammatory exudate 
in response to infection). This may reflect differences in the immunological processes at 
these different levels in the equine respiratory tract at different stages. This in turn may help 
explain age-related clinical phenomena such as pharyngeal lymphoid hyperplasia, the 
severity of which has been shown to have an inverse correlation with age (Burrell, 1985) 
and the marked reduction in prevalence of nasal discharge between yearling Thoroughbreds 
and older horses (Wood et aL, 1998; Wood, 1999). 
The finding of a dose response relationship between S. zooepidemicus in tracheal 
washes and the clinical sign of abnormal breathing/dyspnoea is consistent with this 
bacterium being the most frequently isolated organism from cases of pneumonia and 
pleuropnemonia, which frequently demonstrate abnormal patterns of breathing (Chaffin et 
aL, 1994a; 1994b; Raidal, 1995). 
No individual infections were found to be significantly associated with SMLN 
enlargement during the 10 weeks of intensive examinations in this study, although as 
described previously, there was a significant difference in this outcome between the late 
introduction ponies and all others, possibly due to differences in earlier infections. 
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9.3.1.2 Clinical signs in previous weeks 
For all individual clinical signs with the exception of ocular discharge, presence of 
the sign in an earlier week significantly increased the risk of an animal having the same sign 
in the current week, although nasal discharge was not consistent with other signs because 
only discharge 3 weeks previously was significant. The variables for signs in previous weeks 
were referred to in analyses as autoregressive variables and in this study corresponded to 
signs one, 2 and 3 weeks previously to that being considered (current). 
In presenting results of multivariable analyses for individual clinical signs, it was 
considered appropriate to include at least the autoregressive variable for the sign one week 
previously. Where appropriate and to avoid unnecessary loss of effective sample size, 
autoregressive variables for earlier weeks were only included when they at least approached 
statistical significance. 
It is of note that for nasal discharge and abnormal breathing/dyspnoea that only the 
autoregressive variables corresponding to 3 and 2 weeks previously, respectively, were 
significantly associated with the presence of the clinical sign in the current week. This most 
probably reflected the somewhat intermittent nature of these clinical signs between 
successive weeks (as seen in the clinical sign profiles outlined in Figure A2.6). It is not clear 
whether this truly reflected repeated occurrence of clinical signs of short duration or a 
variation in severity of signs associated with the same prolonged clinical episode. The 
inclusion of other variables and particularly pony-level random effects terms in the final 
logistic regression models for individual clinical signs significantly altered the level of 
significance and size of effects of the autoregressive variables compared to univariable 
analyses. This reflected confounding between temporally related outcomes accounted for by 
inclusion of autoregressive fixed effects parameters and pony-level random effect terms, 
which accounted for random variation between individual ponies. 
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Previous studies of equine respiratory disease using repeated measures are extremely 
limited (Morley, 1995; Wood, 1999). Where a longitudinal study design has been conducted 
previously in Thoroughbreds in training (Wood, 1999), the sampling interval (one month) 
and duration of the study (3 years) were both extended compared to the current study. In 
the longitudinal study by Wood (1999) autoregressive variables for IAD and mucus in the 
trachea the previous month were included in final regression models and demonstrated at 
least marginal significance, but a final model for nasal discharge did not include a significant 
autoregressive variable. It was, therefore, not surprising that in this study where clinical 
examination and sampling was conducted at shorter weekly intervals, that autoregressive 
variables were significant predictors of clinical signs. 
9.3.1.3 Transferrin haplotype 
Consistent with the results of the preliminary univariable analyses of pony-level 
summary data, coughing and abnormal breathing/dyspnoea were both significantly 
associated with specific transferrin haplotypes possessed by ponies. As with the preliminary 
analyses 2 final models were produced for these 2 outcomes, corresponding to the separate 
inclusion of transfeffin D and F2 haplotypes. 
There was consistency of direction of the effect of each transferrin haplotype 
between the 2 different clinical signs. Possession of transferrin D haplotype was associated 
with a significant protective effect whilst possession of the F2 haplotype was associated 
with a significantly increased risk of clinical signs. Results were also consistent with the 
pony-level analyses in that the size and significance of the protective effect associated with 
possession of the transferrin D haplotype were each slightly smaller than the corresponding 
values for the increased risk attributed to the F2 haplotype. This most likely reflected the 
influence of the 4 ponies that had DF2 phenotypes and as such acted to contribute to the 
effect of both haplotypes. As was seen in the pony-level data, ponies with transferrin DF2 
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phenotype generally suffered more severe clinical signs than other D haplotypes that were 
not also F2 haplotype. This resulted in the overall effect of the D haplotype being reduced 
compared with the F2 haplotype. 
The implications of the findings of this study with respect to transferrin haplotype as 
a significant risk factor for equine respiratory disease and possible mechanisms of action are 
discussed in detail in the discussion of aggregated clinical scores. 
9.3.1.4 Potty-level random effects 
As well as the inclusion of autoregressive outcomes for earlier weeks, final models 
for individual clinical signs were presented with inclusion of a pony-level random effect 
term. This was in order to account for correlation between repeated observations from the 
same individual ponies, which were themselves assumed as having some random variability 
with respect to the outcomes of interest. Pony-level random effects were retained in all final 
models irrespective of whether they were considered to be themselves statistically 
significant as suggested by Mauritsen (1984) and adopted also by Wood (1999). This 
allowed the size and significance of other effects to be examined without the effects of 
clustering of repeated observations within ponies. 
Examination of the coefficient estimates and their standard errors for the random 
effects terms in the final models for each of the clinical signs excluding ocular discharge, 
demonstrated variation in the likely significance of these terms and hence differences in the 
likely clustering of different signs within ponies. Consistent with transferrin haplotype being 
an important predictor of respiratory disease at the pony-level, its inclusion in models for 
coughing and abnormal breathing/dyspnoea apparently resulted in lower likely significance 
of random effects terms than in models for nasal discharge and SMLN enlargement, that did 
not include transferrin haplotype variables. This difference was particularly noticeable for 
models generated using second order PQL IGLS estimates in MLwiN software. This 
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suggested that the inclusion of particular transferrin haplotypes, which were fixed effects at 
the pony-level, was accounting for some of the random variation between ponies and was 
consistent with ponies of different haplotypes having different susceptibilities to coughing 
and abnormal breathing/dyspnoea. 
9.3.2 Risk factors associated with aggregated clinical and IAD scores 
9.3.2.1 Use of aggregated scores 
Clinical score 
Two aggregated weekly clinical scores were used to quantify the overall severity of 
clinical respiratory disease for each pony during each week of the study. Both these scores 
were the sum of weighted individual clinical sign scores. Clinical score was derived from the 
sum of the average weekly scores for all 5 clinical signs with nasal and ocular discharges, 
coughing and abnormal breathing/dyspnoea each weighted equally with a maximum possible 
contribution of 2 points to the score. SMLN enlargement was considered less important 
than the other signs and as such only contributed a single point when present. The other 
aggregated score, which was derived from the weekly sums of coughing (C), abnormal 
breathing/dyspnoea (D), nasal discharge (N) and SMLN enlargement (S), was referred to as 
CDNS score and did not include a score for ocular discharge on the pren-dse that this might 
not be a sign of respiratory disease per se. From analyses of data from individual clinical 
signs and comparisons of analyses using clinical and CDNS scores, this premise appears to 
have been well founded as ocular discharge was not strongly associated with plausible risk 
factors for respiratory signs and its exclusion from the aggregated scoring did not 
sioficantly alter results. 
Aggregated clinical scores used in this study were derived from simple classifications 
of each clinical sign that with the probable exception of ocular discharge, were believed to 
be specific to and indicative of respiratory disease at particular levels of the respiratory 
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tract. Although in this trial there was a single observer, the clinical scoring that was adopted 
attempted to avoid subjective interpretation of parameters for which measures of severity 
could not be well defined such as demeanour, appetite and depression. These clinical 
parameters were, therefore, not used because the time spent observing animals was short, 
the presence of an observer might influence their behaviour and assessment of appetite in 
animals grouped together was very difficult. 
In this study, multilevel models with inclusion of autocorrelated outcomes were used 
to examine the relationships between disease outcomes and expoasures which clustered at 2 
different levels within the data. However, alternative approaches could have been taken to 
examine the functional form of these relationships, including generalised additive models, 
orthogonal polymonials and time series with independent autocorrelation, which are 
available in various different software packages such as SAS, S-Plus and MLwiN (Grohn el 
aL, 1999; Green el aL, 2002; I-Erst el aL, 2002; Pinchbeck el aL, 2002). 
Airway inflammation 
In this study a 9-point scoring system was used based on an expanded version of the 
3-point system used in earlier studies conducted by the AHT (Whitwell & Greet, 1984; 
Wood el aL, 1993a; Burrell et aL, 1996) and similar to that described by Chapman el aL 
(2000). It was considered that this expanded scoring systern, because it used 0-3 scores for 
each of the contributory elements (tracheal mucus, tracheal wash smear cell density and 
neutrophil proportion) rather than single scores as described by Whitwell & Greet (1984), 
was likely to be more discriminating as to the severity of airway inflammation. In addition, 
the use of nucleated cell counts, which have been found to be problematical, particularly 
when done automatically because of the clumping of cells in mucoid exudate, was replaced 
by serni-quantitative assessment of the density of cells on cytological smears. This was 
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considered likely to be a more reproducible measure of the absolute number of cells present 
in tracheal washes. 
In considering airway inflammation as a disease outcome it is important to also 
consider possible causal relationships ain conjunction with possible causal pathway effects 
between risk factors and these outcomes. By way of example, tracheal mucus forms part of 
the scoring system for airway inflammation in this study and has itself been used as an 
outcome in previous studies (Wood, 1999). Although there is multiple evidence for a causal 
association between mucus in the trachea and bacterial infections with a restricted number 
of specific bacterial species (Wood & Chante, 1994), it has been proposed that tracheal 
bacterial infection is on the causal pathway of tracheal mucus because mucus acts to trap 
bacteria and numbers are increased with reduced mucociliary clearance (N. E. Robinson - 
personal communication). 
9.3.2.2 Infections 
No specific nasopharyngeal bacteria were significantly associated with any 
aggregated clinical and airway inflammation scores, although 3 bacterial species isolated 
from tracheal washes were. 
For clinical, CDNS and airway inflammation score models, S. zooepidemicus and 
non-haernolytic Streplococcus spp. were identified as significant predictors when included 
as linear and quadratic terms, respectively. This indicated that higher scores for all 3 
outcomes were associated with higher colony numbers of S. zooepidemicus in tracheal 
washes and was consistent with previous studies of both clinical disease (Burrell el aL, 
1994; Christley et aL, 1999b; 2001b) and airway inflanimation (Wood et aL, 1993a; Burrell 
et al., 1996; Wood, 1999; Chapman et al., 2000). The relationship between outcome scores 
and non-haernolytic Streplococcus spp. in this study appears less straightforward than for S. 
zooepidemicus as it is best fitted by a quadratic function (Figure 8.4). This function 
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indicated that the majority of counts of non-haemolytic Streptococcus spp. (102 _ 
106 
cfiL/ml) were associated with no difference or a decrease in outcome score and only the 
extremes of no bacteria isolated and very high colony counts were associated with slightly 
higher scores. This sort of distribution was consistent with disease being associated with 
mixed infections with large numbers of other bacteria in the absence of non-haemolytic 
Streplococcus spp. in tracheal washes. This finding appeared consistent with observations in 
some species of bacteria (Staphylococcus and Acinelobacter spp. ) in the case control study 
of clinical respiratory disease in Thoroughbreds in that their presence, or at least their 
identification, was more likely in the absence of disease and isolation of other bacteria in 
large numbers. 
In models for clinical and CDNS scores but not airway inflammation score, 
Pasteurella spp. in tracheal washes were also predictive of outcome when modelled as a 
quadratic function (Figure 8.3). This function indicated that in this study the majority of 
counts of Pasteurella spp. (<106 cfu/ml) were associated with no difference in outcome 
scores and only the higher colony counts, which were relatively small in number, were 
associated with higher scores. This finding appeared somewhat inconsistent with previous 
observations in Thoroughbreds in training in which Pasteurella spp. have been shown to be 
strongly associated with clinical signs (Burrell el aL, 1994; Christley el aL, 1999b; Christley 
et aL, 2001b) and airway inflammation (Wood et aL, 1993a; Burrell el aL, 1996; Wood, 
1999; Chapman el aL, 2000). However, this was a very restricted study with respect to 
numbers of ponies and period of study and important bacterial species may have been 
missing. 
With all infections taken together, results were suggestive that in this group of 
young Welsh mountain pony foals the predominant infection associated with clinical and 
airway inflammation was S. zooepidemicus isolated from the trachea. 
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9.3.2.3 Scores in previous weeks andpony-level random effects 
As with most individual clinical signs, aggregated outcome scores from at least the 
previous week were significantly predictive of outcome score in the current week and 
inclusion of a pony-level random effect term allowed sample sizes to be maximised as 
autoregressive variables from earlier weeks were no longer significant and were dropped 
from analyses. 
In the multilevel modeling, pony-level random effects were retained in all final 
models, whether they were statistically significant or not. In the final clinical score model 
the pony-level random effect term appeared statistically significant and there was an intra- 
pony correlation of 14.4% for both models that contained transferrin D or, F2 haplotypes as 
a fixed effect parameter. With exclusion of ocular discharge and use of CDNS score as the 
outcome, the significance of the pony-level random effect term and the intra-pony 
correlation (12.7%) were both reduced compared to the clinical score model. It was 
possible that this might have been due to the reduction in parameters contributing to CDNS 
score, making all scores more similar, although as expected this led to both a reduction in 
observation-level as well as pony-level variances with the reduction in observation-level 
variance being greater. 
The final multilevel model for airway inflammation was equivalent to the multiple 
linear regression model as it did not have statistically significant pony-level random effects 
and the intra-pony correlation was consequently very small. It is likely that the use of a 9- 
point inflammation score from a single sampling occasion per week was not satisfactorily 
discriminating to demonstrate any residual pony-level random variation when all 
significantly predictive variables were included. This would have arisen if the range of 
airway inflammation scores in individual animals was limited over the duration of the study 
as a consequence of a high prevalence of airway inflammation. A high prevalence would be 
expected if the duration of airway inflammation was long relative to the 10 consecutive 
267 
Equine Munnuatory Anway Dowase Epidenuology 
weeks of sampling. Indeed in these recently weaned ponies, >80% (252/314) of samplings 
demonstrated inflammation scores of ý! 5/9. In a previous study of inflammatory airway 
disease in Thoroughbreds, the mean duration of disease defined on the basis of similar 
criteria was almost 8 weeks, not far short of the consecutive sampling period in this study 
(Wood et al., 1998; Wood, 1999). 
9.3.2.4 Transferrin haplotype 
Results of both pony-level and observation-level analyses demonstrated clear 
evidence that, after controlling for other significant factors, different transferrin haplotypes 
were associated with significant differences in aggregated clinical scores, particularly when 
CDNS score was used. As discussed previously, both the pony- and observation-level 
analyses were consistent in demonstrating the direction of effect for the 2 significant 
haplotypes (possession of transferrin D haplotype was protective and the F2 haplotype was 
associated with increased risk). If this was manifested by differences in the ability of 
different transferrin haplotypes to relinquish iron to bacteria by either TBPs or other 
mechanisms, then it would be reasonable to predict that iron was more readily sequestered 
from F2 haplotype transferrin than D. The finding that DF2 phenotypes behaved more like 
F2 haplotypes than D was consistent with this hypothesis. However, the small numbers 
(n: 55) of animals of specific phenotypes precluded the meaningful investigation of 
differences between haplotypes other than D or F2 or specific haplotype combinations 
(phenotypes). 
Results, particularly those from the pony-level analyses, suggested that in this study 
the significant differences in clinical outcomes observed between ponies with different 
transferrin haplotypes were associated with differences in infectious outcomes with S. 
zooepidemicus rather than either Pasleurella or Actinohacillus spp.. The specific 
mechanism by which transferrin haplotype is related to differences in S. zooepidemicus 
268 
Equme hffla=&tmy Aimay Dmme EptdenfiolM 
infection in ponies is not known at this stage. It is possible that there is a direct link 
between pathogenesis of S. zooepidemicus infection and transferrin haplotype similar to that 
identified for S. intermedius by Brochu el al. (1998). Alternatively, the association between 
transferrin haplotype and S. zooepidemicus may be evidence of a different mechanism that is 
manifested through a gene closely linked to the equine transferrin locus. Further studies 
specifically aimed at characterising iron binding in Streptococci of clinical importance in 
horses (S. equi, S. zooepidemicus and equine isolates of S. pneumoniae capsule type 3) are 
warranted. This research, in conjunction with the imminent completion of the sequencing of 
the S. equi genome, may provide significant benefits in development of effective equine 
bacterial vaccines. 
Whatever the mechanism of action the results of this study appear to be novel and as 
such require confirmation vvith respect to their repeatability in other groups of horses. To 
-this end routine prospective data collection has been initiated at the AHT in order to 
systematically monitor clinical respiratory disease in Welsh Mountain pony foals within a 
few months of their arrival from Wales. This data will be analysed for evidence of significant 
differences in clinical respiratory disease between ponies of different transferrin haplotypes 
and with sufficient numbers of animals it is hoped to better elucidate differences between 
ponies with specific transferrin phenotypes. 
In analyses of clinical and CDNS scores, the use of multilevel modelling 
incorporating random variability between repeatedly sampled ponies and including addition 
of pony-level fixed effect variables such as sex, vaccine group and transferrin haplotype, 
permitted examination of these variables in explaining variation between ponies. Results of 
model building demonstrated that inclusion of transferrin haplotype but not sex or vaccine 
group, which each varied between ponies but not between observations in the same pony, 
did significantly account for some but not all of the variation between individual ponies. As 
a proportion of the between pony variation was not explained by transferrin haplotype, this 
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demonstrates that there must be other horse-level factors such as different major 
histocompatibility complex (MHC) classes that may also account for variation in disease 
outcomes between individual animals. 
Recent analogous data from Thoroughbred 
As far as the author is aware these are the first data that suggest significant 
differences in clinical respiratory disease associated with bacterial infections between equids 
on the basis of equine transferrin haplotypes, a genetically deterrnined trait. If this is a true 
effect then the results seen here should be supported by analogous data from other equine 
populations. 
To this end recent results of analyses examining the effects of transferrin haplotypes 
on IAD in young racehorses have also demonstrated a significantly protective effect with 
possession of the D haplotype (R. Newton, unpublished observations). Despite marked . 
differences in the 2 study populations with respect to breed and age of animals, definitions 
of respiratory disease and interval and duration of sampling, this was consistent with the 
direction of the effect of this transferrin haplotype for clinical respiratory disease in Welsh 
Mountain pony foals. 
This pony study identified significant and opposing effects from transferrin D and F2 
haplotypes on infectious measures and there was evidence from the Thoroughbred data for 
similar directions of association with these 2 haplotypes. For transferrin haplotype D, 
infectious variables were reduced overall in horses possessing this haplotype which was 
consistent with the direction of effect seen in ponies. Observations from racehorses 
possessing haplotype F2 had significantly increased counts of S. pneumoniae, S. equisimilis 
and M equirhinis, which was consistent with the direction of effect seen in ponies and 
opposite to that observed for haplotype D. 
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Multivariable logistic regression analyses of IAD in Thoroughbreds demonstrated at 
least marginal significance for transferrin haplotype D with inclusion of other significant 
variables including different infections. 
Additional horse-level analyses were conducted to investigate whether there were 
significant differences in the prevalence and duration of IAD between horses with and 
without transferrin haplotype D. Results showed a significant difference in duration of IAD 
episodes (significantly reduced duration with haplotype D), which would account for some 
of the significant difference in overall IAD prevalence, although there was still a marginally 
significant difference between prevalence of separate IAD episodes. This suggested that 
horses with transferrin haplotype D suffered less IAD episodes and those that they did 
suffer were on average of shorter duration than horses that did not possess this haplotype. 
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SECTION 4 
THE MOLECULAR EPIDEMIOLOGY OF 
STREPTOCOCCUS ZOOEPIDEMICUS INFECTION IN 
WELSH MOUNTAIN PONY FOALS 
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CHAPTERIO 
INTRODUCTION 
10.1 Background 
As already discussed epidemiological studies have consistently demonstrated 
significant associations between tracheal S. zooepidemicus infection and IAD, with or 
without coughing, in racehorses (Wood et aL, 1993a; Burrell el aL, 1996; Wood, 1999; 
Chapman et aL, 2000; Christley et aL, 2001b). In addition, previous observations in 
Thoroughbred (Hoffman et aL, 1993c) and Welsh Mountain pony foals (AHT unpublished 
observations) have identified S. zooepidemicus associated with both clinical and 
endoscopically visible respiratory disease. From this evidence it is clear that young horses 
suffer prolonged and repeated episodes of respiratory disease associated with lower airway 
infection with S. zooepidemicus and higher counts of S. zooepidemicus in tracheal washes 
are associated with more severe respiratory disease (Wood el al., 1993a; Wood, 1999). 
However, as S. zooepidemicus is not a homogenous bacterial species of a single 
subtype but comprises many different subtypes (Moore & Bryans, 1969; Jorm el aL, 1994; 
Chanter et aL, 1997; Walker & Timoney, 1998), it is not clear how the prolonged and 
repeated nature of respiratory disease in young horses relates to variations in infections vvith 
different subtypes. In order to address this issue, stored frozen isolates of S. zooepidemicus 
from tracheal washes and nasoPharyngeal swabs from the study of natural respiratory 
disease in Welsh Mountain pony foals (Section 3) were re-cultured and typed by 2 separate 
PCR assays (Chanter el aL, 1997; Walker & Timoney, 1998). The typing was conducted as 
part of a project on the molecular epidemiology of S. zooepidemicus in horses funded by the 
Horserace Betting Levy Board (Project 673). A dedicated graduate technician with 
previous experience of PCR conducted the typing of pony isolates after optimising the 
assays. The results were initially collated and checked by the project's bacteriologist, Dr. 
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Neil Chanter, and then by myself immediately prior to formal statistical analyses, which are 
presented here. 
10.2 Aims of the study 
The first aim of the study was to type isolates of S. zooepidemicus from tracheal 
washes and nasopharyngeal swabs recovered from Welsh Mountain ponies suffering natural 
respiratory disease during an experimental bacterial vaccine trial through application of 2 
different PCR typing techniques. As the PCR techniques are able to characterise up to 8 
types of the 16S-23S RNA gene intergenic spacer (Chanter el aL, 1997) and up to 5 types 
of the M-protein hypervariable region (Walker & Timoney, 1998), together they can 
potentially identify up to 40 different types. 
Using this typing information, additional aims of the study were: 
i) to estimate the overall prevalence of different S. zooepidemicus types among the 
group of 29 Welsh Mountain ponies during the study, 
ii) to assess the prevalence of the same types at different locations in the respiratory 
tract by comparing tracheal and nasopharyngeal samples, 
iii) to assess the changes in prevalence of different types both overall and at the 
different sites in the respiratory tract (trachea and nasopharynx) over the period of 
the study, 
iv) to investigate the association of speci fic S. zooepidemicus types with respiratory 
disease whilst controlling for the effects of other risk factors including the 
experimental bacterial vaccine, which contained antigens from 2 specific S. 
zooepidemicus types, 
V) to assess whether there was evidence for clonal succession of types during natural 
respiratory infection by S. zooepidemicus in these ponies. 
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CHAPTER11 
MATERIALS AND METHODS 
11.1 Laboratory methods 
The bacteriology laboratory methods used to identify and quantify bacterial species 
in the pony study in both tracheal wash and nasopharyngeal swab samples have been 
described previously in Chapter 3 in Section 2. 
11.1.1 Storage and re-isolation of S. zooepidemicus isolates 
After 3 passages on streptococcal selective agar (BioMerieux) colonies of S. 
zooepidemicus were transferred from the agar to Eppendorf tubes containing 1.0 n-d of j 
sterile 25% (v/v) glycerol in Todd-Hewitt broth by immersion of a sterile cotton swab after 
streaking across the culture. Isolates were immediately stored frozen at -50'C until typing 
was conducted subsequently with subculture of the frozen stock on 5% (v/v) horse blood 
agar. 
11.1.2 S. zooepitlemicus DNA extraction for PCR 
A single colony forming unit of the subcultured S. zooepidemicus isolate was picked 
from the agar plate using a sterile flamed loop and added to 25 pl Proteinase K buffer (Ix 
Gene Amp Buffer [Perkin Elmer], 0.5% [v/v] Tween 20, lOOpg/n-d proteinase K [Sigma- 
Aldrich]) in a 1.5ml Eppendorf tube. Samples were incubated at 55*C for 30 minutes in a 
water bath, denatured by boiling for 5 minutes and centrifuged for 5 minutes at 10,000g to 
collect the supernatant fraction for immediate PCR. 
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11.1.3 Polymerase chain reaction (PCR) assays 
Nine different PCR assays based on the 16S-23S RNA gene intergenic spacer 
(Chanter el aL, 1997) (4 reactions: A-D) and hypervariable region of the M-like protein 
(Walker & Timoney, 1998) (5 reactions: 1-5) of S. zooepidemicus were used on each 
isolate. The gene regions, primer sequences and product sizes for these PCRs are 
surnmarised in Table 11.1. 
During the conduct of PCR assays on isolates from this study, it became clear that 
some isolates did not have PCR products from any of the 5 reactions for M-like protein 
hypervariable regions. In order to confirm that these isolates did indeed possess M-like 
proteins but that their hypervariable regions were distinct from those used in the existing 
reactions, a reaction using the forward SON and reverse SzPNC3 primers was additionally 
used (Walker & Timoney, 1998). Isolates that yielded product for this but not other 
reactions were classified as having untyped hypervariable regions (HV untyped, HVu). 
The 16S-23S RNA gene intergenic spacer PCR was conducted by mixing lpl of 
extracted sample with 2.5ýd of IN GeneAmp PCR buffer (Perkin Elmer), 0.5gl of lOmM 
dNTP mix, l[tl of each forward and reverse primer mix at 25pMol/pl and O. Ipl of 
AmpliTaq (Perkin Elmer) 5 units/gI and 18.9gl of sterile pure water. 
The M-like protein hypervariable region PCR was conducted by mixing lpl of 
extracted sample with 2.5gl of I Ox GeneAmp PCR buffer 11 (Perkin Elmer), 3.5pl of 20mM 
magnesium chloride, 0.5pl of lOmM dNTP mix, Iýtl of each forward and reverse primer 
mix at 25pMol/gl 0.1 ýtl of AmpliTaq (Perkin Elmer) 5 units/pl and 15.4gl of sterile pure 
water. 
For both reactions, the mixture was heated at 95T for 10 minutes followed by 40 
cycles of 94'C for I minute, 56'C for 2 minutes and 72'C for 2 minutes followed by a 
period of 7 minutes at 72T. 
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Table 11.1: Summary of gene regions, primer sequences and product sizes for typing 
of S. zooepidemicus isolates by 16S-23S RNA gene intergenic spacer and 
M-like protein hypervariable region PCRs 
Primers Region Primer sequence Type(s) Product size (bp) 
Intergenic spacer 
Reaction A Al, Cl 142,311 
Forward primers Rcgla AAAAAGGAAGCACGT17AGCG 
mixture Regla* AAAAAGGAACACGMAGCG 
Reverse primer Reg5a/6a CCGTCTGTTAGTATCCTGTIT 
Reaction B BI, Dl 261,424 
Forward primers Rcgla AAAAAGGAAGCACGTITAGCG 
mixture Rcgla* AAAAAGGAACACGTITAGCG 
Reverse primer Reg6b ATCGACGATGTGTG=AC 
Reaction C A2, C2 145,314 
Forward primer Reglb AAAAAWGGAAGCATGMGGAAG 
Reverse primer Rcg5a/6a CCGTCTGTTAGTATCCTGTTT 
Reaction D B2, D2 264,427 
Forward primer Reglb AAAAAWGGAAGCATGTTTGGAAG 
Reverse primer Reg6b ATCGACGATGTGTG=AC 
Hypervariable region 
Reaction 1 1 403 
Forward primer SzPN ACAAAAGGGGAATAAAATGGC 
Reverse primer HVIR CTGATAGTTGTITACCAGCA 
Reaction 2 2 781 
Forward primers HV2F AGTCGTTCTTGAGCAGAAAA 
mixture HV2VAR AGTTGTTCTTGAGCAAAAAA 
Reverse primer SzPNC3 TTTACCACTGGGGTATA 
Reaction 3 3 411 
Forward primer SzPN ACAAAAGGGGAATAAAATGGC 
Reverse primer HV3R ATGTAAACCTCCACCTGATAA 
Reaction 4 4 409 
Forward primer SzPN ACAAAAGGGGAATAAAATGGC 
Reverse primer HV4R CCCACACGTTCAGGTGATAA 
Reaction 55 780 
Forward primer HV5F ATCATTCGTMAACAAGGCCC 
Reverse primer SzPNC3 T17ACCACTGGGGTATA 
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11.1.4 Detection of PCR products 
After PCR reaction cycling was completed, products were detected by 
electrophoresis of 3pl of sample mixed with 3pl sample buffer in 2% (w/v) agarose 
(Promega), 0.04 mol/l Tris acetate (pH 8.3), 0.001 mol/I ethylene diarnine tetra acetic acid 
(Sigma Aldrich) in GNA 100 apparatus (Pharmacia) at 110 volts for 35 minutes. Product 
sizes were determined by comparison with the relative mobilities of the Gibco I kb standards 
(Gibco). Gels were examined on an ultraviolet transilluminator after immersion in 0.5gg/ml 
ethidium bromide for 15 minutes. 
11.2 Data 
The structure of much of the data for this study has been described previously in 
detail in Chapter 7 in Section 3. In addition to these existing data, results of the PCR typing 
of S. zooepidemicus isolates from tracheal wash and nasopharyngeal swab samples were 
generated and collated to form a larger dataset. 
11.2.1 S. zooepidemicus typing data 
Individual binary variables were initially generated corresponding to each specific S. 
zooepidemicus type as defined by its intergenic spacer type, its hypervariable region type 
and whether it was from either a tracheal wash or nasopharyngeal swab sample. 
Observations corresponded to each week of the study for each pony (n--319). These S. 
zooepidemicus type binary variables were classified as either zero if S. zooepidemicus was 
not isolated from the sample or if isolated was of a different type to that of the variable, as 
one if the isolate was of the exact type corresponding to the variable and as ýnissing if no 
sample or isolate for typing was available. Pooling of data as a baseline category when S. 
zooepidemicus was a different type or not isolated from the sample was done to maximise 
reference category size as very few samples did not have this bacterial species isolated. 
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Additional continuous variables were generated corresponding to the quantification 
of specific S. zooepidemicus types in tracheal washes. These were generated by 
multiplication of the binary type variable by the logio cfu/ml of S. zooepidemicus in the 
tracheal wash, as described in Chapter 5. These variables again took the value of zero if S. 
zooepidemicus was not isolated from the sample or if isolated was of a different specific 
type to that of the variable and were missing if no sample or isolate for typing were 
available. 
11.3 Statistical analyses 
Data from the typing of S. zooepidemicus was initially examined descriptively in 
terms of the proportions of typed isolates of each specific type for each site of sampling 
(trachea and nasopharynx). In addition, the proportion of ponies possessing specific S. 
zooepidemicus types in each sampling site was also investigated in terms of temporal trends 
and differences between vaccine groups. 
Data were also examined for any association between individual S. zooepidemicus 
types and measures of respiratory disease. These were based largely on the methods 
described previously, substituting the generic S. zooepidemicus variable for specific types. 
Due to limitations on the numbers of positive isolates of particular specific types, analyses 
were restricted to the 5 most prevalent S. zooepidemicus types. 
11.3.1 Aggregated clinical sign and airway inflammation scores 
11.3.1.1 Univariable analyses 
Data were examined in the first instance to determine whether there were any 
statistically significant relationships between outcome scores (Clinical score, CDNS score 
and airway inflammation score) and each of the 5 most prevalent S. zooepidemicus types. 
Linear and polynomial regression as described in Chapter 7 in Section 3 were used to 
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examine separately the relationship of logio cfu/ml of specific S. zooepidemicus types with 
the aggregated scores. The most suitable polynomial forms for fitting the data were 
evaluated using the FRACPOLY and COMPARE commands available for linear regression 
analysis in Stata5.0 software. The results of polynomial regression analyses represented the 
best fitting regression models containing 2 or more power terms tested from combinations 
Of X72, X-1, X-0.5, X0.5' X1, X2, X3 and log, x and including products of log, x vvith all other 
powers including itself 
The Wilcoxon rank sum test was used to examine whether there were any 
statistically significant differences in aggregated clinical and airway inflammation scores 
between the presence and absence of specific S. zooepidemicus types on nasopharyngeal 
swabs. Where significant differences were identified, the direction of the difference in 
clinical outcome score was examined. All univariable analyses were conducted using 
Stata5.0 computer software (Stata Corporation). 
11.3.1.2 Multivariable linear regression modelling exchidingpony-level random 
effects 
Multiple linear and polynomial regression modelling was conducted using Stata5.0 
computer software in the same manner as that described in Chapter 7, but with inclusion of 
appropriate variables to best represent individual S. zooepidemicus types in place of the 
generic S. zooepidemicus term. 
11.3.1.3 Multilevel linear regression modelling includingpony-level random effects 
NI[LwiNI. 10 computer software was used to perform multilevel linear and 
polynomial regression modelling with inclusion of random effects. Analyses were conducted 
as previously described in Chapter 7 but with inclusion of appropriate variables representing 
individual S. zooepidemicus types instead of the S. zooepidenficus variable. 
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11.3.2 Individual clinical signs 
Univariable analyses 
Data were initially exarnined for the univariable association of the probability of 
presence of each individual clinical sign (nasal and ocular discharge, coughing, abnormal 
breathing/dyspnoea and submandibular lymph node enlargement) with each of the 5 most 
prevalent S. zooepidemicus types by inclusion in simple ordinary logistic regression (OLR) 
models. Tracheal wash S. zooepidemicus types were examined as binary (type not isolated 
or isolated), ordered categorical (type not isolated, isolated at <10' loglo cfu/mI or isolated 
at ý: 10' loglo cfu/n-A) and continuous (loglo cfu/ml) outcomes. The association between 
outcome and each explanatory variable was expressed as a beta estimate and standard error 
(p & S. E. 0), an estimated unadjusted (crude) odds ratio (OR) with 95% confidence 
intervals around the estimate and corresponding Wald X2 P-value. 
The risk of each outcome with loglo cfu/H of S. zooepidemicus types in tracheal 
washes were examined graphically to assess the most suitable way to express the levels of 
these variables in further multivariable analyses. Where there was not a satisfactory linear 
relationship between the logit of outcome risk and logio cfu/ml S. zooepidemicus, an 
appropriate categorical summary was examined for its suitability of fitting data. 
11.3.2.2 Multivariable logistic regression analysis ignoringpony-level random 
effects 
Multiple logistic regression modelling was conducted as described in Chapter 7 
using Egret computer software with inclusion of appropriate variables representing 
individual S. zooepidemicus types in place of the single, general tenn for S. zooepidemicus. 
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11.3.2.3 Multivariable logistic regression analysis accountingforpony-level random 
effects 
Multilevel logistic regression modelling with inclusion of pony-level random effects, 
was performed as previously described using MLwiNI. 10 and Egret computer software. 
Analyses were conducted with inclusion of appropriate variables representing individual S. 
zooepidemicus types. 
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CHAPTER12 
RESULTS 
12.1 Description of S. zooepidemicus typing data 
12.1.1 All S. zooepitlemicus types 
Table 12.1 summarises the numbers and proportions of samples, isolations and 
different types of S. zooepidemicus from tracheal wash and nasopharyngeal swab samples 
from repeated sampling of 29 Welsh Mountain pony foals. 
Table 12.1: Summary of numbers and proportions of samples, isolations and types of 
S. zooepidemicus from tracheal wash (TW) and nasopharyngeal (NP) swab 
samples 
TW NP swab All samples 
samples samples (TW+NP) 
n%n% n--- 
_% _ 
Total samples 314* 100 319 100 633 100 
S. zooepidemicus not isolated 20 6.4 40 12.5 60 9.5 
S. zooepidemicus isolated (% = prevalence) 294 93.6 279 87.5 573 90.5 
S. zooepidemicus isolate not available for typing 19 16 35 
Number of S. zooepidemicus isolates typed 275 100 263 100 538 100 
Isolates of 10 most prevalent types (Table 12.2) 230 83.6 222 84.4 452 84.0 
Isolates of other types 45 16.4 41 15.6 86 16.0 
Isolates of types from both TW and NP 262 95.3 254 96.6 516 95.9 
Isolates of types from TW or NP guly 13 4.7 9 3.4 22 4.1 
No. of S. zooepidemicus types represented 33 100 27 100 39 100 
Types isolated from both TW and NP 21 63.6 21 77.8 21 53.8 
Types isolated from TW or NP Qnly 12 36.4 6 22.2 18 46.2 
*No tracheal wash sample collected on 5 occasions 
A total of 314 tracheal wash and 319 nasopharyngeal swab samples were collected 
from 29 Welsh Mountain pony foals sampled on II separate occasions (10 consecutive 
weeks [weeks I- 10] and a further sampling 16 weeks later [week 26]). 
S. zooepidemicus was isolated more frequently from tracheal washes than 
nasopharyngeal swabs, with 93.6% of washes and 87.5% of swabs being positive (S. 
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zooepidemicus prevalence). Of the 573 S zooepidemicus isolates that were stored frozen 
after bacterial culture of samples, 538 (94%) were suitable and/or available for typing by 
characterisation of the 16S-23S RNA gene intergenic spacer and M-like protein 
hypervariable region using polymerase chain reaction (PCR). 
PCR tests identified 39 different specific types of S. zooepidemicus among all 
isolates, with 33 types represented among tracheal wash isolates and 27 types among 
nasopharyngeal swab isolates. There were 21 specific types common to both tracheal wash 
and nasopharyngeal swab isolates and these represented 96% of all isolates. Of all isolates 
from washes, swabs and combined, 84% were represented by the 10 most prevalent specific 
types (Table 12.2, Figure 12.1). 
Table 12.2: Summary of specific S. zooepidemicus types isolated from tracheal wash 
(TW) and nasopharyngeal (NP) swab samples 
S. zooepitlemicus type Isolates from TWs 
n% cum. % 
Isolates from NP swabs 
n% cum. % 
Al HVI 47 17.1 17.1 46 17.5 17.5 
Al HV untyped 39 14.2 31.3 41 15.6 33.1 
Al HV3 28 10.2 41.5 20 7.6 40.7 
Cl HV3 26 9.5 50.9 31 11.8 52.5 
Al HV4 18 6.5 57.5 18 6.8 59.3 
Al HV2/3 16 5.8 63.3 13 4.9 64.3 
Cl HV2/3 16 5.8 69.1 17 6.5 70.7 
Al HV2 14 5.1 74.2 13 4.9 75.7 
Al HV2/4 14 5.1 79.3 11 4.2 79.8 
BI/Dl HVI 12 4.4 83.6 12 4.6 84.4 
Other types (Table 12.3) 45 16.4 100 41 15.6 100 
Total 275 100 263 100 
Table 12.2 summarises the number, proportion and cumulative proportion of 
different specific S. zooepidemicus types isolated from tracheal washes and nasopharyngeal. 
swabs. The proportions of all isolates that were specific types were very similar for both 
kinds of samples. Type Al HVI was the most prevalent type (>17%) isolated from both 
tracheal wash and nasopharyngeal. swabs samples and for both these kinds of samples >50% 
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of isolates were represented by the 4 most prevalent types (Al HVI, Al HV untyped, Al. 
HV3 and CI HV3). 
Table 12.3: Summary of numbers of the least prevalent S. zooepidefflicus types 
isolated from tracheal wash (TW) and nasopharyngeal (NP) swab 
samples 
S. zooepidemicus type Isolates from 
TWs 
Isolates from NP 
swabs 
(n) 
Isolates from TWs 
and/or NP swabs 
(n) 
Al HVI/2 8 9 17 
DI HV3 7 1 8 
BI HVI 3 4 7 
CI HV untyped 3 2 5 
BI HV2/3 3 3 6 
BI HV3 2 4 6 
BI HV untyped 2 3 5 
C1 HVI/2 2 0 2 
A2 HV3 1 0 1 
Cl HV2 1 1 2 
DI HV2 1 1 2 
Al. HVIA 1 0 1 
Al HV2/5* 1 0 1 
A1/131 HVI 1 0 1 
DI HVI/2 1 0 1 
DI HVI/3 1 0 1 
Al/D1 HVI/2 1 2 3 
Bl/D1 HVIA 1 0 1 
Al/Bl/D1 HVI 1 0 1 
Cl/D1 HVI/2 1 0 1 
Al/A2 HVI 1 0 1 
DI HV2/3 1 2 3 
DI HV2/5 1 0 1 
BI HV2 0 1 1 
Cl/D1 HVI 0 1 1 
DI HV untyped 0 3 3 
Al HVI/3 0 2 2 
A2 HV2/3 0 1 1 
Al/Cl HV3 0 1 1 
Total number of isolates 45 41 86 
Total number of tvpes, 23 17 29 
* Al HV2/5 was one of 2 types contained in the bacterial vaccine adniinistcrcd to the vaccine group 
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Details of the specific S. zooepidemicus types represented by those other than the 10 
most prevalent types are surnmarised in Table 12.3 and Figure 12.1. For tracheal washes, 45 
isolates were represented by 23 different specific types, 15 of which had only one isolate 
recovered and for nasopharyngeal swabs, 41 isolates were represented by 17 different types, 
II of which had only one or 2 isolates recovered. 
The bacterial vaccine used in the study contained S. zooepidemicus types Al HV2/5 
and D2 HV3. Type D2 HV3 was not isolated during the study and type Al HV2/5 was 
isolated on a single occasion from the tracheal wash of a vaccinated pony in week 3 of the 
study (Table 12.3). 
Table 12.4, which is derived from Tables 12.2 and 12.3, summarises separately the 
different intergenic spacer and hypervariable region type categories of the S. zooepidemicus 
isolates cultured from tracheal wash and nasopharyngeal swab samples. 
Table 12.4: Summary of intergenic spacer and hypervariable region type 
classifications of S. zooepidemicus isolates from tracheal wash (TW) and 
nasopharyngeal (NP) swab samples 
S. zooepidemicus type Isolates from TWs Isolates from NP swabs 
n % cum % ty pes* n % cum % ty pes* 
Intergenic spacer types 
Al 186 67.6 67.6 10 173 65.8 65.8 9 
C1 48 17.5 85.1 5 51 19.4 85.2 4 
DI 12 4.4 89.5 6 7 2.7 87.8 4 
BI 10 3.6 93.1 4 15 5.7 93.5 5 
A2 1 0.4 93.5 1 1 0.4 93.9 1 
Polymorphic (e. g. AUDI) 18 6.5 100 7 16 6.1 100 4 
Total 275 100 33 263 100 27 
Hypervariable region types 
HVI 65 23.6 23.6 6 63 23.9 23.9 4 
HV3 64 23.3 46.9 5 57 21.7 45.6 5 
HV untyped 44 16.0 62.9 3 49 18.6 64.3 4 
HV4 18 6.5 69.5 1 is 6.8 71.1 1 
HV2 16 5.8 75.3 3 16 6.1 77.2 4 
Polymorphic (e. g. HVI/2) 68 24.7 100 15 60 22.8 100 9 
Total 275 100 33 263 100 27 
*Number of specific types represented 
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Of the intergenic spacer types, type Al was by far the most prevalent single type, 
accounting for approximately two-thirds of all isolates. Only 2 A2 types were isolated, each 
on a single occasion from a tracheal wash and nasoPharyngeal swab. Although several 
specific intergenic spacer types, including C2, B2 and D2, were not among the isolates from 
the study, other polymorphic intergenic spacer types (i. e. those containing more than one 
type) were identified and these accounted for approximately 6% of all isolates. 
Among the hypervariable region types, types HVI and HV3 each accounted for a 
little under a quarter of all isolates. There were no HV5 types isolated and a much larger 
proportion (24%) of all isolates were represented by polymorphic hypervariable region 
types compared to those characterised by polymorphic intergenic spacer types (6%). 
12.1.2 The 4 most prevalent S. zooepidemicus types 
12.1.2.1 Distribution of types over time 
Among both tracheal wash and nasopharyngeal swab samples, S. zooepidemicus 
types Al HVI, Al HV untyped (Al HVu), Al HV3 and Cl HV3 were the 4 most 
prevalent types, accounting for more than half of isolates for each sample category. 
Figure 12.2 illustrates on separate graphs the proportion of ponies that were positive 
in tracheal wash and nasopharyngeal swab samples for each of the 4 most prevalent S. 
zooepidemicus types for the 10 consecutive weeks of sampling of the study. Results indicate 
that for each S. zooepidemicus type there was a broadly equivalent pattern of prevalence 
over time for both the tracheal and nasopharyngeal isolates. The prevalence pattern over 
time did, however, vary for individual S. zooepidemicus types and this is illustrated in Figure 
12.3 which shows on 2 separate graphs the distribution of proportions of ponies with 
tracheal washes positive for 2 different types with equivalent peak prevalences. These 
results show that some S. zooepidemicus types such as Al HVI and CI HV3 were 
relatively common in the earlier weeks after sampling started and then declined in the later 
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weeks. In contrast other types such as Al HVu and Al HV2/3 (polymorphic hypervariable 
region) demonstrated the reverse pattern of prevalence, only becoming more prevalent in 
the later weeks of sampling. 
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Figure 12.2: Proportion of ponies positive by week for tracheal wash (TW) and 
nasopharyngeal (NP) isolates of the 4 most prevalent S. zooepidemicus 
types 
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Figure 12.2 continued 
40 
35 
30 
25 
20 
15 
10 
5 
40 
35 
30 
25 
20 
15 
10 
5 
0 
--*-TWAl HV31 
--'4" 'NPAIHV3 I 
WClHV3 
'NPClHV3j 
6789 10 
Week 
3456789 10 
Week 
292 
Equuw InfliflianatwN Aimay h, a, e Epdonwh, gy 
Figure 12.3: Proportion of ponies positive by week for tracheal wash (TW) of 
different S. zooepitlemicus types demonstrates distinct variation in 
temporal distribution 
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12.1.2.2 Distribution of types among vaccine groups and over time 
The 29 ponies in the study were allocated to different vaccine groups. These 
included 5 non-vaccine or placebo ponies from 5 different locations in Wales and 24 ponies, 
comprising 12 animals that were vaccinated and 12 that received placebo, all of which were 
from the same small geographic area. The study design supposed that the mixing of 5 ponies 
(referred to as the late introductions) each from geographically distinct locations with 24 
ponies from a single location would provide an opportunity to increase the number of S. 
zooepidemicus types encountered by the larger groups. In order to examine whether this 
was likely to have occurred, the relative distribution of different types among these groups 
was investigated, both overall and as a distribution over the 10 consecutive weeks of 
examination. 
Figures 12.4 and 12.5 summarise the relative proportions of all the isolates (% of n 
isolates) of the 4 most prevalent S. zooepidemicus types in each vaccine group category for 
tracheal wash and nasopharyngeal swab samples, respectively. Due to the different numbers 
of animals and samples in these groups, the proportions were adjusted for differences in the 
sample numbers between groups. Results show that there were broadly similar distributions 
between the vaccine and placebo groups for the 4 S. zooepidemicus types at both sampling 
sites, with the exception that almost 30% of Cl HV3 isolates came from tracheal washes of 
horses in the placebo group compared to <10% from vaccinated animals. In contrast, there 
was a marked difference in the proportion for types Al HVI, Al HV3 and especially Cl 
HV3, between the late introduction group and the other 2 groups for both sampling sites. A 
much higher proportion of CI HV3 isolates were among ponies in the late introduction 
group compared to the other 2 groups, particularly the vaccinated animals. A much lower 
proportion of both Al HVI and Al HV3 isolates were among the late introductions 
compared to the other groups. Type Al HVu was the most evenly distributed between the 
vaccine groups of the 4 most prevalent types, particularly for the nasopharyngeal isolates. 
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Figure 12A Distribution of tracheal wash isolates of the 4 most prevalent S. 
zooepidemicus types by vaccine group, adjusting for differences in 
sample numbers 
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Figure 12.5: Distribution of nasopharyngeal isolates of the 4 most prevalent S 
zooepidemicus types by vaccine group, adjusting for differences in 
sample numbers 
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Table 12.5 summarises separately for tracheal and nasopharyngeal samples the total 
numbers and proportions of ponies in each vaccine group from which each of the 4 most 
prevalent S. zooepidemicus types were isolated. Results are broadly similar to those for the 
relative proportions of isolates by vaccine group (% of n isolates) adjusting for sample 
numbers in that there is a different distribution of prevalences between vaccine groups for 
different S. zooepidemicus types. 
Table 12.5: Numbers and proportions of ponies in each vaccine group and in total 
from which the 4 most prevalent S. zooepidemicus types were isolated 
Vaccine Placebo Late intro 
S. zooepidemicus group group group Total 
type (n=12) (n=12) (n=5) (n=29) 
n% n% n% n% 
TW AIHVI 11 92% 9 75% 2 40% 22 76% 
NP AIHVI 9 75% 9 75% 1 20% 19 66% 
TW AlHVu 10 83% 9 75% 2 40% 21 72% 
NP AlHVu 8 67% 8 67% 4 80% 20 69% 
TW AIHV3 6 50% 9 75% 1 20% 16 55% 
NP AIHV3 4 33% 7 58% 1 20% 12 41% 
TW ClHV3 2 17% 5 42% 5 100% 12 41% 
NP ClHV3 3 25% 6 50% 4 80% 13 45% 
TW = tracheal wash isolates NP = nasopharyngcal swab isolates 
Figure 12.6 illustrates on separate graphs the proportion of ponies in each vaccine 
group that were positive in tracheal wash samples for each of the 4 most prevalent S. 
zooepidemicus types for the 10 consecutive weeks of sampling of the study. Results indicate 
that for S. zooepidemicus type Al HVI, isolations in the first 5 weeks were from horses in 
the vaccine and placebo groups only and there was a general trend in these 2 groups over 
the entire period for the proportions of positive horses to decline. 
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Figure 12.6: Proportion by week of ponies of each vaccine group positive for tracheal 
wash (TW) isolates of the 4 most prevalent S. zooepidemicus types 
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Figure 12.6 continued 
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In weeks 6 and 7 of the study only one pony from the late introduction group was 
positive in tracheal washes for type Al HVI. 
- 
For type Al HVu there was a similar 
distribution over time for all 3 groups, with the proportion of positive animals increasing 
markedly in the last 4 weeks compared to the first 6 weeks. For type Al HV3 there was a 
difference in temporal distribution of proportion of positive ponies by week between the late 
introduction and the other 2 groups. The peak for the late introduction group occurred in 
weeks 2 and 3 but for the other groups was later at weeks 6 to 8. For type Cl HV3 the 
small proportion of positive vaccine administered ponies occurred in the first 2 weeks, for 
the larger proportion of placebo administered ponies the peak proportion infected occurred 
at week 3 and declined to zero in week 9 and for the late introduction group most animals 
were infected between weeks 5 and 7. 
12.2 Association of S. zooepidemicus types with respiratory disease 
12.2.1 Aggregated clinical sign and airway inflammation scores 
Univariable analyses 
Table AM (Appendix 3) summarises the results and comparisons of linear and best 
fitting polynomial regression analyses of clinical, CDNS and airway inflammation scores 
with loglo cfa/ml tracheal wash counts for each of the 5 most prevalent S. zooepidemicus 
types (Al HVI, Al HVu, Al HV3, CI HV3 and Al. HV4). All analyses were based on a 
sample size of n--295 which comprised 275 sampling occasions when tracheal S. 
zooepidemicus isolates were typed and 20 occasions when S. zooepidemicus was not 
isolated. Higher order models containing 3 or more power terms were investigated but 
found not to significantly improve the fit of the data. 
Figures A3.1 - A3.3, each comprising 5 component graphs for each of the 5 most 
prevalent S. zooepidemicus types, represented the individual data points of logio cfu/ml in 
tracheal washes plotted against the corresponding clinical (Figure A3.1), CDNS (Figure 
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A3.2) and airway inflammation (Figure A3.3) scores and include the summary regression 
line of the best fitting polynon-ýial regression. 
Comparison of the respective linear and polynomial model W values showed that in 
all cases the fitting of a 2-power polynomial regression model increased the amount of 
variability in the data explained by the models. The last 2 columns of Table AM 
represented the decrease in deviance by the polynomial model compared to the linear 
regression and the corresponding P-value based on 3 degrees of freedom in a chi-squared 
distribution. This indicated whether the polynomial model provided a significantly improved 
fit of the data compared to the linear model. 
Results showed a similar pattern across each of the 3 outcome measures, in that the 
same S. zooepidemicus types generally demonstrated similar relationships between the linear 
and polynomial regressions. Linear regression of outcome scores with loglo cfu/ml of types 
Al. HVI and Al HV3 did not demonstrate a significant association between bacterial 
numbers and increasing outcome scores, but polynomial regression predicted a significant, 
non-linear relationship (Figures A3.1-A3.3). This was also true for loglo cfu/ml of CI HV3 
with airway inflammation score. Loglo cfii/ml of types Al HVu and Cl HV3 showed 
significant positive association with clinical and CDNS scores by both linear and polynomial 
regressions and although there was no evidence of a significant difference between the 2, W 
values were greater in the polynomial models. There was a similar relationship between the 
polynomial and linear regression models for logio cfu/ml of Al HVu and Al HV4 and 
airway inflammation score. Although linear regression of Al HV4 with clinical and CDNS 
scores was significant there was also significant improvement and increased R2s with 
polynotnial regression. 
Table 12.6 summarises the results of non-parametric analyses (Wilcoxon rank sum 
test) for significant differences in clinical, CDNS and airway inflammation scores with the 
isolation of each of the 5 most prevalent S. zooepidemicus types on nasopharyngeal swabs. 
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Results showed that although there was no statistically significant association at 
P<0.05 between clinical and CDNS scores and whether specific types of S. zooepidemicus 
were isolated from nasopharyngeal swabs, there was evidence that CDNS scores were 
higher when types CI HV3 or Al. HV4 were isolated from swabs (P<0.07). Consistent with 
this, airway inflammation scores were significantly higher when types Cl HV3 or Al HV4 
were isolated from swabs. 
Table 12.6: Summary of non-parametric analyses examining differences in clinical, 
CDNS & airway inflammation scores with isolation of the 5 most 
. prevalent S. zooepidemicus types on nasopharyngeal swabs 
Outcome variable Explanatory variable Non-parametric test P-value 
Clinical score Nasopharyngeal. Al. HVI isolate 
Nasopharyngeal Al HVu isolate 
Nasopharyngeal. Al. HV3 isolate 
Nasopharyngeal Cl HV3 isolate 
Nasopharyngeal Al. HV4 isolate 
CDNS score Nasopharyngeal Al. HVI isolate 
Nasopharyngcal Al HVu isolate 
Nasopharyngeal Al HV3 isolate 
Nasopharyngeal C1'HV3 isolate 
Nasopharyngeal Al HV4 isolate 
Airway inflammation score Nasopharyngeal Al. HVI isolate 
Nasopharyngeal Al HVu isolate 
Nasopharyngeal Al HV3 isolate 
NasoPharyngeal C1 HV3 isolate 
NasoPharyngeal Al HV4 isolate 
Wilcoxon rank sum 0.510 
Wilcoxon rank sum 0.377 
Wilcoxon rank sum 0.519 
Wilcoxon rank sum 0.176 
Wilcoxon rank sum 0.073 
Wilcoxon rank sum 0.466 
Wilcoxon rank sum 0.384 
Wilcoxon rank sum 0.839 
Wilcoxon rank sum 0.068 
Wilcoxon rank sum 0.061 
Wilcoxon rank sum 0.091 
Wilcoxon rank sum 0.634 
Wilcoxon rank sum 0.344 
Wilcoxon rank sum 0.018 
Wilcoxon rank sum 0.042 
12.2.1.2 Multivariable analyses exchidingpony-level random effects 
Table 12.7 summarises the results from the final ordinary multiple linear regression 
analysis for the clinical score outcome variable including different S. zooepidemicus types as 
explanatory variables. As previously, 2 final models are presented, corresponding to 
separate models for the inclusion of transferrin D and transferrin F2 haplotypes. Both 
models are virtually identical other than for the direction of the regression coefficient 
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estimate for the transferrin haplotype terms. Final models included 2 autoregressive 
variables for the clinical score the week and 2 weeks previously, which had the effect of 
reducing the sample size to n--218. 
Table 12.7: Results of multivariable linear regression of clinical score, including 
individual terms for S. zooepitlemicus types 
Outcome Explanatory variables Regression 95% CI of R' value P-value 
variable / Model in the models (n) coefficient coefficient (%) 
Clinical score (n--218) 
Model I Intercept 6.88 3.34-10.4 57.3 <0.001 
Clinical score I week previously 0.42 0.29-0.55 <0.001 
Clinical score 2 weeks previously 0.15 0.03-0.27 0.016 
Logio cfu/ml non-haera. Strep. -0.49 -0.84 - -0.14 0.006 
[Loglo cfu/ml non-haern. Strep. ]2 0.07 0.02-0.13 0.010 
Logio cfu/ml Pasteurella spp. -0.39 -0.68 - -0.10 0.008 
[Loglo cfu/n-d Pasteurella Spp. ]2 0.07 0.02-0.12 0.008 
Logto cfu/ml Al HVu -1.04 -2.11-0.03 0.056 
[Logio cfu/ml Al HVu12 0.56 0.11-1.01 0.016 
[Logio cfu/ml Al HVu]3 -0.06 -0.11 --0.01 0.010 
Logio cfu/ml Al HV3 -0.39 -0.89-0.12 0.134 
[Loglo cfuhrd Al HV3]2 0.10 0.01-0.19 0.039 
Logio cfu/ml CI HV3 0.23 0.09-0.37 0.001 
[Log 1o cfu/n-d AI HV41 0.92 0.25-1.59 0.007 
[Logto cfuhnl Al. HV41-0-5 -9.70 -16.8 --2.64 0.007 
Transferrin D. haplotype -0.47 -0.87 - -0.07 0.021 
Model 2 Intercept 5.88 2.36-9.41 57.0 0.001 
Clinical score I week previously 0.43 0.30-0.56 <0.001 
Clinical score 2 weeks previously 0.14 0.02-0.26 0.021 
Logio cfu/ml non-haern. Strep. -0.46 -0.81 --0.11 0.010 
12 [Logio cfuhni non-haern. Strep. 0.08 0.02-0.13 0.008 
Loglo cfu/ml Pasteurella spp. -0.41 -0.70 - -0.12 0.005 
[Loglo cfu/ml Pasteurella SpP. 12 0.07 0.02-0.12 0.007 
Logio cfu/ml Al HVu -1.08 -2.15 --0.01 0.048 
12 [Logio cfu/ml Al HVu 0.57 0.12-1.03 0.014 
[Logio cfu/rnl Al HVu1' -0.06 -0.11 --0.02 0.009 
Logio cfu/ml Al HV3 -0.43 -0.93-0.08 0.100 
Pg1o cfu/n-d Al HV3]2 0.10 0.01-0.19 0.031 
Logio cfu/rnl CI HV3 0.22 0.09-0.36 0.003 
[Loglo cfu/ml Al HV411 0.85 0.17-1.53 0.014 
[Logio cfu/ml Al HV4]'0-5 -8.95 -16.1 - -1.85 0.014 
Transferrin F2 haplotype 0.42 -0.01-0.85 0.054 
Models also included various terms for logio cfii/ml counts of tracheal wash bacteria 
including different S. zooepidemicus types. Retained significant terms included counts of 
non-haernolytic Streplococcus spp., Pasteurella spp. and Al HV3 type S. ZOoepidemicus all 
expressed as quadratic terms. S. zooepidemicus type Al HVu was expressed as a cubic 
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term, CI HV3 as a linear term and Al HV4 as a polynomial term. It is of note that the most 
prevalent S. zooepidemicus type, Al HVI, was not statistically associated with clinical 
score in whatever form it was modelled. The W values for these models indicated that 57% 
of the variability of clinical score was explained by the factors retained in thern. 
Table 12.8 summarises the results from the final ordinary multiple linear regression 
analyses for the CDNS and airway inflammation score outcome variables, including 
different S. zooepidemicus types as explanatory variables. As for clinical score, 2 final 
models are presented for CDNS score, corresponding to models containing variables for 
different transferrin haplotypes. Both CDNS score models were virtually identical to those 
for clinical score with the exception that only one autoregressive outcome variable (CDNS 
score one week previously) was retained, this increased the available sample size to n--244. 
The final model for airway inflammation score also included several terms for logio 
cfu/ml counts of tracheal wash bacteria including different S. zooepidemicus types. Retained 
significant or approaching significant terms included counts of non-haemolytic 
Streplococcus spp expressed as a quadratic, S. zooepidemicus types Al HVu and Cl HV3 
expressed as polynomials and Al HV4 as a linear term. Again the most prevalent S. 
zooepidemicus type, Al. HVI, was not statistically associated with airway inflammation 
score in whatever form it was modelled. The Rý values for this model indicated that 40% of 
the variability of airway inflammation score was explained by the factors included in the 
model. 
303 
Equm Mflammatmy Anway DLqmw Epidamology 
Table 12.8: Results of multivariable linear regression of CDNS and airway 
inflammation (Al) score, including individual terms for S. zooepidemicus 
types 
Outcome Explanatory variables Regression 95% C1 of R'value P-value 
variable / Model in the models (n) coefficient coefficient (%) 
CDNS score (n--244) 
Model I Intercept 4.90 2.12-7.67 57.3 0.001 
CDNS score I week previously 0.51 0.40-0.61 <0.001 
Logio cfu/ml non-haem. Strep. -0.45 -0.73 --0.17 0.002 
[Logio cfu/mI non-haem. Strep. 12 0.06 0.02-0.10 0.008 
Logio cfu/n-d Pasteurella spp. -0.34 -0.56 --0.11 0.003 
[Logio cfuhnl Pasteurella SPP. 12 0.06 0.02-0.10 0.003 
Loglo cfuhnl Al IIVu -0.71 -0.60-0.18 0.116 
[Loglo cfu/ml Al HVU]2 0.40 0.02-0.78 0.037 
[Logio cfu/mI Al HVu]3 -0.04 -0.08 - -0.004 0.027 
Loglo cfu/ml Al HV3 -0.34 -0.74-0.07 0.104 
[Logto cfu/nil Al HV3]2 0.07 0.001-0.01 0.046 
Logio cfu/ml CI HV3 0.13 0.01-0.24 0.027 
[Loglo cfuhnl Al HV4]-2 0.006 0.001-0.10 0.016 
[Logio cfu/ml Al HV4]-0.5 -6.50 -11.8 --1.21 0.016 
Transferrin D haplotype -0.40 -0.71 - -0.10 0.010 
Model 2 Intercept 4.07 1.30-6.84 57.2 0.004 
CDNS score I week previously 0.51 0.40-0.61 <0.001 
Loglo cfu/mI non-haern. Strep. -0.42 -0.70 - -0.15 0.003 
[Logio cfu/ml non-haem. Strep. 12 0.06 0.02-0.11 0.006 
Logto cfu/ml Pasteurella spp. -0.35 0.58-0.13 0.002 
[Log Io cfu/ml Pasteurella SPp. ]2 0.06 0.02-0.10 0.002 
Logio cfu/n-d Al HVU -0.72 -1.61-0.16 0.110 
[Loglo cfu/ml Al HVuj2 0.41 0.03-0.78 0.036 
[Logio cfu/ml. Al HVU]3 -0.04 -0.08 - -0.004 0.027 
Loglo cfu/ml Al HV3 -0.36 -0.77-0.04 0.080 
[Logio cfti/mI Al HV3]2 0.08 0.004-0.15 0.039 
Logio cfu/ml CI HV3 0.12 0.006-0.23 0.039 
[Logio cfuhnI Al HV4]-2 0.01 0.001-0.01 0.028 
[Uglo cfu/ml Al HV4], 
0.5 
-5.90 -11.2 - -0.61 0.029 
Transfeffin F2 haplotype 0.42 0.10-0.74 0.011 
AirwavinflammatiOn score (n--214) 
Intercept 3.65 -0.20-7.50 39.6 0.063 
Al score I week previously 0.30 0.18-0.43 <0.001 
AI score 2 weeks previously 0.20 0.10-0.31 <0.001 
Logio cfu/ml non-haern. Strep. -0.59 -0.93 - -0.25 0.001 
[Loglo cfu/ml non-haem. Strep. ]2 0.09 0.04-0.15 0.002 
[Logio cfu/ml Al HVu]" 0.40 0.12-0.69 0.006 
[Loglo cfu/mI Al HVujO-5 4.29 -7.34 - -1.24 0.006 
[Logio cfu/n-d CI HV31-0 5 1.11 -0.07-2.30 0.066 
Log. Pgjo cfb/mI CI HV3] 1.83 -0.03-3.69 0.054 
Loglo cfu/ml Al HV4 0.16 -0.002 - 0.32 0.053 
12.2.1.3 Multivariable analyses accountingfor pony-level random effects 
Table A3.2 summarises the results from multilevel linear regression modelling for 
the outcome variables of clinical score and CDNS score with inclusion of autoregressive 
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explanatory variables, different tracheal wash bacterial variables including S. zooepidemicus 
types and transferrin haplotype variables. Table A3.3 shows similar results for the outcome 
variable of airway inflammation score. Tables 12.9 and 12.10 summarise the final results 
from multilevel linear regression modelling for the 3 outcome variables. 
Sequential inclusion of terms for the different S. zooepidemicus types and where 
relevant transferrin haplotypes, resulted in significant improvements of model fit as judged 
by reduction in deviance and significance of likelihood ratio statistics. Comparison of final 
multilevel models with corresponding final multivariable linear regression models (Tables 
12.7 and 12.8) shows they were very similar in terms of the direction and value of estimated 
coefficients and this was consistent with the non-significant pony-level random effect terms 
in the final multilevel models for clinical and airway inflammation scores. The final 
multilevel models for CDNS score had evidence that the pony-level random effect terms 
were just statistically significant. 
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Table 12.9: Summary of multilevel linear regression modelling of clinical and CDNS 
scores, including individual terms for S. zooepitlemicus types 
Outcome variable / Effect type 
Explanatory variable in model 
Estimate 
(S. E. ) 
Estimate 
(S. E. ) 
Clinical score Model 5a Model 5b 
n--2 19 n=218 
Fixed effect 
Intercept 7.28(l. 73) 6.26(l. 71) 
Clinical score I week previously 0.38(0.06) 0.38(0.06) 
Clinical score 2 weeks previously 0.13(0.06) 0.12(0.06) 
Logio cfu/n-d non-haem. Strep. -0.48 (0.17) -0.46 (0.17) 
[Logio cfu/ml non-haem. Strep. ]2 0.07(0.03) 0.08(0.03) 
Loglo cfu/ml Pasteurella spp. -0.38 90.14) -0.39 (0.14) 
[Loglo cfu/ml Pasteurella SPP12 0.06(0.02) 0.07(0.02) 
Loglo cfuhnl Al Hvu -0.93 (0.52) -0.90 (0.52) 
[Loglo cfu/n-d Al HVu]2 0.52(0.22) 0.50(0.22) 
[Logio cfu/ml Al HVuj3 -0.06 (0.02) -0.05 (0.02) 
Loglo cfu/ml Al HV3 -0.35 (0.25) -0.36 (0.24) 
]2 [Logto cfu/n-d Al HV3 0.09(0.04) 0.09(0.04) 
Loglo cfu/n-d Cl HV3 0.22(0.07) 0.21(0.07) 
[Logio cfu/ml Al HV4]" 0.98(0.33) 0.90(0.33) 
[Logio cfu/ml Al HV4r*5 -10.3 (3.45) -9.48 (3.41) 
Transferrin D phenotype -0.53 (0.23) 
TransferTin F2 phenotype 0.52(0.25) 
Random effect 
Level 2 variance: Pony 0.09(0.08) 0.14(0.09) 
Level I variance: Observation 1.54(0.16) 1.52(0.16) 
-2*loglikelihood 723.16 724.28 
LRS v2 (d. f. ) 5.36(l) 4.24(l) 
P-value 0.021 0.040 
Intra-pony correlation ('16) 5.8 8.2 
CDNS score Model 5a Model 5b 
n--244 rr--244 
Fixed effe9t 
Intercept 5.13(l. 33) 4.42(l. 34) 
CDNS score I week previously 0.42(0.05) 0.42(0.05) 
Logio cfuhnl non-haern. Strep. -0.40 (0.14) -0.38 (0.14) 
[Loglo cfu/ral non-haern. Strep. ]2 0.05(0.02) 0.05(0.02) 
Logio cfu/ml Pasteurella spp. -0.33 (0.11) -0.34 (0.11) 
[Logio cfu/n-d Pasteurella Spa 0.06(0.02) 0.06(0.02) 
Logio cfu/ml Al Hvu -0.59 (0.43) -0.58 (0.42) 
[Logio cfu/ml Al IWU12 0.34(0.18) 0.34(0.18) 
[Logio cfu/mI Al HVU]3 -0.04 (0.02) -0.04 (0.02) 
Logio cfu/nd Al HV3 -0.30 (0.19) -0.31 (0.19) 
j2 [Logio cfuhnI Al HV3 0.07(0.04) 0.07(0.04) 
Loglo cfu/mI CI HV3 0.12(0.06) 0.11(0.06) 
1-2 [Logio cfu/nil Al HV4 0.01 (0.002) 0.01 (0.002) 
[Logio cfu/ml Al HV4]'o 5 -6.86 (2.51) -6.56 (2.52) 
Transferrin D phenotype -0.45 (0.21) 
Transferrin F2 phenotype 0.48(0.21) 
Random effec 
Level 2 variance: Pony 0.15(0.07) 0.15(0.07) 
Level I variance: Observation 1.04(0.10) 1.03(0.10) 
-2*loglikelihood 723.96 723.47 
LRS X2 (d. f. ) 4.56(l) 5.05(l) 
P-value 0.033 0.025 
Intra-pony correlation (116) 12.4 12.8 
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Table 12.10: Summary of multilevel linear regression modelling of airway 
inflammation (AI) score, including individual terms for S. zooepitlemicus 
types 
Outcome variable / Effect Estimate 
Explanatory variable in model (S. E. ) 
Airwav inflammation score Model 5 
n--214 
Fixed effec 
Intercept 3.63(l. 91) 
Al I week previously 0.30(0.06) 
AI 2 weeks previously 0.21(0.05) 
Logio cfu/n-d non-haern. Strep. -0.59 (0.17) 
[Loglo cfu/ml non-haern. Strep. ]2 0.09(0.03) 
[Loglo cfu/mI Al HVu]-1 0.40(0.14) 
[Logio cfu/n-d Al HVu]'0 5 -4.26 (1.51) 
[Logio cfu/ml CI HV3]'0-5 1.11(0.59) 
Log. [Logio cfu/ml CI HV3] 1.83(0.92) 
Loglo cfu/ml Al HV4 0.16(0.08) 
Random effec 
Level 2 variance: Pony 0.00(0.00) 
Level I variance: Observation 1.92(0.19) 
-2*1oglikelihoM 747.14 
LRS X2 (d. f) 3.94(l) 
P-value 0.047 
Intra-pony correlation (/o) 0.0 
Examination of pony-level residuals 
Figures A3.4 and A3.5 represent caterpillar plots of the ranked pony-level residuals 
and their 95% confidence limits for the final multilevel regression models for clinical score 
including transferrin D and F2 haplotypes, respectively. Both figures illustrated that there 
were no significant departures of pony-level residuals as judged by 95% confidence intervals 
that did not include zero (hatched line) and were consistent with the non-significant pony- 
level random effect terms in both these final models (Table 12.9 and A3.2). 
Figures A3.6 and A3.7 represent caterpillar plots of the ranked pony-level residuals 
and their 95% confidence limits for the final multilevel regression models for CDNS score 
including transferrin D and F2 haplotypes, respectively. The pony-level residuals for the 
model with transferrin haplotype D showed that pony 28 was the most extreme outlier only 
pony with a negative residual value i. e. had lower CDNS score than was predicted by the 
final model. For the final model including the transferrin F2 haplotype variable, pony 28 
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again had a significant negative residual and ponies 23 and 26 had significant positive 
residuals i. e. had higher CDNS scores than were predicted by the final model. 
To assess the influence of the largest pony-level residuals on the fit of final models 
for CDNS score, models were refitted with data from the relevant ponies added to the fixed 
effect part of the models as a separate intercept and excluded from the pony-level random 
effects. Table A3.4 summarises the results of further modelling of CDNS score. Results are 
presented for the re-classification of pony 28 in both transferrin D (Model 5b) and F2 
(Model 6b) models and for the reclassification of pony 23 (Model 7b) and pony 26 (Model 
8b) in the transferrin F2 model. 
Results of each stage in the further modelling of CDNS score showed that as the 
ponies with largest absolute value residuals were reassigned in the models there was a 
decrease in deviance and the overall fit of models improved significantly. In all except one 
modelling stage (reclassification of pony 26 in Model 8b) there was an increase in the 
absolute value (but in a negative direction for transferrin D) of the fixed effect estimates for 
the transferrin parameters. This was accompanied by a corresponding decrease in the 
standard errors for these estimates and hence the significance of their association with 
CDNS score also increased. In addition, there was a notable decrease in both the estimates 
and significance of pony level variances across the sequential modelling, which also resulted 
in a sequential decrease in intra-pony correlation. The estimates and standard errors for the 
autoregressive, fixed effect parameters and observation level variances remained largely 
unaltered during this modelling process. 
The final multilevel model (Model 5, Table 12.10) for airway inflammation was 
virtually identical to the final multiple linear regression model (Table 12.8). The model 
contained 2 autoregressive variables, a quadratic term for non-haernolytic Streplococcus 
spp. and various polynomial and linear terms for 3 S. zooepidemicus types in tracheal 
washes. The model had very small pony-level variance and consequently, did not have pony- 
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level residuals that significantly varied' from zero. The model that included the 
autoregressive and non-haemolytic Streplococcus spp. quadratic term (Model 2) did have a 
small amount of non-significant pony-level variance although all pony-level residuals for this 
model had 95% confidence intervals that were small in value and included zero (Figure 
A3.8). 
12.2.2 Individual clinical signs 
12. Z2.1 Univariable analyses 
Tables A3.5 - A3.9 surnmarise results of univariable, ordinary logistic regression 
analyses of the association of different S. zooepidemicus types with the binary outcomes of 
nasal and ocular discharge, coughing, abnormal breathing/dyspnoea and SMLN enlargement 
respectively. 
Results are presented for tracheal and nasopharyngeal isolates of each of the 5 most 
prevalent S. zooepidemicus types, with tracheal isolates represented separately as binary, 
ordered categorical and continuous outcomes and nasopharyngeal. isolates as binary 
outcomes only. 
Results in Table A3.5 indicated that only isolation of S. zooepidemicus type CI HV3 
in tracheal washes was associated with an increased risk of nasal discharge, with the 
significant ordered categorical and continuous results suggesting that risk increased with 
higher logio cfu/ml values. Isolation of any of the 5 most prevalent S. zooepidemicus types 
from the nasopharynx was not shown to be significantly associated with increased risk of 
nasal discharge in these ponies. 
Results in Table A3.6 indicated that isolation of any of the 5 most prevalent types 
from either the trachea or nasopharynx were not shown to be significantly associated with 
increased risk of ocular discharge in these ponies. 
309 
Equine hfflammatmy Aaway Disam Epidenuology 
Results in Table A3.7 indicated that isolation of S. zooepidemicus type Al HVu in 
tracheal washes and type Al HV4 from the nasopharynx were associated with an increased 
risk of coughing. The significant results from ordered categorical and continuous outcomes 
suggested that risk of coughing increased with higher loglo cfu/ml values of Al HVu in 
tracheal washes. 
Results in Table A3.8 indicated that isolation of S. zooepidemicus types Al HVu and 
Al HV4 in tracheal washes and type Al HV4 from the nasopharynx were associated with 
an increased risk of abnormal breathing/dyspnoea. The significant results from ordered 
categorical and continuous outcomes suggested that risk of abnormal breathing/dyspnoea 
increased with higher logio cfu/ml values of both S. zooepidemicus types in tracheal washes. 
Results in Table A3.9 indicated that isolation of S. zooepidemicus type CI HV3 
from the trachea and nasopharynx were both associated with an increased risk of SM[LN 
enlargement. The significant results from ordered categorical and continuous outcomes 
suggested that risk of SMLN enlargement increased with higher loglo cfu/ml values of this 
S. zooepidemicus type in tracheal washes. 
12.2.2.2 Multivariable analyses 
Table 12.11 summarises the final multivariable logistic regression models that 
include pony-level random effects and for illustration of principal purposes the most 
significant terms for individual S. zooepidemicus types for each of the individual clinical 
outcomes of nasal discharge, coughing, abnormal breathing/dyspnoea and SNILN 
enlargement. Results of multivariable logistic regression analyses incorporating pony-level 
random effects are now discussed for each of the individual clinical signs. 
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Table 12.11: Summary of final multivariable logistic regression models including 
pony-level random effects and most significant terms for individual S. 
zooepidemicus types for individual clinical outcomes 
Clinical outcome beine modelled (n) 
Explanatory variables in model 
Egret software 
maximum likelihood estimates (MLE) 
S. E. Odds ratio 95% C1 P-value 
Nasal discharee (n=194) 
Intercept -0.95 0.53 
Nasal discharge I week previously 0.41 0.49 1.51 0.59-3.89 0.394 
Nasal discharge 2 weeks previously 0.14 0.45 1.16 0.48-2.79 0.748 
Nasal discharge 3 weeks previously 1.19 0.37 3.29 1.60-6.73 0.001 
NP B. bronchiseptica 0.86 0.43 2.37 1.03-5.47 0.043 
TW CI HV3 S. zooepidemicus isolated 1.04 0.75 2.83 0.65-12.4 0.165 
Pony level random effects term 0.57 0.53 
Couehint! (n=238) 
Intercept -5.06 0.96 
Coughing I week previously 1.34 0.54 3.81 1.33-10.9 0.013 
Vaccine group: placebo 2.40 0.79 11.0 2.31-52.0 0.003 
Vaccine group: late introduction -0.03 0.92 0.97 0.16-5.91 0.976 
<103 cfu/n-d TW Al HV3 S. zooepidemicus 0.64 1.31 1.90 0.14-24.9 0.625 
>103 cfu/ml TW Al HV3 S. zooepidemicus 1.69 0.78 5.41 1.17-25.0 0.030 
<103 cfu/ml TW Al HV u S. zooepidemicus 0.30 0.94 1.35 0.21-8.56 0.750 
>103CfU/IW TW Al HV u S. zooepidemicus 2.96 0.78 19.2 4.13-89.3 <0.001 
NP Al HV4 S. zooepidemicus isolated 1.53 0.69 4.60 1.20-17.7 0.026 
Transferrin F2 1.77 0.72 5.86 1.44-23.8 0.013 
Pony level random effects term 0.86 0.38 
Abnormal breathinp-/dvspnoea (n=218) 
Model I 
Intercept -0.32 0.54 
Dyspnoea I week previously 0.30 0.47 1.35 0.54-3.39 0.520 
Dyspnoea. 2 weeks previously 1.07 0.42 2.92 1.27-6.71 0.012 
<103 CfU/Ml TW Cl RV3 S. zooepidemicus 2.99 1.44 20.0 1.19-336 0.038 
>103 cfu/ml TW CI HV3 S. zooepidemicus 0.35 0.77 1.41 0.32-6.34 0.650 
<103 cfu/mI TW Al HV4 S. zooepidemicus -0.53 1.93 0.59 0.01-26.1 0.785 
>103 cfu/mI TW Al HV4 S. zooepidemicus 1.39 0.81 4.02 0.82-19.7 0.087 
Transferrin D -1.66 0.62 0.19 0.06-0.64 0.007 
Pony level random effects tenn 0.96 0.41 
Model 2 
Intercept -2.21 0.42 
Dyspnoea I week previously 0.19 0.46 1.21 0.49-2.96 0.677 
Dyspnoea 2 weeks previously 0.98 0.41 2.68 1.19-6.03 0.018 
<103 cfu/ml TW CI HV3 S. zooepidemicus 2.81 1.49 16.7 0.90-309 0.059 
>103 cfii/n-d TW CI HV3 S. zooepidemicus 0.07 0.76 1.07 0.24-4.75 0.928 
<103 cfu/n-d TW Al HV4 S. zooepidemicus -0.33 1.94 0.72 0.02-32.1 0.864 
>103 cfu/ml TW Al HV4 S. zooepidemicus 1.34 0.81 3.82 0.78-18.6 0.097 
Transferrin F2 1.93 0.63 6.90 2.02-23.6 0.002 
Pony level random effects term 0.92 0.38 
SMLN enlargement (n=244) 
Intercept -1.87 0.42 
SNEN enlargement I week previously 1.60 0.45 4.97 2.07-11.9 <0.001 
Vaccine group: placebo 0.26 0.55 1.30 0.44-3.78 0.636 
Vaccine group: late introduction 1.77 0.76 5.85 1.33-25.8 0.019 
<103 cfu/ml TW CI HV3 S. zooepidemicus -0.06 1.38 0.94 0.06-14.1 0.964 
>103 cfu/ml TW CI HV3 S. zooepidemicus 1.26 0.78 3.51 0.76-16.2 0.107 
Pony level random effects term 0.90 0.38 
311 
Equine Inflantmatory Airway Disease Epuleirdology 
Nasal discharg 
The final logistic regression model presented for nasal discharge included all 3 
autoregressive variables, binary terms for type CI HV3 type S. zooepidemicus isolated in 
tracheal washes (not statsitically significant) and Bordetella hronchiseplica recovered from 
the nasopharynx and a pony-level random effect term. 
Examination of the final model showed that among the autoregressive variables, a 
nasal discharge 3 weeks previously was significantly associated with a greater than 3-fold 
increased risk of the same sign in any given week. The autoregressive variables for nasal 
discharge one and 2 weeks previously were retained a priori, irrespective of whether they 
themselves were significantly associated with the clinical outcome. Controlling for the other 
variables in the final model, isolation of Bordefella bronchiseptica from the nasopharynx 
was found to be associated with an increased risk (adjusted OR 2.4, P=0.043) of nasal 
discharge. Although not demonstrated to be statistically significant at the 5% level the best 
evidence for an association between an individual S. zooepidemicus type and nasal discharge 
was for isolation of type CI HV3 from tracheal washes, for which there was an increased 
but non-significant risk (OR 2.8, P=O. 165). 
As these data were highly correlated within individual ponies all final models were 
produced a priori including a pony-level random effects term in order to account for 
random variability between ponies. However, in this final model of nasal discharge including 
all 3 autoregressive variables there was no evidence for significant random variability 
between ponies. 
CoughLn 
Logistic regression analysis of the binary clinical outcome of coughing resulted in a 
final model which included the autoregressive variable of coughing the previous week, 
vaccine group category, categorical classifications of S. zooepidemicits types Al HV3 and 
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Al. HVu in tracheal washes, a binary variable for isolation of Al HV4 from the nasopharynx 
and a pony-level random effect term. 
With inclusion of a significant pony-level random effect term there was evidence of 
an increased risk of coughing in any given week when ponies had coughed the previous 
week, was administered placebo rather than vaccine, had >103 cfu/ml of either type Al HV3 
or particularly type Al. HVu S. zooepidemicus isolated from tracheal washes, had type Al 
HV4 S. zooepidemicus isolated from the nasopharynx or possessed transferrin haplotype 
F2. 
Abnormal breathinedyspnoe 
As with the results of multivariable analyses of aggregated clinical outcome scores, 
2 final models, corresponding to inclusion of either transferrin D (Model 1) or F2 (Model 2) 
haplotypes, were derived for the logistic regression analysis of the binary clinical outcome 
of abnormal breathing/dyspnoea. Other significant or marginally significant and/or a priori 
variables in the final models included the autoregressive variable of abnormal 
breathing/dyspnoea one (a priori) and 2 weeks (significant) previously, categorical 
classifications of S. zooepidemicus types CI HV3 and Al HV4 in tracheal washes 
(marginal) and pony-level random effect term (apriori and significant). 
With inclusion of a significant pony-level random effect term there was evidence of 
an increased risk of abnormal breathing/dyspnoea in any given week when ponies had 
abnormal breathing/dyspnoea 2 weeks previously, had <10' cfu/rnl of type CI HV3 or >103 
cfu/ml of type Al. HV4 S. zooepidemicus isolated from tracheal washes or possessed 
transferrin haplotype F2. There was evidence from model I that ponies that possessed 
transferrin haplotype D were at decreased risk of abnormal breathing/dyspnoea. 
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SMLN enlaraement 
The final logistic regression model for SMLN enlargement included the 
autoregressive variable for clinical outcome the previous week, vaccine group category, a 
categorical classification of S. zooepidemicus types CI HV3 in tracheal washes and a pony- 
level random effect term. 
With inclusion of a significant pony-level random effect term there was evidence of 
an increased risk of SMLN enlargement among ponies that were affected the previous week 
(adjusted OR 5.0, P<0.001) and in ponies that were introduced later compared to 
vaccinated animals (adjusted OR 5.9, P=0.019). Although not demonstrated to be 
statistically significant at the 5% level the best evidence for an association between an 
individual S. zooepidemicus type and SMLN enlargement was for isolation of >10' cfii/n-d 
type CI HV3 from tracheal washes, for which there was an increased but non-significant 
risk (OR 3.5, P=O. 107). 
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CHAPTER13 
DISCUSSION 
13.1 S. zooepidemicus types identified in this study 
Results from this study indicated that compared to the number of ponies (n--29) 
there were a relatively large number of different types of S. zooepidemicus (n--39) isolated 
during the few weeks of intensive sampling. However, there was a marked variation in the 
prevalence of these different types, with a relatively small number of types (n=10) 
accounting for a large proportion of all isolates (84%) and many types being isolated 
relatively infrequently. 
The findings of highly variable prevalence of different types was consistent with 
different S. zooepidemicus types having variable dominance during the period of sampling. 
That is the most prevalent types appeared to become established as dominant types and 
were isolated much more frequently than some other types, which did not appear to become 
established. In this context it is important to note that typing of multiple colonies of S 
zooepidemicus from the same samples in a parallel study in Thoroughbreds demonstrated 
that they were of the same type (R. Laxton & N. Chanter, unpublished observations). This 
was consistent with the findings of Timoney el aL (1997) and confirmed that S. 
zooepidemicus isolates from respiratory tract infections are usually single clones. 
There was also generally similar overall prevalence of different types isolated from 
both nasopharyngeal and tracheal samples (Figure 12.1) and a very similar pattern of 
prevalence of isolates of the same type from these 2 different sites in the respiratory tract 
over the course of the study (Figure 12.2). However, different S. zooepidemicus types, 
whether from the trachea or nasopharynx, demonstrated markedly different patterns of 
prevalence over the course of the study, with some types (e. g. Al HVI and CI HV3) 
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demonstrating declining prevalence and others (e. g. Al HVu and Al HV2/3) showing 
increasing prevalence during the 10 weeks of consecutive sampling. 
Taken together these results provide strong evidence for clonal succession of S. 
zooepidemicus types among groups of ponies. The evidence for such a phenomenon in 
individual animals is at this stage (data not shown), however, less convincing due to the 
large number of individual types isolated from most animals during the course of the study 
relative to the limited number of sampling occasions for each animal. 
This study identified novel S. zooepidemicus types that had not been apparently 
recognised by the original authors of the 2 typing techniques that were simultaneously 
adopted in this study, although a much larger number of isolates were typed in the current 
study. PCR of the M-protein hypervariable region demonstrated that 16% and 18.6% of 
tracheal and nasopharyngeal isolates, respectively, were of a type or types other than the 5 
regions described by Walker & Timoney (1998). Isolates with these untyped hypervariable 
regions have been shown to possess the M-protein gene and produce a product of 
appropriate size when PCR using SzPN and SzPNC3 primers is applied to them (R. Laxton 
& N. Chanter, unpublished observations). Work remains to be done to sequence these 
untyped hypervariable regions and to demonstrate whether or not they are all of the same 
novel type or comprise several different types, which would potentially identify many more 
specific S. zooepidemicus types among the isolates from this and other similar studies. 
This study also demonstrated that some isolates of S. zooepidemicus possessed 
polymorphism of either the M-protein hypervariable region or 16S-23S RNA gene 
intergenic spacer and this also contributed greatly to the increased number of different S. 
zooepidemicus types identified during the study. Results also showed that a far larger 
proportion of isolates had polymorphism of the HV region (23.8%) than the intergenic 
spacer (6.3%) and this was actually a larger proportion of isolates than any other single HV 
region type. Subsequent PCR and Southern blotting investigations using isolates from triple 
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repeated single colony subcultures confirmed the presence of multiple copies of different M- 
protein HV region genes and 16S-23S RNA intergenic spacers (R. Laxton & N. Chanter, 
unpublished observations). 
This study demonstrated that slightly more S. zooepidemicus types were isolated 
from the trachea (n=33) than the nasopharynx (n--27) and a similar finding was observed in 
a parallel study in young Thoroughbreds in training (22 types isolated from tracheal washes 
and 14 types from nasopharyngeal swabs). In addition, there was a larger proportion of 
positive isolations of S. zooepidemicus from the trachea (94%) than the nasopharynx (87%). 
These findings appear somewhat counter to the observation by Timoney et al, (1997) that 
multiple clones of S. zooepidemicus were demonstrated in the tonsils of the upper 
respiratory tract and single clones, all of which were represented among the tonsillar 
isolates, were isolated from lungs of pneumonia cases. From their observations, Timoney et 
aL (1997) hypothesised that lower airway infection with S. zooepidemicus was an 
endogenous opportunistic infection (presumably from a tonsillar source) by a single clone. 
Although tonsils were not specifically sampled in the current study, it may have been 
expected that there would be a gradient of infection to the lower airways, with swabs from 
the nasopharynx detecting more types due to the proximity of the tonsils to the 
nasopharyngeal sampling site and less types identified in the trachea and lungs. If it is a true 
finding that more types are isolated from the lower airway than the upper, this might be 
suggestive of 2 issues. Firstly, there are possible differences in the conditions for 
colonisation between the upper and lower airways and this is possibly related to anatomical 
and physiological differences between these sites. For instance, the difference in proxirnity 
and extent of lymphoid tissue in these different sites may be important and permits the 
preferential persistence of more types more frequently in the lower respiratory tract than the 
upper respiratory tract. Secondly, the ability of the lower and upper respiratory tracts to 
maintain S. zooepidemicus of different types to different extents might be consistent with 
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the source of such infections actually being extraneous (i. e. from the environment) and not 
necessarily endogenous in all cases. 
Examination of data for S. zooepidemicus isolates with specific intergenic spacer 
types but ignoring their HV region types, showed that the most prevalent type was Al, 
which comprised two-thirds of all isolates. The second most prevalent intergenic spacer 
type was Cl, which comprised only 18% of all isolates and in this series of samples 
representatives of some intergenic spacer types were not isolated, including B2, C2 and D2 
types. Among specific HV region types ignoring their intergenic spacer types, there was a 
greater equality of prevalence among the 2 most prevalent (HVI 22.5% and HV3 21.3%) 
and the 2 least prevalent (HV2 5.9% and HV4 6.7%) individual types. A large proportion of 
all isolates (4 1 %) were either polymorphic or untyped (HVu) by the PCRs used in this study 
and no HV5 region types were isolated at all in this study. 
With hindsight, it would have been beneficial if all the ponies had been sampled 
before the group of 5 'late introductions' had been mixed with the 24 other ponies from a 
geographically restricted area and moved to Newmarket. This would have established the 
probable origin of sutypes of S. zoopeidemicus that were later identified. This would have 
made it clearer as to which types probably came from the 'late introductions' and which 
were met in the environment at the new premises in Newmarket. 
13.2 Vaccine strains of S. zooepidemicus 
The strains of S. zooepidemicus included in the vaccine were not typed by the PCR 
methods used in this study prior to their inclusion in the vaccine. Strains of S. 
zooepidemicus were selected by using the opsonins naturally occurring in AHT ponies, 
essentially by the methods of Causey el aL (1995), further supplemented with studies of 
cross-opsonisation using rabbit antisera raised to hot acid extracts of a series from 
temporally and geographically disparate sources. The 2 isolates selected for the vaccine 
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were those exhibiting the least cross-opsonisation. Subsequent typing identified the vaccine 
strains as D2 HV3 and Al HV2/5, which with completion of all typing of S. zoopidemicus 
isolates were found to have an overall prevalence among 538 typed isolates of 0% and 
<0.2%, respectively. This indicated that by M-protein HV region and 16S-23S intergenic 
spacer PCR typing techniques, the 2 specific vaccine strains were not represented (except 
for a single isolate from a vaccinated pony) even among non-vaccinated animals in this 
study. However, one vaccine S. zooepidemicus type was of the most frequently isolated 
intergenic spacer type (Al HV2/5) and the other was of the second most prevalent specific 
single HV region type (D2 HV3). This indicates that typing of an increased number of 
representative equine isolates from different, discrete populations of horses is required so 
that a consensus as to the most appropriate individual types can be achieved. This would 
then allow inclusion in future vaccines of the important virulence determinants in these 
prevalent types, rather than unrepresentative types. 
The degree of immunological cross-protection between different subtypes of S. 
zooepidemicus is not known and therefore it is difficult to properly assess the ability of the 
vaccine in the study to protect against infection vAth different subtypes of the same bacteria. 
However, it is probable from the wide range of subtypes isolated from ponies with overt 
clinical signs of respiratory disease that there was little cross-protection from vaccination, 
although the apparent failure of the vaccine may have occurred for several reasons. Ponies 
may have had previous exposure to the vaccine subtypes and were already protected against 
them or there may have been no natural exposure to the vaccine subtypes during the study 
and as such the vaccine was not actually challenged. 
13.3 Association of S. zooepidemicus types with disease 
There is some evidence that in this population of ponies during the period of study 
that not all of the 5 most prevalent types of S. zooepidemicus demonstrated an equivalent 
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degree of association with disease. This was illustrated in the variation in slopes of the 
regression lines from the best fitting, 2-power polynomial regression models of outcome 
scores plotted against logio cfu/ml of specific S. zooepidemicus types. This was particularly 
evident for the associations of types Al HVI and Al HV4 with clinical scores (Figure 
A3.1). This impression was confirmed with the inclusion of different S. zooepidemicus types 
in multivariable regression and multilevel modelling. In each of the final models using these 
different analysis techniques, S. zooepidemicus type Al HVI was not retained as being 
statistically significantly associated with any of the 3 outcomes of interest after controlling 
for other factors including autoregressive variables, transferrin type and other S. 
zooepidemicus types. 
With individual clinical signs multivariable analyses suggested that after controlling 
for other factors there were some differences in the association of different S. 
zooepidemicus types with specific clinical signs. There was evidence that types Al HV3 and 
Al HVu were more strongly associated with coughing whereas types CI HV3 and Al HV4 
were associated with abnormal breathing/dyspnoea. Care is required though in the 
interpretation of many of these final models as several variables for infection by different S. 
zooepidemicus subtypes were not statistically significantly associated with outcomes at the 
5% level but were retained for illustration of principal purposes only. 
However, considerable care needs to be taken in interpreting these apparent 
differences in association between different S. zooepidemicus types and disease measures as 
they may not necessarily reflect true differences in the virulence of different types. This is 
because there are differences in the previous infectious burdens and consequential immune 
responses of each pony, reflecting likely differences in previous exposure to different types. 
in addition, there would have been acquisition of immunity to different types during the 
course of the study period, albeit that this period was only a few weeks. Therefore, it might 
be expected that the more prevalent types in the earlier weeks of sampling (e. g. type Al 
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HVI) would result in being the most prevalent types overall. With ponies developing 
immunity over the period, this would also result in them having apparently reduced 
virulence compared with isolates that increased in prevalence at a later stage in the study 
period and for which less immunity would have developed. This is again strong evidence for 
clonal succession. 
However, given the ubiquitous nature of S. zooepidemicus infection in horses, 
experimental infections in specific-pathogen-free (SPF) foals would be required to 
definitively demonstrate that there were true differences in the virulence of different S. 
zooepidemicus types (type-specific virulence). From what is known already about likely 
determinants of virulence in S. zooepidemicus and S. equi, it is probable that the HV region 
of the M-protein would be more predictive of virulence than would the 16S-23 S RNA gene 
intergenic spacer, although there will be undoubtedly other important determinants that vary 
between isolates possessing the same HV region and which may possibly be linked to 
intergenic spacer type. The current identification of many different potential virulence 
determinants arising from the sequencing of the genome of S. equi (Carl Robinson, personal 
communication) and cross-checking for their presence or absence in isolates of S. 
zooepidemicus, may allow some future prediction of likely virulence in the absence of 
I. 
challenge infections in SPF foals. In addition, consistency between S. zooepidemicus types 
associated with disease in different animal populations may also help to identify more 
virulent types. In this regard results of sinffir typing techniques applied in Thoroughbred 
racehorses (unpublished observation) and even kennels of dogs suffering severe respiratory 
disease associated with S. zooepidemicus infection (V. Chalker, RVC, personal 
communication) may confirm some of the findings of this study. 
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CHAPTER14 
CONCLUSIONS AND FUTURE WORK 
14.1 Conclusions 
14.1.1 Clinical respiratory disease in Thoroughbred racehorses 
A matched case control study demonstrated that clinically apparent respiratory 
disease in young Thoroughbred racehorses was statistically associated with several 
infectious and non-infectious risk factors. Different comparisons were made between cases 
and controls with and without subclinical disease and controls with sub-clinical disease were 
compared to those with none: 
i) Horses that had ActinobacilluslPasteurella spp. or Mycoplasmafelis isolated from 
the trachea were at increased risk of suffering clinical respiratory disease. 
ii) Streplococcus zooepidemicus in the trachea was significantly associated with both 
subclinical inflammatory airway disease (IAD) in controls and clinical respiratory 
disease in cases when compared with controls with no endoscopic or cytological 
evidence of IAD. 
iii) The only significant upper respiratory tract bacterial infection associated with 
clinical respiratory disease was ActinohacilluslPasteurella spp., which was identified 
only when clinical cases were compared with horses with no endoscopic or 
cytological evidence of IAD. 
iv) There was no significant association found between viral infections and clinical 
disease other than for equine influenza, which was an extremely rare infection in this 
well vaccinated population. 
V) Younger horses were at increased risk of suffering clinical respiratory disease, 
particularly yearlings. 
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vi) Horses that had entered training within the last 3 months were at increased risk of 
suffering clinical respiratory disease. 
vii) Although there was clear potential for confounding between age and recent entry 
into training (e. g. yearlings have invariably entered training within the last 3 
months), simultaneous inclusion of these variables suggested significant independent 
effects. 
In conclusion, this case control study demonstrated that risk of clinical respiratory 
disease in flat trained racehorses in the United Kingdom decreased as horses grew older, 
and spent more time in training. These findings suggest that horses somehow develop 
resistance to the disease following exposure. A limited number of bacterial and mycoplasma 
infections of the trachea and equine influenza virus infection were important risk factors for 
clinical presentation of respiratory disease and development of resistance to these infections 
might explain the reduction in disease in older, longer trained animals. 
14.1.2 Respiratory disease in Welsh Mountain ponies 
The efficacy of an experimental bacterial vaccine was evaluated for its effect on 
natural respiratory disease in recently weaned and transported Welsh Mountain pony foals 
using a blinded and randonýsed, controlled trial. 
Repeated weekly clinical evaluations and microbiological samplings were conducted 
in 12 ponies that received vaccine, 12 ponies that received placebo and 5 other ponies that 
were added after vaccination with the intention of introducing additional infections into the 
group. Both pony-level and observation-level analyses were conducted on study data. 
Isolates of S. zooepidemicus from the trachea and nasopharynx were subjected to 
molecular typing by 2 PCR assays. The hypervariable (HV) region of the M-protein (5 
possible types) and the 16S-23S RNA gene intergenic spacer (8 possible types) were typed. 
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i) Pony-level and observation-level analyses using aggregated clinical scores as the 
dependent variable did not demonstrate any significant effect from vaccination on 
respiratory disease. However, among individual signs there was evidence for 
significantly reduced coughing among vaccinated ponies compared with those that 
received placebo. The vaccine was not associated with a reduction in the burden of 
infection with S. zooepidemicus or Actinobacillus/Pasteurella spp. The apparent 
failure of the vaccine to protect against infection with S. zooepidemicus may have 
occurred for several reasons. The study ponies may have had previous exposure to 
the vaccine subtypes and were already protected against them. Alternatively there 
may have been no natural exposure to the vaccine subtypes during the study and as 
such the vaccine was not actually challenged. If this was the case, however, it would 
suggest that there was little cross-protection conveyed between the vaccine and 
natural challenge subtypes. 
ii) Infection of the trachea with S. zooepidemicus was an important risk factor for 
aggregated clinical scores and some individual clinical signs (nasal discharge, cough 
and abnormal breathing/dyspnoea). There was evidence for a significant dose 
response between S. zooepidemicus infection and dyspnoea and airway 
inflammation. There was only limited evidence for high numbers of Pasteurella spp. 
in tracheal washes being associated with clinical signs. These findings were largely 
consistent with those of previous studies of respiratory disease in young racehorses, 
although the limited sampling frame and relative scarcity of Pastelfrella spp. may 
have contributed to some apparent inconsistency with these studies. 
iii) Observation-level data were analysed using both autoregressive outcomes and use of 
pony-level random effects. There were significant pony-level random effects for 
aggregated clinical scores but not for airway inflammation score and there was 
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variation in the significance of pony-level random effects for different individual 
clinical signs. Models generally included significant autoregressive variables. 
iv) Pony-level analyses demonstrated significant variation between cumulative 
aggregated clinical scores and S. zooepidemicus infectious measures (i. e. summary 
measures of aggregated clinical scores and S. zooepidemicus infections) between 
ponies with different transferrin haplotypes. Compared to ponies that did not 
possess these haplotypes, ponies with haplotype D had significantly lower clinical 
and infectious scores and those with haplotype F2 had significantly higher clinical 
and infectious scores. Observation-level analyses also demonstrated significant 
associations between aggregated clinical scores, coughing and abnormal 
breathing/dyspnoea and transferrin haplotypes D and F2. Haplotypes D and F2 had 
opposing directions of effect, which were consistent with those seen in pony-level 
analyses. 
V) Examination of data from the molecular typing of respiratory isolates of S. 
zooepidemicus from ponies in this study may indicate clonal succession of types 
over time. There is a need in future to look at time series of infections in individual 
animals (e. g. using trellis plots) in order to try and properly assess clonal succession 
of infections by different subtypes of S. zooepidemicus. 
vi) Novel S. zooepidemicus types were identified during the typing of isolates for this 
study (R. Laxton & N. Chanter, unpublished observations). These included 
previously untyped hypervariable region(s) (HVu) and intra-strain polymorphisms of 
both the HV region and intergenic spacer types. These findings indicate that the 
total possible number of S. zooepidemicus types from the simultaneous application 
of these 2 typing techniques could theoretically exceed the originally envisaged total 
of 40. 
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vii) There were more S. zooepidemicus types isolated from the trachea than the 
nasopharynx. 
viii) Although there were apparent differences in the strength of association of different 
S. zooepidemicus types with respiratory disease, considerable care is required in 
interpreting these findings. Further studies are required before drawing any firm 
conclusions (see below). 
In conclusion, this study demonstrated that clinical respiratory disease in 
Welsh Mountain pony foals was associated with respiratory S. zooepidemicus 
infection, irrespective of any effect from the experimental vaccine being evaluated. 
Significant differences in clinical scores and S. zooepidemicus infections between 
ponies was associated with possession of particular transferrin haplotypes. Ponies 
with transferrin haplotypes D were at signifiantly decreased risk of disease and 
infection, whereas those with haplotype F2 were at significantly increased risk. 
14.2 Future work 
This thesis has improved our knowledge of infectious and non-infectious factors 
associated with equine respiratory disease. However, a more complete understanding of the 
disease and its aetiology is needed. In particular, further investigations should include the 
following: 
i) Development of PCR typing techniques fo r accurately identifying 
ActinobacilluslPasteurella spp. and their application in future epidemiological 
studies. Ward et aL (1998) demonstrated the inaccuracy of existing typing methods 
and consequently studies of the association with respiratory disease and these 
bacterial species have remained non-specific. This may lead to a significant 
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underestimation of the strength of association of some specific bacterial species. 
This also leads onto studies of type specific immunity. 
ii) Prospective and specific investigation of the effects of travel and racing on clinical 
and subclinical respiratory disease in racehorses in the United Kingdom may be 
warranted. Possible covariates worthy of examination would include the distance 
and time spent travelling, posture during travel and various racing variables 
particularly including surface and going types. 
iii) The significant differences in measurýs of respiratory disease between ponies 
possessing different transferrin haplotypes identified in this study appear novel and 
as such require confirmation with respect to their repeatability in other groups of 
horses. To this end routine prospective data collection has been initiated at the AHT 
in order to systematically monitor clinical respiratory disease in Welsh Mountain 
pony foals within a few months of their arrival from Wales. These data will be 
analysed for evidence of significant differences in clinical respiratory disease 
between different transferrin haplotypes and with sufficient numbers of animals it is 
hoped to better elucidate differences between ponies of specific transferrin 
phenotypes. In addition, these investigations could easily be extended to examine 
retrospective or prospective data on respiratory disease in Thoroughbred racehorses 
in training yards that keep good clinical records, as transferrin haplotypes are readily 
available through routine blood typing. Retrospective analyses have been performed 
with data from a longitudinal study of respiratory disease in racehorses and results 
are consistent with those found in the pony study in this thesis. 
iv) Investigation of whether the apparently significant effect of transferrin haplotype is 
due to a direct mechanism of action or is due to an alternative mechanism 
manifested through a gene closely linked to the equine transferrin locus, is required. 
Examination of genes in the region of the transferrin locus in other mammalian 
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species with typed genomes (e. g. man, mouse, dog) may reveal likely candidates that 
offer an alternative explanation for these data. These candidates could then be 
specifically identified in the equine genome for their proximity to the transferrin 
locus and their association with disease specifically examined. 
V) Studies to characterise iron binding in the streptococci of clinical importance in 
horses (S. equi, S. zooepidemicus and equine isolates of S. pneumoniae capsule type 
3) are warranted. 
vi) Possible differences in the conditions of colonisation by S. zooepidemicus between 
the upper and lower respiratory tract should be investigated. 
vii) Characterisation of S. zooepidemicus types involved with respiratory disease should 
be extended to other populations such as Thoroughbred racehorses. To this end S. 
zooepidemicus isolates from a small prospective study in 3 Newmarket training 
yards have been typed already and are awaiting analysis of their association with 
inflammatory airway disease. 
viii) The association of specific S. zooepidemicus types with respiratory disease requires 
further investigation. Ideally this should be done through type-specific S. 
zooepidemicus challenge infections in SPF foals, although such animals are not 
currently available. In the absence of SPF foals, characterising likely virulence 
determinants in S. zooepidemicus, identified through the S. equi genome project, 
may provide a preliminary means of predicting virulence. 
in conclusion, this is a novel and exciting area of research for the horse, which in 
future collaborations with specialists in microbial pathogenesis including iron acquisition, 
equine and microbial genetics and infectious disease molecular epidemiology, should bring 
closer the prospect of practical methods for preventing bacterial respiratory disease in 
horses. 
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APPENDIX I 
Relationship between clinical respiratory disease in racehorses and time 
in training and time since last racing 
Figure A I. I: Relationship between time in training and odds of clinical disease 
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Figure A 1.2: Relationship between time since last raced and odds of clinical disease 
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Relationship between tracheal bacteria and mycoplasma and clinical 
respiratory disease in racehorses 
Figure A 1.3: Relationship between S. zooepitlemicus infection and odds of clinical 
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Figure AIA Relationship between ActinobacilluslPasteurefla spp. infection and odds 
of clinical disease 
12 
10 
8 
o6 
4 
2 
0- 
0 
3 
2.5 
2 
1.5 Ix 
0 1 tm 0 
0.5 -j 
0 
-0.5 
-1 
6 
371 
2345 
log cfu 
OR In(OR) --- A--- fitted In(OR) 
2345 
log cfu 
OR In(OR) --- A--- fitted In(OR) 
I jum, Ajm, ýý I h-,, Epidmnolop 
Figure AI. 5: Relationship between S. pneumoniae infection and odds of clinical 
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Figure AI. 6: Relationship between non-haemolyticStreptococcus spp. infection and 
odds of clinical disease 
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Figure AI. 7: Relationship between Staphylococcus spp. infection and odds of clinical 
disease 
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Figure AI. 8: Relationship between Acinetobacter spp. infection and odds of clinical 
disease 
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Figure AI. 9: Relationship between Mycoplasma. felis infection and odds of clinical 
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Figure Al. 10: Relationship between Mycoplasma equirhinis infection and odds of 
clinical disease 
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Table A2.3: Summary of results of non-parametric analyses examining differences in 
cumulative clinical outcome scores according to different pony level 
explanatory variables 
Outcome variable Explanatory variable Non-parametric test P-value 
Clinical score Sex Wilcoxon rank sum 0.18 
Vaccine group Kruskal-Wallis 0.33 
Transferrin D* Wilcoxon rank sum 0.014 
Transferrin F2** Wilcoxon rank surn 0.0024 
Transferrin HI Wilcoxon rank sum 0.72 
Transferrin H2 Wilcoxon rank sum 0.85 
Transferrin 0 Wilcoxon rank sum 0.72 
Transferrin R Wilcoxon rank sum 0.97 
Pr. inhibitor I Wilcoxon rank sum 0.38 
Pr. inhibitor L Wilcoxon. rank sum 0.10 
Pr. inhibitor L2 Wilcoxon rank sum 0.15 
Pr. inhibitor R Wilcoxon rank sum 0.40 
Pr. inhibitor S Wilcoxon rank sum 0.24 
CDNS score Sex Wilcoxon rank sum 0.06 
Vaccine group Kruskal-Wallis 0.29 
Transferrin D* Wilcoxon. rank sum 0.0246 
Transferrin F2** Wilcoxon rank surn 0.0014 
Transferrin HI Wilcoxon. rank sum 0.77 
Transferrin 112 Wilcoxon rank sum 0.61 
Transferrin 0 Wilcoxon rank sum 0.59 
Transferrin R Wilcoxon rank sum 0.97 
Pr. inhibitor I Wilcoxon rank sum 0.54 
Pr. inhibitor L Wilcoxon rank sum 0.15 
Pr. inhibitor L2 Wilcoxon rank sum 0.09 
Pr. inhibitor R Wilcoxon rank surn 0.90 
Pr. inhibitor S Wilcoxon rank sum 0.45 
Nasal discharge Sex Wilcoxon rank sum 0.06 
Vaccine group Kruskal-Wallis 0.46 
Transferrin D* Wilcoxon rank sum 0.19 
Transferrin F2** Wilcoxon. rank sum 0.0052 
Transferrin HI Wilcoxon rank sum 0.57 
Transferrin H2 Wilcoxon rank sum 0.31 
Transferrin 0 Wilcoxon. rank sum 0.56 
Transferrin R Wilcoxon rank surn 0.59 
Pr. inhibitor I Wilcoxon rank surn 0.58 
Pr. inhibitor L Wilcoxon rank sum 0.21 
Pr. inhibitor L2 Wilcoxon rank sum 0.12 
Pr. inhibitor R Wilcoxon rank sum 0.90 
Pr. inhibitor S Wilcoxon rank sum 0.64 
Ocular discharge Sex Wilcoxon rank sum 0.97 
Vaccine group Kruskal-Wallis 0.27 
Transferrin D Wilcoxon rank sum 0.08 
Transferrin F2 Wilcoxon rank sum 0.37 
Transferrin III Wilcoxon rank sum 0.64 
Transferrin H2 Wilcoxon rank sum 0.70 
Transferrin 0 Wilcoxon rank sum 0.18 
Transferrin R Wilcoxon rank sum 0.53 
Pr. inhibitor I Wilcoxon rank sum 0.24 
Pr. inhibitor L Wilcoxon rank sum 0.19 
Pr. inhibitor L2 Wilcoxon rank sum 0.37 
Pr. inhibitor R Wilcoxon rank sum 0.23 
Pr. inhibitor S Wilcoxon rank sum 0.09 
18 ponies with transferrin D haplotype ranked significantly LOWER scores 
** 14 ponies with transferrin F2 haplotype ranked significantly IRGHER scores 
Excluding 4 DF2 phenotypes produces P=0.0426 with significantly LOWER ranking in haplotype +ve ponies 
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Table A2.3 continued 
Outcome variable Explanatory variable Non-paramctric test P-value 
Cough Sex Wilcoxon rank sum 0.15 
Vaccine group Kruskal-Wallis 0.17 
Transferrin D" Wilcoxon rank sum 0.14 
Transferrin F2** Wilcoxon rank sum 0.0225 
Transferrin HI Wilcoxon rank sum 0.34 
Transferrin H2 Wilcoxon rank sum 0.84 
Transferrin 0 Wilcoxon rank sum 0.73 
Transferrin R Wilcoxon rank sum 0.56 
Pr. inhibitor I Wilcoxon rank sum 0.15 
Pr. inhibitor L Wilcoxon rank sum 0.14 
Pr. inhibitor L2 Wilcoxon rank sum 0.32 
Pr. inhibitor R Wilcoxon rank sum 0.32 
Pr. inhibitor S Wilcoxon rank sum 0.28 
Breathing Sex Wilcoxon rank sum 0.08 
Vaccine group Kruskal-Wallis 0.48 
Transferrin D* Wilcoxon rank sum 0.0075 
Transfcrrin F2** Wilcoxon rank sum 0.0002 
Transferrin HI Wilcoxon rank sum 0.52 
Transferrin H2 Wilcoxon rank sum 0.75 
Transferrin 0 Wilcoxon rank sum 0.23 
Transferrin R Wilcoxon rank sum 0.97 
Pr. inhibitor I Wilcoxon rank sum 0.54 
Pr. inhibitor L Wilcoxon Tank sum 0.11 
Pr. inhibitor L2 Wilcoxon rank sum 0.18 
Pr. inhibitor R Wilcoxon rank sum 0.40 
Pr. inhibitor S Wilcoxon rank sum 0.21 
Sub-mandibular LN Sex Wilcoxon rank sum 0.69 
Vaccine group Kruskal-Wallis 0.09 
Transferrin D Wilcoxon rank sum 0.60 
Transferrin F2 Wilcoxon rank sum 0.33 
Transferrin HI Wilcoxon rank sum 0.26 
Transferrin H2 Wilcoxon rank sum 0.95 
Transferrin 0 Wilcoxon rank sum 0.91 
Transferrin R Wilcoxon rank sum 0.44 
Pr. inhibitor I Wilcoxon rank sum 0.98 
Pr. inhibitor L Wilcoxon rank sum 0.77 
Pr. inhibitor L2 Wilcoxon rank sum 0.12 
Pr. inhibitor R Wilcoxon rank sum 0.43 
Pr. inhibitor S Wilcoxon rank sum 0.26 
18 ponies with transferrin D haplotype ranked significantly LOWER scores 
14 ponies with transferrin F2 haplotype ranked significantly FUGHER scores 
Excluding 4 DF2 phenotypes produces P--0.0228 with significantly LOWER ranking in haplotype +ve 
ponies 
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'I'ahle A2 4 continued 
poný Congil 
Score 
Trallsf. 
D/F2 
Poný Breathing 
score 
rransf. 
D/F2 
Pony SMLN 
score 
TransC 
D/F2 
4 D 4 D 2 D 
I D I D 4 D 
17 D 2 D 16 0 D 
is D 7 D 22 D 
2 D 6 D 3 F2 
7 D 19 D 14 F2 
9 D 17 1 D 13 0.5 D 
D S I D 7 0.5 D 
27 F2 28 1 F2 28 0.5 F2 
3 F2 1 2 D 8 0.5 F2 
25 F2 20 2 D I I D 
6 1 D 16 2 D 6 1 D 
22 1 D 13 2 D I I D 
20 1 D 27 2 F2 21 1.5 DF2 
29 1 DF2 9 3 D 18 1.5 DF2 
10 2 D 22 1 D 11 1.5 F2 
19 2 D 3 3 F2 12 2 DF2 
18 2 DF2 18 4 DF2 24 2 F2 
8 2 F2 10 4 DF2 19 2.5 D 
11 2 F2 14 4 F2 17 3 D 
I D 21 5 DF2 20 1) D 
I DF2 8 8 F2 27 3 F2 
14 F2 25 10 F2 5 3.5 D 
29 F2 23, 1 () - 10 4.5 DF2 
26 3 F2 29 11 DF2 9 5.5 D 
21 4 DF2 26 11 F2 29 7 DF2 
21 - 24 11 F2 23 7.5 
12 7 DF2 12 12 DF2 26 8 F2 
24 1 F2 11 13 F2 25 9 F2 
11 2 25 P 0.0002 P 0.33 
P 022Y, p 0. ()()03 p 0.19 
Wilcoxon rank sum Icst for fransfurin F2 haplot)pc (highlightcd) 
Wilcoxon rank suni Icst for transfurin D liaplotýpe cxcluding DF2 phenotype 
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Table A2.5: Results of linear regression of cumulative clinical parameter scores and 
summary explanatory variables for S. zooephlemicus 
Outcome 
variable 
Explanatory 
Variable 
Regression 
coefficient 
95% CI of 
coefficient 
Intercept R2 value 
(%) 
P-value 
Clinical score Loglo total cfu/ml 4.7 1.8-7.6 -2.1 29.0 0.003 
Maximum login cfU/ml 4.2 1.4-7.1 1.7 25.6 0.005 
Geometric mean login cfu/mI 7.6 3.7-11.6 -0.6 36.6 0.001 
Total weeks with ZA03 cfu/ml 1.6 0.1-3.1 15.6 14.9 0.039 
Total weeks with 2404 cfu/ml 2.7 1.2-4.1 16.0 35.1 0.001 
Total weeks with ; ->105 cfu/ml 
3.5 1.5-5.5 19.2 32.5 0AW1 
Week 26 logloctu/ml 1.8 -0.8-4.3 21.3 7.3 0.166 
CDNS score Login total cfu/ml 4.5 2.1-6.9 -10.4 35.1 0.001 
Maximum ]ogle cfu/ml 4.1 1.7-6.5 -7.1 31.7 0.001 
Geometric mean login cfu/ml 7.4 4.2-10.6 -9.4 45.7 <0.001 
Total weeks with Zq03 CfU/Ml 1.7 0.4-3.0 5.7 21.3 0.012 
Total weeks with Z404 cfu/ml 2.5 1.3-3.7 7.2 39.4 <0.001 
Total weeks with >-105 cfu/mI 3.2 1.5-4.9 10.3 36.0 0.001 
Week 26 loglocfu/ml 1.8 -0.4-4.0 11.9 10.2 0.098 
Nasal discharge Login total cfu/ml 6.3 2.4-10.2 -6.8 28.8 0.003 
Maximum login cfu/mI 5.9 2.2-9.7 -3.1 27.9 0.003 
Geometric mean login cfu/ml 9.8 4.3-15.2 -3.1 33.3 0.001 
Total weeks with >-103 cfu/mI 2.4 0.4-4.4 15.5 18.5 0.020 
Total weeks with 2tI04 cfu/m1 3.0 0.9-5.0 19.8 24.2 0.007 
Total weeks with ZA05 cfu/ml 3.7 0.8-6.7 23.7 17.6 0.014 
Week 26 login cfuln-d 2.2 -1.2-5.6 24.9 6.6 0.188 
Ocular discharge Log in total cfu/ml 0.7 -3.8-5.2 33.4 0.4 0.746 
Maximum loglocfu/ml 0.5 -3.8-4.8 35.0 0.2 0.829 
Geometric mean loglo cfu/ml 0.8 -5.7-7.3 34.9 0.2 0.808 
Z: 103 Cf, /ml Total weeks with -u -0.2 -2.4-1.9 
39.1 0.2 0.827 
ýq04 CfU/rnl Total weeks with - 
0.8 -1.5-3.1 34.6 1.9 0.475 
Total weeks with >-I 05 cfu/ml. 1.1 -2.0-4.2 35.6 1.9 0.478 
Week 26 login cfu/ml -0.2 -3.6-3.3 37.6 0.04 0.923 
Cough Logle total cfu/mI 1.2 -0.1-2.5 -3.4 12.4 0.061 
Maximum logiocfu/ml 1.0 -0.2-2.3 -1.9 9.1 0.111 
Geometric mean login cfu/mI 2.6 0.9-4.3 -5.0 26.1 0.005 
Total weeks with > 103 CfU/Ml 0.5 -0.1-1.1 0.6 9.8 0.099 
Total weeks with ., ý104 CfU/Ml 0.9 0.4-1.5 0.5 26.1 0.005 
Total weeks with, >10s cfu/ml 1.4 0.6-2.2 1.3 31.3 0.002 
Week 26 logio du/ml. 0.8 -0.2-1.8 1.8 10.4 0.094 
Breathing Login total cfu/mI 3.1 1.0-5.3 -10.0 25.0 0.006 
Maximum logle cfU/mI 2.9 0.8-4.9 -7.6 22.5 0.009 
Geometric mean ]ogle cfu/ml 5.0 2.0-8.0 -8.7 30.7 0.002 
, ý103 Total weeks with'- cfU/m1 1.0 -0.2-2.1 2.5 10.4 0.088 
ý. 104 CfU/Ml Total weeks with _ 
1.8 -2.8 0.7 2.0 30.8 0.002 
; >105 CfU/Ml Total weeks with _ 
2.0 -4.0 1.1 3.9 33.4 0.001 
Week 26 loglocfu/ml 0.9 -1.0-2.8 6.5 3.5 0.338 
SMLN Login total cfu/ml 1.5 0.1-2.9 4.1 15.5 0.034 
Maximum login cfu/ml 1.4 0.04-2.7 -3.1 14.3 0.043 
Geometric mean login cfu/ml 2.4 0.4-4.3 -3.4 18.3 0.021 
Total weeks with; ->10" cfu/ml 
0.6 -0.04-1.3 0.8 12.1 0.064 
Total weeks with 2q04 CfU/Ml 0.7 -0.01-1.4 2.2 13.2 0.053 
Total weeks with -? -105 cfu/ml 
0.6 -0.4-1.7 3.6 5.7 0.212 
Week 26 log jo cfu/ml 0.7 -0.4-1.9 3.2 6.7 0.185 
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Figure A2.1: CDNS score vs. logio total cfu/ml S. zooepidemicus in tracheal washes 
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Figure A2.2: CDNS score vs. maximum logio cfu/ml S. zooepidemicus in tracheal washes 
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Figure A2.3: CDNS score vs. mean loglo cfu/ml S. zooepidemicus in tracheal washes 
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Figure A2.4: CDNS score vs. total weeks with ýq04 CfU/Ml S. zooepidemicus in tracheal 
washes 
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Figure A2.5: CDNS score vs. total weeks with ý405 cfu/ml S. zooepidemicus in tracheal 
washes 
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Table A2.6: Results of linear regression of cumulative clinical parameter scores and 
summary explanatory variables for A. equuli 
Outcome 
variable 
Explanatory 
Variable 
Regression 
coefficient 
95% CI of 
coefficient 
Intercept R'value 
(%) 
P-value 
Clinical score Loglo total cfu/ml 3.2 0.03-6.5 16.5 13.7 0.048 
Maximum logio cfu/ml 3.3 0.1-6.5 16.6 14.1 0.044 
Geometric mean loglo cfu/n-d 6.1 -10.1-22.2 22.9 2.2 0.448 
Total weeks with ', 103 CfU/Ml 5.5 -2.5-13.5 23.2 6.9 0.168 
Total weeks with ýq04 cfu/n-d 8.3 -6.7-23.2 24.9 4.6 0.266 
Total weeks with ; ->105 cfu/ml 
16.3 -1.0-33.5 24.6 12.2 0.064 
Week 26 logio cfuhnl 1.0 4.8-6.7 25.2 0.5 0.732 
CDNS score Uglo total cfu/mI 2.6 -0.3-5.4 9.0 7.4 0.074 
Maximum loglo cfu/ml 2.6 -0.3-5.4 9.1 7.4 0.074 
Geometric mean logio cfu/ml 6.1 -7.9-20.1 13.4 2.9 0.379 
Total weeks with ý: 103 CfUhnl 4.2 -2.9-11.2 14.4 5.2 0.233 
ý: 104 Cflij/ml Total weeks with - 
7.1 -6.0-20.2 15.6 4.4 0.274 
Total weeks with ý->105 cfu/ml 15.3 0.4-30.2 15.2 14.1 0.045 
Week 26 logio cfu/ml -0.3 -5.4-4.7 16.2 0.07 0.890 
Nasal discharge Logio total cfu/ml 1.9 -2.7-6.5 25.3 2.6 0.402 
Maximum 1091DCfU/Ml 1.9 -2.7-6.4 25.5 2.5 0.413 
Geometric mean loglocfu/ml 4.8 -17.1-26.7 28.5 0.7 0.659 
Total weeks with ýq03 CfU/Ml 5.9 -5.0-16.8 28.0 4.3 0.279 
Total weeks with ýq04 cfu/n-d -0.03 -20.7-20.6 30.7 0.00 0.998 
Total weeks with ý! 105 cfuhnl 2.5 -22.3-27.3 30.5 0.2 0.839 
Week 26 logio cfu/ml 0.4 -7.3-8.1 30.1 0.04 0.918 
Ocular discharge Loglo total cfu/ml 2.7 -1.7-7.2 29.8 5.7 0.211 
Maximum loglocfu/ml 2.9 -1.5-7.3 29.5 6.5 0.183 
Geometric mean loglo cfu/n-d 0.02 -21.4-21.4 37.6 0.00 0.998 
Total weeks with 2ý 103 CfU/ml 5.6 -5.1-16.2 35.1 4.1 0.294 
Total weeks with _I 
04 CfU/ml 4.9 -15.1-24.9 37.1 0.9 0.620 
Total weeks with ý: 105 cfu/ml 4.2 -19.9-28.2 37.3 0.5 0.725 
Week 26 loglo cfu/ml 5.3 -1.9-12.5 36.0 8.0 0.144 
Cough Logio total cfu/mI 1.4 0.2-2.7 -0.2 16.7 0.028 
Maximum logio cfu/mI 1.5 0.2-2.7 -0.2 17.7 0.023 
Geometric mean logle cfu/ml 6.6 0.6-12.6 0.8 16.1 0.031 
. 
103 Cfl, /Ml Total weeks with - 
1.5 -1.8-4.8 3.2 3.2 0.353 
Total weeks with 2t104 CfU/Ml 5.4 -0.4-11.1 3.3 11.9 0.066 
Total weeks with; ->105 cfu/ml 
9.8 3.6-16.1 3.2 27.7 0.003 
Week 26 logio cfu/ml 0.5 -1.8-2.7 3.6 0.7 0.680 
Breathing Idogio total cfu/mI 2.3 -0.1-4.6 2.2 12.8 0.056 
Maximum logio cfulml 2.3 -0.1-4.6 2.3 12.9 0.056 
Geometric mean 1091D CfU/Ml 5.2 -6.3-16.8 6.2 3.1 0.360 
Total weeks with 2: 103 CfU/Ml 3.5 -2.3-9.3 7.1 5.3 0.230 
Total weeks with 2: 104 CfU/Ml 6.7 4.0-17.4 7.9 5.8 0.207 
Total weeks with 2tI05 cfu/ml 14.4 2.4-26.3 7.6 18.3 0.020 
Week 26 loglocfuhnl -0.2 -4.4-4.0 8.6 0.03 0.927 
SMLN Log jo total cfu/ml 0.5 -1.0-2.0 3.5 1.5 0.521 
Maximum loglocfuhnl 0.5 -1.0-2.0 3.5 1.5 0.534 
Geometric mean logio cfu/ml -2.1 -9.3-5.0 5.8 1.4 0.542 
Total weeks with 2: 103 cfu/n-d 0.4 -3.3-4.0 4.7 0.2 0.544 
Total weeks with _104 CfU/Ml 2.1 -4.6-8.7 4.6 1.4 0.535 
Total weeks with ýt105 cfu/n-d 5.0 -2.8-12.9 4.5 6.0 0.201 
Week 26 logio cfu/ml -1.2 -3.7-1.3 5.2 3.5 0.343 
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Table A2.7: Results of linear regression of cumulative clinical parameter scores and 
summary explanatory variables for Pasteurella spp. 
Outcome 
variable 
Explanatory 
Variable 
Regression 
coefficient 
95% CI of 
coefficient 
Intercept R2 value 
(%) 
P-value 
Clinical score Logio total cfu/ml 8.1 1.3-14.9 -24.2 18.1 0.022 
Maximum logio cfU/ml 6.6 0.1-13.1 -13.2 13.8 0.048 
Geometric mean logio cfu/ml 2.9 -3.0-8.9 17.0 3.6 0.321 
Total weeks with ý, 103 CfU/Ml 0.5 -2.3-3.3 22.7 0.5 0.715 
ý: 104Cfa/ml Total weeks with - 
1.9 -0., 3-4.2 16.7 10.1 0.093 
Total weeks with ý105 cfu/ml 3.1 0.6-5.7 17.3 19.1 0.018 
Week 26 logio cfu/ml 1.6 -0.6-3.7 21.8 7.7 0.152 
CDNS score Lagio total cfu/ml 8.2 2.5-14.0 -34.5 24.5 0.006 
Maximum logio cfu/ml 6.5 1.0-12.0 -22.2 17.7 0.023 
Geometric mean loglocfuhnl 4.4 -0.6-9.4 3.0 11.0 0.079 
ýt 103 CfU/ml Total weeks with - 
1.1 -1.3-3.5 9.6 3.1 0.361 
Total weeks with ý: 104 CfU/Ml 2.4 0.6-4.3 5.0 20.8 0.013 
Total weeks with ýq05 CfU/Ml 3.5 1.5-5.6 6.8 31.4 0.002 
Week 26 logio cfu/ml. 1.5 -0.4-3.4 12.6 9.5 0.111 
Nasal discharge Logio total cfU/ml 10.5 1.3-19.8 -34.1 16.7 0.028 
Maximum logio cfu/ml 8.5 -0.3-17.3 -19.4 12.6 0.059 
Geometric mean logio cfu/ml 5.2 -2.7-13.1 15.3 6.2 0.191 
Total weeks with ýt 103 CfU/nd 1.3 -2.4-5.0 22.8 1.9 0.491 
; >104 CfU/Ml Total weeks with _ 
3.8 -6.7 1.0 12.8 21.8 0.011 
Total weeks with; >-105 cfu/ml 4.4 1.0-7.8 18.9 20.5 0.014 
Week 26 logio cfu/ml 0.2 -2.9-3.2 29.8 0.04 0.918 
Ocular discharge Logio total cfu/ml -0.7 -10.6-9.1 42.1 0.08 0.882 
Maximum logio cfu/ml 0.1 -9.1-9.2 37.3 0.00 0.989 
Geometric mean loglocfu/ml -6.1 -13.7-1.4 55.9 9.3 0.108 
Total weeks with ý: 103 CfU/ml -2.4 -6.0-1.1 52.4 6.8 0.173 
Total weeks with ýt 104 CfUhnl -1.9 -5.0-1.1 46.7 5.9 0.205 
Total weeks with; ->105 cfu/n-d -1.5 -5.1-2.2 
41.6 2.4 0.422 
Week 26 logio cfu/ml 0.01 -2.8-3.1 36.9 0.03 0.925 
Cough Log, o total cfuhnl 2.0 -0.9-4.9 -8.8 7.2 0.159 
Maximum loglocfu/ml 1.6 -1.2-4.3 -5.5 5.0 0.246 
Geometric mean loglocUral. 0.5 -1.9-2.9 2.3 0.7 0.663 
Total weeks with; >-103 cfu/ml -0.2 -1.3-0.9 5.2 0.6 0.692 
Total weeks with ý! 104 CfU/Ml 0.2 -0.7-1.2 2.8 0.9 0.632 
Total weeks with Z: 105 cfu/ml 0.9 -0.1-2.0 1.4 10.4 0.081 
Week 26 loglocfu/ml 0.4 -0.5-1.3 2.8 3.3 0.358 
Breathing Logio total cfu/ml 6.3 1.5-11.1 -30.3 21.2 0.012 
Maximum logto cfu/ml 5.1 0.5-9.7 -20.5 15.9 0.032 
Geometric mean loglo cfu/ml 4.3 0.3-8.3 4.2 15.0 0.038 
Z! 103 CfU/ml Total weeks with 1.1 -0.8-3.1 1.7 5.0 0.243 
Total weeks with : ý104 CfU/Ml 1.9 0.3-3.4 -0.1 18.0 0.022 
; >105 CfU/Ml Total weeks with _ 
2.9 -4.6 1.2 0.9 30.5 0.002 
Week 26 logle cfu/ml 1.4 -0.1-2.9 5.3 12.0 0.071 
SMLN lAgio total cfu/ml 2.9 -0.2-6.0 -13.3 12.3 0.062 
Maximum loglo cfu/ml 2.2 -0.7-5.2 -8.4 8.2 0.133 
Geometric mean logjocfu/ml 1.5 -1.1-4.1 0.2 5.2 0.235 
ý: 103 CfU/Ml Total weeks with - 
0.6 -0.6-1.8 1.0 4.0 0.296 
Total weeks with Z: 104 CfU/Ml 0.8 -0.2-1.8 0.9 9.8 0.099 
Total weeks with; -> 
105 cfu/ml 1.0 -0.1-2.2 2.0 10.8 0.081 
Week 26 10gl@ cfu/ml 1.2 0.3-2.0 2.2 21.8 0.012 
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Table A2.8: Results of linear regression of cumulative clinical parameter scores and 
summary explanatory variables for R bronchiseptica 
Outcome 
variable 
Explanatory 
Variable 
Regression 
coeff icient 
95% CI of 
coefficient 
Intercept R'value 
(%) 
P-value 
Clinical score Log jo total cfu/ml -1.5 4.5-1.5 34.4 3.8 0.312 
Maximum logiocfu/ml -1.6 4.6-1.4 34.9 4.3 0.279 
Geometric mean loglocfu/n-d -3.8 -11.0-3.3 30.9 4.3 0.280 
Total weeks with ý: 103 CfU/Inj -1.5 4.6-1.7 28.9 3.4 0.340 
Total weeks with Z: 104 CfU/ml -0.8 4.6-2.9 27.0 0.8 0.651 
Total weeks with; -> 105 cfu/ml -1.5 -5.9-2.9 
27.7 1.8 0.490 
Week 26 logiocfu/ml* - - - - 
CDNS score I. A)glo total cfb/ml -1.8 4.4-0.8 26.5 7.0 0.165 
Maximum logio cfu/ml -1.9 4.5-0.7 27.0 7.7 0.144 
Geometric mean loglo cfu/ml -3.9 -10.1-2.3 21.6 5.9 0.206 
Total weeks with , 103 CfU/ml -1.6 4.4-1.1 19.8 5.4 0.227 
Total weeks with Zý104 cfu/n-d -0.7 -3.9-2.6 17.3 0.7 0.677 
Total weeks with; ->105 cfu/n-d -1.2 -5.1-2.6 
17.9 1.6 0.516 
Week 26 logio cfu/ml* - - - 
Nasal discharge Loglototal cfuhnl -2.5 -6.5-1.5 45.0 5.7 0.210 
Maximum loglocfu/n-d -2.7 -6.7-1.3 45.8 6.5 0.183 
Geometric mean loglocfulml 4.4 -14.1-5.2 36.7 3.2 0.354 
Total weeks with,, 103 CfU/nd -2.3 -6.5-1.9 35.6 4.4 0.276 
Total weeks with . 
104 CfU/Ml -0.7 -5.8-4.3 31.8 0.3 0.768 
Total weeks with; -> 
105 cfu/ml 0.1 -5.9-6.1 30.5 0.01 0.962 
Week 26 logio cfu/ml* - - - - 
Ocular discharge Logio total cfb/ml 1.2 -2.8-5.2 30.8 1.4 0.542 
Maximum logto cfu/n-d 1.1 -2.8-5.1 31.1 1.3 0.560 
Geometric mean loglocfu/ml 0.4 -9.2-9.9 37.1 0.03 0.934 
2t103 Total weeks with - cfu/n-d 
0.6 -3.6-4.8 36.4 0.3 0.773 
Total weeks with Z: 104 CfU/ml -0.6 -5.5-4.3 38.5 0.2 0.804 
Total weeks with Z! 105 cfuhni -0.9 -6.7-4.9 38.8 0.4 0.751 
Week 26 1091DCfU/Ml* - - - - 
Cough Logio total cfu/ml -0.4 -1.6-0.8 5.9 1.4 0.545 
Maximum loglocfu/n-d -0.4 -1.6-0.8 6.1 1.7 0.504 
Geometric mean logio cfu/ml -0.02 -2.9-2.9 3.9 0.00 0.990 
Total weeks with Zt 103 CfU/Ml -0.02 -1.3-1.3 3.9 0.01 0.970 
Total weeks with ýt 104 CfU/Ml 0.4 -1.0-1.9 3.2 1.4 0.542 
Total weeks with Z: l 05 cfu/n-d 0.3 -1.5-2.1 3.5 0.4 0.744 
Week 26 logio cfu/nil* - - 
Breathing Logio total cfu/ml -0.9 -3.0-1.3 13.5 2.4 0.423 
Maximum logio cfb/ml. -0.9 -3.1-1.3 13.7 2.6 0.405 
Geometric mean logio cfb/ml -3.8 -8.8-1.2 13.8 8.2 0.133 
ýt 103 CfU/ml Total weeks with - -1.4 -3.6-0.8 
11.6 5.8 0.208 
ýq04' Total weeks with - cfu/n-d -0.8 -3.5-1.9 
9.9 1.4 0.546 
Total weeks with Z: 105 cfu/n-d -1.4 4.5-1.8 10.3 2.8 0.388 
Week 26 logio cfu/ml* - - - - 
SNEN Log jo total cfu/ml. -1.1 -2.4-0.1 11.3 11.2 0.076 
Maximumlogjocfb/ml -1.2 -2.4-0.1 11.5 11.8 0.068 
Geometric mean logio cfu/ml -1.8 -5.0-1.3 7.3 5.1 0.241 
Total weeks with . 103 Cfl, 
/Ml 
-0.7 -2.1-0.7 6.3 3.9 0.305 
Total weeks with Z: 104 CfU/ml -0.6 -2.3-1.0 5.8 2.4 0.421 
Total weeks with Z! 105 cfu/nd -0.6 -3.4-0.3 6.8 9.9 0.097 
Week 26 log io cfu/ml* - - - - 
* Analyses not possible as B. bronchiseptica was not isolated from any tracheal -, vashcs at week 26 of the study 
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Table A2.9: Results of linear regression of cumulative clinical parameter scores and 
summary explanatory variables for non-haemolytic Streptococcus spp. 
Outcome 
variable 
Explanatory 
Variable 
Regression 
coefficient 
95% CI of 
coefficient 
Intercept R2 value 
(%) 
P-value 
Clinical score Logia total cfu/ml -1.1 -6.6-4.4 31.9 0.6 0.690 
Maximum loglo cfu/ml -0.6 -6.4-5.1 29.2 0.2 0.818 
Geometric mean logio cfu/mI -3.9 -7.5--0.2 38.1 14.8 0.039 
; >103 CfU/Ml Total weeks with _ -1.7 -3.2--0.2 
36.9 16.7 0.028 
Total weeks with ý: 104 CfU/Ml -0.6 -2.3-1.1 28.4 2.0 0.467 
Total weeks with -? -105 cfuhnl 
0.1 -2.1-2.3 25.5 0.03 0.929 
Week 26 lo-10 cfu/n-d -1.2 -3.4-1.1 28.6 4.1 0.293 
CDNS score Logio total cfuhnl -0.4 -5.2-4.4 18.6 0.1 0.865 
Maximum loglo cfuhnl 0.1 4.9-5.1 15.8 0.00 0.973 
Geometric mean logle cfu/mI -3.7 -6.8--0.5 28.0 17.3 0.025 
; >103 CfU/Ml Total weeks with _ -1.7 -2.8--0.3 
26.8 19.2 0.017 
Total weeks with ý! 104 CfU/nd -0.7 -2.1-0.8 19.3 3.2 0.355 
Total weeks with; ->105 cfu/ml. 
0.04 -1.9-2.0 16.2 0.01 0.964 
Week 26 loglo cfu/ml -1.2 -3.1-0.8 19.1 2.0 0.222 
Nasal discharge Logio total cfu/rnl -1.2 -8.7-6.2 37.7 0.4 0.737 
Maximum logio cfu/ml -0.7 -8.4-7.0 34.5 0.1 0.852 
Geometric mean logio cfu/ml -5.2 -10.1--0.3 47.4 14.7 0.040 
; >103 CfU/Ml Total weeks with _ -2.0 
4.0-0.1 43.8 12.6 0.059 
Total weeks with ý: 104 cfulml -0.8 -3.1-1.4 34.4 2.1 0.450 
Total weeks with ý: 10' cfu/ml -0.9 -3.9-2.1 32.7 1.4 0.540 
Week 26 logio cfu/ml -3.0 -5.8--0.1 37.8 14.2 0.044 
ocular discharge Logio total cfu/ml -2.6 -9.8-4.6 52.3 2.0 0.469 
Maximum loglocfu/ml -2.8 -10.2-4.6 52.8 2.2 0.444 
Geometric mean loglo cfu/n-d -0.8 -6.0-4.4 40.2 0.4 0.749 
Total weeks with ý: 103 cfu/n-d -0.4 -2.5-1.8 40.1 0.5 0.727 
Total weeks with >104 CfUhnl 0.3 -1.9-2.5 36.2 0.3 0.769 
; >105 Cf Total weeks with _ U/Ml 
0.3 -2.6-3.2 37.0 0.2 0.841 
Week 26 logio cfu/ml 0.02 -3.0-3.0 37.6 0.00 0.989 
Cough Logio total cfu/ml 0.6 -1.6-2.8 0.5 1.1 0.587 
Maximuni logio cfu/ml 0.8 -1.5-3.0 -0.3 1.7 0.495 
Geometric mean logio cfu/ml -0.6 -2.2-1.0 5.7 2.1 0.449 
; >103 Total weeks with _ cfuhnl -0.2 -0.8-0.5 
5.1 1.2 0.571 
Total weeks with ý: 104 CfU/ml -0.1 -0.8-0.5 4.5 0.6 0.685 
Total weeks with; -> 
105 cfu/n-d 0.4 -0.5-1.3 3.0 0.7 0.376 
Week 26 logio cfu/ml 0.7 -0.1-1.6 2.1 9.9 0.099 
Breathing Logio total cfu/ml -0.5 -4.5-3.5 11.6 0.3 0.791 
Maximum logio cfu/m1 -0.1 -4.2-4.0 9.2 0.01 0.960 
Geometric mean logio cfu/ml -2.9 -5.6--0.3 18.0 13.4 0.029 
Total weeks with 2: 103 CfU/Ml -1.3 -2.4--0.3 17.4 19.9 0.015 
Total weeks with ýq04 CfU/ml -0.6 -1.8-0.6 11.3 3.8 0.308 
Total weeks with '? -105 cfu/ml 
0.2 -1.4-1.8 8.1 0.3 0.783 
Week 26 logio cfu/rnl -0.7 -2.3-1.0 10.2 2.5 0.412 
SMLN Log jo total cfu/ml -0.3 -2.8-2.1 6.8 3.4 0.776 
Maximum logio cfu/ml -0.2 -2.7-2.3 5.9 0.1 0.870 
Geometric mean logio cfb/nd -1.2 -2.9-0.5 8.7 4.0 0.154 
; >103 CfU/Ml Total weeks with _ -0.7 -1.4--0.03 
9.5 14.7 0.040 
Total weeks with ý: 104 cfu/ml -0.2 -0.9-0.5 5.7 1.2 0.575 
Total weeks with ; -> 
10' cfu/n-d -0.1 -1.1-0.9 5.1 0.2 0.835 
Week 26 logio cfu/ml -1.0 -1.9-0.01 7.1 10.6 0.047 
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Table A2.10a: Summary of non-parametric analyses examining differences in tracheal S. 
zooepidemicus cumulative variables according to pony level explanatory 
variables 
_Outcome 
variable Explanatory variable Non-parametric te%t P-value 
Loglo total S. zooepidemicus Sex Wilcoxon rank sum 0.05 
Vaccine group Kruskal-Wallis 0.09 
Transferrin D* Wilcoxon rank sum 0.0118 
Transferrin F2** Wilcoxon rank sum 0.0011 
Transferrin Ii I Wilcoxon rank sum 0.20 
Transferrin H2 Wilcoxon rank sum 0.53 
Transferrin 0 Wilcoxon rank sum 0.16 
Transferrin R Wilcoxon rank sum 0.70 
Pr. inhibitor I Wilcoxon rank sum 0.93 
Pr. inhibitor L Wilcoxon rank sum 0.67 
Pr. inhibitor L2 Wilcoxon rank sum 0.15 
Pr. inhibitor R Wilcoxon rank sum 0.19 
Pr. inhibitor S Wilcoxon rank sum 0.64 
Maximum LogloS. zooepidemicus Sex Wilcoxon rank sum 0.05 
Vaccine group Kruskal-Wallis 0.11 
Transferrin D* Wilcoxon rank sum 0.0186 
Transferrin F2** Wilcoxon rank sum 0.0012 
Transferrin HI Wilcoxon rank sum 0.13 
Transferrin H2 Wilcoxon rank sum 0.41 
Transferrin 0 Wilcoxon rank sum 0.17 
Transferrin R Wilcoxon rank sum 0.75 
Pr. inhibitor I Wilcoxon rank sum 0.97 
Pr. inhibitor L Wilcoxon rank sum 0.77 
Pr. inhibitor L2 Wilcoxon rank sum 0.19 
Pr. inhibitor R Wilcoxon rank sum 0.23 
Pr. inhibitor S Wilcoxon raA sum 0.60 
Mean Log, & S. zooepidemicus Sex Wilcoxon rank sum 0.08 
Vaccine group Kruskal-Wallis 0.15 
Transferrin D* Wilcoxon rank sum 0.016 
Transferrin F2** Wilcoxon rank sum 0.004 
Transferrin HI Wilcoxon rank sum 0.57 
Transferrin H2 Wilcoxon rank sum 0.25 
Transferrin 0 Wilcoxon rank sum 0.37 
Transferrin R Wilcoxon rank sum 0.90 
Pr. inhibitor I Wilcoxon rank sum 0.63 
Pr. inhibitor L Wilcoxon rank sum 0.15 
Pr. inhibitor L2 Wilcoxon rank sum 0.09 
Pr. inhibitor R Wilcoxon rank sum 0.12 
Pr. inhibitor S Wilcoxon rank sum 0.86 
Weeks with k103S. zooepidemicus Sex Wilcoxon rank sum 0.24 
Vaccine group Kruskal-Wallis 0.66 
Transferrin D Wilcoxon rank gum 0.12 
Transferrin F2 Wilcoxon rank sum 0.12 
Transferrin HI Wilcoxon rank sum 0.35 
Transferrin H2 Wilcoxon rank sum 0.37 
Transferrin 0 Wilcoxon rank sum 0.83 
Transferrin R Wilcoxon rank sum 0.97 
Pr. inhibitor I Wilcoxon rank sum 0.48 
Pr. inhibitor L Wilcoxon rank sum 0.11 
Pr. inhibitor L-2 Wilcoxon rank sum 0.90 
Pr. inhibitor R Wilcoxon rank sum 0.15 
Pr. inhibitor S Wilcoxon rank sum 1.00 
* 14 ponies with transfemn D but no F2 haplotype Tanked significantly LOWER Scores 
*0 14 ponies with transferrin F2 haplorype ranked significantly HIGBER scores 
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Table A2. I Oa continued 
Outcome variable Explanatory variable Non-parametric test P-value 
Weeks with >-104S. zooepidemicus Sex Wilcoxon rank sum 0.056 
Vaccine group Kruskal-Wallis 0.45 
Transferrin D* Wilcoxon rank sum 0.0093 
Transferrin F2** Wilcoxon rank sum 0.0063 
Transferrin HI Wilcoxon rank sum 0.66 
Transferrin H2 Wilcoxon rank sum 0.44 
Transfcrrin 0 Wilcoxon rank sum 0.79 
Transferrin R Wilcoxon rank sum 0.73 
Pr. inhibitor I Wilcoxon rank sum 0.61 
Pr. inhibitor L Wilcoxon rank sum 0.10 
Pr. inhibitor L2 Wilcoxon rank sum 0.18 
Pr. inhibitor R Wilcoxon rank sum 0.40 
Pr. inhibitor S Wilcoxon rank sum 0.82 
Weeks with '? -105S. zooepidemicus 
Sex Wilcoxon rank sum 0.06 
Vaccine group Kruskal-Wallis 0.07 
Transferrin D* Wilcoxon rank sum 0.0115 
Transferrin F2** Wilcoxon rank sum 0.0007 
Transferrin HI Wilcoxon rank sum 0.74 
Transferrin H2 Wilcoxon rank sum 0.11 
Transferrin 0 Wilcoxon rank sum 0.17 
Transferrin R Wilcoxon rank sum 0.95 
Pr. inhibitor I Wilcoxon rank sum 0.48 
Pr. inhibitor L Wilcoxon rank sum 0.17 
Pr. inhibitor L2 Wilcoxon rank sum 0.24 
Pr. inhibitor R Wilcoxon rank sum 0.14 
Pr. inhibitor S Wilcoxon rank sum 0.49 
Loglo S. zooepidemicus at week 26 Sex Wilcoxon rank sum 0.87 
Vaccine group Kruskal-Wallis 0.29 
Transferrin D Wilcoxon rank sum 0.07 
Transferrin F2 Wilcoxon rank sum 0.27 
Transferrin HI Wilcoxon rank sum 0.97 
Transferrin H2 Wilcoxon rank sum 0.35 
Transferrin 0 Wilcoxon rank sum 0.40 
Transferrin R Wilcoxon rank sum 0.71 
Pr. inhibitor I Wilcoxon rank sum 0.11 
Pr. inhibitor L Wilcoxon rank sum 0.08 
Pr. inhibitor L2 Wilcoxon rank sum 0.12 
Pr. inhibitor R Wilcoxon rank sum 0.75 
Pr. inhibitor S Wilcoxon rank sum 0.83 
14 ponies with transferrin D but no F2 haplotype ranked significantly LOWER scores 
** 14 ponies with transferrin F2 haplotype ranked significantly HIGHER scores 
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Table A2.11: Summary of non-parametric analyses examining differences in tracheal 
A. equuli cumulative variables according to pony level explanatory 
variables 
Outcomeva ri able Explanatory variable Non-parametric test P-value 
Loglo total A. Equuli Sex Wilcoxon rank sum 0.79 
Vaccine group Kruskal-Wallis 0.22 
Transferrin D Wilcoxon rank sum 0.95 
Transferrin F2 Wilcoxon rank sum 0.38 
Transferrin HI Wilcoxon rank sum 0.67 
Transferrin H2 Wilcoxon rank sum 0.31 
Transferrin 0 Wilcoxon rank sum 0.57 
Transferrin R Wilcoxon rank sum 0.45 
Pr. inhibitor I Wilcoxon rank sum 0.52 
Pr. inhibitor L Wilcoxon rank sum 0.12 
Pr. inhibitor L2 Wilcoxon rank sum 0.59 
Pr. inhibitor R Wilcoxon rank sum 0.14 
Pr. inhibitor S Wilcoxon rank sum 0.47 
Maximum Logio A. equuli Sex Wilcoxon rank sum 0.83 
Vaccine group Kruskal-Wallis 0.27 
Transferrin D Wilcoxon rank sum 0.93 
Transferrin F2 Wilcoxon rank sum 0.53 
Transferrin HI Wilcoxon rank sum 0.59 
Transferrin H2 Wilcoxon rank sum 0.30 
Transferrin 0 Wilcoxon rank sum 0.78 
Transferrin R Wilcoxon rank sum 0.43 
Pr. inhibitor I Wilcoxon rank sum 0.44 
Pr. inhibitor L Wilcoxon rank sum 0.12 
Pr. inhibitor L2 Wilcoxon rank sum 0.68 
Pr. inhibitor R Wilcoxon rank sum 0.14 
Pr. inhibitor S Wilcoxon rank sum 0.53 
Mean Log, O A. equuli Sex Wilcoxon rank sum 0.90 
Vaccine group Kruskal-Wallis 0.16 
Transferrin D Wilcoxon rank sum 0.84 
Transferrin F2 Wilcoxon rank sum 0.22 
Transferrin HI Wilcoxon rank sum 0.32 
Transferrin H2 Wilcoxon rank sum 0.70 
Transferrin 0 Wilcoxon rank sum 0.67 
Transferrin R Wilcoxon rank sum 0.41 
Pr. inhibitor I Wilcoxon rank sum 0.58 
Pr. inhibitor L Wilcoxon rank sum 0.13 
Pr. inhibitor L2 Wilcoxon rank sum 0.51 
Pr. inhibitor R Wilcoxon rank sum 0.14 
Pr. inhibitor S Wilcoxon rank sum 0.44 
Weeks with ýt, 03 A. equuli Sex Wilcoxon rank sum 1.00 
Vaccine group Kruskal-Wallis 0.34 
Transferrin D Wilcoxon rank sum 0.84 
Transferrin F2 Wilcoxon rank sum 0.69 
Transferrin III Wilcoxon rank sum 0.74 
Transferrin H2 Wilcoxon rank sum 0.19 
Transferrin 0 Wilcoxon rank sum 0.66 
Transfcrrin R Wilcoxon rank sum 0.77 
Pr. inhibitor I Wilcoxon rank sum 0.54 
Pr. inhibitor L Wilcoxon rank sum 0.18 
Pr. inhibitor L2 Wilcoxon rank sum 0.41 
Pr. inhibitor R Wilcoxon rank sum 0.41 
Pr. inhibitor S Wilcoxon rank sum 0.28 
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Table A2.11 continued 
Outcome variable Explanatory variable Non-parametric test P-value 
; >104 Weeks with A. equuli Sex Wilcoxon rank sum 0.51 
Vaccine group Kruskal-Wallis 0.86 
Transferrin D Wilcoxon rank sum 0.86 
Transferrin F2 Wilcoxon rank sum 0.59 
Transferrin HI Wilcoxon rank sum 0.54 
Transferrin H2 Wilcoxon rank sum 0.31 
Transferrin 0 Wilcoxon rank sum 0.93 
Transferrin R Wilcoxon rank sum 0.31 
Pr. inhibitor I Wilcoxon rank sum 0.68 
Pr. inhibitor L Wilcoxon rank sum 0.54 
Pr. inhibitor L2 Wilcoxon rank sum 0.73 
Pr. inhibitor R Wilcoxon rank sum 0.73 
Pr. inhibitor S Wilcoxon rank sum 0.41 
Weeks with ý->105A. equuli Sex Wilcoxon. rank sum 0.96 
Vaccine group Kruskal-Wallis 0.96 
Transferrin D Wilcoxon rank sum 0.72 
Transferrin F2 Wilcoxon rank sum 0.96 
Transfcrrin HI Wilcoxon rank sum 0.62 
Transfcrrin H2 Wilcoxon rank sum 0.13 
Transferrin 0 Wilcoxon rank sum 0.55 
Transferrin R Wilcoxon rank sum 0.56 
Pr. inhibitor I Wilcoxon rank sum 0.88 
Pr. inhibitor L Wilcoxon rank sum 0.62 
Pr. inhibitor L2 Wilcoxon rank sum 0.79 
Pr. inhibitor R Wilcoxon rank sum 0.79 
Pr. inhibitor S Wilcoxon rank sum 0.51 
Loglo A. equuli at week 26 Sex Wilcoxon rank sum 0.96 
Vaccine group Kruskal-Wallis 0.73 
Transferrin D Wilcoxon. rank sum 0.07 
Transferrin F2 Wilcoxon rank sum 0.12 
Transfcrrin HI Wilcoxon rank sum 0.62 
Transfcrrin H2 Wilcoxon rank sum 0.56 
Transfcrrin 0 Wilcoxon rank sum 0.04 
Transferrin R Wilcoxon rank sum 0.56 
Pr. inhibitor I Wilcoxon rank sum 0.10 
Pr. inhibitor L Wilcoxon rank sum 0.08 
Pr. inhibitor L2 Wilcoxon rank sum 0.78 
Pr. inhibitor R Wilcoxon rank sum 0.78 
Pr. inhibitor S Wilcoxon rank sum 0.25 
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Table A2.12: Summary of non-parametric analyses examining differences in tracheal 
Pasteurella spp. cumulative variables according to pony level 
explanatory variables 
Outcome variable Explanatory variable Non-parametric test P-value 
Loglo total Pasteurella spp. Sex Wilcoxon rank sum 0.16 
Vaccine group Kruskal-Wallis 0.12 
Transferrin D Wilcoxon rank sum 0.50 
Transferrin F2 Wilcoxon rank sum 0.18 
Transferrin HI Wilcoxon rank sum 0.22 
Transferrin H2 Wilcoxon rank sum 0.49 
Transferrin 0* Wilcoxon rank sum 0.04 
Transferrin R Wilcoxon. rank sum 0.21 
Pr. inhibitor I Wilcoxon rank sum 0.10 
Pr. inhibitor L Wilcoxon rank sum 0.94 
Pr. inhibitor L2 Wilcoxon rank sum 0.19 
Pr. inhibitor R Wilcoxon rank sum 0.63 
Pr. inhibitor S Wilcoxon rank sum 0.45 
Maximum Loglo Pasteurefla spp. Sex Wilcoxon rank sum 0.16 
Vaccine group Kruskal-Wallis 0.18 
Transferrin D Wilcoxon rank sum 0.62 
Transferrin F2 Wilcoxon rank sum 0.26 
Transferrin HI Wilcoxon rank sum 0.15 
Transferrin H2 Wilcoxon rank sum 0.41 
Transferrin 0* Wilcoxon. rank sum 0.05 
Transferrin R Wilcoxon rank sum 0.12 
Pr. inhibitor I Wilcoxon rank sum 0.04 
Pr. inhibitor L Wilcoxon rank sum 0.64 
Pr. inhibitor L2 Wilcoxon rank sum 0.28 
Pr. inhibitor R Wilcoxon. rank sum 0.72 
Pr. inhibitor S Wilcoxon. rank sum 0.36 
Mean Logio Pasteurella spp. Sex Wilcoxon rank sum 0.18 
Vaccine group Kruskal-Waflis 0.05 
Transferrin D Wilcoxon rank sum 0.75 
Transferrin F2 Wilcoxon rank sum 0.14 
Transferrin HI Wilcoxon rank sum 0.43 
Transferrin H2 Wilcoxon rank sum 0.45 
Transferrin 0* Wilcoxon rank sum 0.0125 
Transferrin R Wilcoxon rank sum 0.31 
Pr. inhibitor I Wilcoxon rank sum 0.09 
Pr. inhibitor L Wilcoxon rank sum 1.00 
Pr. inhibitor L2 Wilcoxon rank sum 0.40 
Pr. inhibitor R Wilcoxon rank sum 0.23 
Pr. inhibitor S Wilcoxon rank sum 0.82 
Weeks with ýA 03 Pasteurella spp. Sex Wilcoxon rank sum 0.21 
Vaccine group Kruskal-Wallis 0.18 
Transferrin D Wilcoxon rank sum 0.46 
Transferrin F2 Wilcoxon rank sum 0.41 
Transferrin HI Wilcoxon rank sum 0.38 
Transferrin H2 Wilcoxon rank sum 0.97 
Transferrin 0* Wilcoxon rank sum 0.07 
Transferrin R Wilcoxon rank sum 0.52 
Pr. inhibitor I Wilcoxon rank sum 0.13 
Pr. inhibitor L Wilcoxon rank sum 1.00 
Pr. inhibitor L2 Wilcoxon rank sum 0.81 
Pr. inhibitor R Wilcoxon rank sum 0.18 
Pr. inhibitor S Wilcoxon rank sum 0.70 
*9 ponics -Aith transfurin 0 haplotypc ranked significantly LOWER scores 
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Table A2.12 continued 
Outcome variable Explanatory variable Non-parametric test P-value 
2q04 Weeks with Pasteurella spp. Sex Wilcoxon rank sum 0.08 
Vaccine group Kruskal-Wallis 0.16 
Transferrin D Wilcoxon rank sum 0.49 
Transferrin F2 Wilcoxon rank sum 0.20 
Transferrin HI Wilcoxon rank sum 0.19 
Transferrin H2 Wilcoxon rank sum 0.23 
Transferrin 0* Wilcoxon rank sum 0.055 
Transferrin R Wilcoxon rank sum 0.09 
Pr. inhibitor I Wilcoxon rank sum 0.24 
Pr. inhibitor L Wilcoxon rank sum 0.97 
Pr. inhibitor L2 Wilcoxon rank sum 0.36 
Pr. inhibitor R Wilcoxon rank sum 0.30 
Pr. inhibitor S Wilcoxon rank sum 0.72 
Weeks with 2tlOsPasteurella spp. Sex Wilcoxon rank sum 0.17 
Vaccine group Kruskal-Wallis 0.26 
Transferrin D Wilcoxon rank sum 0.61 
Transferrin F2 Wilcoxon rank sum 0.18 
Transferrin HI Wilcoxon rank sum 0.40 
Transferrin H2 Wilcoxon rank sum 0.26 
Transferrin 0 Wilcoxon rank sum 0.14 
Transfcrrin R Wilcoxon rank sum 0.20 
Pr. inhibitor I Wilcoxon rank sum 0.34 
Pr. inhibitor L Wilcoxon rank sum 0.61 
Pr. inhibitor L2 Wilcoxon rank sum 0.71 
Pr. inhibitor R Wilcoxon rank sum 0.71 
Pr. inhibitor S Wilcoxon rank sum 0.75 
Loglo Pasteurella spp. at week 26 Sex Wilcoxon rank sum 0.37 
Vaccine group Kruskal-Wallis 0.36 
Transferrin D Wilcoxon rank sum 0.48 
Transferrin F2 Wilcoxon rank sum 0.09 
Transferrin HI Wilcoxon rank sum 0.57 
Transferrin H2 Wilcoxon rank sum 0.34 
Transferrin 0 Wilcoxon rank sum 0.35 
Transferrin R Wilcoxon rank sum 0.09 
Pr. inhibitor I Wilcoxon rank sum 1.00 
Pr. inhibitor L Wilcoxon rank sum 0.30 
Pr. inhibitor L2 Wilcoxon rank sum 0.95 
Pr. inhibitor R Wilcoxon rank sum 0.75 
Pr. inhibitor S Wilcoxon rank sum 0.18 
*9 ponies with transferrin 0 haplotypc ranked significantly LOWER scores 
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Table A2.13: Summary of non-parametric analyses examining differences in tracheal R 
bronchiseptica cumulative variables according to pony level explanatory 
variables 
Outcome variable Explanatory variable Non-parametric test P-value 
Logio total B. Bronchiseptica Sex Wilcoxon rank sum 0.37 
Vaccine group Kruskal-Wallis 0.44 
Transferrin D Wilcoxon rank sum 0.36 
Transferrin F2 Wilcoxon rank sum 0.91 
Transfcrrin H1 Wilcoxon rank sum 0.39 
Transfcrrin H2 Wilcoxon rank sum 0.66 
Transferrin 0 Wilcoxon rank sum 0.42 
Transferrin R Wilcoxon rank sum 0.80 
Pr. inhibitor I Wilcoxon rank sum 0.31 
Pr. inhibitor L Wilcoxon rank sum 0.09 
Pr. inhibitor L2 Wilcoxon rank sum 0.12 
Pr. inhibitor R Wilcoxon rank sum 0.81 
Pr. inhibitor S Wilcoxon rank sum 0.84 
Maximum Loglo B. hronchiseptica Sex Wilcoxon rank sum 0.41 
Vaccine group Kruskal-Wallis 0.36 
Transferrin D Wilcoxon rank sum 0.50 
Transferrin. F2 Wilcoxon rank sum 0.73 
Transferrin HI Wilcoxon rank sum 0.50 
Transferrin H2 Wilcoxon rank sum 0.66 
Transferrin 0 Wilcoxon rank sum 0.40 
Transferrin R Wilcoxon rank sum 0.61 
Pr. inhibitor I Wilcoxon rank sum 0.35 
Pr. inhibitor L Wilcoxon rank sum 0.14 
Pr. inhibitor L2 Wilcoxon rank sum 0.12 
Pr. inhibitor R Wilcoxon rank sum 0.90 
Pr. inhibitor S Wilcoxon rank sum 1.00 
Mean Logio B. hronchiseptica Sex Wilcoxon rank sum 0.39 
Vaccine group Kruskal-Wallis 0.87 
Transferrin D Wilcoxon rank sum 0.51 
Transferrin F2 Wilcoxon rank sum 0.27 
Transferrin HI Wilcoxon rank sum 0.09 
Transferrin H2 Wilcoxon rank sum 0.75 
Transferrin 0 Wilcoxon rank sum 0.57 
Transferrin R Wilcoxon rank sum 0.45 
Pr. inhibitor I Wilcoxon rank sum 0.83 
Pr. inhibitor L Wilcoxon rank sum 0.30 
Pr. inhibitor L2 Wilcoxon rank sum 0.19 
Pr. inhibitor R Wilcoxon rank sum 0.09 
Pr. inhibitor S Wilcoxon rank sum 0.40 
Weeks with ýj03 B. hronchiseptica Sex Wilcoxon rank sum 0.25 
Vaccine group Kruskal-Wallis 0.97 
Transferrin D Wilcoxon rank sum 0.41 
Transferrin F2 Wilcoxon rank sum 0.46 
Transferrin HI Wilcoxon rank sum 0.35 
Transferrin H2 Wilcoxon rank sum 0.76 
Transferrin 0 Wilcoxon rank sum 0.59 
Transferrin R Wilcoxon rank sum 0.78 
Pr. inhibitor I Wilcoxon rank sum 0.91 
Pr. inhibitor L Wilcoxon rank sum 0.82 
Pr. inhibitor L2 Wilcoxon rank sum 0.08 
Pr. inhibitor R Wilcoxon rank sum 0.07 
Pr. inhibitor S Wilcoxon rank sum 0.83 
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Table A2.13 continued 
Outcome variable Explanatory variable Non-parametric test P-, s, alue_ 
Weeks with ýt104 B. bronchiseplica Sex Wilcoxon rank sum 0.66 
Vaccine group Kruskal-Wallis 0.64 
Transferrin D Wilcoxon rank sum 0.25 
Transferrin F2 Wilcoxon rank sum 0.60 
Transferrin HI Wilcoxon rank sum 0.17 
Transferrin H2 Wilcoxon rank sum 0.84 
Transferrin 0 Wilcoxon rank sum 0.96 
Transferrin R Wilcoxon rank sum 0.62 
Pr. inhibitor I Wilcoxon rank sum 0.63 
Pr. inhibitor L Wilcoxon rank sum 0.57 
Pr. inhibitor L2 Wilcoxon rank sum 0.13 
Pr. inhibitor R Wilcoxon rank sum 0.08 
Pr. inhibitor S Wilcoxon rank sum 0.24 
Weeks with 2tlft. bronchiseptica Sex Wilcoxon rank sum 0.40 
Vaccine group Kruskal-Wallis 0.20 
Transferrin D Wilcoxon rank sum 0.76 
Transferrin F2 Wilcoxon rank sum 0.73 
Transferrin HI Wilcoxon rank sum 0.29 
Transferrin H2 Wilcoxon rank sum 0.64 
Transferrin 0 Wilcoxon rank sum 0.98 
Transferrin R Wilcoxon rank sum 0.89 
Pr. inhibitor I Wilcoxon rank sum 0.89 
Pr. inhibitor L Wilcoxon rank sum 0.29 
Pr. inhibitor L2 Wilcoxon rank sum 0.17 
Pr. inhibitor R Wilcoxon rank sum 0.09 
Pr. inhibitor S Wilcoxon rank sum 0.09 
Loglo B. bronchiseplica at week 26 Sex Wilcoxon rank sum 0.92 
Vaccine group Kruskal-Wallis 0.75 
Transferrin D Wilcoxon rank sum 0.68 
Transferrin F2 Wilcoxon rank sum 0.16 
Transferrin HI Wilcoxon rank sum 0.62 
Transferrin H2 Wilcoxon rank sum 0.11 
Transferrin 0 Wilcoxon rank sum 0.03 
Transferrin R Wilcoxon rank sum 0.56 
Pr. inhibitor I Wilcoxon rank sum 0.84 
Pr. inhibitor L Wilcoxon rank sum 0.62 
Pr. inhibitor L2 Wilcoxon rank sum 0.79 
Pr. inhibitor R Wilcoxon rank sum 0.79 
Pr. inhibitor S Wilcoxon rank sum 0.51 
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Table A2.14: Summary of non-parametric analyses examining differences in tracheal non- 
haemolytic Streptococcus spp. cumulative variables for pony level variables 
Outcome variable Explanatory variable Non-parametric test P-value 
Loglo total non-haemolYtic Strep. spp. Sex Wilcoxon rank sum 0.86 
Vaccine group Kruskal-Wallis 0.55 
Transferrin D Wilcoxon rank sum 0.18 
Transferrin F2 Wilcoxon rank sum 0.16 
Transferrin HI Wilcoxon rank sum 0.06 
Transferrin H2 Wilcoxon rank sum 0.85 
Transferrin 0 Wilcoxon rank sum 0.11 
Transferrin R Wilcoxon rank sum 0.80 
Pr. inhibitor I Wilcoxon rank sum 0.51 
Pr. inhibitor L Wilcoxon rank sum 0.47 
Pr. inhibitor L2 Wilcoxon rank sum 0.12 
Pr. inhibitor R Wilcoxon rank sum 0.34 
Pr. inhibitor S Wilcoxon rank sum 0.07 
Maximum Loglo non-haemolytic Strep. Sex Wilcoxon rank sum 0.71 
SPP. Vaccine group Kruskal-Wallis 0.47 
Transferrin D Wilcoxon rank sum 0.15 
Transferrin F2 Wilcoxon rank sum 0.40 
Transferrin HI Wilcoxon rank sum 0.07 
Transferrin H2 Wilcoxon rank sum 0.59 
Transferrin 0 Wilcoxon rank sum 0.08 
Transferrin R Wilcoxon rank sum 0.90 
Pr. inhibitor I Wilcoxon rank sum 0.66 
Pr. inhibitor L Wilcoxon rank sum 0.52 
Pr. inhibitor L2 Wilcoxon rank sum 0.12 
Pr. inhibitor R Wilcoxon rank sum 0.47 
Pr. inhibitor S Wilcoxon rank sum 0.08 
Mean Loglo non-haemolytic Strep. spp. Sex Wilcoxon rank sum 0.16 
Vaccine group Kruskal-Wallis 0.0345 
Transferrin D Wilcoxon rank sum 0.39 
Transferrin F2* Wilcoxon rank sum 0.0006 
Transferrin HI Wilcoxon Tank sum 0.57 
Transferrin H2 Wilcoxon rank sum 0.28 
Transferrin 0** Wilcoxon rank sum 0.0301 
Transferrin R Wilcoxon rank sum 0.66 
Pr. inhibitor I Wilcoxon rank sum 0.36 
Pr. inhibitor L Wilcoxon rank sum 0.89 
Pr. inhibitor L2 Wilcoxon rank sum 0.15 
Pr. inhibitor R Wilcoxon rank sum 0.23 
Pr. inhibitor S Wilcoxon rank sum 0.30 
Weeks with ýAO3 non-haemolytic Sex Wilcoxon rank sum 0.10 
Strep. spp. Vaccine group Kruskal-Wallis 0.0245 
Transferrin D Wilcoxon rank sum 0.40 
Transferrin F2* Wilcoxon rank sum 0.0009 
Transferrin HI Wilcoxon rank sum 0.77 
Transferrin R2 Wilcoxon rank sum 0.32 
Transferrin 0** Wilcoxon rank sum 0.0401 
Transferrin R Wilcoxon rank sum 0.59 
Pr. inhibitor I Wilcoxon rank sum 0.21 
Pr. inhibitor L Wilcoxon rank sum Q. 83 
Pr. inhibitor L2 Wilcoxon rank sum 0.12 
Pr. inhibitor R Wilcoxon rank sum 0.40 
Pr. inhibitor S Wilcoxon rank sum 0.31 
14 ponies with transferrin F2 haplotype ranked significantly LOWER scores 
9 ponieswith transferrin 0 haplotype ranked significantly HIGHER scores 
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Table A2.14 continued 
Outcome variable Explanatory variable Non-parametric test P-value 
Weeks With ýq04 non-haemolytic Sex Wilcoxon rank sum 0.44 
Strep. spp. Vaccine group Kruskal-Wallis 0.07 
Transferrin D Wilcoxon rank sum 0.98 
Transferrin F2* Wilcoxon rank sum 0.0083 
Transferrin HI Wilcoxon rank sum 0.31 
Transferrin H2 Wilcoxon rank sum 0.36 
Transferrin 0** Wilcozon rank sum 0.0435 
Transferrin R Wilcoxon rank sum 0.61 
Pr. inhibitor I Wilcoxon rank sum 0.10 
Pr. inhibitor L Wilcoxon rank sum 0.89 
Pr. inhibitor L2 Wilcoxon rank sum 0.19 
Pr. inhibitor R Wilcoxon rank sum 0.31 
Pr. inhibitor S Wilcoxon rank sum 0.21 
Weeks with ýt 105 non-haemolytic Sex Wilcoxon rank sum 0.91 
Strep. spp. Vaccine group Kruskal-Wallis 0.18 
Transferrin D Wilcoxon rank sum 0.29 
Transferrin F2 Wilcoxon rank sum 0.29 
Transferrin HI Wilcoxon rank sum 0.13 
Transferrin H2 Wilcoxon rank sum 0.37 
Transferrin 0 Wilcoxon rank sum 0.07 
Transferrin R Wilcoxon rank sum 0.56 
Pr. inhibitor I Wilcoxon rank sum 0.46 
Pr. inhibitor L Wilcoxon rank sum 0.36 
Pr. inhibitor L2 Wilcoxon rank sum 0.54 
Pr. inhibitor R Wilcoxon rank sum 0.54 
Pr. inhibitor S Wilcoxon rank sum 0.23 
Loglo non-haemolytic Strep. spp. at Sex Wilcoxon rank sum 0.46 
week 26 Vaccine group Kruskal-Wallis 0.21 
Transferrin D Wilcoxon rank sum 0.95 
Transferrin F2 Wilcoxon rank sum 0.11 
Transferrin HI Wilcoxon rank sum 0.49 
Transferrin H2 Wilcoxon rank sum 0.67 
Transferrin 0 Wilcoxon rank sum 0.68 
Transferrin R Wilcoxon rank sum 0.21 
Pr. inhibitor I Wilcoxon rank sum 0.56 
Pr. inhibitor L Wilcoxon rank sum 0.40 
Pr. inhibitor L2 Wilcoxon rank sum 0.25 
Pr. inhibitor R Wilcoxon rank sum 1.00 
Pr. inhibitor S Wilcoxon rank sum 0.35 
14 ponics "ith transfcrrin F2 haplotype ranked significantly LOWER scores 
** 9 ponies with transferrin 0 haplotypc ranked significantly HIGHER scores 
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Figure A2.6: Summary of weekly clinical signs and TW bacterial counts by pony 
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ndaN gý Nasal discharge average Nwcklý score 
odaN gý Ocular discharge average NvcckI) score 
colighaN gý Coughing average N%ceklý score 
dýspa%gi Abnormal brcatliing/dýspnoea average %Neeklý score 
S111111,1% g: SMLN enlargement average N%cekh score 
1%% fills: Log,. cfu/nd iioii-liaciiiolý'lic. lýtreplococ'cus Spp. in tracheal wash 
t%%Szoo: Log,. cfu/niI . 1ýireptococc-ii. v. -ooepi(leniicus 
in tracheal wash 
IN%bord: Log,,, cfu/nd Bordetella bronchiseptica. in tracheal wash 
hupsp: Log,,, cfti/nil Pasteurella-like spp. in tracheal Nush 
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Table A2.15: Results and comparison of univariable linear and best fitting polynomial 
regressions of clinical and airway inflammation parameter scores with tracheal 
wash bacterial count data and autoregressive variables 
Outcome var. 
Regression 
type 
Explanatory 
Variable 
Regression 
coefficient 
Intercept Rzvalue 
(%) 
P-value Deviance P-value 
benefit (X2,3 df) 
Clinical score 
Linear 
------------------ -- 
tq&Lq. ýfu/ml total bacteria 0.49 -0.15 10.7 <0.001 
Polywomial - --------------------------------------- [loglo cfuhnl total bacteria]o -0.37 1.94 13.2 
---------- 0.511 ----------------------- 8.93 0.030 
[logio cfii/n-d total bacteria]3 0.008 <0.001 
jinear 
--------- _; 
q!?. jýt, ýTims -- ep 
0.44 0.85 18.2 <0.001 
Polynomial [loglo cfu/ml S. zooepidemicus - -- --- ----- -ý. 
ii 1.76 --- --- --- -7 20.0 ,- 0.009 ----------------------- 6.99 0.072 
[logio cfu/ml S. zooepidemicusf 0.88 <0.001 
Linear 
- ----- _ -- fink - -0.08 
2.40 0.2 0.444 
ý; j; oi ý; o ia aý [logio cfu/ml A. equuli]l ---------- --- -: 66ý 
--- 2.41 ---- -- 0.8 --- - 0.125 ----------------------- 1.99 0.574 
[logio cfu/n-d A. eqUUli]3X ln[x] 0.03 0.114 
Linear 
----- - -- 
tý&q. Sfulml Posteurella spp. 
' --- 
0.03 2.27 0.1 0.503 
ZZia ý ------- ----- [logio c iYrtýý3as il teurella spp. ] ---- ----- ----------- 2.53 --------- 6.3 ---------- <0.001 ----------------------- 19.96 <0.001 
[logio cfu/ml Pasteurella spp. 1' 0.01 <0.001 
Linear 
----- -- 
tqZtq. ýfu/m1 B. bronchtlepttcl -0.02 2.39 0.05 0.695 
[log io 
jitYrýi R Wronc, ý isepticaf-5 3 T( 
[logio cfu/ml B. bronchisepticaf -0.25 0.331 
Linear 
--- --- "' 
b/ml non-haem. ýLUe. 
-- 
týgLq. ýf 
- -0.21 
3.05 5.2 <0.001 
Aoij;; mWiaý ------- [logio ýOý-fýe- m--. Strep. ]0-5 ------------- -1.35 
----------- 3.78 --------- 15.8 ---------- <0.001 ----------------------- 37.21 <0.001 
[logio cfu/ml non-haem. Strep. ]3 0.01 <0.001 
Linear Clinical sýore_l week 0.59 1.16 34.2 <0.001 
[Clinical score I wk previously]2 ----- 0. -2-1 ---- --- 1.36 34.6 - --- -, -- ------ <0.001 ------------- 1.42 
[Clinical score I Wk- previously]' -0.02 0.001 
Linear 
----- - - -- 
ýYSSýsylqviously 0.51 1.47 25.2 <0.001 
j; 
0iy;; o)Wia 
ý ---- -- [Clinical score 2 wks prev. ------------ 0.34 ------------ 1.39 --------- 26.2 ---------- <0.001 ----------------------- 3.03 0.387 
[Clin. score 2 wks PreV-12X 109n[XI -0.15 <0.001 
Linear Clinical score 3 weeks previously 0.43 1.90 17.3 <0.001 -- --- f. -ii ------ , 
Foil re 3s previously] 0.25 ---------------- 
[Clinical score 3 wks previouslyf -0.03 <0.001 
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Table A2.15 continued 
Outcome var. 
Regression 
type 
Explanatory 
Variable 
Regression 
coefficient 
Intercept R'value P-value Deviance 
benefit 
P-value 
(X2,3 df) 
CDNS score 
Linear logio cfu/ml total bacteria 0.45 -0.81 12.7 <0.001 ----------- -5 ------------ --- Polynomial [logio cfu/ml total bacteria] -0.02 
--- ------- ---- 0.99 17.9 --------------------------------- 0.186 19.15 <0.001 
]3XIogjX] [loglo cfu/ml total bact. 0.01 0.067 
Linear 10gio cfu/ml S. zooepidemicus - 
0.40 0.13 21.0 <0.001 
- ------ ------ --------- Polynomial -- -- ------------- [logio cfuhnl S. zooepidemicus]o 5 -------------- -0.33 
----------- 1.03 ---------- 26.0 ------ -- 0.152 ------ 20.32 ------ <0.001 
[logio cfuhnl S. zooepidemiCUS]2 0.07 <0.001 
Linear loglo cfu/ml A. equuli - 0,03 1,52 0.03 0.770 --------- Polynomial _ ------------ -- [logio cfuhnl A. equulil3 ----- ---- -0.05 
---- --- 1.54 --- -- 1.5 --- - 0.088 ------------ 4.61 ------------ 0.203 
[logio cfu/nd A. equUlij3Xl0gn[X] 0.03 0.061 
Linear lo 10 cfu/ml Pasteurella spy - gj 0.03 1.42 0.2 0.434 ---------- Polywomial ---------- -------------------- - [logio cfu/ml Pasteurella Spp. ]2 --- ---- ! U. 13 - ---1 1-6--1 --- ----- 7--4 --- -- <-O- -0-0- 1 ---- --- 2-3-. -4-2 ------ < 0-- 0- -0-1---- 
[logio cfu/ml Pasteurella Spp. 13 0.02 <0.001 
Linear 
-- - 
I? glo cfu/ml B, broýchiseptica 
-- ---------- -- 
0.02 
-- - 
1.53 0.09 0.600 
-------- Polynomial ----- [logio cfu/ml B. bronchisepticaf 
- - --- -- 0.04 ---- --- ---- 1.52 ----- --- 0.12 ..... 0.942 0.10 0.992 
[logio cfu/ml B. bronch. ]1xlog,, [x] -0.04 0.755 
Linear I gio cfu/rnl non-haem. Strep. - 9 -0.25 
2.30 9.9 <0.001 
-ýolyn- 
o--m- ial- 
--------- - -[Iogio 
cfu/ml non-haem. Strep. )'--5 
----------- 
-1.23 
----------- 2.92 ---------- 19.9 ----------- <0.00 1 -- ----------------- 37.04 <0.001 
[logio cfu/ml non-haern. Strep. 13 0.01 <0.001 
Linear CDNS score I week pLeviously 0.66 0.62 41.2 <0.001 
omial 
-- ); 
0- 
i; ý - Z515Ký'sc-ore- -1 wk previously 1 ------ 11 ----------- 0.55 ----------- 0.52 ---------- 41.3 ----------- 0.001 ---- I ------ "I -------- 0.42 0.936 
[CDNS score I Wk preViOUSI Y] 
2 0.02 0.520 
Linear CDNS score 2 weeks previously - 
0.53 0.91 26.2 <0.001 
--------- ýOýmomial ----- ------ ------- ----------- - - [CDNS - score 2 wks - previously]2 ----- ----- --- 0.37 --- ---- ---- 0.87 --- ---- ---- 26.8 -- ------- - <0.001 --- --- --- ---- 1-37 ----- 0.6i-f 
[CDNS score 2 wks prev. ] 3XIogn[XI -0.17 <0.001 
Linear CDNS score 3 weeks pleviously 0.41 1.23 15.0 <0.001 
-------- 
ý, nomial Pal 
3 Kiýscore 3 wks previously] 0.14 ---- 1.25 ---- 18.6 ------- <0.001 ----- ------ 8.65 0.034 
. [CDNS score 3 wks prev. 1 3XIogn[X] -0.07 <0.001 
Airway inflammation score 
Linear loglo cfu/ml total bacteria 0.80 2.06 26.4 <0.001 
ýo-i; ýomial [loglo cfu/ml total bacteria] 0.001 -2.26 27.7 <0.001 5.35 0.148 
[logio cfu/ml total bacterialo-5 3.74 <. 001 
Linear logio cfu/ml S. AqqeXjqýq! ýc!!, ý 0.59 4.23 27.9 <0.001 
Polynomial . [loglo cfu/ml S. zooepidemicusff 
---- ------- - 0.0002 --- ---- --- 1.97 ---- ----- -- 28.41- ------- -- <0.001 --- ----- ------ -- 2.17 ------ 0.538 
[loglo cfuhnl S. zooepidemicus]0-5 2.33 . 
<0.00 I 
Linear equyli logio cfu/ml A. 0.12 6.15 0.4 0.278 
------- -- Polynomial - --------------- - [loglo cfu/ml A. equUlij-2 ---- --- -0.0001 
--- ---- 6.26 ---- -- 0.7 ---- --- 0.725 ---------------------- 0.93 0.818 
[logio cfu/ml A. equUli]3 0,006 0.248 
Linear loglo cfu/ml Pasteurella ýR - 0.17 5.71 4.0 <0.001 - ------------ -- 
Polyvomial . -------- 
------------------------ 
Spp. ]2 [logio cfuhnl Pasteurella --- 
------- 
-0.12 
------------ 5.93 --------- 8.0 ----------- 0.053 ----------------------- 13.47 0.004 
[logio cfu/ml Past. Spp. ]2XIOgn[X] 0.08 0.011 
Linear logio cfu/ml B, brq! ýpkýsfp! ýýq 0.02 6.23 0.04 0.720 
Polynomial [loglo cfu/ml B. bronchiseptica] 
3 --- 
-0.04 
-7-- 6.27 ----- 0.50 ----- 0.063 3.53 0.317 
[logio cfti/n-d B. bronch. fxlogn[x] 0.02 0.059 
Linear logio cfu/ml non-haerq. ýtýep . 0.10 6.53 1.0 0.074 ------- -- Polynomial ........ . - [logio cfu/ml non-haem. Strep. ]-l 
.. -------- 0.09 ----------- 4.28 ---------- 9.8 ----------- <0.001 ----------------------- 29.00 <0.001 
L. [Iogio cfu/ml non-haern. Strep. ] 1.23 <0.001 
Linear Inflam. score I week previously 0.46 3.45 22.7 <0.001 
- y ------------- ----------- - Polynomial [hiflam. score I wk previously]-o 13.1 --------------------- -11.6 26.2 
----------- <0.001 ----------------------- 11.89 0.008 
[hiflam. score I wk previously]0-5 4.82 <0.001 
Linear Inflarn. score 2 weeks previously 0.37 4.18 17.4 <0.001 
----------- -- ---------------- 2 ------------- Polynomial [hiflarn. score 2 wks previously]- -2.81 
--------------------- 8.09 20.1 ----------- <0.001 ----------------------- 7.59 0.055 
[Inflam. score 2 wks prev. ]-2XIog, [X] -36.1 <0.001 
Linear Inflam. score 3 weeks previously 0.16 5.75 4.0 <0.001 ----------- --- --------- I -------------------------------------------------------------------- Polywomial [Inflam. score 3 Wks; previously]- 1.53 5.62 7.5 0.037 7.51 0.057 
[hiflam. score 3 wks previoUSlyl2 0.02 <0.001 
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Table A2.16: Summary of non-parametric analyses examining differences in clinical & 
airway inflammation outcomes for various binary/categorical explanatory 
variables 
Outcome variable Explanatory variable Non-parametric test P-value 
Clinical score Sex Wilcoxon rank sum 0.0156 
Vaccine group Kruskal-Wallis 0.0074 
Transferrin D Wilcoxon rank sum <0.0001 
Transferrin F2 Wilcoxon rank sum <0.0001 
Transferrin H1 Wilcoxon rank sum 0.67 
Transferrin H2 Wilcoxon rank sum 0.63 
Transferrin 0 Wilcoxon rank sum 0.79 
Transferrin R Wilcoxon rank sum 0.70 
Protease inhibitor I Wilcoxon rank sum 0.13 
Protease inhibitor L Wilcoxon rank sum 0.0021 
Protease inhibitor L2 Wilcoxon rank sum 0.0105 
Protease inhibitor R Wilcoxon rank sum 0.21 
Protease inhibitor S Wilcoxon rank sum 0.0072 
NP S. zooepidemicus Wilcoxon rank sum <0.0001 
NP Pasteurella spp. Wilcoxon rank sum 0.0530 
NP B. hronchiseptica Wilcoxon rank sum 0.68 
NP non-haemolytic Streptococcus spp. Wilcoxon rank sum 0.63 
NP Staphylococcus spp. Wilcoxon rank sum 0.67 
CDNS score Sex Wilcoxon rank sum 0.0062 
Vaccine group Kruskal-Wallis 0.0056 
Transferrin D Wilcoxon rank sum <0.0001 
Transferrin F2 Wilcoxon rank sum <0.0001 
Transferrin HI Wilcoxon rank sum 0.83 
Transferrin H2 Wilcoxon rank sum 0.60 
Transferrin 0 Wilcoxon rank sum 0.46 
Transferrin R Wilcoxon rank sum 0.74 
Protease inhibitor I Wilcoxon rank sum 0.17 
Protease inhibitor L Wilcoxon rank sum 0.0014 
Protease inhibitor L2 Wilcoxon rank sum 0.0022 
Protease inhibitor R Wilcoxon rank sum 0.96 
Protease inhibitor S Wilcoxon rank sum 0.075 
NP S. zooepidemicus Wilcoxon rank sum <0.0001 
NP Pasteurella spp. Wilcoxon rank sum 0.62 
NP B. bronchiseptica Wilcoxon rank sum 0.74 
NP non-haemolytic Streptococcus spp. Wilcoxon rank sum 0.32 
NP Staphylococcus spp. Wilcoxon rank sum 0.38 
Airway inflammation score Sex Wilcoxon rank sum 0.0019 
Vaccine group Kruskal-Wallis 0.19 
Transferrin D Wilcoxon rank sum 0.26 
Transferrin F2 Wilcoxon rank sum 0.0059 
Transferrin HI Wilcoxon rank sum 0.0242 
Transferrin H2 Wilcoxon rank sum 0.39 
Transferrin 0 Wilcoxon rank sum 0.18 
Transferrin R Wilcoxon rank sum 0.07 
Protease inhibitor I Wilcoxon rank sum 0.46 
Protease inhibitor L Wilcoxon rank sum 0.0423 
Protease inhibitor L2 Wilcoxon rank sum 0.0534 
Protease inhibitor R Wilcoxon rank sum 0.49 
Protease inhibitor S Wilcoxon rank sum 0.35 
NP S. zooepidemicus Wilcoxon rank sum 0.0073 
NP Pasteurella spp. Wilcoxon rank sum 0.0484 
NP B. bronchiseptica Wilcoxon rank sum 0.29 
NP non-haemolytic Streptococcus spp. Wilcoxon rank sum 0.26 
NP Stapkylococcus spp. Wilcoxon rank sum 0.24 
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Figure A2.7: Caterpillar plot of ranked pony level residuals (± 95% Cl) for final 
multilevel linear regression model for clinical score. including 
transferrin D haplotype (Model 4a) 
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Figure A2.8: Caterpillar plot of ranked pony level residuals (± 95% Cl) for final 
multilevel linear regression model for clinical score, including 
transferrin F2 haplotype (Model 4b) 
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Note. Colour scheme represents the transferrin D/F2 haplot, %Pe status of each ponN light blueý transferrin D 
haploIvpc (n= 14). red: transferrin F2 haploINPe (n= 10). ight green: transferrin DF2 haplotN pe (n=4) 
& grey other transfcrrin haplot-, pe (n= 1) 
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Figure A2.9: Caterpillar plot of ranked pony level residuals (± 95% Cl) for final multilevel 
linear regression model for CDNS score, including transferrin D haplotype 
(Model 4a) 
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Figure A2.10: Caterpillar plot of ranked pony level residuals (± 95% Cl) for final multilevel 
linear regression model for CDNS score, including transferrin F2 haplotype 
(Model 4b) 
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Ponies ranked by residuals 
Note: Colour scheme represents the transferrin D/F2 haplotype status of cach pony light bluc: transferrin D 
haplotype (n= 14). red: transferrin F2 liaploIN-pe (n= 10). light green: transferrin DF2 Implolype (n=4) 
& grey other transferrin haplolý pe (n= 1) 
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Table A2.17: Summary of multilevel linear regression modelling of clinical score with 
sequential exclusion from random effects components or ponies with 
largest value residuals 
Outcomevariabl /Effectbin/ 
Explanatory variable in model 
Estimate 
(& E. ) 
Estimate 
(& E. ) 
Estimate 
(& E. ) 
Estimate 
(S. E. ) 
Clinical score (TTaniferrin D Model) Model 4a Model 5z Model 6a Model 7a 
i d ffe 
n=237 n-257 n-257 n-257 
F xe e c 
Intercept 2.20(0.42) 2.39(0.41) 218(0.40) 2.14(0.39) 
Clinical score I week previously 0.35(0.05) 0.35(0.05) 0.36(0.05) 0.37(0.05) 
Logja cfu/mI S. zooepidemicus 0.16(0.06) 0.18(0.06) 0.18(0.06) 0.19(0.06) 
Loglo cfu/mI non-hacm. Strep. -0.40 (0.16) -0.44 (0.16) -0.40 (0.16) . 0.34 (0.16) 
12 [Logio cfu/ml non-haern. Strep. 0,06(0.03) 0.06(0.03) 0.06(0.03) 0.05(0.03) 
Logio cfu/ml Pasteurella spp. -0.44 (0.13) -0.45 (0.13) . 0.47(0.13) -0.49 (0.13) 
[Loglo cfu/ml Pasteurella spp. 12 0.09(0.02) 0.08(0.02) 0.08(0.02) 0.09(0.02) 
Transfcrrin D haplotype -0.63 (0.27) -0.79 (0.24) -0.93(011) -0.94 (0.20) 
Pony 28 (Transferrin F2) intercept . 1.99 (0.62) . 1.84 (0.56) . 1.80 (0,50) 
Pony 21 (Transferrin DF2) intercept 1.61(0.59) 1.78(0.54) 
Pony 29 (Transferrin DF2) intercept 1.34(0.50) 
Random effec 
Level 2 variance: Pony 0.27(0.12) 0.15(0.09) 0.09(0,07) 0.03(0.06) 
Level I variance: Observation 1.61(0.15) 1.62(0.15) 1.62(0.15) 1.61(0.15) 
-2*loglikelihood 878.49 870.40 863.41 856.82 
LRS j (I df. ) &09 6.99 6.59 
P-value 0.004 0.003 0.01 
Intra-pony correlation (1/6) 14.4 &5 4.7 1.8 
Clinical score (Traniferrin F2 Model) Model 4b Model 5b Model 6b Model 7b 
Fi d ffe 
n=257 n-257 n*257 nm257 
xe e c 
Intercept 1.46(0.39) 1 A7 (0.39) 1.33(0.37) 1 AO (0.37) 
Clinical score I week previously 0.35(0.05) 0.35(0.05) 0.34(0.03) 0.34(0.05) 
Loglo cfulml S. zooepidemicus 0.15(0.06) 0.16(0.06) 0.17(0.06) 0.16(0.06) 
Loglo cfu/n-J non-haern. Strep. -0.38 (0.16) . 0.41 (0.16) -0.34 (0.16) -0.37 (0.16) 
[Logio cfu/n-d non-haern. Strep. 12 0.06(0.03) 0.07(0.03) 0.05(0.03) 0.05(0.03) 
Logio cfu/ml Pasteurella spp. -0.43 (0.13) . 0.46 (0.13) -0.44 (0.13) -0.44 (0.13) 
[Logio cfu/n-d Pasteurella Spp. 12 0.08(0.02) 0.08(0.02) 0.08(0.02) 0.08(0.02) 
Transferrin F2 haplotype 0.68(0.27) 0.79(0.25) 0.88(0.22) 0.79(0.21) 
Pony 28 (Transferrin F2) intercept . 1.72 (0.63) -1.74 (0.56) . 1.64 (0.31) 
Pony 23 (Transferrin 0112) intercept 1.80(0.59) 1.78(0.55) 
Pony 24 (Transferrin F2) intercept 1.12(0.50) 
Random effect 
Level 2 variance: Pony 0.27(0.12) 0.17(0.09) 0.09(0.07) 0.05(0.06) 
Level I variance: Observation 1.61(0.15) 1.61(0.15) 1.60(0.15) 1.61(0.15) 
-2*loglikelihood 877.80 871.00 862.42 857.84 
LRS X2 (I d. f. ) 6.80 8.53 4.58 
P-value 0.009 0.003 0.032 
Intra-pony correlation (016) 14.4 9.6 5.3 3.0 
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Table A2.18: Summary of multilevel linear regression modelling of CDNS score with 
sequential exclusion from random effects components of ponies with largest 
value residuals 
Outcome va ri able/ Effect t3 Transferrin D models Transferrin F2 models 
Explanatory variable in model Estimate Estimate Estimate Estimate Estimate 
(S. E. ) (S. E. ) (S. E. ) (S. E. ) (S. E. ) 
CDNS sco 
Fixed effix 
Intercept 
CDNS score I mcck previously 
Loglo cfu/ml S. zooepidenticus 
Log lo cfu/ml non-haem. Strep. 
[Uglo cfu/n-d non-haern. Strep. ]2 
Loglo cfu/mI Pasteurella spp. 
lLoglo cfu/ml Pasteurella spp. ]2 
Transferrin D haplotype 
Transferrin F2 haplot)lv 
Pony 28 (Transferrin F2) intercept 
Pony 23 (Transferrin 0112) intercept 
Random ellec 
Level 2 variance: Pony 
Level I variance: Observation 
Model 4a 
n=257 
1.56(0.33) 
0.39(0.05) 
0.14(0.05) 
-0.35 (0.13) 
0.04(0.02) 
-0.36 (0.11) 
0.06(0.02) 
-0.46 (0.21) 
Model 5a 
n=257 
1.67(0.32) 
0.39(0.05) 
0.16(0.05) 
-0.38 (0.13) 
0.04(0.02) 
-0.37 (0.11) 
0.06(0.02) 
-0.56 (0.19) 
. 1.30 (0.50) 
0.16(0.07) 0.09(0.06) 
1.10(0.10) 1.10(0.10) 
Model 4b 
n=257 
1.03(0.31) 
0.39(0.05) 
0.14(0.05) 
-0.33 (0.13) 
0.04(0.02) 
-0.37 (0.11) 
0.06(0.02) 
Model 5b 
n--257 
1.03(0.31) 
0.39(0.05) 
0.14(0.05) 
-0.35 (0.13) 
0.04(0.02) 
-0.38 (0.11) 
0.06(0.02) 
Model 6b 
n--257 
0.90(0.30) 
0.38(0.05) 
0.16(0.05) 
-0.31 (0.13) 
0.03(0.02) 
-0.36 (0.11) 
0.06(0.02) 
0.48(0.21) 0.55(0.20) 0.63(0.18) 
-1.18 (0.51) -1.19 (0.45) 
1.45(0.49) 
0.16(0.08) 0.11(0.06) 0.06(0.05) 
1.10(0.10) 1.10(0.10) 1.09(0.10) 
-2'loglikelihoal 776.70 770.63 776.50 771.51 763.21 
LRS ,, 2 (1 d. f. ) 6.07 4.99 8.30 
P-Value 0.014 0.025 0.004 
Intra-pony conylation 12.7 Z5 IZ7 9.1 5.2 
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Figure A2.1 1: Caterpillar plot of ranked pony level residuals (± 95% CI) for 
multilevel linear regression model for airway inflammation score 
excluding transferrin HI haplotype (Model 2, Table 8.2) 
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Note: Colour scheme represents the transierrin D/F2 haplotype status of each pony light blue: transferrin D 
haploiNpe (n= 14), re& transferrin F2 haplotvpc (n= 10). light green: transferrin DF2 haplotypc (n=4) 
& grey other transferrin haplotype (n= 1) 
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Table A2.19a: Results of univariable ordinary logistic regression (OLR) analyses of the risk 
of nasal discharge with different explanatory variables 
Explanatory variable S. E. OR 95% C1 P-value 
Outcome - nasal discharge 
TW Loglofu/ml total bacteria Intercept -2.06 0.54 
Not isolated referent 
Log cfU/ml-1 0.38 0.10 1.46 1.20-1.78 <0.001 
TW Loglocfu/ml total S. zooepidemicus Intercept -1.43 0.28 
Not isolated referent 
Log cfu/ml-1 0.39 0.07 1.48 1.28-1.71 <0.001 
TW S. zooepidemicus (categorical) Intercept -0.54 0.14 
<101cfulml referent 
10, ý-101 cfu/nil 0.50 0.31 1.65 0.90-3.03 0.108 
10%101 cfU/mI 2.33 0.56 10.3 3.43-30.7 <0.001 
>106 CfU/MI 2.62 0.63 13.7 3.99-47.0 <0.001 
TW L4oglocfu/ml A. equu1i Intercept -0.05 0.12 
Not isolated referent 
Log cfulml-l -0.09 0.11 0.92 0.74-1.14 0.441 
TWA. equu1i (categorical) Intercept -0.02 0.13 
Not isolated referet 
<102 CfU/MI -0.33 0.37 0.72 0.35-1.48 0.370 
ý-- 101 cfu/ml -0.28 0.37 0.75 0.36-1.57 0.453 
TW Loglocfu/ml Pasteurella spp. Intercept -0.06 0.18 
Not isolated referent 
Log cfu/ml-1 -0.01 0.05 0.99 0.90-1.09 0.840 
W Pasteurella spp. (categorical) Intercept -0.15 0.15 
<101cfu/ml referent 
I V-101 cfu/ml 0.44 0.32 0.64 0.35-1.20 0.162 
10%101 cfU/mI 0.43 0.31 1.54 0.94-2.82 0.161 
>106 cfu/ml 0.77 0.46 2.17 0.88-5.37 0.094 
TW Loglocfu/ml B. bronchiseptica Intercept -0.15 0.13 
Not isolated referent 
Log cfu/ml-l 0.05 0.05 1.05 0.95-1.16 0.366 
TW B. bronchiseptica (categorical) Intercept -0.15 0.14 
Not isolated referent 
<103 CfU/Ml 0.34 0.39 1.40 0.66-2.99 0.378 
10- 101 cfu/ml -0.10 0.42 0.91 0.40-2.09 0.822 
>I 01 cfu/ml 0.25 0.35 1.29 0.64-2.56 0.476 
TW Loglocfu/ml non-haemolytic Strep. spp. Intercept 0.60 0.22 
Not isolated referent 
Log cfU/ml-, -0.22 0.06 0.80 0.72-0.90 <0,001 
TW non-haemolytic Strep. spp. (categorical) Intercept 1.12 0.29 
Not isolated referent 
<I 0' cfu/n-d -1.48 0.40 0.23 0.10-0.49 <0.001 
103ý. 104 CfU/Ml -1.63 0.39 0.20 0.09-0.42 <0.001 
I V-1 01 cfulml -1.65 0.39 0.19 0.09-0.41 <0.001 
>I 01 cfulml -1.27 0.38 0.28 0.13-0.59 0.001 
Nasal discharge I week previously Intercept -0.57 0.18 
Absent referent 
Present 1.01 0.26 2.75 1.67-4.54 <0.001 
Nasal discharge 2 weeks previously Intercept -0.37 0.19 
Absent referent 
Present 0.73 0.28 2.09 1.23-3.51 0.006 
Nasal discharge 3 weeks previously Intercept -0.41 0.19 
Absent referent 
Pre-ent 1.25 0.30 3.48 1.94-6.25 <0.001 
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Table A2.19a continued 
Explanatory variable SM OR 93% C1 P-value 
Outcome = naval discharge 
Sex Intercept 0.11 0.16 
Fernale referent 
Male . 0.45 0.23 064 0.41 - 0. " 0.046 
Vaccine group Intercept -0.21 0.19 
Vaccine referent 
Placebo 0.03 015 1.03 063-1.67 0.902 
Late intro 0.54 0.32 1.72 0.91-3.23 0.094 
Transferrin D haplotypc Intercept 0.22 0.19 
Absent referent 
Present -0.52 0.23 0.59 0.39-0.94 0.025 
Transferrin F2 haplotype Intercept -0.48 0.16 
Absent referent 
Present 0.77 0.23 2.16 1.39-3.38 0.001 
Transferrin III haplotype Intercept -0.10 0.12 
Absent referent 
Present -0.09 0.37 0.92 0.45-1.99 0.819 
Transferrin 112 haplotype Intercept . 0.08 0.12 
Absent referent 
Present -0.19 0.33 0.83 0.43-1.56 0.553 
Transferrin 0 haplot)pe Intercept -0.09 0.13 
Absent referent 
Present -0.03 0.24 0.95 0.59-1.53 0.834 
Transferrin R haplot), pe Intercept -0.09 0.12 
Absent referent 
Present -0.09 0.33 0.92 0,411-1.74 0.789 
Protease inhibitor I haplot)pe Intercept -0.21 0.13 
Absent referent 
Present 0.22 0.23 1.23 0.90-1.94 0.331 
Protease inhibitor L haplot)pe Intercept 0.56 0.36 
Absent referent 
Present -0.74 0.39 0.49 0.23-1.00 0.051 
Proteasc inhibitor 1.1 haplot)T)e Intercept -0.16 0.11 
Absent referent 
Present 1.66 0.79 3.26 1.11-24.7 0.036 
Protease inhibitor R haplotypc Intercept -0.12 0.11 
Absent referent 
Present 0.30 0.62 1.35 0.40-4.51 0.627 
Protcase inhibitor S haplotype Intercept -0.11 0.12 
Absent referent 
Present 0.17 0.30 1.19 0.66-2.13 0.560 
NP S. zooepidemicus Intercept -0.73 0.39 
Not isolated referent 
Isolated 0.71 0.36 2.03 1.00-4.10 0.048 
NP Pasteurella spp. Intercept 0.14 0.39 
Not isolated referent 
Isolated -0.27 0.40 0.76 0.33-1.65 0.490 
NP B. Bronchiseptica Intercept -0.19 0.13 
Not isolated referent 
Isolated 0.33 0.27 1.42 0.94-2.41 0.198 
NP non-hacrnolytic Streptococcus spp. Intercept 0.33 0.36 
Not isolated referent 
Isolated -0.49 0.39 0.62 0.29-1.31 0,211 
NP Staphylococcus spp. Intercept 0.25 0.36 
Not isolated referent 
Isolated -040 039 067 032-140 0,2R9 
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Table A2.19b: Results of univariable ordinary logistic regression (OLR) analyses of the risk 
of ocular discharge with different explanatory variables 
Explanatory variable S. E. OR 95% C1 P-value 
Outcome - ocular discharge 
TW Logja cfu/ml total bacteria Intercept -2.41 0.64 
Not isolated refernt 
Log aulmr, 0.22 0.12 1.25 0.99-1.57 0.058 
7W Loglo cfu/ml total S. zooepidemicus Intercept -1.58 0.30 
Not isolated referent 
Log cfu/mrl 0.10 0.09 1.10 0.95-1.28 0.209 
TW S. zooepidemicus (categorical) Intercept -1.19 0.16 
<101cfulml referent 
104_101 CfU/Ml -0.54 0.42 0.59 0.26-1.33 0.199 
10%106 cfuhnl -0.33 0.52 0.72 0.26-1.98 0.520 
>106 cfulml 0.50 0.44 1.65 0.69-3.90 0.258 
TW Loglo cfu/ml A. equuli Intercept -1.26 0.15 
Not isolated referent 
Log curarl 0.01 0.13 1.01 0.79-1.31 0.910 
TWA. equu1i (categorical) Intercept -1.27 0.15 
Not isolated referent 
<102 CfU/Ml -0.08 0.45 0.93 0.38-2.24 0.866 
ýq02 CfU/Ml 0.29 0.42 1.34 0.59-3.05 0.486 
TW Logja cfu/ml Pasteurella spp. Intercept -1.12 0.21 
Not isolated referent 
Log curni-, -0.04 0.06 0.96 0.85-1.07 0.452 
TW Pasteurella spp. (categorical) Intercept -1.18 0.18 
<101cfu/ml referent 
W-105 cfU/MI -0.12 0.37 0.89 0.43-1.84 0.752 
10%101 cfu/ml -0.23 0.38 0.80 0.38-1.68 0.551 
>I 01 cfU/MI -0.10 0.54 0.91 0.32-2.59 0.854 
TW Logio cfu/ml B. bronchiseptica Intercept -1.41 0.16 
Not isolated referent 
Log cfu/ml-1 0.12 0.06 1.12 1.00-1.26 0.052 
*IW B. bronchiseptica (categorical) Intercept -1.44 0.17 
Not isolated referent 
<103 CfU/Ml 0.55 0.43 1.73 0.74-4.04 0.202 
101-101 cfU/MI 0.87 0.45 2.38 0.99-5.77 0.054 
>I 01 cfU/M1 0.41 0.41 1.51 0.68-3.36 0.308 
TW Logio cfu/ml non-haernolytic Strep. spp. Intercept -1.41 0.27 
Not isolated referent 
Log cfuhnl-l 0.05 0.07 1.05 0.91-1.20 0.497 
TW non-haLmolytic Strep. spp. (categorical) Intercept -1.39 0.31 
Not isolated referent 
<I 01 cfulml 0.19 0.44 1.21 0.51-2.88 0.668 
lo'-10'cfuhnl -0.19 0.45 0.83 0.34-2.02 0.682 
I V-1 01 cfulml 0.35 0.42 1.42 0.62-3.22 0.406 
>I 0, cfulml 0.27 0.42 1.31 0.57-2.99 0.528 
Ocular discharge I week previously Intercept -0.91 0.16 
Absent referent 
Present -0.23 0.33 0.79 0.92-1.51 0.483 
Ocular discharge 2 weeks previously Intercept -1.12 0.18 
Absent referent 
Present 0.09 0.34 1.09 0.56-2.13 0.796 
Ocular discharge 3 weeks previously Intercept -0.97 0.19 
Absent referent 
Present -0.57 0.39 0.56 0.26-1.22 0.146 
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Table A2.19b, continued 
Explanatory variable SM OR "% C1 P-value 
Outcome = ocular discharge 
Sex Intercept -1.46 0.20 
Female referent 
Male 0.43 0.27 1.57 0.92-2.66 0.096 
Vaccine group Intercept -117 0.21 
Vaccine referent 
Placebo -0.09 0.30 0,91 0.51-1.65 0.763 
Late intro, 0.38 0.36 1.46 0.71-2.97 0.301 
Transferrin D haplotype Intercept -1.20 0.22 
Absent referent 
Present -0.05 0-29 0.95 0.55-1.63 0.849 
Transferrin F2 haplot)pe Intercept -1.24 0.19 
Absent referent 
Present 0.02 0.27 1.02 0.60-1.72 0.948 
Transferrin III haplotype Intercept -1.22 0.14 
Absent referent 
Present -0.09 0.45 0.92 0,39-2.21 0. &44 
Transferrin 112 haplotype Intercept -1.23 0.14 
Absent referent 
Present 0.01 0.39 1.01 0.47-2.16 0.979 
Transferrin 0 haplotypc IntercqA -1.17 0.16 
Absent referent 
Present -0.20 0.30 0.92 0.46-1.46 0.498 
Transferrin R haplot)l)e Intercept -1.21 0.14 
Absent referent 
Present -0.14 0.40 0.117 0.39-1.90 0.719 
Protease inhibitor I haplotype Intercept -1.22 0.19 
Absent referent 
Present -0.02 0.27 0.99 0.59-1.66 0.941 
Protease inhibitor L haplot)pe Intercept -0.98 0.39 
Absent referent 
Present -0.28 0.42 0.75 0,33-1.70 0.496 
Protease inhibitor L2 haplotypc Intercept -1.24 0.14 
Absent referent 
Present 0.26 0.69 1.30 0.34-5.03 0.705 
Protease inhibitor R haplot)j)e Intercept -1.24 0.14 
Absent referent 
Present 0.26 0.69 1.30 0.34-5.03 0.705 
Protcasc inhibitor S haplotype Intercept -1.30 0.14 
Absent referent 
Present 0.31 0.34 1.36 0.70-2.64 0.360 
NP S. zooepidemicus Intercept -1.73 0.44 
Not isolated referent 
Isolated 0.56 0.46 1.76 0.71-4.37 0.226 
NP Pasteurella spp. Intercept -3.33 1.02 
Not isolated referent 
Isolated 2.21 1.03 9.08 1.21-67.9 0.032 
NP B. Bronchiseptica Intercept -1.33 0.16 
Not isolated reffzcnt 
Isolated 0.46 0.30 1.58 0.97-2.87 0.130 
NP non-haemolytic Streptococcu., spp. Intercept -1.63 0.49 
Not isolated referent 
Isolated 0.46 0.51 1.59 0.58-4.27 0.370 
NP Staphylococcus spp. Intercept -1.69 0.49 
Not isolated referent 
Isolated 050 051 164 061-444 0.326 
*Model predicted disease perfectly as all cases had Pasteu"Ila spp. isolatod from nasopharyngcal swabs. 
Model convergence was achieved by modification or nasopharyngcal culturc rcsult for %%, cck 3 swab sampic 
for pony 14. 
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Table A2.19c: Results of univariable ordinary logistic regression (OLR) analyses of the risk 
of coughing with different explanatory variables 
Explanst ryvariable S. E. P OR 95% C1 P-value 
Outcome - coughing 
TW Loglocfu/ml total bacteria Intercept -6.08 0.98 
Not isolated referent 
Log ctwml-l 0.80 0.17 2.22 1.60-3.08 <0.001 
TW Loglo cfu/ml total S. zooepidenticus Intercept -3.49 0.44 
Not isolated referent 
IJDg CfU/Ml-' 0.46 0.10 1.59 1.32-1.92 <0.001 
TW S. zooepidendcus (categorical) Intercept -2.35 0.25 
<104 cfu/n-d referent 
W-105 cWhil 0.46 0.47 1.59 0.63-4.03 0.329 
101-10, cfulml 1.91 0.46 6.76 2.75-16.6 <0.001 
> 106 CfU/Ml 2.27 0.46 9.70 3.96-13.8 <0.001 
TW Loglo cfu/n-d A. equu1i Intercept -1.77 0.17 
Not isolated referent 
Log cfu/mrl 0.15 0.13 1.17 0.90-1.52 0.247 
TWA. equu1i (categorical) Intercept -1.77 0.18 
Not isolated referent 
<102 CfUIMI 0.23 0.48 1.26 0.49-3.25 0.638 
ýt 102 CfU/nll 0.46 0.46 1.58 0.64-3.91 0.324 
TW Loglocfu/ml Pasteurella spp. Intercept -1.51 0.24 
Not isolated referent 
Log cfu/ml-1 -0.06 0.07 0.94 0.83 - 1.07 0.361 
TW Pasteurella spp. (categorical) Intercept -1.60 0.20 
<101cfu/ml referent 
W-105 cfU/nd -0.72 0.51 0.49 0.18-1.32 0.158 
101-10, cfU/mI -0.05 0.42 0.95 0.42-2.14 0.904 
>106 CfU/Ml 0.32 0.54 1.38 0.48-4.00 0.554 
TW Loglo cfu/ml B. bmichiseptica Intercept -1.80 0.19 
Not isolated referent 
Log cfu/mrl -0.08 0.07 1.09 0.95-1.24 0.213 
TW B. bronchiseptica (categorical) Intercept -1.85 0.20 
Not isolated referent 
<103 cfu/inl 0.42 0.50 1.52 0.58-4.01 0.398 
101-10, cfU/mI 0.90 0.49 1.46 0.95-6.40 0.064 
> 101 cfu/ml 0.17 0.49 1.19 0.46-3.08 0.724 
TW Loglo cfu/ml non-haemolytic Strep. spp. Intercept -0.99 0.25 
Not isolated referent 
Log cfu/ml" -0.24 0.08 0.78 0.67-0.91 0.002 
TW non-haernolytic Strep. spp. (categorical) Intercept -0.60 0.26 
Not isolated referent 
< 0, cfulml -0.96 0.58 0.14 0.05-0.44 0.001 
I 0ý_l 04 CfU/Ml -1.67 0.50 0.19 0.07-0.50 0.001 
I 0ý-l 01 cfu/ml -1.88 0.53 0.15 0.05-0.43 <0.001 
> 105 cfu/n-d -0.99 0.42 0.37 0.16-0.85 0.019 
Coughing I week previously Intercept -1.92 0.20 
Absent referent 
Present 1.82 0.37 6.20 3.01-12.8 <0.001 
Coughing 2 weeks previously Intercept -1.75 0.20 
Absent referent 
Present 1.47 0.40 4.34 2.00-9.45 <0.001 
Coughing 3 weeks previously Intercept -1.59 0.20 
Absent referent 
Present 1.08 0.42 2.94 1.29-6.67 0.010 
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Table A2.19c continued 
Explanatory variable S. L OR 95% C1 P-value, 
Outcome - coughing 
Sex Intercept -IA2 0.20 
Female referent 
Male -0.66 0.32 0.52 0.27-0.97 0.041 
Vaccine group Intercept -2.30 0.30 
Vaccine referent 
Placebo 1.07 0.37 2.94 1.43-6.04 0.003 
Late intro 0.39 0.51 1.46 0.54-3.93 0.455 
Transferrin D haplotype Intercept -115 0.22 
Absent referent 
Present -0.83 0.31 0.44 0.24-0.91 0.008 
Transferrin F2 haplotype Intercept -2.30 017 
Absent referent 
Present 1.04 0.33 2.83 1 A7 - 5.44 0.002 
Transferrin III haplotype Intercept -1.86 0.17 
Absent referent 
Present 1.19 0.41 3.26 1.47-7.26 0.004 
Transferrin 112 haplotype Intercept -1.71 0.17 
Absent referent 
Present 0.05 0.44 1.05 0.44-2.51 0.913 
Transferrin 0 haplotype Intercept -1.67 0.19 
Absent referent 
Present -0.14 0.34 0.97 0.45-1.70 0.696 
Transferrin R haplotype Intercept -1.61 0.16 
Absent referent 
Present -1.01 0.62 0.36 0.11-113 0.103 
Protcasc inhibitor I haplotype Intercept -2.03 0.24 
Absent referent 
Present 0.69 0.32 1.98 1.07-3.69 0.030 
Protease inhibitor L haplotype Intercept -0.56 0.36 
Absent referent 
Present -1.33 0.40 016 0.12-0.37 0.001 
Protease inhibitor L2 haplotypc Intercept -1.74 0.16 
Absent referent 
Present 0.76 0.70 2.14 0.33-9.35 0.275 
Protease inhibitor R haplotype Intercept -1.74 0.16 
Absent referent 
Present 0.76 0.70 2.14 0.53-9.33 0.275 
Protease inhibitor S haplotype Intercept -1.59 0.16 
Absent referent 
Present -0.96 0.54 0.39 0.13-1.11 0.077 
NP S. zooepidemicus Intercept -3.66 1.01 
Not isolated referent 
Isolated 2.09 1.03 9.10 1.09-60.4 0.041 
NP Pasteurella spp. Intercept -3.33 1.02 
Not isolated referent 
Isolated 1.71 1.03 5.35 0.74-41.8 0.096 
NP B. Bronchiseptica Intercept -1.90 0.19 
Not isolated referent 
Isolated 0.39 0.35 IA6 0.74-2.90 0.277 
NP non-haemolytic Streptococcus spp. Intercept -2.67 0.73 
Not isolated referent 
Isolated 1.04 0.75 2.93 0.65-12.3 0.165 
NP Staphylococcus spp. Intercept -2.71 0.73 
Not isolated referent 
I%olated 109 0.75 294 0 Mt - 12 7 0,149 
*Model predicted disease perfectly as all cases had Pasteurella spp. isolated from nasopliaryngcal swabs. 
Model convergence was achieved by modification of nasophar)-ngcal culture result for %%cck 5 swab sample 
for pony 14. 
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Table A2.19d: Results or univariable ordinary logistic regression (OLR) analyses of the risk 
or abnormal breathing/dyspnoea with different explanatory variables 
Explanatory variable S. E. OR 95% C1 P-value 
Oukome - abnormal brradoing%, spnoea 
IV Logiocfu/ml total bacteria Intercept -. 3.39 0.66 
Not isolated referent 
Log cfu/n-d" 0.46 0.12 1.59 1.26-2.01 <0.001 
'nV Logio cfu/ml total S. zooepidemicus Intercept -2.40 0.33 
Not isolated referent 
Log cfu/mrl 0.40 0.08 1.49 1.28-1.74 <0.001 
TW S. : ooepidenticus (categorical) Intercept -1.33 0.17 
< 104 cfu/ml referent 
I Ot 101 cfulml 0.31 0.36 1.36 0.68-2.73 0.386 
I 0ý. l 06 CfU/Ml 1.62 0.42 5.05 2.23-11.5 <0.001 
> 106 CfU/Ml 1.71 0.17 5.51 2.39-12.7 <0.001 
TW Loglo cfu/ml A. equuh Intercept -0.90 0.14 
Not isolated referent 
Log cfu/n-d" -0.07 0.13 0.94 0.73-1.20 0.600 
TWA. equmli (categorical) Intercept -0.89 0.14 
Not isolated referent 
<102 CfU/nll -0.13 0.41 0.88 0.39-1.97 0.747 
; -. 101 c 
fulml -0.25 0.43 0.78 0.34-1.81 0.559 
TW Log, ocfuhnI Pasteurella spp. Intercept -1.05 0.21 
Not isolated referent 
Log cfu/ml-1 0.04 0.05 1.04 0.94-1.16 0.438 
TW Pasteurella spp. (categorical) Intercept -1.09 0.17 
<104CfU/Ml referent 
I V-10, cfulml 0.09 0.35 1.09 0.55-2.15 0.805 
10%106 cfu/ml 0.34 0.33 1.41 0.73-2.71 0.303 
>I 06 cfUlml 1.00 0.45 2.73 1.13-6.61 0.026 
TW Logl0cfuhril B. bronchiseptica Intercept -0.90 0.14 
Not isolated referent 
Log cfu/n-d-1 -0.03 0.06 0.97 0.87-1.10 0.671 
TW B. bmichiseprica (categorical) Intercept -0.89 0.15 
Not isolated referent 
<I 0, cfu/ml -0.17 0.44 0.85 0.36-1.99 0.705 
16ý101 cfUlml 0.14 0.45 1.15 0.47-2.79 0.762 
>105 cfu/n-d -0.28 0.41 0.76 0.34-1.69 0.495 
TW Loglo cfu/ml non-haernol)tic Strep. spp. Intercept -0.41 0.22 
Not isolated referent 
Log cfu/n-d" -0.17 0.06 0.84 0.75-0.95 0.007 
TW non-haernolytic Strep. spp. (categorical) Intercept -0.03 0.25 
Not isolated referent 
<I 0, cfU/mI -1.17 0.40 0.31 0.14-0.69 0.004 W-IO'cWh-d -1.44 0.41 0.34 0.11-0.53 <0.001 
I V-1 01 cfalml -1.36 0.40 0.26 0.12-0.56 0.001 
> 105 cfu/n-d -0.85 0.37 0.43 0.21-0.88 0.021 
Abnonnal breathing I week previously Intercept -1.19 0.18 
Absent referent 
Present 1.46 0.29 4.32 2.47-7.55 <0.001 
Abnonnal breathing 2 weeks previously Intercept -1.15 0.18 
Absent referent 
Present 1.67 0.31 5.34 2.92-9.76 <0.001 
Abnonnal breathing 3 weeks previously Intercept -0.84 0.18 
Absent referent 
Present 1.23 0.32 3.43 1.81-6.48 <0.001 
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Table A2.19d continued 
Explanatory variable S. L OR 95% Cl P-value 
Oukome = abnormal brealhingldyspnoea 
Sex Intercept -0.61 0.16 
Female referent 
Male -0.77 0.26 0.46 019-0.77 0.003 
Vaccine group Intercept -1.02 010 
Vaccine referent 
Placebo -0.09 0.29 0.92 0.53-1.60 0.778 
Late intro, 0.54 0.34 1.71 0.97-3.34 0.114 
Transferrin D haplot)pe Intercept -0.22 0.19 
Absent referent 
Present -1.32 0.26 0.27 0.16-0.44 <0.001 
Transferrin F2 haplotype Intercept -1.93 0.23 
Absent referent 
Present 1.69 0.211 5.42 3.10-9.47 <0.001 
Transferrin III haplotype Intercept . 1.00 0.13 
Absent referent 
Present 0.44 0.39 1.55 0.73-3.30 0.255 
Transferrin 112 haplotype Intercept -0.93 0.13 
Absent rcfercnt 
Present -0.17 0.37 0.94 0.41-1.75 0.644 
Transferrin 0 haplotype Intercept -0.83 0.15 
Absent referent 
Present -0.43 0.29 0.63 0.37-1.14 0.131 
Transferrin R haplotype Intercept -0.96 0.13 
Absent referent 
Present 0.09 0.36 1.10 0.33-2.21 0.793 
Proteasc inhibitor I haplotype Intercept -1.07 0.17 
Absent referent 
Present 0.26 0.25 1.29 0.79-2.11 0.304 
Protease inhibitor L haploqW Intercept 0.31 0.33 
Absent referent 
Present -1.43 0.39 0.24 0.11-0.50 <0,001 
Protease inhibitor L2 haplotype Intercept -1.00 0.13 
Absent referent 
Present 1.19 0.62 3.25 0.97-10.9 0.057 
Protease inhibitor R haplotype Intercept -0.42 0.13 
Absent refixent 
Present -1.39 1.06 0.23 0.03-1.98 0.199 
Proteasc inhibitor S haplotype Intercept -1.06 0.14 
Absent referent 
Present 0.59 0.31 1.79 0.97-3.28 0.064 
NP S. zooepidemicus Intercept -3.66 1.01 
Not isolated referent 
Isolated 2.99 1.02 ISO 2.43- 0.005 
132.9 
NP Pasteurella spp. Intercept -3.33 1.02 
Not isolated referent 
Isolated 2.50 1.03 12.2 1.63-91.1 0,015 
NP B. Bronchiseptica Intercept -0.95 0.14 
Not isolated refacnt 
Isolated -0.01 0.30 0. " 0.53-1.711 0.979 
NP non-haernolytic Streptococcus spp. Intercept -1.23 0.43 
Not isolated referent 
Isolated 0.31 0.45 1.36 0.57-3.29 0.489 
NP Staphylococcus spp. Intercept -1.27 0.43 
Not isolated referent 
Isolated 0.36 045 141 059-341 0425 
*Model predicted disease perfectly as all cases had Pasteurella spp. isolated ftorn nasoplur)ngeal s%abs. 
Model convergence was achieved by modification of nasopharyngcal culturc rcsult for % cck 5 su ab sample 
for pony 14. 
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Table A2.19e: Results of univariable ordinary logistic regression (OLR) analyses of the risk 
of SMLN enlargement with different explanatory variables 
Explanatory variable S. E. OR 95% CI P-value 
Outcome = SALLN enlargement 
TW Logio cfu/mI total bacteria Intercept -3.40 0.65 
Not isolated referent 
Log cfu/ml-1 0.48 0.12 1.62 1.29-2.04 <0.001 
TW Loglo cfu/ml total S. zooepidemicus Intercept -1.93 0.30 
Not isolated referent 
Log cfu/ml-1 0.31 0.07 1.36 1.18-1.57 <0.001 
TW S. zooepidemicus (categorical) Intercept -1.22 0.17 
<104CfU/Ml referent 
W-105 cfu/n-d 0.64 0.33 1.89 0.99-3.62 0.054 
101-101 cfU/mi 1.08 0.41 2.93 1.30-6.60 0.009 
> 106 CfU/Ml 1.59 0.43 4.92 2.14-11.3 <0.001 
TWLoglocfu/mI A. equuli Intercept -0.76 0.13 
Not isolated referent 
Log cfu/n-d-1 -0.19 0.13 0.83 0.64-1.08 0.168 
TWA. equuli (categorical) Intercept -0.74 0.14 
Not isolated referent 
<101 cfU/mi -0.29 0.41 0.75 0.34-1.68 0.488 
ý: 102 CfU/Ml -0.77 0.47 0.46 0.18-1.17 0.103 
TW Loglo cfuhnI Pasteurella spp. Intercept -0.96 0.20 
Not isolated referent 
Log cfu/ml-1 0.04 0.05 1.04 0.94-1.15 0.447 
TW Pasteurella spp. (categorical) Intercept -1.03 0.17 
< 104 CfU/rnl referent 
104_105 CfU/ml 0.12 0.34 1.12 0.58-2.19 0.733 
I Oý_106 Cf /Ml u 0.52 0.32 1.69 0.89-3.19 0.107 
> 106 CfU/Ml 0.95 0.45 2.57 1.06-6.23 0.036 
TW Logio cfu/ml B. bronchiseptica Intercept -0.93 0.14 
Not isolated referent 
Log cfu/ml-1 0.07 0.06 1.07 0.96-1.20 0.215 
TW B. bronchiseptica (categorical) Intercept -0.96 0.15 
Not isolated referent 
<103 CfUhnl 0.36 0.40 1.43 0.65-3.17 0.373 
I Oki 0, cfU/mI 0.88 0.43 2.41 1.04-5.56 0.040 
>I 0, cfUlmi 0.06 0.39 1.06 0.50-2.27 0.877 
TW Logio cfu/ml non-haemolytic Strep. spp. Intercept -0.23 0.22 
Not isolated referent 
Log cfu/ml-1 -0.20 0.06 0.82 0.73-0.93 0.001 
TW non-haemolytic Strep. spp. (categorical) Intercept 0.03 0.25 
Not isolated referent 
< 01 cfU/mI -0.70 0.38 0.50 0.24-1.04 0.064 
103_104 CfU/nd -1.98 0.45 0.14 0.06-0.37 <0.001 
104_105 cfu/n-d -0.99 0.37 0.37 0.18-0.77 0.008 
>I 0, cfulml -1.07 0.38 0.34 0.16-0.72 0.004 
SNEN enlargement I week previously Intercept -1.52 0.19 
Absent referent 
Present 2.31 0.31 10.1 5.48-18.6 <0.001 
SNEN enlargement 2 weeks previously Intercept -1.09 0.18 
Absent referent 
Present 1.59 0.31 4.92 2.70-8.98 <0.001 
SNEN enlargement 3 weeks previously Intercept -0.94 0.18 
Absent referent 
Present 1.26 0.33 3.52 1.86-6.66 <0.001 
431 
Eq- Md-y A-W Do- EpWa-*vY 
Table A2.19e continued 
Explanatory variable S. E. OR 95% C1 P-value 
Outcome - &I ILS enlargement 
Sex Intercept -0.83 0.17 
Female referent 
Male -0.05 0.25 0.95 0.59-1.54 0.833 
Vaccine group Intercept -1.27 0.21 
Vaccine referent 
Placebo 0.21 0.29 1.23 0.70-2.17 0.471 
Late intro 1.60 0.34 4.94 2.51-9.71 <0.001 
Transferrin D haplot)pe Intercept -0.67 0.19 
Absent referent 
Prcscnt -0.31 0.25 0.73 0.45-1.19 0.211 
Transferrin F2 haplot)pc Intercept -1.07 0.18 
Absent referent 
Present 0.43 0.25 1.54 0.95-2.49 0.081 
Transferrin III haplot)pe Intercept -0.76 0.13 
Absent referent 
Present -1.22 0.55 0.30 0.10-0.87 0.026 
Transfi. rrin 112 haplotype Intercept -0.93 0.13 
Absent referent 
Present 0.46 0.34 1.59 0.82-3.08 0.164 
Transferrin 0 haplot)pe Intercept -0.85 0.15 
Absent referent 
]Present -0.03 0.27 0.97 0.57-1.63 0.898 
Transferrin R haplot)p: Intercept -0.77 0.13 
Absent referent 
Present -0.73 0.41 0.48 0.21-1.08 0.075 
Protcase inhibitor I haplot)pe Intercept -0.76 0.16 
Absent referent 
Present -0.22 0.25 0.80 0.49-1.31 0.379 
Protcase inhibitor L haplot)pc Intercept -1.50 0.45 
Absent referent 
Present 0.71 0.47 2.03 0.81-5.10 0.130 
Protcase inhibitor L2 haplotype Intercept -0.95 0.13 
Absent referent 
Present 2.45 0.79 11.6 2.46-54.9 0.002 
Protease inhibitor R haplot)pc Intercept -0.82 0.12 
Absent referent 
Present -1.48 1.06 0.23 0.03-1.80 0.161 
Protease inhibitor S haplot)pc Intercept -1.00 0.14 
Absent referent 
Present 0.74 0.31 2.10 1.16-3.83 0.015 
NP S. zooepidemicus Intercept -2.20 0.53 
Not isolated referent 
Isolated 1.47 0.54 4.36 1.50-12.6 0.007 
NP Pasteurella spp. Intercept -1.10 0.44 
Not isolated referent 
Isolated 0.26 0.45 1.30 0.53-3.17 0.563 
NP B. Bropichiseptica Intercept -0.91 0.14 
Not isolated referent 
Isolated 0.21 0.29 1.24 0.71-2.17 0.454 
NP non-hao--mol)lic Streptococcus spp. Intercept -1.23 0.43 
Not isolated referent 
Isolated 0.41 0.45 1.51 0.63-3.63 0.359 
NP Staphylococcus spp. Intercept -1.27 0.43 
Not isolated referent 
Isolated 0.46 0.45 1.58 0.66-3.79 0.306 
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Figure A2.12a: Relationship betweenS. zooepidemicus infection and odds of nasal 
discharge 
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Figure A2.12b: Relationship betweenS. zooepidemicus- infection and odds of coughing 
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Figure A2.12c: Relationship betweenS. zooepitlenticus infection and odds of 
abnormal breath ing/dys pn oea 
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Figure A2.13: Caterpillar plot of ranked pony level residuals (± 95% Cl) estimated using an 
iterative generalised least squares (IGLS) algorithm for final logistic 
regression model for nasal discharge including random effect term 
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Figure A2.14: Caterpillar plot of ranked pony level residuals (± 95% CI) estimated using a 
restricted iterative generalised least squares (RIGLS) algorithm for final 
logistic regression model for nasal discharge including random effect term 
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Ponies ranked by residuals 
Note: Colour scheme represents the transferrin D/F2 haploINPe status of each pony light blue: transferrin D 
haplotype (n= 14). red: transferrin F2 haplotype (n= 10), light green: transferrin DF2 haplotype (n=4) 
& grey other transferrin haplotype (n=1) 
435 
Eqiwie lnflanundtt)rý Aim ay Disease Epidenuohigy 
Figure A2.15: Caterpillar plot of ranked pony level residuals (± 95% Cl) for final 
logistic regression model of coughing including transferrin D 
haplotype and random effect terms 
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Figure A2.16: Caterpillar plot of ranked pony level residuals (± 951X) Cl) for final logistic regression model 
for coughing including transferrin F2 haplotype and random effect terms 
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Note: Colour scheme represents the transfcrrin D/F2 haplotype status of each pony light blue: transferrin D 
haplotvpc (n=14)- red: transfcrrin F2 haplotNpe (n=10). light green: transferrin DF2 haplotypc (n=4) 
& grey: other transferrin haplotýpe (n= 1) 
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Figure A2.17: Caterpillar plot of ranked pony level residuals (± 95% CI) for final logistic 
regression model for abnormal breath ing/dyspnoea including transferrin D 
haplotype and random effect terms 
Figure A2.18: Caterpillar plot of ranked pony level residuals (± 95% Cl) for final logistic 
regression model for abnormal breath ing/dyspnoea including transferrin F2 
haplotype and random effect terms 
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Ponies ranked by residuals 
Note: Colour scherne represents the transferrin DAF2 haplotypc status of each pony light blue: transferrin D 
liaplotvpe(n=14). red: transferrin F2 haplotype 0=10). light green: transferrin DF2 haplot, *PC 
(n=4) & grey other transferrin haplotype (n= 1) 
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Figure A2.19: Caterpillar plot of ranked pony level residuals (± 95%, Cl) for final 
logistic regression model for SMLN enlargement and random effect 
term 
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Note: Colour scheme represents the transferrin D/F2 haplotypc status of cach pony light bluc: transferrin D 
haplotýpe (n- 14). red: transfmin F2 haplolýpe 0=10), lighl green: transferrin DF2 haplotypc 
(n- 4) & grcý other transferrin haplotypc (n= I) 
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Chapter 12: Tables & figures 
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Table A3.1: Results and comparison of univariable linear and best fitting polynomial 
regressions of clinical and airway inflammation parameter scores with 
tracheal wash bacterial count data for the 5 most prevalent S. 
zooepitlemicus types 
Outcome var. 
Regression type 
Explanatory 
Variable 
Regression 
coefficient 
Intercept R'value 
(%) 
P-value Deviance 
benefit 
P-value 
(72,3 df) 
Clinical sco, (n--295) 
Linear Al HVI logio cfu/ml -0.13 2.47 1.0 0.088 
Polynomial [Al HVI logio cfu/n-d]'2 0.0002 0.30 4.1 0.002 
[Al HVI logio cfu/ml]l 0.39 0.036 9.52 0.023 
Linear Al HVu logio cfu/n-d 0.28 2.26 4.3 <0.001 
Polynomial [Al HVu logio cfu/mll-0 5 0.97 0.57 4.9 0.013 
log. [Al HVu logio cfu/n-djl 1.74 0.006 1.99 0.574 
Linear Al HV3 logio cfu/n-d 0.08 2.37 0.3 0.972 
Polyvomial [Al HV3 loglo du/mIll -1.27 2.50 4.0 0.002 
[Al HV3 logio cfb/mlf x logn [x] 0.84 0.001 11.11 0.011 
Linear Cl HV3 logia cfu/n-d 0.25 2.30 2.9 0.004 
Poývnomial lo& [Cl HV3 loglo cfu/ml]l 1.61 0.006 4.5 0.001 
(109n [Cl HV3 logio cfu/n-d]ý 0.46 0.003 5.01 0.171 
Linear Al HV4 logio cfu/ml 0.27 2.32 2.5 0.006 
Polynomial [Al HV4 logio cfu/m1r5 4.13 2.75 5.9 0.001 
[Al HV4 logio cfu/ml]l 1.99 <0.001 10.55 0.014 
CDNS scor (n=295) 
Linear Al HVI logio cfu/ml -0.09 1.56 0.6 0.189 
Polynomial [Al HVI loglo cfuhnl]-2 0.0001 0.44 4.9 <0.001 
[Al HVI loglo CfU/MI13 0.008 0.004 13.13 0.004 
Linear Al HVu logio cfu/nil 0.23 1.41 4.1 <0.001 
Polynomial [Al fWU loglo CfU/Mlj-2 0.0001 0.35 5.3 0.055 
[Al HVu logio cfu/n-dll 0.46 0.001 3.71 0.294 
Linear Al HV3 logio cfu/ml 0.08 1.49 0.3 0.321 
Polynomial [Al HV3 logio cfu/ml]l -1.02 1.60 3.7 0.004 
[Al HV3 logio cfu/mll 1x log. [x] 0.68 0.002 10.19 0.017 
Linear CI HV3 logio cfuhnl 0.21 1.44 2.8 0.004 
Polynomial [CI HV3 logio cfu/n-djo, 5 -1.58 2.12 3.7 0.108 
[C I HV3 loglo cfu/n-djo-5 x lo& [x] 1.11 0.038 2.81 0.422 
Linear Al HV4 logio cfu/n-d 0.23 1.46 2.7 0.005 
Polynomial [Al HV4 logio cfulmll' -1.14 1.53 6.5 0.005 
[Al HV4 logio cfu/nil] 1x log,, [x] 0.81 0.001 11.94 0.008 
Ai rway inflammation score (n--295) 
Linear Al HVI logio cfu/ml 0.10 6.17 0.5 0.222 
Poývnomial [Al HVI logio cfu/n-dl-0-3 1.53 2.41 3.4 0.002 
log. [Al RVI loglo cfu/mljl 2.49 0.001 8.70 0.034 
Linear Al HVu logio cfu/ml 0.27 6.10 3.7 0.001 
Pol)momial [Al HVu logto cfuhnl]-2 0.0002 3.36 4.6 0.022 
[Al HVu logto cfu/ml]o 5 1.90 0.002 2.86 0.414 
Linear Al HV3 logio cfu/ml 0.12 6.18 0.6 0.201 
Poývnomial [Al HV3 loglo CfU/Mlj15 -2.53 6.55 4.1 0.029 
[Al HV3 logio cfu/ml]l 1.20 0.017 4.82 0.185 
Linear CI HV3 loglo cfu/ml 0.13 6.18 0.7 0.153 
Polywomial logn [CI HV3 logio cfu/n-dll 1.56 3.33 3.1 0.003 
(log. [CI HV3 logio cfu/nil])2 0.48 0.003 7.11 0.068 
Linear Al HV4 loglo cfuhnl 0.23 6.17 1.8 0.021 
Polywomial [Al HV4 loglo cfuhnl]-2 0.0016 3.02 3.7 0.003 
lOgn [Al HV4 logio cfu/ml]l 2.80 0.002 5.68 0.128 
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Figure A3.1: Logio cfu/ml vs clinical score for the 5 most prevalent S. zooepidemicus types 
including plotted regression line from the best-fitting, 2-power polynomial 
model 
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Figure A3.1 continued 
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Figure A3.1 continued 
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Figure A3.2: Loglo cfu/mI vs CDNS score for the 5 most prevalent S. zooepillemicus 
types including plotted regression line from the best-fitting, 2-power 
polynomial model 
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Figure A3.2 continued 
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Figure A3.2 continued 
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Figure A3.3: Loglo efu/ml vs airway inflammation score for the 5 most prevalent S. 
zooepidemicus types including plotted regression line from the best-ritting, 2- 
power polynomial model 
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Figure A3.3 continued 
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Figure A3.2 continued 
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Table A3.2: Summary of multilevel linear regression modelling of clinical and CDNS 
scores, including individual terms for S. zooepitlemicus types 
Outcome variable / Effect Estimate Estimate Estimate Estimate Estimate Estimate 
Explanatory variable in model (S. E. ) (S. E. ) (S. E. ) (S. E. ) (S. E. ) (&E. ) 
Clinical score Model 1 Model 2 Model 3 Model 4 Model Sa Model 5b 
n--218 n--218 n=21 8 n=218 n--219 n--218 
Fixed effec 
Intercept 2.26(0.34) 2.07(0.36) 1.76(0.35) 6.73(l. 73) 7.29(l. 73) 6.26 (1.71) 
Clinical score I week previously 0.42(0.07) 0.41(0.07) 0.44(0.06) 0.40(0.06) 0.39(0.06) 0.38(0.06) 
Clinical score 2 weeks previously 0.12(0.06) 0.12(0.06) 0.14(0.06) 0.14(0.06) 0.13(0.06) 0.12(0.06) 
Logio cfu/ml non-haem. Strep. -0.68 (0.17) -0.55 (0.18) -0.49 (0.17) -0.47 (0.17) -0.48 (0.17) -0.46 (0.17) 
[Logio cfuhnl non-haem. Strep. ]2 0.10(0.03) 0.08(0.03) 0.08(0.03) 0.07(0.03) 0.07(0.03) 0.08(0.03) 
Logio cfuhnl Pasteurella spp. -0.47 (0.15) -0.48 (0.14) -0.46 (0.14) -0.40 (0.14) -0.39 90.14) -0.39 (0.14) 
[Loglo cfu/mI Pasteurella SPP]2 0.08(0.03) 0.08(0.03) 0.08(0.02) 0.07(0.02) 0.06(0.02) 0.07(0.02) 
Logio cfu/ml Al HVu -1.10 (0.55) -1.02 (0.54) -1.04 (0.53) -0.97 (0.52) -0.93 (0.52) -0.90 (0.52) 
]2 [Logio cfu/ml Al HVu 0.57(0.23) 0.53(0.23) 0.55(0.23) 0.53(0.22) 0.52(0.22) 0.50(0.22) 
]3 [Logio cfu/ml Al HVu -0.06 (0.02) -0.06 (0.02) -0.06 (0.02) -0.06 (0.02) -0.06 (0.02) -0.05 (0.02) 
Loglo cfU/ml Al HV3 -0.37 (0.26) -0.39 (0.25) -0.37 (0.25) -0.35 (0.25) -0.36 (0.24) 
]2 [Logio cfu/mI Al HV3 0.09(0.05) 0.09(0.05) 0.09(0.04) 0.09(0.04) 0.09(0.04) 
Logio cfu/n-d CI HV3 0.22(0.07) 0.22(0.07) 0.22(0.07) 0.21(0.07) 
[Logio cfu/n-d Al HV4]-' 0.96(0.33) 0.98(0.33) 0.90(0.33) 
[Logio cfu/ml Al HV4]'0-5 -10.1 (3.47) -10.3 (3.45) -9.48 (3.41) 
Transferrin D phenotype -0.53 (0.23) 
Transferrin F2 phenotype 0.52(0.25) 
Random effect 
Level 2 variance: Pony 0.12(0.09) 0.17(0.11) 0.07(0.08) 0.14(0.09) 0.09(0.08) 0.14(0.09) 
Level I variance: Observation 1.75(0.18) 1.66(0.17) 1.65(0.17) 1.55(0.16) 1.54(0.16) 1.52(0.16) 
-2*loglikelihood 751.84 745.74 736.56 728.52 723.16 724.28 
LRS. e (d. f) 6.10(2) 9.18(l) 8.04(2) 5.36(l) 4.24(l) 
P-value 0.048 0.002 0.018 0.021 0.040 
Intra-pony correlation ('1q) 6.3 9.4 4.2 8.2 5.8 8.2 
CDNS score Model I Model 2 Model 3 Model 4 Model Sa Model 5b 
n=244 n--244 n=244 n=244 n=244 n--244 
Fixed effec 
Intercept 1.80(0.25) 1.67(0.26) 1.54(0.26) 4.84(l. 34) 5.13(1.33) 4.42(l. 34) 
CDNS score I week previously 0.45(0.05) 0.45(0.05) 0.45(0.05) 0.43(0.05) 0.42(0.05) 0.42(0.05) 
Logio cfuhnl non-haem. Strep. -0.51 (0.13) -0.42 (0.14) -0.38 (0.14) -0.40 (0.14) -0.40 (0.14) -0.39 (0.14) ]2 [Loglo cfu/ml non-haern. Strep. 0.07(0.02) 0.05(0.02) 0.05(0.02) 0.05(0.02) 0.05(0.02) 0.05(0.02) 
Log Io cfu/n-d Pasteurella spp. -0.39 (0.11) -0.39 (0.11) -0.38 (0.11) -0.34 (0.11) -0.33 (0.11) -0.34 (0.11) 
[Loglo cfu/nil Pasteurella Spp]2 0.07(0.02) 0.07(0.02) 0.06(0.02) 0.06(0.02) 0.06(0.02) 0.06(0.02) 
Loglo cfu/ml Al Hvu -0.64 (0.44) -0.61 (0.44) -0.57 (0.43) -0.60 (0.43) -0.59 (0.43) -0.58 (0.42) 12 [Logio cfu/ml Al HVu 0.36(0.19) 0.35(0.19) 0.34(0.19) 0.34(0.18) 0.34(0.18) 0.34(0.18) 
[Loglo cfu/n-d Al HVu]' -0.04 (0.02) -0.04 (0.02) 0.04(0.02) -0.04 (0.02) -0.04 (0.02) -0.04 (0.02) 
Loglo cfu/rnl Al HV3 -0.30 (0.20) -0.30 (0.20) -0.30 (0.20) -0.30 (0.19) -0.31 (0.19) j2 [Logio cfu/n-d Al HV3 0.07(0.04) 0.07(0.04) 0.07(0.04) 0.07(0.04) 0,07(0.04) 
Loglo cfu/ml CI HV3 0.12(0.06) 0.12(0.06) 0.12(0.06) 0.11(0.06) 
1-2 [Loglo cfu/ml Al HV4 0.01 (0.002) 0.01 (0.002) 0.01 (0.002) 5 [Log, () cfu/ml Al HV4 -6.90 (2.54) -6.86 (2.51) -6.56 (2.52) 
Transferrin D phenotype -0.45 (0.21) 
Transferrin F2 phenotype 0.48(0.21) 
Random effect 
Level 2 variance: Pony 0.16(0.08) 0.19(0.08) 0.17(0.08) 0.20(0.09) 0.15(0.07) 0.15(0.07) 
Level I variance: Observation 1.14(0.11) 1.10(0.11) 1.08(0.10) 1.04(0.10) 1.04(0.10) 1.03(0.10) 
-2*loglikelihood 746.33 740.85 736.31 728.52 723.96 723.47 
LRS X2 (d. f) 5.48(2) 4.54(l) 7.79(2) 4.36(1) . 5.05(l) P-value 0.065 0.033 0.020 0.033 0.025 
Intra-pony correlation (116) 12.3 14.4 13.9 16.0 12.4 12.8 
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Table A3.3: Summary of multilevel linear regression modelling of airway inflammation (AI) 
score, including individual terms for S. zooepidemicus types 
Outcome variable / Effect I Estimate Estimate Estimate Estimate Estimate 
Explanatory variable in model (S. E. ) (S. E. ) (S. E. ) (S. E. ) (S. E. ) 
Airwav inflammation score Model 1 Model 2 Model 3 Model 4 Model 5 
n--225 n--225 n--214 n=214 n--214 
Fixed cffec 
Intercept 2.81(0.42) 3.78(0.51) 6.36(l. 03) 3.65(l. 93) 3.63(l. 91) 
AI I week previously 0.34(0.06) 0.32(0.06) 0.30(0.06) 0.31(0.06) 0.30(0.06) 
Al 2 weeks previously 0.25(0.06) 0.22(0.05) 0.20(0.05) 0.20(0.05) 0.21(0.05) 
Loglo cfu/ml non-haern. Strep. -0.74 (0.16) -0.73 (0.16) -0.67 (0.17) -0.59 (0.17) 
[Loglo cfu/mI non-haem. Strep. 12 0.12(0.03) 0.11(0.03) 0.10(0.03) 0.09(0.03) 
[Logio cfU/n-d Al HVuj-' 0.39(0.15) 0.39(0.14) 0.40(0.14) 
[Logio cfu/ml Al HVU]-0.5 4.09(l. 54) 4.17(l. 52) 4.26(1.51) 
[Logio cfu/mI C1 HV3]-0-5 1.08(0.59) 1.11(0.59) 
Logn [Logio cfu/ml CI HV3] 1.77(0.93) 1.83(0.92) 
Loglo cfuhnl Al IIV4 0.16(0.08) 
Random effect 
Level 2 variance: Pony 0.03 (0.09) 0.004 (0.08) 0.00(0.00) 0.00(0.00) 0.00(0.00) 
Level I variance: Observation 2.36(0.24) 2.19(0.22) 2.00(0.19) 1.96(0.19) 1.92(0.19) 
-2*loglikelihood 834.63 815.22 756.05 751.08 747.14 
LRS ," (d. f) 19.4](2) 4.97(2) 3.94(l) 
P-value <0.0001 0.083 0.047 
Intra-pony correlation (016) 1.3 0.2 0.0 0.0 0.0 
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Figure A3.4: Caterpillar plot of ranked pony level residuals (± 95% Cl) for final 
multilevel linear regression model for clinical score, including 
transferrin D haplotype (Model 5a) 
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Figure A3.5: Caterpillar plot of ranked pony level residuals (± 951% CI) for final 
multilevel linear regression model for clinical score, including 
transferrin F2 haplotype (Model 5b) 
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Figure A3.6: Caterpillar plot of ranked pony level residuals (± 95% Cl) for final multilevel 
linear regression model for CDNS score, including transferrin D haplotype 
(Model 5a) 
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Figure A3.7: Caterpillar plot of ranked pony level residuals (± 95% CI) for final multilevel 
linear regression model for CDNS score, including transferrin F2 haplotype 
(Model 5b) 
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Table A3.4: Summary of multilevel linear regression modelling of CDNS scores, 
including individual terms for S. zooepitlemicus types and with 
sequential exclusion from random effects components of ponies with 
largest value residuals 
Outcome variable / Effect Estimate Estimate Estimate Estimate Estimate Estimate 
Exvlanatorv variable in model (S. E. ) (S. E. ) (S. E. ) (S. E. ) (S. E. ) (S. E. ) 
CDNS score Model 5a Model 6a Model 5b Model 6b Model 7b Model 8b 
n--244 n=244 n--244 n--244 n=244 n--244 
Fixed effec 
Intercept 5.13(l. 33) 5.40(l. 35) 4.42(l. 34) 4.40(l. 33) 4.22(l. 32) 3.95(l. 30) 
CDNS score I week previousIy 0.42(0.05) 0.43(0.05) 0.42(0.05) 0.42(0.05) 0.41(0.05) 0.42(0.05) 
Logio cfuhnl non-haem. Strep. -0.40 (0.14) -0.41 (0.13) -0.39 (0.14) -0.39 (0.13) -0.35 (0.13) -0.32 (0.13) 
[Logio cfuhnl non-haern. Strep. ]2 0.05(0.02) 0.05(0.02) 0.05(0.02) 0.05(0.02) 0.04(0.02) 0.04(0.02) 
Logio cfu/ml Pasteurella spp. -0.33 (0.11) -0.35 (0.11) -0.34 (0.11) -0.36 (0.11) -0.35 (0.11) -0.36 (0.10) 
[Loglo cfuhnl Pasteurella Spp] 2 0.06(0.02) 0.06(0.02) 0.06(0.02) 0.06(0.02) 0.06(0.02) 0.06(0.02) 
Logio cfu/ml Al HVU -0.59 (0.43) -0.53 (0.42) -0.58 (0.42) -0.53 (0.42) -0.49 (0.42) -0.47 (0.42) 
[Logio cfu/nil Al HVU]2 0.34(0.18) 0.31(0.18) 0.34(0.18) 0.30(0.18) 0.28(0.18) 0.28(0.18) 
[Logio cfu/ml Al HVu]3 -0.04 (0.02) -0.03 (0.02) -0.04 (0.02) -0.03 (0.02) -0.03 (0.02) -0.03 (0.02) 
Logio cfu/nd Al HV3 -0.30 (0.19) -0.23 (0.20) -0.31 (0.19) -0.26 (0.19) -0.27 (0.19) -0.28 (0.19) 
[Loglo cfu/nd Al HV3]2 0.07(0.04) 0.06(0.04) 0.07(0.04) 0.07(0.04) 0.07(0.04) 0.07(0.04) 
Loglo cfu/ml Cl HV3 0.12(0.06) 0.13(0.06) 0.11(0.06) 0.12(0.06) 0.13(0.05) 0.13(0.05) 
[Logio cfu/ml Al HV4 0.01 (0.002) 0.01 (0.002) 0.01 (0.002) 0.01 (0.002) 0.01 (0.002) 0.01 (0.002) 
[LogID cfu/ml Al HV4]-0'5 -6.86 (2.51) -7.10 (2.55) -6.56 (2.52) -6.50 (2.53) -6.21 (2.50) -5.82 (2.47) 
Transferrin D phenotype -0.45 (0.21) -0.56 (0.19) 
Transferrin F2 phenotype 0.48(0.21) 0.56(0.20) 0.63(0.19) 0.56(0.17) 
Pony 28 intercept -1.42 (0.54) -1.34 (0.55) -1.34 (0.51) -1.28 (0.48) 
Pony 23 intercept 1.19(0.49) 1.18(0.45) 
Pony 26 intercept 0.97(0.41) 
Random effec 
Level 2 variance: Pony 0.15(0.07) 0.09(0.06) 0.15(0.07) 0.11(0.06) 0.07(0.05) 0.04(0.04) 
Level I variance: Observation 1.04(0.10) 1.04(0.10) 1.03(0.10) 1.03(0.10) 1.03(0.10) 1.03(0.10) 
-2*loglikelihood 723.96 717.66 723.47 717.87 712.24 707.18 
LRS x2 (d. f. ) 6.30(l) 5.60(l) 5.63(1) 5.06(l) 
P-value 0.012 0.018 0.018 0.024 
Intra-pony correlation (/o) 12.4 8.1 12.8 9.2 6.3 3.3 
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Figure A3.8: Caterpillar plot of ranked pony level residuals (± 95% CI) for multilevel linear 
regression model for airway inflammation score including 2 autoregressive 
variables and a quadratic term for non-haemolytic Streptococcus spp. (Model 2) 
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Table A3.5: Results of univariable ordinary logistic regression (OLR) analyses of the 
risk of nasal discharge with the 5 most prevalent S. zooepitlemicus types 
Explanatory variable type S. E. P OR 95% CI P-value 
Tracheal wash Al HVI S. zooepidemicus 
Binary Intercept -0.07 0.13 
Not isolated referent 
Isolated -0.32 0.32 0.73 0.39-1.37 0.326 
Ordered categorical Intercept -0.06 0.13 
Not isolated referent 
<103CfU/Ml 
-1.11 0.59 0.33 0.10-1.03 0.057 
103 CfU/Ml 0.06 0.39 1.07 0.50-2.28 0.867 
Continuous linear Intercept -0.13 0.13 
Not isolated referent 
Log cfu/mrl 0.02 0.08 1.02 0.87-1.20 0.780 
Nasopharyngeal Al HVI S. zooepidemicus 
Binary Intercept -0.06 0.12 
Not isolated referent 
Isolated -0.24 0.32 0.79 0.42-1.48 0.456 
Tracheal wash Al HVu S. zooepidemicus 
Binary Intercept -0.14 0.12 
Not isolated referent 
Isolated 0.14 0.34 1.15 0.59-2.23 0.685 
Ordered categorical Intercept -0.13 0.13 
Not isolated referent 
< 101 cfU/mI -0.57 0.52 0.57 0.21-1.56 0.270 
Z. I 
. 
103 CfU/M 0.61 0.47 1.84 0.74-4.59 0.191 
Continuous linear Intercept -0.16 0.12 
Not isolated referent 
Log cfb/mI-1 0.10 0.09 1.11 0.94-1.31 0.229 
Nasopharyngeal Al HVu S. zooepidemicus 
Binary Intercept -0.11 0.12 
Not isolated referent 
Isolated 0.06 0.34 1.06 0.55-2.04 0.866 
Tracheal wash Al HV3 S. zooepidemicus 
Binary Intercept -0.12 0.12 
Not isolated referent 
Isolated -0.03 0.40 0.97 0.45-2.12 0.948 
Ordered categorical Intercept -0.11 0.12 
Not isolated referent 
.,: ý103CfU/Ml -1.14 0.81 0.32 0.07-1.57 0.160 
ý: 103 CfUhnl 0.43 0.48 1.54 0.60-3.95 0.370 
Continuous linear Intercept -0.14 0.12 
Not isolated referent 
Log cfu/ml-1 0.08 0.10 1.09 0.90-1.31 0.396 
Nasopharyngeal Al HV3 S. zooepidemicus 
Binary Intercept -0.10 0.12 
Not isolated referent 
Isolated 0.10 0.46 1.11 0.45-2.75 0.821 
Tracbeal wasb Cl HV3 S. zooepidemicus 
Binary Intercept -0.17 0.12 
Not isolated referent 
Isolated 0.64 0.42 1.90 0.83-4.35 0.126 
Ordered categorical Intercept -0.17 0.12 
Not isolated referent 
<101 cfu/ml -1.62 1.09 0.20 0.02-1.67 0.136 
2tio, cfu/ml 1.49 0.58 4.45 1.44-13.8 0.010 
Continuous linear Intercept -0.20 0.12 
Not isolated referent 
L, og cfu/mrl 0.26 0.11 1.30 1.05-1.60 0.015 
Nasopharyngeal CI HV3 S. zooepidemicus 
Binary Intercept -0.16 0.12 
Not isolated referent 
Isolated 0.62 0.39 1.86 0.87-3.97 0.110 
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Table A3.5 continued 
Explanatory variable type S. E. OR 95% CI P-value 
Tracheal wash Al HV4 S. zooepidemicus 
Binary Intercept -0.13 0.12 
Not isolated referent 
Isolated 0.13 0.49 1.14 0.44-2.94 0.794 
Ordered categorical Intercept -0.12 0.12 
Not isolated referent 
<101cfu/ml 0.12 1.01 1.13 0.16-8.14 0.903 
--101 cfulml 0.12 0.55 1.13 0.39-3.31 0.823 
Continuous linear Intercept -0.14 0.12 
Not isolated referent 
Log cfu/ml-1 0.10 0.11 1.10 0.89-1.36 0.357 
Nasopharyngeal. Al HV4 S. zooepidemicus 
Binary Intercept -0.13 0.12 
Not isolated referent 
Isolated 0.58 0.50 1.79 0.68-4.75 0.241 
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Table A3.6: Results of univariable ordinary logistic regression (OLR) analyses of the 
risk of ocular discharge with the 5 most prevalent S. zooepidemicus types 
Explanatory variable type S. E. OR 95% C1 P-value 
Tracheal wash Al HVI S. zooepidemicus 
Binary Intercept -1.29 0.15 
Not isolated referent 
Isolated 0.33 0.36 1.39 0.69-2.81 0.360 
Ordered categorical Intercept -1.32 0.16 
Not isolated referent 
<101cfu/ml 0.72 0.53 2.06 0.73-5.82 0.175 
Z-10' cfuhnl 0.14 0.46 1.15 0.47-2.82 0.765 
Continuous linear Intercept -1.28 0.15 
Not isolated referent 
Log cfu/ml-1 0.03 0.10 1.03 0.86-1.24 0.741 
Nasopharyngeal Al HVI S. zooepidemicus 
Binary Intercept -1.20 0.15 
Not isolated referent 
Isolated -0.24 0.40 0.79 0.36-1.73 0.553 
Tracheal wash Al HVu S. zooepidemicus 
Binary Intercept -1.26 0.15 
Not isolated referent 
Isolated 0.16 0.39 1.17 0.54-2.54 0.687 
Ordered categorical Intercept -1.30 0.15 
Not isolated referent 
<101cfu/ml 0.34 0.55 1.41 0.48-4.11 0.534 
ý:, 03 CfU/Ml 0.13 0.53 1.14 0.40-3.26 0.804 
Continuous linear Intercept -1.30 0.15 
Not isolated referent 
Log cfu/rnl-' 0.08 0.09 1.08 0.90-1.29 0.419 
Nasopharyngeal Al HVu S. zooepidemicus 
Binary Intercept -1.23 0.15 
Not isolated referent 
Isolated -0.03 0.40 0.97 0.44-2.13 0.931 
Tracheal wash Al HV3 S. zooepidemicus 
Binary Intercept -1.21 0.14 
Not isolated referent 
Isolated -0.32 0.51 0.73 0.27-1.99 0.537 
Ordered categorical Intercept -1.24 0.15 
Not isolated referent 
<103CfU/Ml* - - - 
2ý 103 CfU/Ml 0.21 0.54 1.23 0.43-3.56 0.700 
Continuous linear Intercept -1.25 0.15 
Not isolated referent 
Log cfu/ml-1 -0.03 0.12 0.97 0.76-1.23 0.786 
Nasopharyngeal Al HV3 S. zooepidemicus 
Binary Intercept -1.25 0.14 
Not isolated referent 
Isolated 0.15 0.54 1.16 0.41-3.32 0.780 
Tracheal wash CI HV3 S. zooepidemicus 
Binary Intercept -1.20 0.14 
Not isolated referent 
Isolated -0.51 0.56 0.60 0.20-1.81 0.367 
Ordered categorical Intercept -1.23 0.15 
Not isolated referent 
<103CfU/Ml* - - - 
ý: 10' cfuhnl -0.10 0.58 0.91 0.29-2.84 0.870 
Continuous linear Intercept -1.25 0.15 
Not isolated referent 
Log cfu/ml-1 -0.04 0.12 0.96 0.77-1.21 0.753 
Nasopharyngeal CI HV3 S. zooepidemicus 
Binary Intercept -1.22 0.14 
Not isolated referent 
Isolated -0.21 0.48 0.81 0.32-2.07 0.661 
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Table A3.6 continued - 
Explanatory variable type S. E. OR 95% C1 P-value 
Tracheal wash Al HV4 S. zooepidemicus 
Binary Intercept -1.23 0.14 
Not isolated referent 
Isolated -0.02 0.58 0.98 0.31-3.09 0.975 
Ordered categorical Intercept -1.26 0.14 
Not isolated referent 
<103CfUIMI* - - - 
ý! 101 cfu/ml 0.35 0.61 1.42 0.43-4.67 0.568 
Continuous linear Intercept -1.29 0.15 
Not isolated referent 
Log cfu/nA-1 0.10 0.11 1.10 0.88-1.37 0.389 
Nasopharyngeal Al HV4 S. zooepidemicus 
Binary Intercept -1.30 0.14 
Not isolated referent 
Isolated 0.85 0.50 2.33 0.87-6.26 0.093 
* No ponies with <103 loglo Cfl, /Ml Of this S. zooepidemicus type in tracheal washes had ocular discharge. 
Category dropped from the analysis to permit model convergence. 
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Table A3.7: Results of univariable ordinary logistic regression (OLR) analyses of the 
risk of coughing with the 5 most prevalent S. zooepitlemicus types 
Explanatory variable type S. E. P OR 95% CI P-value 
Tracheal wash Al HVI S. zooepidemicus 
Binary Intercept -1.62 0.17 
Not isolated referent 
Isolated -0.50 0.50 0.60 0.23-1.62 0.315 
Ordered categorical Intercept -1.59 0.17 
Not isolated referent 
<101cfu/ml -0.42 0.77 0.65 0.14-2.97 0.582 
ý10'. cfuhnl -0.61 0.63 0.54 0.16-1.88 0.337 
Continuous linear Intercept -1.62 0.17 
Not isolated referent 
Log cfu/ml-1 -0.10 0.13 0.91 0.71-1.17 0.451 
Nasopharyngeal Al HVI S. zooepidemicus 
Binary Intercept -1.83 0.18 
Not isolated referent 
Isolated 0.39 0.41 1.47 0.66-3.30 0.347 
Tracheal wash Al HVu S. zooepideinicus 
Binary Intercept -1.90 0.18 
Not isolated referent 
Isolated 1.17 0.38 3.23 1.52-6.86 0.002 
Ordered categorical Intercept -1.88 0.18 
Not isolated referent 
, 103Cfu/nll -0.20 0.77 0.82 0.18-3.71 0.793 
ýqO3 CfU/Ml 1.97 0.47 7.18 2.84-18.2 <0.001 
Continuous linear Intercept -1.93 0.18 
Not isolated referent 
Log cfu/ml-' 0.37 0.09 1.45 1.22-1.74 <0.001 
Nasopharyngeal Al HVu S. zooepidemicus 
Binary Intercept -1.76 0.17 
Not isolated referent 
Isolated -0.002 0.47 1.00 0.39-2.53 0.996 
Tracheal wash Al HV3 S. zooepidemicus 
Binary Intercept -1.74 0.17 
Not isolated referent 
Isolated 0.44 0.49 1.55 0.59-4.06 0.372 
Ordered categorical Intercept -1.71 0.17 
Not isolated referent 
<101cfu/ml -0.37 1.07 0.69 0.08-5.66 0.729 
ý! 101 cfu/ml 0.68 0.55 1.97 0.67-5.76 0.216 
Continuous linear Intercept -1.75 0.17 
Not isolated referent 
Log cfU/ml-, 0.19 0.11 1.21 0.98 -I A9 0.069 
Nasopharyngeal Al HV3 S. zooepidemicus 
Binary Intercept -1.74 0.17 
Not isolated referent 
Isolated -0.46 0.76 0.63 0.14-2.82 0.546 
Tracheal wash CI HV3 S. zooepidemicus 
Binary Intercept -1.69 0.17 
Not isolated referent 
Isolated -0.01 0.57 0.99 0.32-3.00 0.979 
Ordered categorical Intercept -1.66 0.17 
Not isolated referent 
<101cfulml -0.13 1.09 0.88 0.10-7.46 0.904 
ý: 10' cfuhnl -0.01 0.65 0.99 0.28-3.53 0.982 
Continuous linear Intercept -1.67 0.17 
Not isolated referent 
Log cfu/ml-1 0.03 0.12 1.03 0.81-1.31 0.809 
Nasopharyngeal. CI HV3 S. zooepidemicus 
Binary Intercept -1.75 0.17 
Not isolated referent 
Isolated -0.16 0.56 0.85 0.28-2.55 0.771 
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Table A3.7 continued 
Explanatory variable type S. E. OR 95% CI P-value 
Tracheal wash Al HV4 S. zzooepidemicus 
Binary Intercept -1.72 0.17 
Not isolated referent 
Isolated 0.47 0.59 1.60 0.50-5.10 0.425 
Ordered categorical Intercept -1.69 0.17 
Not isolated referent 
<103CfU/Ml 0.60 1.17 1.81 0.18-17.8 0.610 
ýt 103 CfU/Ml 0.39 0.67 1.48 -5.54 0.40 0.557 
Continuous linear Intercept -1.71 0.17 
Not isolated referent 
Log cfu/n-d-1 0.14 0.12 1.15 0.91-1.44 0.250 
Nasopharyngeal Al RV4 S. zooepidemicus 
Binary Intercept -1.89 0.17 
Not Isolated referent 
Isolated 1.44 0.51 4.20 1.54-11.5 0.005 
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Table A3.8: Results of univariable ordinary logistic regression (OLR) analyses of the 
risk of abnormal breathing/dyspnoea with the 5 most prevalent S. 
zooepitlemicus types 
Explanatory variable type S. E. OR 95% CI P-value 
Tracheal wash Al HVI S. zooepidemicus 
Binary Intercept -0.84 0.14 
Not isolated referent 
Isolated -0.47 0.38 0.62 0.30-1.32 0.218 
Ordered categorical Intercept -0.80 0.14 
Not isolated referent 
<l03Cf11/n1l -1.22 0.77 0.30 0.07-1.33 0.112 
; >103 -d _ cfu/n -0.21 
0.44 0.81 0.34-1.89 0.623 
Continuous linear Intercept -0.85 0.14 
Not isolated referent 
Log cfti/ml-1 -0.03 0.09 0.97 0.81-1.16 0.726 
Nasopharyngeal Al HVI S. zooepidemicus 
Binary Intercept -0.98 0.14 
Not isolated referent 
Isolated 0.02 0.35 1.02 0.51-2.04 0.960 
Tracheal wash Al HVu S. zooepidemicus 
Binary Intercept -1.01 0.14 
Not isolated referent 
Isolated 0.71 0.35 2.03 1.02-4.02 0.043 
Ordered categorical Intercept -0.98 0.14 
Not isolated referent 
<103Cfu/ml 0.53 0.50 1.69 0.63-4.54 0.297 
ý403 cfU/mI 0.88 0.46 2.42 0.98-5.94 0.055 
Continuous linear Intercept -0.97 0.14 
Not isolated referent 
Log cfu/mrl 0.18 0.09 1.20 1.02-1.42 0.031 
Nasopharyngeal Al HVu S. zooepidemicus 
Binary Intercept -0.99 0.14 
Not isolated referent 
Isolated 0.11 0.37 1.11 0.54-2.30 0.769 
Tracheal wash Al HV3 S. zooepidemicus 
Binary Intercept -0.90 0.13 
Not isolated referent 
Isolated -0.01 0.44 0.99 0.42-2.33 0.977 
Ordered categorical Intercept -0.87 0.13 
Not isolated referent 
<101cfu/ml -0.39 0.81 0.68 0.14-3.35 0.635 
; >103 Cf U/Ml 0.09 0.51 1.10 0.40-2.99 0.854 
Continuous linear Intercept -0.90 0.13 
Not isolated referent 
Log cfU/ml-1 0.08 0.10 1.08 0.89-1.31 0.442 
Nasopharyngeal Al HV3 S. zooepidemicus 
Binary Intercept -0.95 0.13 
Not isolated referent 
Isolated -0.44 0.57 0.65 0.21-1.99 0.448 
Tracheal wash CI HV3 S. zooepidemicus 
Binary Intercept -0.95 0.13 
Not isolated referent 
Isolated 0.48 0.42 1.62 0.70-3.71 0.259 
Ordered categorical Intercept -0.91 0.13 
Not isolated referent 
<101cfulml -0.002 0.85 
ý: 103 CfU/Ml 0.60 0.48 1.00 0.19-5.25 0.998 
Continuous linear Intercept -0.91 0.13 1.81 0.70-4.69 0.219 
Not isolated referent 
Log cfu/ml-1 0.11 0.09 1.11 0.92-1.34 0.269 
Nasopharyngeal CI HV3 S. zooepidemicus 
Binary Intercept -1.00 0.14 
Not isolated referent 
Isolated 0.26 0.41 1.30 0.59-2.89 0.520 
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Table A3.8 continued 
Explanatory variable type S. E. OR 95% CI P-value 
Tracheal wash Al. HV4 S. zooepidemicus 
Binary hitercept -0.95 0.13 
Not isolated referent 
Isolated 0.73 0.49 2.08 0.79-5.45 0.138 
Ordered categorical Intercept -0.92 0.13 
Not isolated referent 
<103 CfU/Ml -0.18 1.16 0.84 0.09-8.15 0.877 
ýq03 CfU/Ml 0.92 0.55 2.51 -7.38 0.85 0.095 
Continuous linear Intercept -0.94 0.13 
Not isolated referent 
Log cfu/mr, 0.23 0.11 1.26 1.02-1.56 0.034 
Nasopharyngeal Al HV4 S. zooepidensicus 
Binary Intercept -1.05 0.13 
Not isolated referent 
Isolated 1.05 0.49 2.85 1.09-7.46 0.032 
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